10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________ 

Commission File Number: 001-39154

SVB FINANCIAL GROUP

(Exact name of registrant as specified in its charter)

Delaware	91-1962278
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

3003 Tasman Drive, Santa Clara, California 95054-1191

(Address of principal executive offices) (Zip Code)

(408) 654-7400

(Registrant’s telephone number, including area code) 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company,” in Rule 12b-2 of the Exchange Act.

Large accelerated filer        ☒             Accelerated filer        ☐    

Non-accelerated filer        ☐                 Smaller reporting company     ☐        

Emerging growth company        ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐  No  ☒

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol	Name of Exchange on Which Registered
Common Stock, par value $0.001 per share	SIVB	The Nasdaq Stock Market LLC
Depositary shares, each representing a 1/40th ownership interest in a share of 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A	SIVBP	The Nasdaq Stock Market LLC

At October 31, 2022, 59,104,124 shares of the registrant’s common stock ($0.001 par value) were outstanding.

TABLE OF CONTENTS

 

		Page
PART I - FINANCIAL INFORMATION		4
Item 1.	Interim Consolidated Financial Statements	4
	Interim Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021 (Unaudited)	4
	Interim Consolidated Statements of Income for the three and nine months ended September 30, 2022 and 2021 (Unaudited)	5
	Interim Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2022 and 2021 (Unaudited)	6
	Interim Consolidated Statements of Stockholders' Equity for the nine months ended September 30, 2022 and 2021 (Unaudited)	7
	Interim Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 (Unaudited)	8
	Notes to Interim Consolidated Financial Statements (Unaudited)	9
	Note 1. Basis of Presentation	9
	Note 2. Stockholders' Equity and EPS	10
	Note 3. Variable Interest Entities	11
	Note 4. Cash and Cash Equivalents	13
	Note 5. Investment Securities	13
	Note 6. Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments	19
	Note 7. Goodwill and Other Intangible Assets	28
	Note 8. Derivative Financial Instruments	29
	Note 9. Noninterest Income	33
	Note 10. Segment Reporting	40
	Note 11. Off-Balance Sheet Arrangements, Guarantees and Other Commitments	43
	Note 12. Income Taxes	44
	Note 13. Fair Value of Financial Instruments	44
	Note 14. Legal Matters	51
	Note 15. Related Parties	52
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	53
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	93
Item 4.	Controls and Procedures	95
PART II - OTHER INFORMATION		97
Item 1.	Legal Proceedings	97
Item 1A.	Risk Factors	97
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	97
Item 3.	Defaults Upon Senior Securities	97
Item 4.	Mine Safety Disclosures	97
Item 5.	Other Information	97
Item 6.	Exhibits	97
SIGNATURES		98

2

Glossary of acronyms and abbreviations that may be used in this Report

ACL — Allowance for Credit Losses	HTM — Held-to-Maturity
AFS — Available-for-Sale	IASB — International Accounting Standards Board
AIR — Accrued Interest Receivable	IOSCO — International Organization of Securities Commissions
ALCO — Asset Liability Management Committee	IPO — Initial Public Offering
AOCI — Accumulated Other Comprehensive Income	IRS — Internal Revenue Service
ARRC — Alternative Reference Rates Committee	ISDA — International Swaps and Derivatives Association, Inc.
ASC — Accounting Standards Codification	IT — Information Technology
ASU — Accounting Standards Update	LCR — Liquidity Coverage Ratio
AUM — Private Bank Assets Under Management	LIBOR — London Interbank Offered Rate
Boston Private — Boston Private Financial Holdings, Inc.	M&A — Merger and Acquisition
BPS — Basis Points	MBS — Mortgage-Backed Securities
C&I — Commercial and Industrial	NFSR — Net Stable Funding Ratio
CECL — Current Expected Credit Losses	NII — Net Interest Income
CET1 — Common Equity Tier 1	NM — Not meaningful
CMBS — Commercial Mortgage-Backed Securities	OREO — Other Real Estate Owned
CMO — Collateralized Mortgage Obligations	PCD — Purchased Credit-Deteriorated
CRA — Community Reinvestment Act	PPP — Paycheck Protection Program
CRE — Commercial Real Estate	PPPLF — Paycheck Protection Program Lending Facility
EHOP — Employee Home Ownership Program of the Company	SBA — U.S. Small Business Association
EPS — Earnings Per Share	SEC — Securities and Exchange Commission
ERI — Energy and Resource Innovation	SLBO — Sponsor-Led Buy-Out
ESOP — Employee Stock Ownership Plan of the Company	SOFR — Secured Overnight Financing Rate
ESPP — 1999 Employee Stock Purchase Plan of the Company	SPAC — Special Purpose Acquisition Company
EVE — Economic Value of Equity	SPD-SVB — SPD Silicon Valley Bank Co., Ltd. (the Bank's joint venture
FASB — Financial Accounting Standards Board	bank in China)
FDIC — Federal Deposit Insurance Corporation	SVB Securities — SVB Securities Holdings LLC
FHLB — Federal Home Loan Bank	TDR — Troubled Debt Restructuring
FRB — Federal Reserve Bank	U.K. — United Kingdom
FTE — Full-Time Equivalent	VIE — Variable Interest Entity
FTP — Funds Transfer Pricing
GAAP — Accounting principles generally accepted in the United
States of America

3

PART I - FINANCIAL INFORMATION

ITEM 1. INTERIM CONSOLIDATED FINANCIAL STATEMENTS

SVB FINANCIAL GROUP AND SUBSIDIARIES

INTERIM CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Dollars in millions, except par value and share data)	September 30, 2022		December 31, 2021
Assets:
Cash and cash equivalents	$	13,968	$	14,586
Available-for-sale securities, at fair value (cost of $29,502 and $27,370, respectively)	26,711		27,221
Held-to-maturity securities, at amortized cost and net of allowance for credit losses of $6 and $7 (fair value of $77,370 and $97,227, respectively)	93,286		98,195
Non-marketable and other equity securities	2,595		2,543
Total investment securities	122,592		127,959
Loans, amortized cost	72,129		66,276
Allowance for credit losses: loans	(557)		(422)
Net loans	71,572		65,854
Premises and equipment, net of accumulated depreciation and amortization	346		270
Goodwill	375		375
Other intangible assets, net	142		160
Lease right-of-use assets	349		313
Accrued interest receivable and other assets	3,523		1,791
Total assets	$	212,867	$	211,308
Liabilities and total equity:
Liabilities:
Noninterest-bearing demand deposits	$	93,988	$	125,851
Interest-bearing deposits	82,831		63,352
Total deposits	176,819		189,203
Short-term borrowings	13,552		71
Lease liabilities	429		388
Other liabilities	2,889		2,467
Long-term debt	3,368		2,570
Total liabilities	197,057		194,699
Commitments and contingencies (Note 11 and Note 14)
SVBFG stockholders’ equity:
Preferred stock, $0.001 par value, 20,000,000 shares authorized; 383,500 and 383,500 shares issued and outstanding, respectively	3,646		3,646
Common stock, $0.001 par value, 150,000,000 shares authorized; 59,104,124 and 58,748,469 shares issued and outstanding, respectively	—		—
Additional paid-in capital	5,272		5,157
Retained earnings	8,676		7,442
Accumulated other comprehensive income (loss)	(2,085)		(9)
Total SVBFG stockholders’ equity	15,509		16,236
Noncontrolling interests	301		373
Total equity	15,810		16,609
Total liabilities and total equity	$	212,867	$	211,308

See accompanying notes to interim consolidated financial statements (unaudited).

4

SVB FINANCIAL GROUP AND SUBSIDIARIES

INTERIM CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions, except per share amounts)	2022		2021		2022		2021
Interest income:
Loans	$	865	$	519	$	2,089	$	1,422
Investment securities:
Taxable	545		332		1,618		807
Non-taxable	35		28		105		73
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities	76		5		105		12
Total interest income	1,521		884		3,917		2,314
Interest expense:
Deposits	249		19		348		41
Borrowings	74		13		122		33
Total interest expense	323		32		470		74
Net interest income	1,198		852		3,447		2,240
Provision for credit losses	72		21		279		75
Net interest income after provision for credit losses	1,126		831		3,168		2,165
Noninterest income:
Gains (losses) on investment securities, net	(127)		189		(199)		661
Gains on equity warrant assets, net	40		147		120		491
Client investment fees	119		20		237		55
Wealth management and trust fees	19		22		63		22
Foreign exchange fees	74		65		216		189
Credit card fees	37		34		114		93
Deposit service charges	32		29		94		82
Lending related fees	20		21		65		55
Letters of credit and standby letters of credit fees	15		13		43		39
Investment banking revenue	75		90		293		335
Commissions	24		17		73		58
Other	31		25		119		97
Total noninterest income	359		672		1,238		2,177
Noninterest expense:
Compensation and benefits	563		548		1,649		1,418
Professional services	117		104		355		282
Premises and equipment	71		54		189		124
Net occupancy	25		25		74		60
Business development and travel	21		6		62		13
FDIC and state assessments	25		13		57		33
Merger-related charges	7		83		39		102
Other	63		46		188		136
Total noninterest expense	892		879		2,613		2,168
Income before income tax expense	593		624		1,793		2,174
Income tax expense	175		149		489		509
Net income before noncontrolling interests and dividends	418		475		1,304		1,665
Net (income) loss attributable to noncontrolling interests	51		(88)		53		(226)
Preferred stock dividends	(40)		(22)		(123)		(40)
Net income available to common stockholders	$	429	$	365	$	1,234	$	1,399
Earnings per common share—basic	$	7.26	$	6.33	$	20.94	$	25.54
Earnings per common share—diluted	7.21		6.24		20.73		25.16

                 

See accompanying notes to interim consolidated financial statements (unaudited).

5

SVB FINANCIAL GROUP AND SUBSIDIARIES

INTERIM CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Net income before noncontrolling interests	$	418	$	475	$	1,304	$	1,665
Other comprehensive income (loss), net of tax:
Change in foreign currency cumulative translation gains and losses:
Foreign currency translation gains (losses), net of hedges	(39)		(6)		(81)		(4)
Related tax benefit (expense)	11		2		23		1
Change in unrealized gains and losses on AFS securities:
Unrealized holding gains (losses)	(1,187)		(30)		(2,734)		(584)
Related tax benefit (expense)	336		8		774		163
Reclassification adjustment for (gains) losses included in net income	—		—		(48)		—
Related tax benefit (expense)	—		—		14		—
Cumulative-effect adjustment for unrealized losses on securities transferred from AFS to HTM	—		(54)		—		(132)
Related tax benefit (expense)	—		15		—		36
Amortization of unrealized holding net gains (losses) on securities transferred from AFS to HTM	3		—		10		(5)
Related tax benefit (expense)	(1)		—		(3)		1
Change in unrealized gains and losses on cash flow hedges:
Reclassification adjustment for gains included in net income	(14)		(16)		(43)		(47)
Related tax benefit (expense)	4		4		12		13
Other comprehensive income (loss), net of tax	(887)		(77)		(2,076)		(558)
Comprehensive income (loss)	(469)		398		(772)		1,107
Comprehensive (income) loss attributable to noncontrolling interests	51		(88)		53		(226)
Comprehensive income (loss) attributable to SVBFG	$	(418)	$	310	$	(719)	$	881

See accompanying notes to interim consolidated financial statements (unaudited).

6

SVB FINANCIAL GROUP AND SUBSIDIARIES

INTERIM CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

	Preferred Stock		Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total SVBFG Stockholders’ Equity		Noncontrolling Interests		Total  Equity
(Dollars in millions, except share data)			Shares	Amount
Balance at December 31, 2020	$	340	51,888,463	$	—	$	1,585	$	5,672	$	623	$	8,220	$	213	$	8,433
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		374,039	—		(1)		—		—		(1)		—		(1)
Issuance of Common Stock	—		4,527,000	—		2,363		—		—		2,363		—		2,363
Issuance of common stock for the acquisition of Boston Private			1,887,981			1,060						1,060				1,060
Issuance of Preferred Stock	1,724		—	—		—		—		—		1,724		—		1,724
Net Income	—		—	—		—		1,439		—		1,439		226		1,665
Capital calls and distributions, net	—		—	—		—		—		—		—		(70)		(70)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(558)		(558)		—		(558)
Share-based compensation, net	—		—	—		93		—		—		93		—		93
Dividends on preferred stock	—		—	—		—		(40)		—		(40)		—		(40)
Balance at September 30, 2021	$	2,064	58,677,483	$	—	$	5,100	$	7,071	$	65	$	14,300	$	369	$	14,669
Balance at December 31, 2021	$	3,646	58,748,469	$	—	$	5,157	$	7,442	$	(9)	$	16,236	$	373	$	16,609
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		355,655	—		(31)		—		—		(31)		—		(31)
Net income	—		—	—		—		1,357		—		1,357		(53)		1,304
Capital calls and distributions, net	—		—	—		—		—		—		—		(19)		(19)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(2,076)		(2,076)		—		(2,076)
Share-based compensation, net	—		—	—		146		—		—		146		—		146
Dividends on preferred stock	—		—	—		—		(123)		—		(123)		—		(123)
Balance at September 30, 2022	$	3,646	59,104,124	$	—	$	5,272	$	8,676	$	(2,085)	$	15,509	$	301	$	15,810

See accompanying notes to interim consolidated financial statements (unaudited).

7

SVB FINANCIAL GROUP AND SUBSIDIARIES

INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

	Nine months ended September 30,
(Dollars in millions)	2022		2021
Cash flows from operating activities:
Net income before noncontrolling interests	$	1,304	$	1,665
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	279		75
Changes in fair values of equity warrant assets, net of proceeds from exercises	(38)		(36)
Changes in fair values of derivatives, net	345		18
Losses (Gains) on investment securities, net	199		(661)
Distributions of earnings from non-marketable and other equity securities	52		166
Depreciation and amortization	155		106
Amortization of premiums and discounts on investment securities, net	271		294
Amortization of share-based compensation	146		93
Amortization of deferred loan fees	(192)		(193)
Deferred income tax (benefit) expense	(173)		73
Excess tax benefit from exercise of stock options and vesting of restricted shares	(20)		(34)
Losses from the write-off of premises and equipment and right-of-use assets	—		38
Changes in other assets and liabilities:
Accrued interest receivable and payable, net	(72)		(117)
Accounts receivable and payable, net	(6)		5
Income tax receivable and payable, net	377		(141)
Accrued compensation	(296)		89
Other, net	(487)		(298)
Net cash provided by operating activities	1,844		1,142
Cash flows from investing activities:
Purchases of AFS securities	(12,407)		(5,395)
Proceeds from sales of AFS securities	8,511		168
Proceeds from maturities and paydowns of AFS securities	1,174		3,892
Purchases of HTM securities	(4,961)		(65,048)
Proceeds from maturities and paydowns of HTM securities	9,605		8,993
Purchases of non-marketable and other equity securities	(292)		(310)
Proceeds from sales and distributions of capital of non-marketable and other equity securities	86		587
Net increase in loans	(5,759)		(9,006)
Purchases of premises and equipment	(141)		(77)
Business acquisitions	—		1,116
Net cash used for investing activities	(4,184)		(65,080)
Cash flows from financing activities:
Net (decrease) increase in deposits	(12,384)		60,216
Net increase in short-term borrowings	13,481		13
Proceeds from issuance of long-term debt	798		990
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests	(19)		(70)
Net proceeds from the issuance of preferred stock	—		1,724
Payment of preferred stock dividend	(123)		(40)
Proceeds from issuance of common stock, ESPP and ESOP, net of restricted stock awards	(31)		2,362
Net cash provided by financing activities	1,722		65,195
Net (decrease) increase in cash and cash equivalents	(618)		1,257
Cash and cash equivalents at beginning of period	14,586		17,622
Cash and cash equivalents at end of period	$	13,968	$	18,879
Supplemental disclosures:
Cash paid during the period for:
Interest	$	412	$	57
Income taxes, net of refunds	249		547
Noncash items during the period:
Changes in unrealized gains and losses on AFS securities, net of tax	$	(1,994)	$	(421)
Distributions of stock from investments	1		62
Transfers from AFS securities to HTM	—		8,953

See accompanying notes to interim consolidated financial statements (unaudited).

8

1.    Basis of Presentation

SVB Financial Group is a diversified financial services company, as well as a bank holding company and a financial holding company. SVB Financial was incorporated in the state of Delaware in March 1999. Through our various subsidiaries and divisions, we offer a diverse set of banking and financial products and services to support our clients of all sizes and stages throughout their life cycles. In these notes to our unaudited interim consolidated financial statements, when we refer to “SVB,” “SVB Financial Group,” “SVBFG," the “Company,” “we,” “our,” “us” or use similar words, we mean SVB Financial Group and all of its subsidiaries collectively, including Silicon Valley Bank (the “Bank”), unless the context requires otherwise. When we refer to “SVB Financial” or the “Parent” we are referring only to the parent company, SVB Financial Group (not including subsidiaries).

The accompanying unaudited interim consolidated financial statements reflect all adjustments of a normal and recurring nature that are, in the opinion of management, necessary to fairly present our financial position, results of operations and cash flows in accordance with GAAP. Such unaudited interim consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results to be expected for any future periods. These unaudited interim consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”).

Use of Estimates and Assumptions

The preparation of unaudited interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Among the more significant estimates are those that relate to: 1) ACL for loans and for unfunded credit commitments, 2) valuation of non-marketable and other equity securities, 3) valuation of equity warrant assets, 4) goodwill, intangible assets and other purchase accounting related adjustments, and 5) income taxes.

Principles of Consolidation and Presentation

Our unaudited interim consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. All significant intercompany accounts and transactions with consolidated entities have been eliminated. For a further description of our accounting policies regarding consolidation refer to Consolidated Financial Statements and Supplementary Data — Note 2 — “Summary of Significant Accounting Policies” under Part II, Item 8 of our 2021 Form 10-K.

Reclassifications

Certain prior period amounts have been reclassified to conform to current period presentation to account for the change in presentation of derivative asset and liability positions and the related cash collateral disclosed in the Summary of Significant Accounting Polices in Part 1, Item 1 of this report. These changes are included in our Consolidated Balance Sheets (unaudited) and Consolidated Statements of Cash Flows (unaudited) as well as the Cash and Cash Equivalents, Derivative Financial Instruments and Fair Value of Financial Instruments footnotes.

Summary of Significant Accounting Policies

During the third quarter of 2022, we changed our presentation of derivative asset and liability positions and the related cash collateral in the unaudited interim consolidated balance sheets. The balances are presented net by counterparty when a legally enforceable right of setoff exists under a master netting arrangement in accordance with ASC 815, Derivatives and Hedging. Previously, fair values of derivative positions were reported in the line items “Accrued interest receivable and other assets” and “Other liabilities” gross. The related cash collateral was reported in the line items "Cash and cash equivalents" and "Short-term borrowings". For impact on presentation, please refer to the balance sheet offsetting section of Note 8 – “Derivative Financial Instruments”. This change had no impact on our net income. We concluded that this presentation was preferable as it better reflects the credit risk of derivatives traded under master netting arrangements. This change represents a change in accounting principle under ASC 250, Accounting Changes and Error Corrections, with retrospective application to the earliest period presented.

In the third quarter of 2022, we also adjusted the allowance models for the CRE and Other C&I loan portfolios to more precisely forecast lifetime loan losses for those portfolios. As a result, the allowance model for the CRE loan portfolio uses a reasonable and supportable forecast period that is less than, but approximately, three years; the Company continues to use a three-year reasonable and supportable forecast period for all other loan loss models. Subsequent to the forecast period

9

period, the CRE and Other C&I models' reversion to average historical losses uses an approach that gradually trends towards the mean historical loss over the remaining contractual lives of loans, whereas all other loan models continue to use an autoregressive approach. The impact on overall reserves as a result of these changes was not material. This change represents a change in accounting estimate under ASC 250, Accounting Changes and Error Corrections, with prospective application.

Other than the above, the accompanying unaudited interim consolidated financial statements have been prepared on a consistent basis with the accounting policies described in Consolidated Financial Statements and Supplementary Data — Note 2 — “Summary of Significant Accounting Policies” under Part II, Item 8 of our 2021 Form 10-K.

2.    Stockholders' Equity and EPS

AOCI

The following table summarizes the items reclassified out of AOCI into the Consolidated Statements of Income (unaudited) for the three and nine months ended September 30, 2022 and 2021:

		Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	Income Statement Location	2022		2021		2022		2021
Reclassification adjustment for losses (gains) included in net income	Gains (losses) on investment securities, net	$	—	$	—	$	(48)	$	—
Related tax expense	Income tax expense	—		—		14		—
Reclassification adjustment for gains on cash flow hedges included in net income	Net interest income	(14)		(16)		(43)		(47)
Related tax expense	Income tax expense	4		4		12		13
Total reclassification adjustment for gains included in net income, net of tax		$	(10)	$	(12)	$	(65)	$	(34)

The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in AOCI for the three and nine months ended September 30, 2022 and 2021. Over the next 12 months, we expect that approximately $46 million in AOCI at September 30, 2022, related to unrealized gains will be reclassified out of AOCI and recognized in net income.

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Balance, beginning of period, net of tax	$	62	$	107	$	83	$	129
Net realized (gain) loss reclassified to net income, net of tax	(10)		(12)		(31)		(34)
Balance, end of period, net of tax	$	52	$	95	$	52	$	95

EPS

Basic EPS is the amount of earnings available to each share of common stock outstanding during the reporting period. Diluted EPS is the amount of earnings available to each share of common stock outstanding during the reporting period adjusted to include the effect of potentially dilutive common shares. Potentially dilutive common shares include incremental shares issuable for stock options and restricted stock unit awards outstanding under our 2006 Equity Incentive Plan and our ESPP. Potentially dilutive common shares are excluded from the computation of dilutive EPS in periods in which the effect would be antidilutive. The following is a reconciliation of basic EPS to diluted EPS for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions except per share amounts, shares in thousands)	2022		2021		2022		2021
Numerator:
Net income available to common stockholders	$	429	$	365	$	1,234	$	1,399
Denominator:
Weighted average common shares outstanding—basic	59,096		57,723		58,945		54,772
Weighted average effect of dilutive securities:
Stock options and ESPP	165		268		206		278
Restricted stock units and awards	288		530		384		567
Weighted average common shares outstanding—diluted	59,549		58,521		59,535		55,617
Earnings per common share:
Basic	$	7.26	$	6.33	$	20.94	$	25.54
Diluted	7.21		6.24		20.73		25.16

10

The following table summarizes the weighted-average common shares excluded from the diluted EPS calculation due to the antidilutive effect for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,		Nine months ended September 30,
(Shares in thousands)	2022	2021	2022	2021
Stock options	142	56	105	31
Restricted stock units	477	—	99	—
Total	619	56	204	31

Preferred Stock

The following table summarizes our preferred stock at September 30, 2022:

Series	Description	Amount outstanding (in millions)		Carrying value (in millions)		Shares issued and outstanding	Par Value		Ownership interest per depositary share	Liquidation preference per depositary share		2022 dividends paid per depositary share
Series A	5.25% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	$	350	$	340	350,000	$	0.001	1/40th	$	25	$	0.984375
Series B	4.100% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	750		739		7,500	0.001		1/100th	1,000		30.75
Series C	4.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	1,000		985		10,000	0.001		1/100th	1,000		30.00
Series D	4.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	1,000		989		10,000	0.001		1/100th	1,000		33.88
Series E	4.700% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	600		593		6,000	0.001		1/100th	1,000		37.47

Consolidated Statement of Changes in Equity

The following table summarizes the changes in our consolidated equity for the three months ended September 30, 2022 and 2021:

	Preferred Stock		Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total SVBFG Stockholders’ Equity		Noncontrolling Interests		Total  Equity
(Dollars in millions, except share data)			Shares	Amount
Balance at June 30, 2021	$	2,064	54,530,307	$	—	$	2,755	$	6,706	$	142	$	11,667	$	300	$	11,967
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		32,195	—		2		—		—		2		—		2
Issuance of Common Stock	—		2,227,000	—		1,245		—		—		1,245		—		1,245
Issuance of common stock for the acquisition of Boston Private	—		1,887,981	—		1,060						1,060				1,060
Net income	—		—	—		—		387		—		387		88		475
Capital calls and distributions, net	—		—	—		—		—		—		—		(19)		(19)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(77)		(77)		—		(77)
Share-based compensation, net	—		—	—		38		—		—		38		—		38
Dividends on preferred stock	—		—	—		—		(22)		—		(22)		—		(22)
Balance at September 30, 2021	$	2,064	58,677,483	$	—	$	5,100	$	7,071	$	65	$	14,300	$	369	$	14,669
Balance at June 30, 2022	$	3,646	59,081,326	$	—	$	5,223	$	8,247	$	(1,198)	$	15,918	$	358	$	16,276
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		22,798	—		(2)		—		—		(2)		—		(2)
Net income	—		—	—		—		469		—		469		(51)		418
Capital calls and distributions, net	—		—	—		—		—		—		—		(6)		(6)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(887)		(887)		—		(887)
Share-based compensation, net	—		—	—		51		—		—		51		—		51
Dividends on preferred stock	—		—	—		—		(40)		—		(40)		—		(40)
Balance at September 30, 2022	$	3,646	59,104,124	$	—	$	5,272	$	8,676	$	(2,085)	$	15,509	$	301	$	15,810

3.    Variable Interest Entities

Our involvement with VIEs includes our investments in venture capital and private equity funds, debt funds, private and public portfolio companies, qualified affordable housing projects, and subordinated debt instruments.

11

The following table presents the carrying amounts and classification of variable interests in consolidated and unconsolidated VIEs as of September 30, 2022 and December 31, 2021:

(Dollars in millions)	Consolidated VIEs		Unconsolidated VIEs		Maximum Exposure to Loss in Unconsolidated VIEs
September 30, 2022:
Assets:
Cash and cash equivalents	$	7	$	—	$	—
Non-marketable and other equity securities (1)	767		1,369		1,369
Accrued interest receivable and other assets (2)	35		6		—
Total assets	$	809	$	1,375	$	1,369
Liabilities:
Other liabilities (1)	$	23	$	672	$	—
Long term debt (2)	—		91		—
Total liabilities	$	23	$	763	$	—
December 31, 2021:
Assets:
Cash and cash equivalents	$	13	$	—	$	—
Non-marketable and other equity securities (1)	768		1,233		1,233
Accrued interest receivable and other assets (2)	31		6		—
Total assets	$	812	$	1,239	$	1,233
Liabilities:
Other liabilities (1)	$	18	$	482	$	—
Long term debt (2)	—		90		—
Total liabilities	$	18	$	572	$	—

(1)    Included in our unconsolidated non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are investments in qualified affordable housing projects of $1.2 billion and $954 million, respectively, and related other liabilities consisting of unfunded commitments of $672 million and $482 million, respectively.

(2)    Included in our unconsolidated accrued interest receivable and other assets are investments in statutory trusts for junior subordinated debt and included in long term debt previously issued by Boston Private and assumed in the acquisition of $6 million and $91 million at September 30, 2022 and $6 million and $90 million at December 31, 2021.

Non-marketable and other equity securities

Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies and qualified affordable housing projects. Many of these are investments held by SVB Financial in third-party funds in which we do not have controlling or significant variable interests. These investments represent our unconsolidated VIEs in the table above. Our non-marketable and other equity securities portfolio also includes investments from SVB Capital. SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. We have a controlling and significant variable interest in four of these SVB Capital funds and consolidate these funds for financial reporting purposes.

Most investments are generally nonredeemable, and distributions are expected to be received through the liquidation of the underlying investments throughout the life of the investment fund. Investments may only be sold or transferred subject to the notice and approval provisions of the underlying investment agreement. Subject to applicable regulatory requirements, including the Volcker Rule, we also make commitments to invest in venture capital and private equity funds. For additional details, see Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments.”

The Bank also has variable interests in low income housing tax credit funds, in connection with fulfilling its responsibilities under the CRA, that are designed to generate a return primarily through the realization of federal tax credits. These investments are typically limited partnerships in which the general partner, other than the Bank, holds the power over significant activities of the VIE; therefore, these investments are not consolidated. For additional information on our investments in qualified affordable housing projects, see Note 5 — “Investment Securities.".

As of September 30, 2022, our exposure to loss with respect to the consolidated VIEs is limited to our net assets of $786 million and our exposure to loss for our unconsolidated VIEs is equal to our investment in these assets of $1.4 billion.

12

Junior subordinated debentures

SVB Financial Group assumed two statutory trusts during the merger with Boston Private. These trusts were for the purpose of issuing trust preferred securities and investing the proceeds in junior subordinated debentures. These statutory trusts created by legacy Boston Private are not consolidated within the financial statements as the Company is not the primary beneficiary of the trusts; however, the total junior subordinated debentures payable to the preferred stockholders of statutory trusts are reported as long-term debt in the financial statements.

4.    Cash and Cash Equivalents

The following table details our cash and cash equivalents at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Cash and due from banks	$	1,411	$	2,168
Interest bearing deposits with the Federal Reserve Bank	7,550		5,686
Interest bearing deposits with other institutions	4,610		5,773
Securities purchased under agreements to resell (1)	397		607
Other short-term investment securities	—		352
Total cash and cash equivalents	$	13,968	$	14,586

(1)At September 30, 2022 and December 31, 2021, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $402 million and $620 million, respectively. None of these securities were sold or repledged as of September 30, 2022 and December 31, 2021.

5.    Investment Securities

Our investment securities portfolio consists of: (i) an AFS securities portfolio and a HTM securities portfolio, both of which represent interest-earning investment securities, and (ii) a non-marketable and other equity securities portfolio, which primarily represents investments managed as part of our funds management business, investments in qualified affordable housing projects, as well as public equity securities held as a result of equity warrant assets exercised.

AFS Securities

The major components of our AFS investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

	September 30, 2022
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Carrying Value
AFS securities, at fair value:
U.S. Treasury securities	$	18,041	$	—	$	(1,196)	$	16,845
U.S. agency debentures	120		—		(20)		100
Foreign government debt securities	1,062		—		(149)		913
Residential MBS:
Agency-issued MBS	7,883		—		(1,200)		6,683
Agency-issued CMO—fixed rate	792		—		(78)		714
Agency-issued CMBS	1,604		—		(148)		1,456
Total AFS securities	$	29,502	$	—	$	(2,791)	$	26,711

	December 31, 2021
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Carrying Value
AFS securities, at fair value:
U.S. Treasury securities	$	15,799	$	121	$	(70)	$	15,850
U.S. agency debentures	200		—		(4)		196
Foreign government debt securities	61		—		—		61
Residential MBS:
Agency-issued MBS	8,786		13		(210)		8,589
Agency-issued CMO—fixed rate	988		3		(9)		982
Agency-issued CMBS	1,536		27		(20)		1,543
Total AFS securities	$	27,370	$	164	$	(313)	$	27,221

13

The following table summarizes sale activity of AFS securities during the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Sales proceeds	$	—	$	168	$	8,511	$	168
Net realized gains and losses:
Gross realized gains	—		—		146		—
Gross realized losses	—		—		(98)		—
Net realized gains (losses)	$	—	$	—	$	48	$	—

The following tables summarize our AFS securities in an unrealized loss position for which an ACL has not been recorded and summarized into categories of AFS securities that were in an unrealized loss for position for less than 12 months, or 12 months or longer, as of September 30, 2022 and December 31, 2021:

	September 30, 2022
	Less than 12 months				12 months or longer				Total
(Dollars in millions)	Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses
AFS securities:
U.S. Treasury securities	$	13,359	$	(958)	$	3,487	$	(238)	$	16,846	$	(1,196)
U.S. agency debentures	20		(1)		80		(19)		100		(20)
Foreign government debt securities	913		(149)		—		—		913		(149)
Residential MBS:
Agency-issued MBS	2,236		(304)		4,448		(896)		6,684		(1,200)
Agency-issued CMO —fixed rate	534		(55)		168		(23)		702		(78)
Agency-issued CMBS	806		(59)		649		(89)		1,455		(148)
Total AFS securities (1)	$	17,868	$	(1,526)	$	8,832	$	(1,265)	$	26,700	$	(2,791)

(1)As of September 30, 2022, we identified a total of 804 investments that were in unrealized loss positions with 289 investments in an unrealized loss position for a period of time greater than 12 months. Based on our analysis of the securities in an unrealized loss position as of September 30, 2022, the decline in value is unrelated to credit loss and is related to changes in market interest rates since purchase, and therefore, changes in value for securities are included in other comprehensive income. Market valuations and credit loss analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis. As of September 30, 2022, we do not intend to sell any of our securities in an unrealized loss position prior to recovery of our amortized cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our amortized cost basis. None of the investments in our AFS securities portfolio were past due as of September 30, 2022.

	December 31, 2021
	Less than 12 months				12 months or longer				Total
(Dollars in millions)	Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses
AFS securities:
U.S. Treasury securities	$	7,777	$	(70)	$	—	$	—	$	7,777	$	(70)
U.S. agency debentures	196		(4)		—		—		196		(4)
Residential MBS:
Agency-issued MBS	8,280		(210)		—		—		8,280		(210)
Agency-issued CMO—fixed rate	740		(9)		—		—		740		(9)
Agency-issued CMBS	603		(11)		163		(9)		766		(20)
Total AFS securities (1)	$	17,596	$	(304)	$	163	$	(9)	$	17,759	$	(313)

(1)As of December 31, 2021, we identified a total of 475 investments that were in unrealized loss positions, of which 4 investments are in an unrealized loss position for a period of time greater than 12 months. None of the investments in our AFS securities portfolio were past due as of December 31, 2021.

14

The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of September 30, 2022 by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments.

	September 30, 2022
(Dollars in millions)	Total		One Year or Less		After One Year to Five Years		After Five Years to Ten Years		After Ten Years
U.S. Treasury securities	$	16,845	$	936	$	15,133	$	776	$	—
U.S. agency debentures	100		—		34		66		—
Foreign government debt securities	913		41		46		826		—
Residential MBS:
Agency-issued MBS	6,683		—		—		45		6,638
Agency-issued CMO—fixed rate	714		—		—		—		714
Agency-issued CMBS	1,456		—		100		1,356		—
Total	$	26,711	$	977	$	15,313	$	3,069	$	7,352

HTM Securities

The components of our HTM investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

	September 30, 2022
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value		ACL
HTM securities, at cost:
U.S. agency debentures (1)	$	486	$	—	$	(53)	$	433	$	—
Residential MBS:
Agency-issued MBS	59,200		—		(10,017)		49,183		—
Agency-issued CMO—fixed rate	10,741		—		(1,813)		8,928		—
Agency-issued CMO—variable rate	83		—		(1)		82		—
Agency-issued CMBS	14,644		—		(2,304)		12,340		—
Municipal bonds and notes	7,429		—		(1,612)		5,817		1
Corporate bonds	709		—		(122)		587		5
Total HTM securities	$	93,292	$	—	$	(15,922)	$	77,370	$	6

(1)    Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.

	December 31, 2021
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value		ACL
HTM securities, at amortized cost:
U.S. agency debentures (1)	$	609	$	8	$	(2)	$	615	$	—
Residential MBS:
Agency-issued MBS	64,439		124		(887)		63,676		—
Agency-issued CMO—fixed rate	10,226		9		(145)		10,090		—
Agency-issued CMO—variable rate	100		1		—		101		—
Agency-issued CMBS	14,959		39		(277)		14,721		—
Municipal bonds and notes	7,157		185		(27)		7,315		1
Corporate bonds	712		2		(5)		709		6
Total HTM securities	$	98,202	$	368	$	(1,343)	$	97,227	$	7

(1)    Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.

15

Allowance for Credit Losses for HTM Securities

For HTM securities, for the three months ended September 30, 2022, the ACL balance remained consistent at $6 million. For HTM securities, for the nine months ended September 30, 2022 the beginning ACL balance was $7 million, the reduction of credit losses was $1 million, and the ending ACL balance was $6 million.

For HTM securities, for the three months ended September 30, 2021, the beginning ACL balance was $5 million, the provision for credit losses was $1 million and the ending ACL balance was $6 million. For HTM securities, for the nine months ended September 30, 2021 the beginning ACL balance was less than $1 million, the provision for credit losses was $6 million and the ending ACL balance was $6 million.

AIR from HTM securities totaled $205 million at September 30, 2022 and $225 million at December 31, 2021 and is reported in "Accrued interest receivable and other assets" in our unaudited interim consolidated balance sheets.

Credit Quality Indicators

On a quarterly basis, management monitors the credit quality for HTM securities through the use of standard credit ratings. The following table summarizes our amortized cost of HTM securities aggregated by credit quality indicator at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Municipal bonds and notes:
Aaa	$	4,270	$	3,774
Aa1	1,880		2,031
Aa2	1,081		1,154
Aa3	171		172
A1	27		26
Total municipal bonds and notes	$	7,429	$	7,157
Corporate bonds:
Aaa	$	39	$	39
Aa2	42		42
Aa3	105		105
A1	282		251
A2	230		264
A3	11		11
Total corporate bonds	$	709	$	712

The following table summarizes the remaining contractual principal maturities on fixed income investment securities classified as HTM as of September 30, 2022. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected remaining maturities for certain U.S. agency debentures may occur earlier than their contractual maturities because the note issuers have the right to call outstanding amounts ahead of their contractual maturity. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as HTM typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments; however, we expect to collect substantially all of the recorded investment on these securities.

16

	September 30, 2022
	Total				One Year or Less				After One Year to Five Years				After Five Years to Ten Years				After Ten Years
(Dollars in millions)	Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value
U.S. agency debentures	$	486	$	433	$	1	$	1	$	118	$	111	$	367	$	321	$	—	$	—
Residential MBS:
Agency-issued MBS	59,200		49,183		1		1		2		2		1,148		1,063		58,049		48,117
Agency-issued CMO—fixed rate	10,741		8,928		—		—		87		83		154		146		10,500		8,699
Agency-issued CMO—variable rate	83		82		—		—		—		—		—		—		83		82
Agency-issued CMBS	14,644		12,340		45		44		159		146		968		802		13,472		11,348
Municipal bonds and notes	7,428		5,817		25		25		235		222		1,265		1,114		5,903		4,456
Corporate bonds	704		587		—		—		115		102		589		485		—		—
Total	$	93,286	$	77,370	$	72	$	71	$	716	$	666	$	4,491	$	3,931	$	88,007	$	72,702

Non-marketable and Other Equity Securities

The major components of our non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

(Dollars in millions)	September 30, 2022		December 31, 2021
Non-marketable and other equity securities:
Non-marketable securities (fair value accounting):
Consolidated venture capital and private equity fund investments (1)	$	147	$	130
Unconsolidated venture capital and private equity fund investments (2)	123		208
Other investments without a readily determinable fair value (3)	176		164
Other equity securities in public companies (fair value accounting) (4)	29		117
Non-marketable securities (equity method accounting) (5):
Venture capital and private equity fund investments	639		671
Debt funds	4		5
Other investments	272		294
Investments in qualified affordable housing projects, net (6)	1,205		954
Total non-marketable and other equity securities	$	2,595	$	2,543

(1)The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at September 30, 2022 and December 31, 2021 (fair value accounting):

	September 30, 2022				December 31, 2021
(Dollars in millions)	Amount		Ownership %		Amount		Ownership %
Strategic Investors Fund, LP	$	2	12.6	%	$	2	12.6	%
Capital Preferred Return Fund, LP	30		20.0		61		20.0
Growth Partners, LP	25		33.0		67		33.0
Redwood Evergreen Fund, LP	90		100.0		—		—
Total consolidated venture capital and private equity fund investments	$	147			$	130

(2)The carrying value represents investments in 141 and 150 funds (primarily venture capital funds) at September 30, 2022 and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30th for our September 30th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

(3)These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment, and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.

17

The following table shows the changes to the carrying amount of other investments without a readily determinable fair value for the nine months ended September 30, 2022:

(Dollars in millions)	Nine months ended September 30, 2022		Cumulative Adjustments
Measurement alternative:
Carrying value at September 30, 2022	$	176
Carrying value adjustments:
Impairment	$	—	$	(1)
Upward changes for observable prices	—		52
Downward changes for observable prices	(6)		(11)

(4)Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in equity securities measured at fair value are recognized through net income.

(5)The following table shows the carrying value and our ownership percentage of each investment at September 30, 2022 and December 31, 2021 (equity method accounting):

	September 30, 2022				December 31, 2021
(Dollars in millions)	Amount		Ownership %		Amount		Ownership %
Venture capital and private equity fund investments:
Strategic Investors Fund II, LP	$	2	8.6	%	$	3	8.6	%
Strategic Investors Fund III, LP	13		5.9		25		5.9
Strategic Investors Fund IV, LP	23		5.0		36		5.0
Strategic Investors Fund V funds	59		Various		87		Various
CP II, LP (i)	2		5.1		2		5.1
Other venture capital and private equity fund investments	540		Various		518		Various
Total venture capital and private equity fund investments	$	639			$	671
Debt funds:
Gold Hill Capital 2008, LP (ii)	$	3	15.5	%	$	4	15.5	%
Other debt funds	1		Various		1		Various
Total debt funds	$	4			$	5
Other investments:
SPD Silicon Valley Bank Co., Ltd.	$	143	50.0	%	$	154	50.0	%
Other investments	129		Various		140		Various
Total other investments	$	272			$	294

(i)Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.

(ii)Our ownership includes direct ownership interest of 11.5 percent and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.

(6)The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of “Other liabilities” on our consolidated balance sheets at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Investments in qualified affordable housing projects, net	$	1,205	$	954
Other liabilities	672		482

The following table presents other information relating to our investments in qualified affordable housing projects for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Tax credits and other tax benefits recognized	$	30	$	9	$	80	$	63
Amortization expense included in provision for income taxes (i)	17		17		52		48

(i)All investments are amortized using the proportional amortization method, and amortization expense is included in the provision for income taxes.

18

The following table presents the net gains and losses on non-marketable and other equity securities for the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Net (losses) gains on non-marketable and other equity securities:
Non-marketable securities (fair value accounting):
Consolidated venture capital and private equity fund investments	$	(52)	$	36	$	(100)	$	72
Unconsolidated venture capital and private equity fund investments	(61)		47		(80)		79
Other investments without a readily determinable fair value	—		(2)		(3)		11
Other equity securities in public companies (fair value accounting)	(8)		(39)		(52)		53
Non-marketable securities (equity method accounting):
Venture capital and private equity fund investments	(12)		144		(20)		438
Debt funds	(1)		—		(1)		2
Other investments	7		3		9		6
Total net (losses) gains on non-marketable and other equity securities	$	(127)	$	189	$	(247)	$	661
Less: realized net gains (losses) on sales of non-marketable and other equity securities	13		(17)		(16)		110
Net (losses) gains on non-marketable and other equity securities still held	$	(140)	$	206	$	(231)	$	551

6.    Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments

We serve a variety of commercial clients in the private equity/venture capital, technology, life science/healthcare, premium wine and commercial real estate industries. Loans made to private equity/venture capital firm clients typically enable them to fund investments prior to their receipt of funds from capital calls and are reported under the Global Fund Banking class of financing receivable below. Our technology clients generally tend to be in the industries of hardware (such as semiconductors, communications, data, storage and electronics), software/internet (such as infrastructure software, applications, software services, digital content and advertising technology) and ERI. Our life science/healthcare clients primarily tend to be in the industries of biotechnology, medical devices, healthcare information technology and healthcare services. Loans to our technology and life science/healthcare clients are reported under the Investor Dependent, Cash Flow Dependent - SLBO and Innovation C&I classes of financing receivable below. We also make commercial and industrial loans, such as working capital lines and term loans for equipment and fixed assets, to clients that are not in the technology and life science/healthcare industries which are reported in the Other C&I class of financing receivable below. Loans to the premium wine industry focus on vineyards and wineries that produce grapes and wines of high quality. Commercial real estate loans are generally acquisition financing for commercial properties such as office buildings, retail properties, apartment buildings, and industrial/warehouse space, which moving forward, will predominantly support the innovation economy segments. In addition to commercial loans, we make consumer loans through SVB Private and provide real estate secured loans to eligible employees through our EHOP.

We also provide community development loans made as part of our responsibilities under the CRA. The majority of these loans are included within the Other loan class below and are primarily secured by real estate. Additionally, beginning in April 2020, we accepted applications under the PPP administered by the SBA under the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") and originated loans to qualified small businesses. PPP funds under the CARES Act were disbursed throughout 2020 and up to June 30, 2021.

19

Loan Portfolio Segments and Classes of Financing Receivables

The composition of loans at amortized cost basis broken out by class of financing receivable at September 30, 2022 and December 31, 2021 is presented in the following table:

(Dollars in millions)	September 30, 2022		December 31, 2021
Global fund banking	$	40,337	$	37,958
Investor dependent:
Early stage	1,911		1,593
Growth stage	4,398		3,951
Total investor dependent	6,309		5,544
Cash flow dependent - SLBO	1,845		1,798
Innovation C&I	8,321		6,673
Private bank	10,102		8,743
CRE	2,609		2,670
Premium wine	1,117		985
Other C&I	1,087		1,257
Other	374		317
PPP	28		331
Total loans (1) (2) (3)	$	72,129	$	66,276
ACL	(557)		(422)
Net loans	$	71,572	$	65,854

(1)    Total loans at amortized cost is net of unearned income, deferred fees and costs, and net unamortized premiums and discounts of $244 million and $250 million at September 30, 2022 and December 31, 2021, respectively.

(2)     Included within our total loan portfolio are credit card loans of $582 million and $583 million at September 30, 2022 and December 31, 2021, respectively.

(3)     Included within our total loan portfolio are construction loans of $454 million and $367 million at September 30, 2022 and December 31, 2021, respectively.

Credit Quality Indicators

For each individual client, we establish an internal credit risk rating for that loan, which is used for assessing and monitoring credit risk as well as performance of the loan and the overall portfolio. Our internal credit risk ratings are also used to summarize the risk of loss due to failure by an individual borrower to repay the loan. For our internal credit risk ratings, each individual loan is given a risk rating of 1 through 10. Loans risk-rated 1 through 4 are performing loans and translate to an internal rating of “Pass,” with loans risk-rated 1 being cash secured. Loans risk-rated 5 through 7 are performing loans; however, we consider them as demonstrating higher risk, which requires more frequent review of the individual exposures; these translate to an internal rating of “Criticized.” All of our nonaccrual loans are risk-rated 8 or 9 and are classified with the internal rating of "Nonperforming." Loans rated 10 are charged-off and are not included as part of our loan portfolio balance. We review our credit quality indicators on a quarterly basis for performance and appropriateness of risk ratings as part of our evaluation process for our ACL for loans.

The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of September 30, 2022 and December 31, 2021:

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Global fund banking:
Risk rating:
Pass	$	512	$	95	$	63	$	31	$	1	$	10	$	39,616	$	—	$	—	$	40,328
Criticized	—		—		—		—		—		—		9		—		—		9
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total global fund banking	$	512	$	95	$	63	$	31	$	1	$	10	$	39,625	$	—	$	—	$	40,337
Investor dependent:
Early stage:
Risk rating:
Pass	$	727	$	626	$	73	$	36	$	2	$	1	$	191	$	—	$	—	$	1,656
Criticized	67		122		27		7		—		2		26		—		—		251
Nonperforming	1		1		—		—		—		—		2		—		—		4
Total early stage	$	795	$	749	$	100	$	43	$	2	$	3	$	219	$	—	$	—	$	1,911

20

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Growth stage:
Risk rating:
Pass	$	1,684	$	1,456	$	360	$	72	$	28	$	6	$	243	$	5	$	—	$	3,854
Criticized	147		233		53		14		5		—		49		—		—		501
Nonperforming	19		18		2		—		—		—		4		—		—		43
Total growth stage	$	1,850	$	1,707	$	415	$	86	$	33	$	6	$	296	$	5	$	—	$	4,398
Total investor dependent	$	2,645	$	2,456	$	515	$	129	$	35	$	9	$	515	$	5	$	—	$	6,309
Cash flow dependent - SLBO:
Risk rating:
Pass	$	678	$	609	$	199	$	203	$	14	$	39	$	30	$	—	$	—	$	1,772
Criticized	20		—		16		2		1		22		5		—		—		66
Nonperforming	—		—		—		—		5		—		2		—		—		7
Total cash flow dependent - SLBO	$	698	$	609	$	215	$	205	$	20	$	61	$	37	$	—	$	—	$	1,845
Innovation C&I
Risk rating:
Pass	$	1,788	$	1,734	$	773	$	166	$	18	$	54	$	3,102	$	—	$	—	$	7,635
Criticized	49		148		121		32		11		—		324		—		—		685
Nonperforming	—		—		—		—		—		—		1		—		—		1
Total innovation C&I	$	1,837	$	1,882	$	894	$	198	$	29	$	54	$	3,427	$	—	$	—	$	8,321
Private bank:
Risk rating:
Pass	$	2,210	$	2,817	$	1,753	$	948	$	441	$	1,054	$	818	$	5	$	—	$	10,046
Criticized	—		16		—		2		—		15		10		—		—		43
Nonperforming	—		—		1		2		1		8		1		—		—		13
Total private bank	$	2,210	$	2,833	$	1,754	$	952	$	442	$	1,077	$	829	$	5	$	—	$	10,102
CRE
Risk rating:
Pass	$	406	$	292	$	181	$	240	$	143	$	894	$	96	$	5	$	—	$	2,257
Criticized	2		4		51		135		24		114		17		—		—		347
Nonperforming	—		—		—		5		—		—		—		—		—		5
Total CRE	$	408	$	296	$	232	$	380	$	167	$	1,008	$	113	$	5	$	—	$	2,609
Premium wine:
Risk rating:
Pass	$	255	$	213	$	91	$	137	$	47	$	144	$	156	$	34	$	—	$	1,077
Criticized	1		5		—		7		9		9		9		—		—		40
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total premium wine	$	256	$	218	$	91	$	144	$	56	$	153	$	165	$	34	$	—	$	1,117
Other C&I
Risk rating:
Pass	$	31	$	149	$	161	$	70	$	81	$	304	$	234	$	10	$	—	$	1,040
Criticized	1		—		3		6		3		19		11		1		—		44
Nonperforming	—		—		1		—		1		1		—		—		—		3
Total other C&I	$	32	$	149	$	165	$	76	$	85	$	324	$	245	$	11	$	—	$	1,087
Other:
Risk rating:
Pass	$	25	$	151	$	172	$	30	$	—	$	—	$	11	$	—	$	(44)	$	345
Criticized	—		3		17		9		—		—		—		—		—		29
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total other	$	25	$	154	$	189	$	39	$	—	$	—	$	11	$	—	$	(44)	$	374
PPP:
Risk rating:
Pass	$	—	$	16	$	3	$	—	$	—	$	—	$	—	$	—	$	—	$	19
Criticized	—		3		6		—		—		—		—		—		—		9
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total PPP	$	—	$	19	$	9	$	—	$	—	$	—	$	—	$	—	$	—	$	28

21

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Total loans	$	8,623	$	8,711	$	4,127	$	2,154	$	835	$	2,696	$	44,967	$	60	$	(44)	$	72,129

(1)    These amounts consist of fees and clearing items that have not yet been allocated at the loan level.

22

	Term Loans by Origination Year
December 31, 2021 (Dollars in millions)	2021		2020		2019		2018		2017		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Global fund banking:
Risk rating:
Pass	$	764	$	115	$	36	$	6	$	8	$	4	$	36,955	$	—	$	—	$	37,888
Criticized	50		18		—		—		—		1		1		—		—		70
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total global fund banking	$	814	$	133	$	36	$	6	$	8	$	5	$	36,956	$	—	$	—	$	37,958
Investor dependent:
Early stage:
Risk rating:
Pass	$	754	$	287	$	122	$	26	$	6	$	1	$	171	$	—	$	—	$	1,367
Criticized	64		87		30		5		—		—		29		—		—		215
Nonperforming	2		5		3		—		—		—		1		—		—		11
Total early stage	$	820	$	379	$	155	$	31	$	6	$	1	$	201	$	—	$	—	$	1,593
Growth stage:
Risk rating:
Pass	$	2,072	$	910	$	265	$	78	$	14	$	1	$	286	$	5	$	—	$	3,631
Criticized	159		85		27		6		3		—		34		—		—		314
Nonperforming	2		—		1		2		—		—		1		—		—		6
Total growth stage	$	2,233	$	995	$	293	$	86	$	17	$	1	$	321	$	5	$	—	$	3,951
Total investor dependent	$	3,053	$	1,374	$	448	$	117	$	23	$	2	$	522	$	5	$	—	$	5,544
Cash flow dependent - SLBO:
Risk rating:
Pass	$	875	$	384	$	252	$	72	$	76	$	2	$	35	$	—	$	—	$	1,696
Criticized	—		—		20		25		—		13		10		—		—		68
Nonperforming	—		—		12		10		7		—		5		—		—		34
Total cash flow dependent - SLBO	$	875	$	384	$	284	$	107	$	83	$	15	$	50	$	—	$	—	$	1,798
Innovation C&I:
Risk rating:
Pass	$	2,230	$	1,058	$	288	$	123	$	58	$	—	$	2,411	$	—	$	—	$	6,168
Criticized	64		130		62		12		—		—		236		—		—		504
Nonperforming	—		—		—		—		—		—		1		—		—		1
Total Innovation C&I	$	2,294	$	1,188	$	350	$	135	$	58	$	—	$	2,648	$	—	$	—	$	6,673
Private bank:
Risk rating:
Pass	$	2,952	$	2,015	$	1,122	$	520	$	432	$	952	$	705	$	8	$	—	$	8,706
Criticized	—		—		2		—		2		9		3		—		—		16
Nonperforming	—		—		2		9		—		8		2		—		—		21
Total private bank	$	2,952	$	2,015	$	1,126	$	529	$	434	$	969	$	710	$	8	$	—	$	8,743
CRE
Risk rating:
Pass	$	326	$	215	$	344	$	155	$	236	$	868	$	110	$	2	$	—	$	2,256
Criticized	3		39		114		37		47		139		18		12		—		409
Nonperforming	—		—		5		—		—		—		—		—		—		5
Total CRE	$	329	$	254	$	463	$	192	$	283	$	1,007	$	128	$	14	$	—	$	2,670
Premium wine:
Risk rating:
Pass	$	217	$	112	$	156	$	69	$	71	$	162	$	125	$	34	$	—	$	946
Criticized	1		7		11		9		—		—		11		—		—		39
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total Premium wine	$	218	$	119	$	167	$	78	$	71	$	162	$	136	$	34	$	—	$	985
Other C&I
Risk rating:
Pass	$	181	$	175	$	82	$	86	$	28	$	301	$	350	$	11	$	—	$	1,214
Criticized	5		6		6		7		2		—		8		5		—		39
Nonperforming	—		—		—		2		—		1		1		—		—		4
Total other C&I	$	186	$	181	$	88	$	95	$	30	$	302	$	359	$	16	$	—	$	1,257
Other:

23

	Term Loans by Origination Year
December 31, 2021 (Dollars in millions)	2021		2020		2019		2018		2017		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Risk rating:
Pass	$	61	$	144	$	82	$	20	$	14	$	—	$	7	$	—	$	(21)	$	307
Criticized	—		7		1		—		2		—		—		—		—		10
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total other	$	61	$	151	$	83	$	20	$	16	$	—	$	7	$	—	$	(21)	$	317
PPP:
Risk rating:
Pass	$	226	$	72	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	298
Criticized	22		9		—		—		—		—		—		—		—		31
Nonperforming	2		—		—		—		—		—		—		—		—		2
Total PPP	$	250	$	81	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	331
Total loans	$	11,032	$	5,880	$	3,045	$	1,279	$	1,006	$	2,462	$	41,516	$	77	$	(21)	$	66,276

(1)    These amounts consist of fees and clearing items that have not yet been allocated at the loan level.

Allowance for Credit Losses: Loans

In the third quarter of 2022, the ACL for loans increased by $12 million, driven primarily by loan growth and the continued deterioration in projected economic conditions.

The Moody's Analytics September 2022 forecast was utilized in our quantitative model for the ACL as of September 30, 2022. The forecast assumptions included a significantly worse housing price index growth rate than that of last quarter, as well as a lower gross domestic product growth rate. The forecast's starting unemployment rate was unchanged from prior quarter, but it is worse in future quarters than in previous projections. The overall impact of these assumptions was a worse forecast than that used at June 30, 2022.

Additionally, we reduced the weighting applied to the Moody's downside economic scenario to reflect that the September forecasts more closely aligned with our expectations as of September 30, 2022, thereby no longer requiring a downside weighting as significant as in the previous quarter. To the extent we identified credit risk considerations that were not captured by the Moody's Analytics September 2022 forecast, we addressed the risk through management's adjustments to the scenario weightings. After adjusting the weightings accordingly, we determined the forecast to be representative of our outlook for the economy given the available information at current quarter end.

We do not estimate expected credit losses on AIR on loans, as AIR is reversed or written off when the full collection of the AIR related to a loan becomes doubtful. AIR on loans totaled $294 million at September 30, 2022 and $171 million at December 31, 2021 and is reported in "Accrued interest receivable and other assets" in our unaudited interim consolidated balance sheets.

The following tables summarize the activity relating to our ACL for loans for the three and nine months ended September 30, 2022 and 2021, broken out by portfolio segment:

Three months ended September 30, 2022	Beginning Balance June 30, 2022		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	89	$	—	$	6	$	(4)	$	—	$	91
Investor dependent	224		(20)		4		25		1		234
Cash flow dependent and innovation C&I	130		(5)		—		11		—		136
Private bank	45		—		—		2		—		47
CRE	34		—		—		(7)		—		27
Other C&I	12		(1)		1		—		—		12
Premium wine and other	11		—		—		3		(4)		10
Total ACL	$	545	$	(26)	$	11	$	30	$	(3)	$	557

24

Three months ended September 30, 2021	Beginning Balance June 30, 2021		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	66	$	—	$	—	$	—	$	(7)	$	59
Investor dependent	158		—		(17)		5		(8)		138
Cash flow dependent and innovation C&I	119		—		(1)		3		(12)		109
Private bank	47		1		(1)		—		(16)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	6		—		—		—		3		9
Total ACL	$	396	$	22	$	(19)	$	8	$	(9)	$	398

Nine months ended September 30, 2022	Beginning Balance December 31, 2021		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	67	$	—	$	6	$	18	$	—	$	91
Investor dependent	146		(53)		13		126		2		234
Cash flow dependent and innovation C&I	118		(9)		—		27		—		136
Private Bank	33		—		2		12		—		47
CRE	36		—		—		(9)		—		27
Other C&I	14		(3)		1		—		—		12
Premium wine and other	8		(1)		1		10		(8)		10
Total ACL	$	422	$	(66)	$	23	$	184	$	(6)	$	557

Nine months ended September 30, 2021	Beginning Balance December 31, 2020		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	46	$	—	$	(80)	$	—	$	93	$	59
Investor dependent	213		—		(37)		13		(51)		138
Cash flow dependent and innovation C&I	125		—		(8)		3		(11)		109
Private Bank	53		1		(3)		—		(20)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	9		—		(1)		—		1		9
PPP	2		—		—		—		(2)		—
Total ACL	$	448	$	22	$	(129)	$	16	$	41	$	398

25

The following table summarizes the aging of our loans broken out by class of financing receivable as of September 30, 2022 and December 31, 2021:

(Dollars in millions)	30 - 59   Days Past   Due		60 - 89   Days Past   Due		Equal to or Greater Than 90   Days Past   Due		Total Past   Due		Current		Total		Loans Past Due 90 Days or More Still Accruing Interest
September 30, 2022:
Global fund banking	$	—	$	—	$	—	$	—	$	40,337	$	40,337	$	—
Investor dependent:
Early stage	2		2		1		5		1,906		1,911		—
Growth stage	26		13		2		41		4,357		4,398		—
Total investor dependent	28		15		3		46		6,263		6,309		—
Cash flow dependent - SLBO	4		—		—		4		1,841		1,845		—
Innovation C&I	6		3		—		9		8,312		8,321		—
Private bank	1		12		5		18		10,084		10,102		1
CRE	1		7		5		13		2,596		2,609		—
Premium wine	3		—		—		3		1,114		1,117		—
Other C&I	—		3		—		3		1,084		1,087		—
Other	—		—		—		—		374		374		—
PPP	—		—		6		6		22		28		5
Total loans	$	43	$	40	$	19	$	102	$	72,027	$	72,129	$	6
December 31, 2021:
Global fund banking	$	—	$	—	$	—	$	—	$	37,958	$	37,958	$	—
Investor dependent:
Early stage	6		5		—		11		1,582		1,593		—
Growth stage	16		—		—		16		3,935		3,951		—
Total investor dependent	22		5		—		27		5,517		5,544		—
Cash flow dependent - SLBO	—		—		—		—		1,798		1,798		—
Innovation C&I	7		—		7		14		6,659		6,673		7
Private bank	28		1		12		41		8,702		8,743		—
CRE	1		—		—		1		2,669		2,670		—
Premium wine	3		—		—		3		982		985		—
Other C&I	1		2		1		4		1,253		1,257		—
Other	—		—		—		—		317		317		—
PPP	1		—		—		1		330		331		—
Total loans	$	63	$	8	$	20	$	91	$	66,185	$	66,276	$	7

Nonaccrual Loans

The following table summarizes our nonaccrual loans with no allowance for credit loss at September 30, 2022 and December 31, 2021:

	September 30, 2022				December 31, 2021
(Dollars in millions)	Nonaccrual Loans		Nonaccrual Loans with no Allowance for Credit Loss		Nonaccrual Loans		Nonaccrual Loans with no Allowance for Credit Loss
Investor dependent:
Early stage	$	4	$	—	$	11	$	—
Growth stage	43		1		6		—
Total investor dependent	47		1		17		—
Cash flow dependent - SLBO	7		—		34		—
Innovation C&I	1		—		1		1
Private bank	13		6		21		8
CRE	5		—		5		—
Other C&I	3		—		4		—
PPP	—		—		2		—
Total nonaccrual loans	$	76	$	7	$	84	$	9

26

TDRs

As of September 30, 2022, we had 39 TDRs with a total carrying value of $85 million where concessions have been granted to borrowers experiencing financial difficulties, in an attempt to maximize collection. We had no unfunded commitments available for funding to the clients associated with these TDRs as of September 30, 2022.

The following table summarizes our loans modified in TDRs, broken out by class of financing receivable at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Loans modified in TDRs:
Investor dependent:
Early stage	$	1	$	12
Growth stage	32		3
Total investor dependent	33		15
Cash flow dependent - SLBO	8		34
Innovation C&I	1		—
Private bank	8		12
CRE	33		33
Other C&I	2		2
Total loans modified in TDRs	$	85	$	96

The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivable, for modifications made during the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Loans modified in TDRs during the period:
Investor dependent:
Early stage	$	1	$	—	$	1	$	1
Growth stage	12		8		32		8
Total investor dependent	13		8		33		9
Cash flow dependent - SLBO	—		—		—		12
Innovation C&I	1		—		1		—
Private bank	—		2		1		2
CRE	5		43		5		43
Total loans modified in TDRs during the period (1)	$	19	$	53	$	40	$	66

(1)There were $4 million of partial charge-offs for the three months ended September 30, 2022 and $9 million of partial charge-offs for the nine months then ended. There were no partial charge-offs for the three months ended September 30, 2021 and $7 million of partial charge-offs for the nine months then ended.

During the three months ended September 30, 2022, new TDRs of $19 million were modified through payment deferrals granted to our clients. During the three months ended September 30, 2021, new TDRs of $17 million were modified through payment deferrals granted to our clients, $14 million were modified through term extensions and $22 million were modified through a combination thereof.

During the nine months ended September 30, 2022, new TDRs of $38 million were modified through payment deferrals granted to our clients, $1 million were modified through rate reductions and $1 million were modified through settlement. During the nine months ended September 30, 2021, new TDRs of $30 million were modified through payment deferrals granted to our clients, $14 million were modified through term extensions and $22 million were modified through a combination thereof.

Of loans modified in TDRs within the previous 12 months, $1 million in Investor Dependent - Early Stage defaulted on the modified terms during the three and nine months ended September 30, 2022. There were no defaults of loans modified in TDRs during the three and nine months ended September 30, 2021.

Charge-offs and defaults on previously restructured loans are evaluated to determine the impact to the ACL for loans, if any. The evaluation of these defaults may impact the assumptions used in calculating the reserve on other TDRs and nonaccrual loans as well as management’s overall outlook of macroeconomic factors that affect the reserve on the loan portfolio as a whole. After evaluating the charge-offs and defaults experienced on our TDRs, we determined that no change to our reserving methodology for TDRs was necessary to determine the ACL for loans as of September 30, 2022.

27

ACL: Unfunded Credit Commitments

We maintain a separate ACL for unfunded credit commitments that is determined using a methodology that is inherently similar to the methodology used for calculating the ACL for loans. At September 30, 2022, our ACL estimates utilized the Moody's economic forecasts from September 30, 2022 as mentioned above. In the third quarter of 2022, the ACL for unfunded commitments increased by $41 million from the prior quarter, driven primarily by continued growth in our outstanding commitments, as well as the same deterioration in projected economic conditions described above.

The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
ACL: unfunded credit commitments, beginning balance	$	224	$	120	171		$	121
Provision for (reduction in) credit losses	42		29		96		28
Foreign currency translation adjustments	(1)		—		(2)		—
ACL: unfunded credit commitments, ending balance (1)	$	265	$	149	$	265	$	149

(1)The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.

7.     Goodwill and Other Intangible Assets

Goodwill

Goodwill at both September 30, 2022 and December 31, 2021 was $375 million, which was a result of goodwill recognized for the acquisitions of SVB Securities, WestRiver Group's debt fund business, Boston Private and MoffettNathanson LLC.

Other Intangible Assets

The components of net other intangible assets were as follows:

	September 30, 2022						December 31, 2021
(Dollars in millions)	Gross Amount		Accumulated Amortization		Net Carrying Amount		Gross Amount		Accumulated Amortization		Net Carrying Amount
Other intangible assets:
Customer relationships	$	135	$	27	$	108	$	135	$	16	$	119
Other	57		23		34		57		16		41
Total other intangible assets	$	192	$	50	$	142	$	192	$	32	$	160

For the nine months ended September 30, 2022, we recorded amortization expense of $18 million. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of September 30, 2022:

Years ended December 31, (Dollars in millions)	Other Intangible Assets
2022 (excluding the nine months ended September 30, 2022)	$	6
2023	22
2024	20
2025	17
2026	15
2027 and thereafter	62
Total future amortization expense	$	142

28

8.    Derivative Financial Instruments

We primarily use derivative financial instruments to manage interest rate risk and currency exchange rate risk and to assist customers with their risk management objectives, which may include currency exchange rate risks and interest rate risks. Also, in connection with negotiating credit facilities and certain other services, we often obtain equity warrant assets, giving us the right to acquire stock in private, venture-backed companies in the technology and life science/healthcare industries.

Interest Rate Risk

Interest rate risk is our primary market risk and can result from timing and volume differences in the repricing of our interest rate sensitive assets and liabilities and changes in market interest rates. To manage interest rate risk on our interest rate sensitive assets, we have entered into interest rate swap contracts to hedge against future changes in interest rates.

Fair Value Hedges

To manage interest rate risk on our AFS securities portfolio, we enter into pay-fixed, receive-floating interest rate swap contracts to hedge against exposure to changes in the fair value of the securities resulting from changes in interest rates. We designate these interest rate swap contracts as fair value hedges that qualify for hedge accounting under ASC 815, Derivatives and Hedging ("ASC 815") and have elected to account for a portion of the hedges using the last-of-layer method as outlined in ASC 815. We record the interest rate swaps in other assets and other liabilities. For qualifying fair value hedges, both the changes in the fair value of the derivative and the portion of the fair value adjustments associated with the last-of-layer attributable to the hedged risk are recognized into earnings as they occur. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "investment securities" as part of interest income, a component of consolidated net income.

We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. In conjunction with the assessment of effectiveness, we assess the hedged item to ensure it is expected to be outstanding at the hedged item’s assumed maturity date and the last-of-layer method of accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any remaining fair value basis adjustments are allocated to the individual assets in the portfolio and amortized into earnings over a period consistent with the amortization of other discounts and premiums associated with the respective assets. As allowed under GAAP, we apply the "shortcut" method of accounting to a portion of our fair value hedges which assumes there is perfect effectiveness.

The following table summarizes the amortized cost basis of hedged assets that are designated and qualify as fair value hedges and the cumulative amount of fair value hedging adjustments included in the carrying value that have been recorded on our unaudited interim consolidated balance sheets as of September 30, 2022 and December 31, 2021:

			Cumulative Amount of Fair Value Hedging Adjustment Included in the Amortized Cost Basis of the Hedged Assets
(Dollars in millions)	Amortized Cost Basis of the Hedged Assets		Active		Terminated
September 30, 2022
AFS securities	$	8,773	$	—	$	(301)
December 31, 2021
AFS securities (1)	$	15,260	$	(131)	$	6

(1)These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At December 31, 2021, the amortized cost basis of the closed portfolios used in these hedging relationships was $11.2 billion, the amounts of the designated hedged items was $6.7 billion and the cumulative basis adjustments associated with these hedging relationships was $83 million.

29

Cash Flow Hedges

To manage interest rate risk on our variable-interest rate loan portfolio, we enter into interest rate swap contracts to hedge against future changes in interest rates by using hedging instruments to lock in future cash inflows that would otherwise be impacted by movements in the market interest rates. We designate these interest rate swap contracts as cash flow hedges that qualify for hedge accounting under ASC 815 and record them in other assets and other liabilities. For qualifying cash flow hedges, changes in the fair value of the derivative are recorded in AOCI and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "loans" as part of interest income, a component of consolidated net income.

We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any amounts remaining as gain or loss in AOCI are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income. As of March 31, 2020, all derivatives previously classified as hedges with notional balances totaling $5.0 billion and a net asset fair value of $228 million were terminated. As of September 30, 2022, the total unrealized gains on terminated cash flow hedges remaining in AOCI was $73 million ($52 million net of tax). The unrealized gains will be reclassified into interest income as the underlying forecasted transactions impact earnings through the original maturity of the hedged forecasted transactions. The total remaining term over which the unrealized gains will be reclassified into earnings is approximately three years.

Currency Exchange Risk

Derivatives not designated as hedging instruments

We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure risk associated with the net difference between foreign currency denominated assets and liabilities. Gains or losses from changes in currency rates on foreign currency denominated instruments are recorded in the line item “other” as part of noninterest income, a component of consolidated net income. We may experience ineffectiveness in the economic hedging relationship, because the instruments are revalued based upon changes in the currency’s spot rate on the principal value, while the forwards are revalued on a discounted cash flow basis. We record forward agreements in gain positions in other assets and loss positions in other liabilities, while net changes in fair value are recorded in the line item “other” as part of noninterest income, a component of consolidated net income.

Derivatives designated as hedging instruments

We enter into net investment hedges to hedge against the foreign currency risk of a net investment in foreign operations. Certain foreign exchange contracts are designated as net investment hedges to minimize our exposure to variability in the foreign currency translation of net investments in non-U.S. subsidiaries. For qualifying net investment hedges under ASC 815, changes in the spot rate of the net investment hedges of foreign operations are recorded in OCI in the line item "foreign currency translation (losses) gains, net of hedges." We assess hedge effectiveness under ASC 815 at least quarterly to ensure all hedges remain effective and hedge accounting can be applied. Net investment hedge pretax gains (losses) of $94 million were recognized in AOCI related to foreign exchange contracts for the three and nine months ending September 30, 2022.

Other Derivative Instruments

We issue loans to clients with conversion features allowing SVBFG to convert the contingent conversion rights to stock in private or public companies. All of our contingent conversion rights qualify as derivatives and are reported at fair value as a component of other assets on our consolidated balance sheet. Any changes in fair value after the grant date are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income.

We enter into total return swaps related to certain of our equity funds, which manages the risk of exposure from the volatility of equity investments in the funds. We do not designate any total return swaps as derivative instruments that qualify for hedge accounting. Gains or losses from changes in fair value are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income.

Also included in our derivative instruments are equity warrant assets and client forward, option, swap, and interest rate contracts. For further description of these other derivative instruments, refer to Note 2 — “Summary of Significant Accounting Policies" under Part II, Item 8 of our 2021 Form 10-K.

Counterparty Credit Risk

We are exposed to credit risk if counterparties to our derivative contracts do not perform as expected. We mitigate counterparty credit risk through credit approvals, limits, and monitoring procedures and by obtaining collateral, as

30

appropriate. With respect to measuring counterparty credit risk for derivative instruments, we measure the fair value of a group of financial assets and financial liabilities on a net risk basis by counterparty portfolio.

The total notional or contractual amounts and fair value of our derivative financial instruments at September 30, 2022 and December 31, 2021 were as follows:

	September 30, 2022						December 31, 2021
	Notional or Contractual Amount		Fair Value				Notional or Contractual Amount		Fair Value
(Dollars in millions)			Derivative Assets (1)		Derivative Liabilities (1)				Derivative Assets (1)		Derivative Liabilities (1)
Derivatives designated as hedging instruments:
Interest rate risks:
Interest rate swaps (2)	$	—	$	—	$	—	$	10,700	$	18	$	—
Currency exchange risks:
Foreign exchange contracts	1,546		94		—		—		—		—
Total derivatives designated as hedging instruments			94		—				18		—
Derivatives not designated as hedging instruments:
Currency exchange risks:
Foreign exchange contracts	2,860		46		—		701		16		—
Foreign exchange contracts	308		—		13		62		—		2
Other derivative instruments:
Equity warrant assets	353		351		—		322		277		—
Contingent conversion rights	52		6		—		—		—		—
Client foreign exchange contracts	10,658		500		—		8,245		146		—
Client foreign exchange contracts	10,615		—		499		7,764		—		126
Total return swaps	110		25		—		—		—		—
Client foreign currency options	266		11		—		688		9		—
Client foreign currency options	266		—		11		688		—		9
Client interest rate derivatives (2)	2,248		128		—		2,178		99		—
Client interest rate derivatives	2,447		—		235		2,315		—		101
Total derivatives not designated as hedging instruments			1,067		758				547		238
Total gross derivatives			1,161		758				565		238
Less: netting adjustment (3)			(495)		(234)				(137)		(120)
Total derivatives			$	666	$	524			$	428	$	118

(1)Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities", respectively, on our consolidated balance sheets.

(2)The amount reported reflects reductions of approximately $117 million and $112 million of derivative assets at September 30, 2022 and December 31, 2021, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses.

(3)For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. There was approximately $6 million of cash collateral in excess of net derivative receivables and $1 million of cash collateral in excess of net derivative payables balances not included in the netting adjustment at September 30, 2022, and December 31, 2021, respectively.

31

A summary of our derivative activity and the related impact on our consolidated statements of income for the three and nine months ended September 30, 2022 and 2021 is as follows:

		Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	Statement of income location	2022		2021		2022		2021
Derivatives designated as hedging instruments:
Interest rate risks:
Amounts reclassified from AOCI into income	Interest income - loans	$	14	$	16	$	43	$	47
Change in fair value of interest rate swaps hedging investment securities	Interest income - investment securities taxable	(2)		5		384		18
Change in fair value of hedged investment securities	Interest income - investment securities taxable	1		(6)		(385)		(19)
Net gains associated with interest rate risk derivatives		$	13	$	15	$	42	$	46
Derivatives not designated as hedging instruments:
Currency exchange risks:
Gains (losses) on revaluations of internal foreign currency instruments, net	Other noninterest income	$	47	$	(14)	26		$	(35)
(Losses) gains on internal foreign exchange forward contracts, net	Other noninterest income	(51)		14		(31)		35
Net losses associated with internal currency risk		$	(4)	$	—	$	(5)	$	—
Other derivative instruments:
Gains on revaluations of client foreign currency instruments, net	Other noninterest income	$	12	$	1	$	7	$	16
(Losses) gains on client foreign exchange forward contracts, net	Other noninterest income	(2)		(5)		5		(15)
Net gains (losses) associated with client currency risk		$	10	$	(4)	$	12	$	1
(Losses) gains on total return swaps	Other noninterest income	$	(2)	$	—	$	25	$	—
Net gains on equity warrant assets	Gains on equity warrant assets, net	$	40	$	147	$	120	$	491
Net gains on other derivatives	Other noninterest income	$	2	$	2	$	8	$	4

32

Balance Sheet Offsetting

Certain of our derivative and other financial instruments are subject to enforceable master netting arrangements with our counterparties. These agreements provide for the net settlement of multiple contracts with a single counterparty through a single payment, in a single currency, in the event of default on or termination of any one contract.

The following table summarizes our assets subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021:

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Statement of Financial Position (1)				Net Amounts of Assets Presented in the Statement of Financial Position (1)		Gross Amounts Not Offset in the Statement of Financial Position		Net Amount
(Dollars in millions)			Financial Instruments		Cash Collateral Received
September 30, 2022
Derivatives	$	597	$	(229)	$	(266)	$	102	$	—	$	102
Reverse repurchase, securities borrowing, and similar arrangements	397		—		—		397		(397)		—
Total	$	994	$	(229)	$	(266)	$	499	$	(397)	$	102
December 31, 2021
Derivatives	$	165	$	(87)	$	(50)	$	28	$	—	$	28
Reverse repurchase, securities borrowing, and similar arrangements	607		—		—		607		(607)		—
Total	$	772	$	(87)	$	(50)	$	635	$	(607)	$	28

(1)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

The following table summarizes our liabilities subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021:

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Statement of Financial Position (1)				Net Amounts of Liabilities Presented in the Statement of Financial Position (1)		Gross Amounts Not Offset in the Statement of Financial Position		Net Amount
(Dollars in millions)			Financial Instruments		Cash Collateral Pledged
September 30, 2022
Derivatives	$	256	$	(229)	$	(5)	$	22	$	—	$	22
Repurchase, securities lending, and similar arrangements	36		—		—		36		—		36
Total	$	292	$	(229)	$	(5)	$	58	$	—	$	58
December 31, 2021
Derivatives	$	148	$	(87)	$	(33)	$	28	$	—	$	28
Repurchase, securities lending, and similar arrangements	61		—		—		61		—		61
Total	$	209	$	(87)	$	(33)	$	89	$	—	$	89

(1)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

9.    Noninterest Income

All of the Company's revenue from contracts with customers within the scope of ASC 606, Revenue from Contracts with Customers, is recognized within noninterest income. Included below is a summary of noninterest income for the three and nine months ended September 30, 2022 and 2021:

33

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Noninterest income:
Gains (losses) on investment securities, net	$	(127)	$	189	$	(199)	$	661
Gains on equity warrant assets, net	40		147		120		491
Client investment fees	119		20		237		55
Wealth management and trust fees	19		22		63		22
Foreign exchange fees	74		65		216		189
Credit card fees	37		34		114		93
Deposit service charges	32		29		94		82
Lending related fees	20		21		65		55
Letters of credit and standby letters of credit fees	15		13		43		39
Investment banking revenue	75		90		293		335
Commissions	24		17		73		58
Other	31		25		119		97
Total noninterest income	$	359	$	672	$	1,238	$	2,177

Gains on investment securities, net

Net gains (losses) on investment securities include both gains and losses from our non-marketable and other equity securities, which include public equity securities held as a result of exercised equity warrant assets, gains and losses from sales of our AFS debt securities portfolio, when applicable, and carried interest.

Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt and credit funds, private and public portfolio companies, which include public equity securities held as a result of exercised equity warrant assets, and qualified affordable housing projects. We experience variability in the performance of our non-marketable and other equity securities from period to period, which results in net gains or losses on investment securities (both realized and unrealized). This variability is due to a number of factors, including unrealized changes in the values of our investments, changes in the amount of realized gains from distributions, changes in liquidity events and general economic and market conditions. Unrealized gains and losses from non-marketable and other equity securities for any single period are typically driven by valuation changes.

The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of certain sales restrictions to which these equity securities may be subject to (e.g., lock-up agreements), changes in prevailing market prices, market conditions, the actual sales or distributions of securities, and the timing of such actual sales or distributions, which, to the extent such securities are managed by our managed funds, are subject to our funds' separate discretionary sales/distributions and governance processes.

Carried interest is comprised of preferential allocations of profits recognizable when the return on assets of our individual managed fund of funds and direct venture funds exceeds certain performance targets and is payable to us, as the general partners of the managed funds. The carried interest we earn is often shared with employees, who are also members of the general partner entities. We record carried interest on a quarterly basis by measuring fund performance to date versus the performance target. For our unconsolidated managed funds, carried interest is recorded as gains on investment securities, net. For our consolidated managed funds, it is recorded as a component of net income attributable to noncontrolling interests. Carried interest allocated to others is recorded as a component of net income attributable to noncontrolling interests. Any carried interest paid to us (or our employees) may be subject to reversal to the extent fund performance declines to a level where inception to date carried interest is lower than actual payments made by the funds. The limited partnership agreements for our funds provide that carried interest is generally not paid to the general partners until the funds have provided a full return of contributed capital to the limited partners. Accrued, but unpaid carried interest may be subject to reversal to the extent that the fund performance declines to a level where inception-to-date carried interest is less than prior amounts recognized. Carried interest income is accounted for under an ownership model based on ASC 323, Equity Method of Accounting and ASC 810, Consolidation.

Our AFS securities portfolio is a fixed income investment portfolio that is managed with the objective of earning an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification as well as addressing our asset/liability management objectives. Though infrequent, sales of debt securities in our AFS securities portfolio may result in net gains or losses and are conducted pursuant to the guidelines of our investment policy related to the management of our liquidity position and interest rate risk.

34

Gains and losses on investment securities are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our investment-related activities. A summary of gains and losses on investment securities for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Gains (losses) on non-marketable and other equity securities, net	$	(127)	$	189	$	(247)	$	661
Gains (losses) on sales of AFS securities, net	—		—		48		—
Total gains (losses) on investment securities, net	$	(127)	$	189	$	(199)	$	661

Gains on equity warrant assets, net

In connection with negotiating credit facilities and certain other services, we often obtain rights to acquire stock in the form of equity warrant assets in primarily private, venture-backed companies in the technology and life science/healthcare industries. Any changes in fair value from the grant date fair value of equity warrant assets will be recognized as increases or decreases to other assets on our balance sheet and as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income.

Gains on equity warrant assets are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of net gains on equity warrant assets for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Equity warrant assets:
Gains on exercises, net	$	9	$	91	$	44	$	381
Terminations	(1)		(1)		(3)		(2)
Changes in fair value, net	32		57		79		112
Total net gains on equity warrant assets	$	40	$	147	$	120	$	491

Client investment fees

Client investment fees include fees earned from discretionary investment management services for managing clients’ portfolios based on their investment policies, strategies and objectives. Revenue is recognized on a monthly basis upon completion of our performance obligation, and consideration is typically received in the subsequent month. Included in our sweep money market fees are Rule 12(b)-1 fees, revenue sharing and customer transactional-based fees. Rule 12(b)-1 fees and revenue sharing are recognized as earned based on client funds that are invested in the period, typically monthly. Transactional based fees are earned and recognized on fixed income securities when the transaction is executed on the clients' behalf. Amounts paid to third-party service providers are predominantly expensed, such that client investment fees are recorded gross of payments made to third parties. A summary of client investment fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Client investment fees by type:
Sweep money market fees	$	64	$	12	$	144	$	31
Asset management fees (1)	16		7		41		22
Repurchase agreement fees	39		1		52		2
Total client investment fees (2)	$	119	$	20	$	237	$	55

(1)Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.

(2)Represents fees earned on client investment funds that are maintained at third-party financial institutions and are not recorded on our balance sheet.

Wealth management and trust fees

Wealth management fees are earned for providing wealth management, retirement plan advisory, family office, financial planning, trust services and other financial advisory services to clients. The Company’s performance obligation under these contracts is satisfied over time as the services are provided. Fees are recognized monthly based on the average monthly, beginning-of-quarter, or, for a small number of clients, end-of-quarter market value of the Private Bank AUM and the applicable fee rate, depending on the terms of the contracts. Fees are also recognized monthly based either on a fixed fee amount or are based on the quarter-end (in arrears) market value of the Private Bank AUM and the applicable fee rate,

35

depending on the terms of the contracts. No performance-based incentives are earned under wealth management contracts. Receivables are recorded on the Consolidated Balance Sheets in the "Accrued interest receivable and other assets" line item.

Trust fees are earned when the Company is appointed as trustee for clients. As trustee, the Company administers the client’s trust and manages the assets of the trust, including investments and property. The Company’s performance obligation under these agreements is satisfied over time as the administration and management services are provided. Fees are recognized monthly or, in certain circumstances, quarterly based on a percentage of the market value of the account as outlined in the agreement. Payment frequency is defined in the individual contracts, which primarily stipulate monthly in arrears. No performance-based incentives are earned on trust fee contracts. Receivables are recorded on the Consolidated Balance Sheets in the "Accrued interest receivable and other assets" line item. A summary of wealth management and trust fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Wealth management and trust fees by type:
Wealth management fees	$	17	$	20	$	58	$	20
Trust fees	2		2		5		2
Total wealth management and trust fees	$	19	$	22	$	63	$	22

Foreign exchange fees

Foreign exchange fees represent the income differential between purchases and sales of foreign currency on behalf of our clients, primarily from spot contracts. Foreign exchange spot contract fees recognized upon the completion of a single performance obligation are recognized within the scope of ASC 606.

Foreign exchange contracts and option premium fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of foreign exchange fee income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Foreign exchange fees by instrument type:
Foreign exchange contract commissions	$	74	$	65	$	215	$	188
Option premium fees	—		—		1		1
Total foreign exchange fees	$	74	$	65	$	216	$	189

Credit card fees

Credit card fees include interchange income from credit and debit cards and fees earned from processing transactions for merchants. Interchange income is earned after satisfying our performance obligation of providing nightly settlement services to a payment network. Costs related to rewards programs are recorded when the rewards are earned by the customer and presented as a reduction to interchange fee income. Rewards programs continue to be accounted for under ASC 310, Receivables. Our performance obligations for merchant service fees are to transmit data and funds between the merchant and the payment network. Credit card interchange and merchant service fees are earned daily upon completion of transaction settlement services.

Annual card service fees are recognized on a straight-line basis over a 12-month period and continue to be accounted for under ASC 310, Receivables.

A summary of credit card fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Credit card fees by instrument type:
Card interchange fees, net	$	29	$	29	$	91	$	78
Merchant service fees	6		4		18		12
Card service fees	2		1		5		3
Total credit card fees	$	37	$	34	$	114	$	93

36

Deposit service charges

Deposit service charges include fees earned from performing cash management activities and other deposit account services. Deposit services include, but are not limited to, the following: receivables services, which include merchant services, remote capture, lockbox, electronic deposit capture, and fraud control services. Payment and cash management products and services include wire transfer and automated clearing house payment services to enable clients to transfer funds more quickly, as well as business bill pay, business credit and debit cards, account analysis, and disbursement services. Deposit service charges are recognized over the period in which the related performance obligation is provided, generally on a monthly basis, and are presented in the "Disaggregation of revenue from contracts with customers" tables below.

Lending related fees

Unused commitment fees, minimum finance fees and unused line fees are recognized as earned on a monthly basis. Fees that qualify for syndication treatment are recognized at the completion of the syndicated loan deal for which the fees were received. Lending related fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our lending-related activities. A summary of lending related fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Lending related fees by instrument type:
Unused commitment fees	$	14	$	14	$	49	$	42
Other	6		7		16		13
Total lending related fees	$	20	$	21	$	65	$	55

Letters of credit and standby letters of credit fees

Standby letters of credit represent conditional commitments issued by us on behalf of a client to guarantee the performance of the client to a third party when certain specified future events have occurred. Fees generated from letters of credit and standby letters of credit are deferred as a component of other liabilities and recognized in noninterest income over the commitment period using the straight-line method, based on the likelihood that the commitment being drawn down will be remote. Letters of credit and standby letters of credit fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our lending related activities.

Investment banking revenue

We earn investment banking revenue from clients for providing services related to securities underwriting, private placements and advisory services on strategic matters such as mergers and acquisitions. Underwriting fees are attributable to public and private offerings of equity and debt securities and are recognized at the point in time when the offering has been deemed to be completed by the lead manager of the underwriting group. Once the offering is completed, the performance obligation has been satisfied; we recognize the applicable management fee as well as the underwriting fee, net of consideration payable to customers. Private placement fees are recognized at the point in time when the private placement is completed, which is generally when the client accepts capital from the fund raise. Advisory fees from mergers and acquisitions engagements are generally recognized at the point in time when the related transaction is completed. Expenses are deferred only to the extent they are explicitly reimbursable by the client and the related revenue is recognized at a point in time. All other deal-related expenses are expensed as incurred. We have determined that we act as principal in the majority of these transactions and therefore present expenses gross within other operating expenses.

A summary of investment banking revenue by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Investment banking revenue:
Underwriting fees	$	24	$	39	$	97	$	248
Advisory fees	40		26		163		39
Private placements and other	11		25		33		48
Total investment banking revenue	$	75	$	90	$	293	$	335

37

Commissions

Commissions include commissions received from customers for the execution of agency-based brokerage transactions in listed and over-the-counter equities. The execution of each trade order represents a distinct performance obligation, and the transaction price is fixed at the point in time or trade order execution. Trade execution is satisfied at the point in time that the customer has control of the asset and as such, fees are recorded on a trade date basis. The Company also earns subscription fees for market intelligence services that are recognized over the period in which they are delivered. Fees received before the subscription period ends are initially recorded as deferred revenue (a contract liability) in other liabilities in our consolidated balance sheet. Commissions are presented in the "Disaggregation of revenue from contracts with customers" table below.

Other

Other noninterest income primarily includes income from fund management fees, gains from conversion of convertible debt options and service revenue. Fund management fees are comprised of fees charged directly to our managed funds of funds and direct venture funds. Fund management fees are based upon the contractual terms of the limited partnership agreements and are generally recognized as earned over the specified contract period, which is generally equal to the life of the individual fund. Fund management fees are calculated as a percentage of committed capital and collected quarterly in advance and recognized over the quarter. Fund management fees for certain of our limited partnership agreements are calculated as a percentage of distributions made by the funds, and revenue is recorded only at the time of a distribution event. As distribution events are not predetermined for these certain funds, management fees are considered variable and constrained under ASC 606.

Gains from conversion of convertible debt options represent unrealized valuation gains on loan conversion derivative assets, and realized gains from the conversion of debt instruments, convertible into a third party’s common stock upon a triggering event such as an IPO. Gains from conversion of convertible debt options are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities.

Other service revenue primarily consists of gains or losses from changes in fair value of total return swaps, dividend income on FHLB/FRB stock, correspondent bank rebate income, incentive fees, or performance fees related to carried interest and other fee income. We recognize revenue when our performance obligations are met and record revenues on a daily/monthly, quarterly, semi-annual or annual basis. For event driven revenue sources, we recognize revenue when: (i) persuasive evidence of an arrangement exists, (ii) we have performed the service, provided we have no other remaining obligations to the customer, (iii) the fee is fixed or determinable and (iv) collectability is probable.

A summary of other noninterest income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Other noninterest income by instrument type:
Fund management fees	$	16	$	15	$	43	$	51
Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)	6		(4)		7		1
Gains on total return swaps	(3)		—		25		—
Other service revenue	12		14		44		45
Total other noninterest income	$	31	$	25	$	119	$	97

(1)Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.

38

Disaggregation of revenue from contracts with customers

The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the three and nine months ended September 30, 2022 and 2021:

Three months ended September 30, 2022	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	119	$	—	$	—	$	—	$	—	$	119
Wealth management and trust fees	—		19		—		—		—		19
Card interchange fees, gross	54		1		—		—		—		55
Merchant service fees	7		—		—		—		—		7
Deposit service charges	32		—		—		—		—		32
Investment banking revenue	—		—		—		75		—		75
Commissions	—		—		—		24		—		24
Fund management fees	1		—		13		2		—		16
Other (1)	1		—		2		—		—		3
Total revenue from contracts with customers	$	214	$	20	$	15	$	101	$	—	$	350
Revenues outside the scope of ASC 606 (2)	94		2		(69)		(1)		(17)		9
Total noninterest income	$	308	$	22	$	(54)	$	100	$	(17)	$	359

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Three months ended September 30, 2021	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	20	$	—	$	—	$	—	$	—	$	20
Wealth management and trust fees	—		22								22
Card interchange fees, gross	52		—		—		—		—		52
Merchant service fees	4		—		—		—		—		4
Deposit service charges	28		—		—		—		1		29
Investment banking revenue	—		—		—		90		—		90
Commissions	—		—		—		17		—		17
Fund management fees	—		—		14		1		—		15
Other (1)	61		1		4		—		—		66
Total revenue from contracts with customers	165		23		18		108		1		315
Revenues outside the scope of ASC 606 (2)	17		2		127		23		188		357
Total noninterest income	$	182	$	25	$	145	$	131	$	189	$	672

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

39

Nine months ended September 30, 2022	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	236	$	—	$	—	$	—	$	1	$	237
Wealth management and trust fees	—		63		—		—		—		63
Card interchange fees, gross	170		1		—		—		2		173
Merchant service fees	18		—		—		—		—		18
Deposit service charges	92		1		—		—		1		94
Investment banking revenue	—		—		—		293		—		293
Commissions	—		—		—		73		—		73
Fund management fees	1		—		37		5		—		43
Other (1)	69		1		6		—		—		76
Total revenue from contracts with customers	$	586	$	66	$	43	$	371	$	4	$	1,070
Revenues outside the scope of ASC 606 (2)	195		6		(121)		(19)		107		168
Total noninterest income	$	781	$	72	$	(78)	$	352	$	111	$	1,238

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Nine months ended September 30, 2021	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	53	$	2	$	—	$	—	$	—	$	55
Wealth management and trust fees	—		22		—		—		—		22
Card interchange fees, gross	140		1		—		—		1		142
Merchant service fees	12		—		—		—		—		12
Deposit service charges	80		—		—		—		2		82
Investment banking revenue	—		—		—		335		—		335
Commissions	—		—		—		58		—		58
Fund management fees	—		—		47		4		—		51
Other (1)	178		1		12		—		—		191
Total revenue from contracts with customers	$	463	$	26	$	59	$	397	$	3	$	948
Revenues outside the scope of ASC 606 (2)	51		2		330		53		793		1,229
Total noninterest income	$	514	$	28	$	389	$	450	$	796	$	2,177

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

The timing of revenue recognition may differ from the timing of cash settlements or invoicing to customers. We record a receivable when revenue is recognized prior to invoicing, and unearned revenue when revenue is recognized subsequent to receipt of consideration. These assets and liabilities are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. During the three and nine months ended September 30, 2022 and 2021, changes in our contract assets, contract liabilities and receivables were not material. Additionally, revenues recognized during the three and nine months ended September 30, 2022 and 2021 that were included in the corresponding contract liability balance at the beginning of the periods were not material.

10.    Segment Reporting

We have four reportable segments for management reporting purposes: Silicon Valley Bank, SVB Private, SVB Capital and SVB Securities. The results of our reportable and operating segments are based on our internal management reporting process.

40

We report segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of our reporting segments. During the quarter ended March 31, 2022, we reevaluated our segments. Based on this reevaluation, the Premium Wine reporting division was moved from Silicon Valley Bank to the SVB Private segment. These changes were made to reflect the manner in which the Company is organized for purposes of making operating decisions and assessing performance. For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been recast to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reclassification of historical segment information has no effect on the Company's previously reported consolidated balance sheets, statements of income, or cash flows, and the change did not have any impact on the determination of the reporting units used to assess impairment under ASC 350, Intangibles - Goodwill and Other.

Our Silicon Valley Bank and SVB Private segments primary source of revenue is from net interest income, which is primarily the difference between interest earned on loans, net of FTP, and interest paid on deposits, net of FTP. Accordingly, these segments are reported using net interest income, net of FTP. FTP is an internal measurement framework designed to assess the financial impact of a financial institution’s sources and uses of funds. It is the mechanism by which a funding credit is given for deposits raised, and a funding charge is made for funded loans. FTP is calculated at an instrument level based on account characteristics.

We also evaluate performance based on provision for credit losses, noninterest income and noninterest expense, which are presented as components of segment operating profit or loss. In calculating each operating segment’s noninterest expense, we consider the direct costs incurred by the operating segment as well as certain allocated direct costs. As part of this review, we allocate certain corporate overhead costs to a corporate account. We do not allocate income tax expense, the provisions for unfunded credit commitments, or HTM securities (included in provision for credit losses) to our segments. Additionally, our management reporting model is predicated on average asset balances; therefore, period-end asset balances are not presented for segment reporting purposes. Changes in an individual client’s primary relationship designation have resulted, and in the future may result, in the inclusion of certain clients in different segments in different periods.

Unlike financial reporting, which benefits from the comprehensive structure provided by GAAP, our internal management reporting process is highly subjective, as there is no comprehensive, authoritative guidance for management reporting. Our management reporting process measures the performance of our operating segments based on our internal operating structure, which is subject to change from time to time, and is not necessarily comparable with similar information for other financial services companies.

For reporting purposes, SVB Financial Group has four operating segments for which we report our financial information:

•Silicon Valley Bank is our commercial bank which offers products and services provided by the Bank and its subsidiaries to commercial clients in key innovation markets. The Bank provides solutions to the financial needs of commercial clients through credit, treasury management, foreign exchange, trade finance, and other services. In addition, the Bank and its subsidiaries offer a variety of investment services and solutions to its clients that enable them to effectively manage their assets. Our commercial bank consists of services provided to clients in the Tech and Healthcare industries, as well as private equity and venture capital firms, and includes clients from international operations in EMEA, Asia and Canada.

•SVB Private is our private bank and wealth management segment of the Bank. SVB Private provides a range of personal financial solutions for consumers. Our clients are primarily private equity/venture capital professionals and executive leaders of the innovation companies they support as well as high net worth clients acquired from Boston Private and our premium wine clients. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted and private stock loans, capital call lines of credit, other secured and unsecured lending products and vineyard development loans, as well as planning-based financial strategies, wealth management, family office, financial planning, tax planning and trust services. In addition, we provide real estate secured loans to eligible employees through our EHOP.

•SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. SVB Capital manages funds (primarily venture capital funds) on behalf of third-party limited partners and, on a more limited basis, SVB Financial Group. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds, as well as debt funds that provide lending and other financing solutions. SVB Capital generates income for the Company primarily from investment returns (including carried interest allocations) and management fees.

•SVB Securities is an investment bank focused on the innovation economy and operates as a wholly-owned subsidiary of SVB Financial Group. SVB Securities provides investment banking services across all major sub-sectors of Healthcare and Technology. Healthcare sub-sectors include Biopharma, Digital Health and HealthTech,

41

Healthcare Services, Medical Devices and Tools and Diagnostics. Technology sub-sectors include Consumer Internet, Commerce Enablement and Marketing Software, Digital Infrastructure and Tech-Enabled Services, Education Technology, Enterprise Software, Industrial Technology and FinTech. SVB Securities focuses on four main product and service offerings: Capital Raising, M&A Advisory, Equity Research and Sales and Trading.

The following table presents a summary of financial results of our reportable segments along with a reconciliation to our consolidated interim results. Our reportable segment information for the three and nine months ended September 30, 2022 and 2021 is as follows:

(Dollars in millions)	Silicon Valley Bank (1)		SVB Private		SVB Capital (1)		SVB Securities (1)		Other Items (2)		Total
Three months ended September 30, 2022
Net interest income	$	1,107	$	111	$	—	$	1	$	(21)	$	1,198
(Provision for) reduction of credit losses	(32)		3		—		—		(43)		(72)
Noninterest income (loss)	308		22		(54)		100		(17)		359
Noninterest expense (3)	(381)		(85)		(17)		(131)		(278)		(892)
Income (loss) before income tax expense (4)	$	1,002	$	51	$	(71)	$	(30)	$	(359)	$	593
Total average loans, amortized cost	$	55,177	$	15,181	$	—	$	—	$	740	$	71,098
Total average assets (5) (6)	175,620		17,032		883		898		21,307		215,740
Total average deposits	172,427		12,436		—		—		693		185,556
Three months ended September 30, 2021
Net interest income (7)	$	766	$	74	$	—	$	—	$	12	$	852
Provision for credit losses	29		(20)		—		—		(30)		(21)
Noninterest income	182		25		145		131		189		672
Noninterest expense (3) (7)	(336)		(93)		(15)		(142)		(293)		(879)
Income before income tax expense (4) (7)	$	641	$	(14)	$	130	$	(11)	$	(122)	$	624
Total average loans, amortized cost (7)	$	44,789	$	13,515	$	—	$	—	$	987	$	59,291
Total average assets (5) (6) (7)	151,352		15,930		730		837		13,841		182,690
Total average deposits (7)	148,879		13,431		—		—		1,082		163,392
Nine months ended September 30, 2022
Net interest income	$	2,993	$	296	$	—	$	1	$	157	$	3,447
Provision for credit losses	(174)		(9)		—		—		(96)		(279)
Noninterest income (loss)	781		72		(78)		352		111		1,238
Noninterest expense (3)	(1,148)		(267)		(53)		(406)		(739)		(2,613)
Income before income tax expense (4)	$	2,452	$	92	$	(131)	$	(53)	$	(567)	$	1,793
Total average loans, amortized cost	$	53,855	$	14,711	$	—	$	—	$	592	$	69,158
Total average assets (5) (6)	178,209		16,456		956		912		20,119		216,652
Total average deposits	175,370		13,327		—		—		731		189,428
Nine months ended September 30, 2021
Net interest income (7)	$	2,084	$	146	$	—	$	—	$	10	$	2,240
(Provision for) reduction of credit losses	(27)		(16)		—		—		(32)		(75)
Noninterest income	514		28		389		450		796		2,177
Noninterest expense (3) (7)	(911)		(126)		(48)		(376)		(707)		(2,168)
Income before income tax expense (4) (7)	$	1,660	$	32	$	341	$	74	$	67	2,174
Total average loans, amortized cost (7)	$	41,591	$	8,610	$	—	$	—	$	1,642	$	51,843
Total average assets (5) (6) (7)	130,177		9,459		641		778		11,897		152,952
Total average deposits (7)	128,006		7,108		—		—		999		136,113

(1)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within “Other Items."

(2)The “Other Items” column reflects the adjustments necessary to reconcile the results of the reportable segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains or losses on equity warrant assets, gains or losses on the sale of AFS securities and gains or losses on equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses.

(3)The Silicon Valley Bank segment includes direct depreciation and amortization of $13 million and $10 million for the three months ended September 30, 2022 and 2021, respectively and $34 million and $25 million for the nine months ended September 30, 2022 and 2021, respectively.

(4)The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.

(5)Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders' equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP.

42

(6)Included in the total average assets for SVB Securities and SVB Private is goodwill of $174 million and $201 million, respectively, for the three and nine months ended September 30, 2022, and included in the total average assets for SVB Securities and SVB Private is goodwill of $138 million and $201 million for the three and nine months ended September 30, 2021, respectively.

(7)For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been allocated to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reallocation had no impact on the "Total" amount.

11.    Off-Balance Sheet Arrangements, Guarantees and Other Commitments

In the normal course of business, we use financial instruments with off-balance sheet risk to meet the financing needs of our customers. These financial instruments include commitments to extend credit, commercial and standby letters of credit and commitments to invest in venture capital and private equity fund investments. These instruments involve, to varying degrees, elements of credit risk. Credit risk is defined as the possibility of sustaining a loss because other parties to the financial instrument fail to perform in accordance with the terms of the contract.

Commitments to Extend Credit

The following table summarizes information related to our commitments to extend credit at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Loan commitments (1)	$	51,769	$	40,327
Standby letters of credit (2)	3,824		3,612
Commercial letters of credit (3)	105		77
Total unfunded credit commitments	$	55,698	$	44,016
Allowance for unfunded credit commitments (4)	265		171

(1)Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.

(2)See below for additional information on our standby letters of credit.

(3)Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature.

(4)Our allowance for credit losses for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.

The table below summarizes our standby letters of credit at September 30, 2022. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged.

(Dollars in millions)	Expires in One Year or Less		Expires After One Year		Total Amount Outstanding		Maximum Amount of Future Payments
Financial standby letters of credit	$	3,617	$	126	$	3,743	$	3,743
Performance standby letters of credit	72		9		81		81
Total	$	3,689	$	135	$	3,824	$	3,824

Deferred fees related to financial and performance standby letters of credit were $20 million at both September 30, 2022 and December 31, 2021.

43

Commitments to Invest in Venture Capital and Private Equity Funds

We make commitments to invest in venture capital and private equity funds, which generally make investments in privately-held companies. Commitments to invest in these funds are generally made for a 10-year period from the inception of the fund. Although the limited partnership agreements governing these investments typically do not restrict the general partners from calling 100% of committed capital in one year, it is customary for these funds to call most of the capital commitments over 5 to 7 years, and in certain cases, the funds may not call 100% of committed capital. The actual timing of future cash requirements to fund these commitments is generally dependent upon the investment cycle, overall market conditions, and the nature and type of industry in which the privately held companies operate. The following table details our total capital commitments, unfunded capital commitments, and our ownership percentage in each fund at September 30, 2022:

(Dollars in millions)	SVBFG Capital Commitments		SVBFG Unfunded Commitments		SVBFG Ownership of each Fund
Redwood Evergreen Fund, LP	$	250	$	119	100.0	%
CP II, LP (1)	1		—		5.1
Capital Preferred Return Fund, LP	13		—		20.0
Growth Partners, LP	25		1		33.0
Strategic Investors Fund, LP	15		1		12.6
Strategic Investors Fund II, LP	15		1		8.6
Strategic Investors Fund III, LP	15		1		5.9
Strategic Investors Fund IV, LP	12		2		5.0
Strategic Investors Fund V funds	1		—		Various
Other venture capital and private equity fund investments (equity method accounting)	18		5		Various
Debt funds (equity method accounting)	59		—		Various
Other fund investments (2)	248		12		Various
Total	$	672	$	142

(1)Our ownership includes direct ownership of 1.3 percent and indirect ownership interest of 3.8 percent through our investment in Strategic Investors Fund II, LP.

(2)Represents commitments to 147 funds (primarily venture capital funds) where our ownership interest is generally less than 5.0 percent of the voting interests of each such fund.

At September 30, 2022 we had $3 million of remaining unfunded commitments to venture capital and private equity funds by our consolidated managed funds of funds (including our interest and the noncontrolling interests).

12.    Income Taxes

We are subject to income tax and non-income based taxes by the U.S. federal tax authorities as well as various state and foreign tax authorities. We have identified the U.S. federal and California state jurisdictions as major tax filings. The state of California is currently examining the years 2013-2016. Our U.S. federal tax returns remain open to full examination for 2019 and subsequent tax years. Our California tax returns remain open to full examination for 2017 and subsequent tax years.

At September 30, 2022, our unrecognized tax benefit was $42 million, the recognition of which would reduce our income tax expense by $34 million. We are unable to estimate the unrecognized tax benefit that will materially change in the next 12 months.

We recognize interest and penalties related to income tax matters as part of income before income taxes. Interest and penalties were not material for the three and nine months ended September 30, 2022.

13.    Fair Value of Financial Instruments

Fair Value Measurements

Our AFS securities, derivative instruments and certain non-marketable and other equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our interim consolidated financial statements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (the “exit price”) in an orderly transaction between market participants at the measurement date. There is a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable and on the significance of those inputs in the fair value measurement. Observable inputs reflect market-derived or market-based

44

information obtained from independent sources, while unobservable inputs reflect our estimates about market data and views of market participants. The three levels for measuring fair value are based on the reliability of inputs and are as follows:

Level 1

Fair value measurements based on quoted prices in active markets for identical assets or liabilities that we have the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree of judgment. Assets utilizing Level 1 inputs include U.S. Treasury securities, foreign government debt securities, exchange-traded equity securities, certain marketable securities accounted for under fair value accounting, and assets and liabilities related to the deferred compensation plan assumed during the merger with Boston Private.    

Level 2

Fair value measurements based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly. Valuations for the AFS securities are provided by independent pricing service providers who have experience in valuing these securities and are compared to the average of quoted market prices obtained from independent brokers. We perform a monthly analysis on the values received from third parties to ensure that the prices represent a reasonable estimate of the fair value. The procedures include, but are not limited to, initial and ongoing review of third-party pricing methodologies, review of pricing trends and monitoring of trading volumes. Additional corroboration, such as obtaining a non-binding price from a broker, may be obtained depending on the frequency of trades of the security and the level of liquidity or depth of the market. Prices received from independent brokers represent a reasonable estimate of the fair value and are validated through the use of observable market inputs including comparable trades, yield curve, spreads and, when available, market indices. If we determine that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly. Below is a summary of the significant inputs used for each class of Level 2 assets and liabilities:

U.S. agency debentures: Fair value measurements of U.S. agency debentures are based on the characteristics specific to bonds held, such as issuer name, issuance date, coupon rate, maturity date and any applicable issuer call option features. Valuations are based on market spreads relative to similar term benchmark market interest rates, generally U.S. Treasury securities.

Agency-issued MBS: Agency-issued MBS are pools of individual conventional mortgage loans underwritten to U.S. agency standards with similar coupon rates, tenor, and other attributes such as geographic location, loan size and origination vintage. Fair value measurements of these securities are based on observable price adjustments relative to benchmark market interest rates taking into consideration estimated loan prepayment speeds.

Agency-issued CMO: Agency-issued CMO are structured into classes or tranches with defined cash flow characteristics and are collateralized by U.S. agency-issued mortgage pass-through securities. Fair value measurements of these securities incorporate similar characteristics of mortgage pass-through securities such as coupon rate, tenor, geographic location, loan size and origination vintage, in addition to incorporating the effect of estimated prepayment speeds on the cash flow structure of the class or tranche. These measurements incorporate observable market spreads over an estimated average life after considering the inputs listed above.

Agency-issued CMBS: Fair value measurements of these securities are based on spreads to benchmark market interest rates (usually U.S. Treasury rates or rates observable in the swaps market), prepayment speeds, loan default rate assumptions and loan loss severity assumptions on underlying loans.

Derivative assets and liabilities: Fair value measurements of these assets and liabilities are priced based on the following:

•Foreign exchange forward and option contract assets and liabilities are priced based on spot and forward foreign currency rates and option volatility assumptions.

•Interest rate derivative and interest rate swap assets and liabilities are priced considering the coupon rate of the fixed leg of the contract and the variable coupon rate on the floating leg of the contract. Valuation is based on both spot and forward rates on the swap yield curve and the credit worthiness of the contract counterparty.

•Total return swaps are based upon the performance of the reference asset, the variable coupon rate and spread of the floating leg of the contract.

Other equity securities: Fair value measurements of equity securities of public companies are priced based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Certain sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sale restrictions which typically range from three to six months.

45

Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions.

Level 3

The fair value measurement is derived from valuation techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect our own estimates of assumptions we believe market participants would use in pricing the asset. The valuation techniques are consistent with the market approach, income approach and/or the cost approach used to measure fair value. Below is a summary of the valuation techniques used for each class of Level 3 assets:

Venture capital and private equity fund investments not measured at net asset value: Fair value measurements are based on consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities, and as it relates to the private company, the current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. The significant unobservable inputs used in the fair value measurement include the information about each portfolio company, including actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Significant changes to any one of these inputs in isolation could result in a significant change in the fair value measurement; however, we generally consider all factors available through ongoing communication with the portfolio companies and venture capital fund managers to determine whether there are changes to the portfolio company or the environment that indicate a change in the fair value measurement.

Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain warrants that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed.

Equity warrant assets (private portfolio): Fair value measurements of equity warrant assets of private portfolio companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public market indices whose members operate in similar industries as companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Overall model asset values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. There is a direct correlation between changes in the volatility and remaining life assumptions in isolation and the fair value measurement while there is an inverse correlation between changes in the liquidity discount assumption and the fair value measurement.

Contingent conversion rights (public portfolio): Fair value measurements of contingent conversion rights of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain conversion rights that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed.

Contingent conversion rights (private portfolio): Fair value measurements are based on consideration of a range of factors including, but not limited to, actual and forecasted enterprise values, probability of conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.

46

The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022:

(Dollars in millions)	Level 1		Level 2		Level 3		Netting Adjustments (1)		Balance at September 30, 2022
Assets:
AFS securities:
U.S. Treasury securities	$	16,845	$	—	$	—	$	—	$	16,845
U.S. agency debentures	—		100		—		—		100
Foreign government debt securities	913		—		—		—		913
Residential MBS:
Agency-issued MBS	—		6,683		—		—		6,683
Agency-issued CMO—fixed rate	—		714		—		—		714
Agency-issued CMBS	—		1,456		—		—		1,456
Total AFS securities	17,758		8,953		—		—		26,711
Non-marketable and other equity securities (fair value accounting):
Non-marketable securities:
Venture capital and private equity fund investments measured at net asset value	—		—		—		—		270
Other equity securities in public companies	27		2		—		—		29
Total non-marketable and other equity securities (fair value accounting)	27		2		—		—		299
Other assets:
Derivative assets	—		804		—		(495)		309
Equity warrant assets	—		6		345		—		351
Contingent conversion rights	—		—		6		—		6
Other assets	4		—		—		—		4
Total assets	$	17,789	$	9,765	$	351	$	(495)	$	27,680
Liabilities:
Derivative liabilities	$	—	$	758	$	—	$	(234)	$	524
Other liabilities	4		—		—		—		4
Total liabilities	$	4	$	758	$	—	$	(234)	$	528

(1)Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties

47

The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021:

(Dollars in millions)	Level 1		Level 2		Level 3		Netting Adjustments (1) (2)		Balance at December 31, 2021
Assets:
AFS securities:
U.S. Treasury securities	$	15,850	$	—	$	—	$	—	$	15,850
U.S. agency debentures	—		196		—		—		196
Foreign government debt securities	61		—		—		—		61
Residential MBS:
Agency-issued MBS	—		8,589		—		—		8,589
Agency-issued CMO—fixed rate	—		982		—		—		982
Agency-issued CMBS	—		1,543		—		—		1,543
Total AFS securities	15,911		11,310		—		—		27,221
Non-marketable and other equity securities (fair value accounting):
Non-marketable securities:
Venture capital and private equity fund investments measured at net asset value	—		—		—		—		338
Other equity securities in public companies	43		74		—		—		117
Total non-marketable and other equity securities (fair value accounting)	43		74		—		—		455
Other assets:
Derivative assets (2)	—		288		—		(137)		151
Equity warrant assets	—		8		269		—		277
Other assets	8		—		—		—		8
Total assets	$	15,962	$	11,680	$	269	$	(137)	$	28,112
Liabilities:
Derivative liabilities (2)	$	—	$	238	$	—	$	(120)	$	118
Other liabilities	8		—		—		—		8
Total liabilities	$	8	$	238	$	—	$	(120)	$	126

(1)Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties

(2)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three and nine months ended September 30, 2022 and 2021:

(Dollars in millions)	Beginning Balance		Total Net Gains (Losses) Included in Net Income		Sales/Exits		Issuances		Transfers Out of Level 3		Ending Balance
Three months ended September 30, 2022
Equity warrant assets (1)	$	318	$	39	$	(21)	$	9	$	—	$	345
Contingent conversion rights (2)	6		—		—		—		—		6
Three months ended September 30, 2021
Equity warrant assets (1)	257		149		(146)		6		(1)		265
Nine months ended September 30, 2022
Equity warrant assets (1)	269		124		(67)		21		(2)		345
Contingent conversion rights (2)	—		(1)		—		7		—		6
Nine months ended September 30, 2021
Equity warrant assets (1)	192		490		(431)		18		(4)		265

(1)Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income.

(2)Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.

48

The following table presents the amount of net unrealized gains and losses included in earnings attributable to Level 3 assets still held at September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Other assets:
Equity warrant assets (1)	$	26	$	21	$	84	$	113
Contingent conversion rights (2)	—		—		(1)		—
Total unrealized gains, net	$	26	$	21	$	83	$	113

(1)Unrealized gains and losses are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income.

(2)Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.

The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of current sales restrictions to which these securities are subject, the actual sales of securities and the timing of such actual sales.

The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at September 30, 2022 and December 31, 2021. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.

(Dollars in millions)	Fair value	Valuation Technique	Significant Unobservable Inputs	Input Range	Weighted  Average
September 30, 2022:
Equity warrant assets (private portfolio)	345	Black-Scholes option pricing model	Volatility	23.8 - 51.3	42.3
			Risk-Free interest rate	3.3 - 4.4	4.2
			Marketability discount (2)	17.1	17.1
			Remaining life assumption (3)	40.0	40.0
Contingent conversion rights (private portfolio)	6	Private company equity pricing	(4)	(4)	(4)
December 31, 2021:
Equity warrant assets (public portfolio)	2	Black-Scholes option pricing model	Volatility	27.8% - 55.0%	43.7	%
			Risk-Free interest rate	0.6- 1.5	1.1
			Sales restrictions discount (1)	10.0 - 20.0	10.7
Equity warrant assets (private portfolio)	267	Black-Scholes option pricing model	Volatility	24.7 - 55.0	43.0
			Risk-Free interest rate	0.06 - 1.40	0.8
			Marketability discount (2)	20.1	20.1
			Remaining life assumption (3)	40.0	40.0

    

(1)We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions, which typically range from three to six months.

(2)Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.

(3)We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At September 30, 2022, the weighted average contractual remaining term was 6.2 years, compared to our estimated remaining life of 2.5 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.

(4)In determining the fair value of our private contingent conversion rights portfolio (not valued using the Black-Scholes model), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted enterprise values, the probability of a conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.

For the three and nine months ended September 30, 2022 and 2021, we did not have any transfers between Level 3 and Level 1. All transfers from Level 3 to Level 2 for the three and nine months ended September 30, 2022 and 2021 were due to the transfer of equity warrant assets from our private portfolio to our public portfolio (see our Level 3 reconciliation above).

49

Financial Instruments not Carried at Fair Value

FASB guidance over financial instruments requires that we disclose estimated fair values for our financial instruments not carried at fair value. The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at September 30, 2022 and December 31, 2021:

			Estimated Fair Value
(Dollars in millions)	Carrying Amount		Total		Level 1		Level 2		Level 3
September 30, 2022:
Financial assets:
Cash and cash equivalents	$	13,968	$	13,968	$	13,968	$	—	$	—
HTM securities	93,286		77,370		—		77,370		—
Non-marketable securities not measured at net asset value	431		431		—		—		431
Non-marketable securities measured at net asset value	660		660		—		—		—
Net loans	71,572		72,489		—		—		72,489
FHLB and Federal Reserve Bank stock	665		665		—		—		665
Financial liabilities:
Short-term borrowings	13,552		13,552		—		13,552		—
Non-maturity deposits (1)	171,545		171,545		171,545		—		—
Time deposits	5,274		4,916		—		4,916		—
3.50% Senior Notes	349		336		—		336		—
3.125% Senior Notes	496		407		—		407		—
1.800% Senior Notes due 2031	495		358		—		358		—
2.100% Senior Notes due 2028	496		408		—		408		—
1.800% Senior Notes due 2026	646		559		—		559		—
4.345% Senior Notes due 2028	348		327		—		327		—
4.570% Senior Notes due 2033	447		396		—		396		—
Junior subordinated debentures	91		91		—		91		—
Off-balance sheet financial assets:
Commitments to extend credit	—		49		—		—		49
December 31, 2021:
Financial assets:
Cash and cash equivalents	$	14,586	$	14,586	$	14,586	$	—	$	—
HTM securities	98,195		97,227		—		97,227		—
Non-marketable securities not measured at net asset value	424		424		—		—		424
Non-marketable securities measured at net asset value	710		710		—		—		—
Net loans	65,854		67,335		—		—		67,335
FHLB and Federal Reserve Bank stock	107		107		—		—		107
Financial liabilities:
Short-term borrowings	71		71		—		71		—
Non-maturity deposits (1)	187,464		187,464		187,464		—		—
Time deposits	1,739		1,728		—		1,728		—
3.50% Senior Notes	349		370		—		370		—
3.125% Senior Notes	496		526		—		526		—
1.800% Senior Notes due 2031	494		474		—		474		—
2.100% Senior Notes due 2028	496		501		—		501		—
1.800% Senior Notes due 2026	645		649		—		649		—
Junior subordinated debentures	90		92		—		92		—
Off-balance sheet financial assets:
Commitments to extend credit	—		47		—		—		47

(1)Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.

50

Investments in Entities that Calculate Net Asset Value Per Share

FASB guidance over certain fund investments requires that we disclose the fair value of funds, significant investment strategies of the investees, redemption features of the investees, restrictions on the ability to sell investments, estimate of the period of time over which the underlying assets are expected to be liquidated by the investee and unfunded commitments related to the investments.

Our investments in debt funds and venture capital and private equity fund investments generally cannot be redeemed. Alternatively, we expect distributions, if any, to be received primarily through IPO and M&A activity of the underlying assets of the fund. Subject to applicable requirements under the Volcker Rule, we do not have any plans to sell any of these fund investments. If we decide to sell these investments in the future, the investee fund’s management must approve of the buyer before the sale of the investments can be completed. The fair values of the fund investments have been estimated using the net asset value per share of the investments, adjusted for any differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30th for our September 30th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of September 30, 2022:

(Dollars in millions)	Carrying Amount		Fair Value		Unfunded Commitments
Non-marketable securities (fair value accounting):
Venture capital and private equity fund investments (1)	$	270	$	270	$	13
Non-marketable securities (equity method accounting):
Venture capital and private equity fund investments (2)	639		639		11
Debt funds (2)	4		4		—
Other investments (2)	17		17		1
Total	$	930	$	930	$	25

(1)Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $42 million and $2 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.

(2)Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.

14.    Legal Matters

Certain lawsuits and claims arising in the ordinary course of business have been filed or are pending against us and/or our affiliates, and we may from time to time be involved in other legal or regulatory proceedings. In accordance with applicable accounting guidance, we establish accruals for all such matters, including expected settlements, when we believe it is probable that a loss has been incurred and the amount of the loss is reasonably estimable. When a loss contingency is not both probable and estimable, we do not establish an accrual. Any such loss estimates are inherently uncertain, based on currently available information and are subject to management’s judgment and various assumptions. Due to the inherent subjectivity of these estimates and unpredictability of outcomes of legal proceedings, any amounts accrued may not represent the ultimate resolution of such matters.

To the extent we believe any potential loss relating to such matters may have a material impact on our liquidity, consolidated financial position, results of operations, and/or our business as a whole and is reasonably possible but not probable, we aim to disclose information relating to such potential loss. Assessments of litigation and claims exposure are difficult because they involve inherently unpredictable factors including, but not limited to, the following: whether the proceeding is in the early stages of litigation; whether damages are unspecified, unsupported, or uncertain; whether there is a potential for punitive or other pecuniary damages; whether the matter involves legal uncertainties, including novel issues of law; whether the matter involves multiple parties and/or jurisdictions; whether discovery has not begun or is not complete; whether meaningful settlement discussions have commenced; and whether the lawsuit involves class allegations. Assessments of class action litigation, which is generally more complex than other types of litigation, are particularly difficult, especially in the early stages of the proceeding when it is not known whether a class will be certified or how a potential class,

51

if certified, will be defined. As a result, even if a loss is reasonably possible, the Company may be unable to estimate reasonably possible losses with respect to some matters.

We also aim to disclose information relating to any material potential loss that is probable but not reasonably estimable. In such cases, where reasonably practicable, we aim to provide an estimate of loss or range of potential loss. No disclosures are generally made for any loss contingencies that are deemed to be remote.

Silicon Valley Bank is among the lenders named as defendants in a complaint originally filed on September 27, 2016 by Unicom Systems, Inc. (“Unicom”) in Los Angeles County Superior Court. The lawsuit alleges breach of the syndicated 2015 Credit Agreement between Unicom and the defendants, breach of the implied covenant of good faith and fair dealing, and seeks monetary damages and declaratory relief. Pursuant to the Credit Agreement and California law, the matter has been referred to a duly appointed judicial referee for trial. The parties have engaged in extensive fact discovery which we currently expect to be concluded in November 2022, with expert witness depositions to follow. Trial is currently scheduled to take place over a three week period in late March 2023.

The Company currently estimates that it is reasonably possible that it may experience a loss in relation to the Unicom matter. However, for various reasons including the current stage of discovery proceedings, the uncertainty regarding damage claims and certain of the other factors noted above, the Company is unable to estimate the reasonably possible loss or range of losses at this time.

Based upon information available to us, our review of lawsuits and claims filed or pending against us to date and consultation with our outside legal counsel, we have not recognized a material accrual liability for any such matters, nor do we currently expect that these matters will result in a material liability to the Company. However, the outcome of litigation and other legal and regulatory matters is inherently uncertain, and it is possible that one or more of such matters currently pending or threatened could have an unanticipated material adverse effect on our liquidity, consolidated financial position, results of operations, and/or our business as a whole, in the future.

15.    Related Parties

We have no material related party transactions requiring disclosure. In the ordinary course of business, the Bank may extend credit to related parties, including executive officers, directors, principal shareholders and their related interests. Additionally, we provide real estate secured loans to eligible employees through our EHOP. For additional details, see Note 19 — “Employee Compensation and Benefit Plans" under Part II, Item 8 of our 2021 Form 10-K.

52

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

		Page Number
Forward-Looking Statements		54
Management's Overview of Performance		55
Critical Accounting Policies and Estimates		58
Results of Operations		58
	Net Interest Income and Margin	58
	Average Balances, Yields and Rates Paid	60
	Provision for Credit Losses	63
	Noninterest Income	65
	Noninterest Expense	72
	Income Taxes	74
	Net Income Attributable to Noncontrolling Interests	74
Operating Segment Results		74
Consolidated Financial Condition		78
	Cash and Cash Equivalents	78
	Investment Securities	78
	Loans	81
	Accrued Interest Receivable and Other Assets	86
	Deposits	88
	Long-Term Debt	88
	Other Liabilities	88
	Noncontrolling Interests	89
Capital Resources		89
	SVBFG Stockholders' Equity	89
	Capital Ratios	90
	Off-Balance Sheet Arrangements	91
	Commitments to Invest in Venture Capital and Private Equity Funds	92
	Liquidity	92

53

Forward-Looking Statements

This Quarterly Report on Form 10-Q, including in particular “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under Part I, Item 2 of this report, contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition, management has in the past and might in the future make forward-looking statements to analysts, investors, the media and others. Forward-looking statements are statements that are not historical facts. Broadly speaking, forward-looking statements include, but are not limited to, the following:

•Financial projections, including with respect to our net interest income, net interest margin, noninterest income, EPS, noninterest expenses (including professional services, compliance, compensation and other costs), cash flows, balance sheet positions, capital expenditures, deposit growth, liquidity and capitalization, effective tax rate or other financial items;

•Descriptions of our strategic initiatives, plans or objectives for future operations, including pending sales or acquisitions, such as the continuing integration of Boston Private and the expansion of SVB Securities into the technology investment banking sector;

•Forecasts of private equity and venture capital funding, investment level and exit activity;

•Forecasts of future interest rates, economic performance, and income from investments;

•Forecasts of expected levels of provisions for credit losses, net loan charge-offs, nonperforming loans, loan and deposit growth, mix and yields/rates;

•The outlook on our clients' performance;

•Forecasts of general or overall market and macroeconomic conditions, including inflation and any U.S. or global recession;

•The potential effects of the COVID-19 pandemic; and

•Descriptions of assumptions underlying or relating to any of the foregoing.

You can identify these and other forward-looking statements by the use of words such as “becoming,” “may,” “will,” “should,” “could,” “would,” “predict,” “potential,” “continue,” “anticipate,” “believe,” “estimate,” “assume,” “seek,” “expect,” “plan,” “intend,” and the negative of such words, or comparable terminology. Forward-looking statements are neither historical facts nor assurances of future performance. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we have based these expectations on our current beliefs as well as our assumptions, and such expectations may not prove to be correct. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside our control. Our actual results of operations and financial performance could differ significantly from those expressed in or implied by our management’s forward-looking statements. Important factors that could cause our actual results and financial condition to differ from the expectations stated in the forward-looking statements include, among others:

•market and economic conditions (including elevated inflation levels, sustained interest rate increases, the general condition of the capital and equity markets, private equity and venture capital investment, IPO, secondary offering, SPAC fundraising, M&A and other financing activity levels) and the associated impact on us (including effects on total client funds and client demand for our commercial and investment banking and other financial services, as well as on the valuations of our investments);

•disruptions to the financial markets as a result of the current or anticipated impact of military conflict, including the ongoing military conflict between Russia and Ukraine, terrorism and other geopolitical events;

•the COVID-19 pandemic, including COVID-19 variants and their effects on the economic and business environments in which we operate, and its effects on our business and operations;

•the impact of changes from the Biden-Harris administration and the U.S. Congress on the economic environment, capital markets and regulatory landscape, including monetary, tax and other trade policies, as well as regulatory changes from bank regulatory agencies;

•changes in the volume and credit quality of our loans as well as volatility of our levels of nonperforming assets and charge-offs;

•the impact of changes in interest rates or market levels or factors affecting or affected by them, including on our loan and investment portfolios and deposit costs;

•the adequacy of our ACL and the need to make provisions for credit losses for any period;

•the sufficiency of our capital and liquidity positions;

•changes in the levels or composition of our loans, deposits and client investment fund balances;

•changes in the performance or equity valuations of funds or companies in which we have invested or hold derivative instruments or equity warrant assets;

•variations from our expectations as to factors impacting our cost structure;

•our ability to attract and retain the appropriate talent to support our growth;

54

•changes in our assessment of the creditworthiness or liquidity of our clients or unanticipated effects of credit concentration risks which create or exacerbate deterioration of such creditworthiness or liquidity;

•variations from our expectations as to factors impacting the timing and level of employee share-based transactions;

•the occurrence of fraudulent activity, including breaches of our information security or cyber security-related incidents;

•business disruptions and interruptions due to natural disasters and other external events;

•the impact on our reputation and business from our interactions with business partners, counterparties, service providers and other third parties;

•the expansion of our business internationally, and the impact of geopolitical events and international market and economic events on us;

•the effectiveness of our risk management framework and quantitative models;

•the impact of governmental policy, legal requirements and regulations including regulations promulgated by the Board of Governors of the Federal Reserve System, and other regulatory requirements;

•our ability to maintain or increase our market share, including through successfully implementing our business strategy and undertaking new business initiatives, including through the continuing integration of Boston Private, the expansion of SVB Private and the growth and expansion of SVB Securities;

•greater than expected costs or other difficulties related to the continuing integration of our business and that of Boston Private;

•variations from our expectations as to the amount and timing of business opportunities, growth prospects and cost savings associated with the acquisition of Boston Private;

•the inability to retain existing Boston Private clients and employees following the Boston Private acquisition;

•unfavorable resolution of legal proceedings or claims, as well as legal or regulatory proceedings or governmental actions;

•variations from our expectations as to factors impacting our estimate of our full-year effective tax rate;

•changes in applicable accounting standards and tax laws;

•regulatory or legal changes (including changes to the laws and regulations that apply to us as a result of the growth of our business), and their impact on us; and

•other factors as discussed in “Risk Factors” under Part I, Item 1A in our 2021 Form 10-K and under Part II, Item 1A of this report.

We urge investors to consider all of these factors, among others, carefully in evaluating the forward-looking statements contained in this Quarterly Report on Form 10-Q. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this filing are made only as of the date of this filing. We assume no obligation and do not intend to revise or update any forward-looking statements contained in this Quarterly Report on Form 10-Q, except as required by law.

The following discussion and analysis of financial condition and results of operations should be read in conjunction with our unaudited interim consolidated financial statements and accompanying notes as presented in Part I, Item 1 of this report and in conjunction with our 2021 Form 10-K.

Management’s Overview of Third Quarter 2022 Performance

In the third quarter, prolonged public market volatility continued to impact public and private fundraising activity, pressuring balance sheet growth and market-related revenues. Despite challenging market conditions, we delivered overall healthy performance. Net interest income grew, with moderating positive impact from high interest rates due to deposit outflows and higher funding costs. We also saw solid loan growth and continued strong credit performance. Core fee income growth was robust, as interest rate increases drove improved client investment fee margins.

Reference Rate Reform

The publication of the British Pound Sterling, Euro, Swiss Franc and Japanese Yen LIBOR settings and one-week and two-month U.S. dollar LIBOR settings terminated at the end of December 2021, leaving the remaining U.S. dollar LIBOR settings (i.e., overnight, one month, three month, six month and 12 month) in place, which are expected to terminate at the end of June 2023. Therefore, existing contracts referencing all other U.S. dollar LIBOR settings must be remediated no later than June 30, 2023. We hold instruments that may be impacted by the discontinuance of LIBOR, including loans, investments and derivative products that use LIBOR as a benchmark rate.

Our LIBOR Transition Program consists of dedicated leadership and staff, and continues to engage with relevant business lines and support groups. As part of this program, we continue to identify, assess and monitor risks associated with the discontinuation of LIBOR, including monitoring the population of loans and contracts that are impacted and how LIBOR reference rates are reflected in our measurement of sensitivity to changes in interest rates until publication of LIBOR rates are

55

fully phased out. We completed a review across all business lines and confirmed that language to facilitate a transition to an alternative reference rate is included in our existing deals that carry LIBOR exposure. Migration of legacy LIBOR contracts has commenced based on regulatory timelines, with proactive remediation conducted for existing LIBOR facilities that contained currencies tied to LIBOR rates that ceased publication as of December 31, 2021. A communications and training plan supports the delivery of new alternative reference rate products and assists with the transition away from LIBOR.

We have adopted SOFR as our preferred replacement index for U.S. dollar LIBOR and received Term SOFR licensing from the Chicago Mercantile Exchange in the fourth quarter of 2021. We currently offer products based on alternative reference rates across multiple currencies including the U.S. Dollar, British Pound Sterling, and Euro.

A summary of our performance for the three months ended September 30, 2022 (compared to the three months ended September 30, 2021, where applicable) is as follows:

BALANCE SHEET	EARNINGS
Assets. $215.7 billion in average total assets (up 18.1%). $212.9 billion in period-end total assets (up 11.5%). Loans. $71.1 billion in average total loan balances (up 19.9%). $72.1 billion in period-end total loan balances (up 17.3%). Total Client Funds. (on-balance sheet deposits and off-balance sheet client investment funds). $368.4 billion in average total client fund balances (up 3.9%). $353.7 billion in period-end total client fund balances (down 4.8%). AFS/HTM Fixed Income Investments. $123.0 billion in average fixed income investment securities (up 31.1%). $120.0 billion in period-end fixed income investment securities (up 13.9%).	EPS. Earnings per diluted share of $7.21 (up 15.5%). Net Income. Consolidated net income available to common stockholders of $429 million (up 17.5%). -Net interest income of $1.2 billion (up 40.6%). -Net interest margin of 2.28% (up 33 bps). -Noninterest income of $359 million (down 46.6%), non-GAAP core fee income+ of $316 million (up 54.9%) and non-GAAP SVB Securities revenue++ of $99 million (down 7.5%). -Noninterest expense of $892 million (up 1.5%). Return on Average Equity. Return on average equity (annualized) performance of 13.62%. Operating Efficiency Ratio. Operating efficiency ratio of 57.29%.
CAPITAL	CREDIT QUALITY
Capital+++. All capital ratios considered “well-capitalized” under banking regulations. SVB Financial and Bank capital ratios, respectively, were: -CET1 risk-based capital ratio of 12.13% and 15.54%. -Tier 1 risk-based capital ratio of 15.58% and 15.54%. -Total risk-based capital ratio of 16.26% and 16.23%. -Tier 1 leverage ratio of 8.00% and 7.91%.	Credit Quality. Stable credit trends in an uncertain market environment; net loan charge-offs and nonperforming loans remained low. -ACL for loans of 0.77% as a percentage of period-end total loans. -Provision for loans was 0.17% as a percentage of period-end total loans (annualized). -Net loan charge-offs of 0.08% as a percentage of average total loans (annualized).

+ Consists of fee income for deposit services, letters of credit and standby letters of credit, credit cards, client investments, wealth management and trust, foreign exchange and lending-related activities. This is a non-GAAP financial measure. (See the non-GAAP reconciliation under “Results of Operations—Noninterest Income”)

++ Consists of investment banking revenue and commissions. This is a non-GAAP financial measure. (See the non-GAAP reconciliation under “Results of Operations—Noninterest Income”).

+++ In March 2020, the federal banking agencies provided transitional relief to banking organizations with respect to the impact of CECL on regulatory capital. Under the 2020 CECL Transition Rule, banking organizations may delay the estimated impact of CECL on regulatory capital for two years, followed by a three-year period to phase out the aggregate capital benefit provided during the initial two-year delay. We have elected to use this five-year transition option. For additional details, see "Capital Resources" within "Consolidated Financial Condition" under Part 1, Item 2 of this report.

56

A summary of our performance for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,								Nine months ended September 30,
(Dollars in millions, except per share data, employees and ratios)	2022			2021			% Change		2022			2021			% Change
Income Statement:
Diluted EPS	$	7.21		$	6.24		15.5	%	$	20.73		$	25.16		(17.6)	%
Net income available to common stockholders	429			365			17.5		1,234			1,399			(11.8)
Net interest income	1,198			852			40.6		3,447			2,240			53.9
Net interest margin	2.28		%	1.95		%	33	bps	2.22		%	2.08		%	14	bps
Provision for credit losses (1) (2)	72			21			242.9	%	279			75			272.0	%
Noninterest income (loss)	359			672			(46.6)		1,238			2,177			(43.1)
Noninterest expense	892			879			1.5		2,613			2,168			20.5
Non-GAAP core fee income (3)	316			204			54.9		832			535			55.5
Non-GAAP core fee income, plus SVB Securities revenue (3)	415			311			33.4		1,198			928			29.1
Balance Sheet:
Average AFS securities	$	28,855		$	23,290		23.9	%	$	28,581		$	25,280		13.1	%
Average HTM securities	94,141			70,512			33.5		96,500			48,073			100.7
Average loans, amortized cost	71,098			59,291			19.9		69,158			51,843			33.4
Average noninterest-bearing demand deposits	106,112			109,638			(3.2)		117,382			91,600			28.1
Average interest-bearing deposits	79,444			53,754			47.8		72,046			44,513			61.9
Average total deposits	185,556			163,392			13.6		189,428			136,113			39.2
Earnings Ratios:
Return on average assets (annualized) (4)	0.79		%	0.79		%	—	%	0.76		%	0.98		%	(22.4)	%
Return on average SVBFG stockholders’ equity (annualized) (5)	13.62			12.47			9.2		13.22			19.41			(31.9)
Asset Quality Ratios:
ACL for loans as a % of total period-end loans	0.77		%	0.65		%	12	bps	0.77		%	0.65		%	12	bps
ACL for performing loans as a % of total performing loans	0.74			0.59			15		0.74			0.59			15
Gross loan charge-offs as a % of average total loans (annualized) (2)	0.15			0.13			2		0.13			0.33			(20)
Net loan charge-offs as a % of average total loans (annualized) (2)	0.08			0.07			1		0.08			0.29			(21)
Capital Ratios:
SVBFG CET1 risk-based capital ratio	12.13		%	12.73		%	(60)	bps	12.13		%	12.73		%	(60)	bps
SVBFG tier 1 risk-based capital ratio	15.58			15.37			21		15.58			15.37			21
SVBFG total risk-based capital ratio	16.26			15.87			39		16.26			15.87			39
SVBFG tier 1 leverage ratio	8.00			7.77			23		8.00			7.77			23
SVBFG tangible common equity to tangible assets (6)	5.36			6.17			(81)		5.36			6.17			(81)
SVBFG tangible common equity to risk-weighted assets (6)	10.24			12.71			(247)		10.24			12.71			(247)
Bank CET1 risk-based capital ratio	15.54			14.68			86		15.54			14.68			86
Bank tier 1 risk-based capital ratio	15.54			14.68			86		15.54			14.68			86
Bank total risk-based capital ratio	16.23			15.21			102		16.23			15.21			102
Bank tier 1 leverage ratio	7.91			7.30			61		7.91			7.30			61
Bank tangible common equity to tangible assets (6)	7.08			7.12			(4)		7.08			7.12			(4)
Bank tangible common equity to risk-weighted assets (6)	13.62			14.98			(136)		13.62			14.98			(136)
Other Ratios:
Operating efficiency ratio (7)	57.29		%	57.68		%	(0.7)	%	55.77		%	49.08		%	13.6	%
Total costs of deposits (annualized) (8)	0.53			0.05			960.0		0.25			0.04			525.0
Book value per common share (9)	$	200.71		$	208.53		(3.8)		$	200.71		$	208.53		(3.8)
Tangible book value per common share (10)	192.54			200.01			(3.7)		192.54			200.01			(3.7)
Other Statistics:
Average full-time equivalent employees	8,236			6,024			36.7	%	7,579			5,144			47.3	%
Period-end full-time equivalent employees	8,429			6,208			35.8		8,429			6,208			35.8

(1)This metric for the three and nine months ended September 30, 2021 includes a post-combination provision of $46 million to record the ACL for non-PCD loans and unfunded credit commitments acquired from Boston Private.

(2)This metric for the nine months ended September 30, 2021 includes the impact of an $80 million charge-off related to fraudulent activity discussed in previous filings.

(3)See “Results of Operations–Noninterest Income” for a description and reconciliation of non-GAAP core fee income and non-GAAP core fee income plus investment banking revenue and commissions.

(4)Ratio represents annualized consolidated net income available to common stockholders divided by quarterly average assets.

(5)Ratio represents annualized consolidated net income available to common stockholders divided by quarterly average SVBFG stockholders’ equity.

(6)See “Capital Resources–Capital Ratios” for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.

(7)The operating efficiency ratio is calculated by dividing total noninterest expense by total net interest income plus noninterest income.

(8)Ratio represents annualized total cost of deposits and is calculated by dividing interest expense from deposits by average total deposits.

(9)Book value per common share is calculated by dividing total SVBFG common stockholders’ equity by total outstanding common shares at period-end.

(10)Tangible book value per common share is calculated by dividing tangible common equity by total outstanding common shares at period-end. Tangible common equity is a non-GAAP measure defined under the section “Capital Resources-Capital Ratios.”

For more information with respect to our capital ratios, please refer to “Capital Ratios” under “Consolidated Financial Condition-Capital Ratios” below.

57

Critical Accounting Policies and Estimates

Our accounting policies are fundamental to understanding our financial condition and results of operations. We have identified one policy as being critical because it requires us to make particularly difficult, subjective and/or complex judgments about matters that are inherently uncertain, and because it is likely that materially different amounts would be reported under different conditions or using different assumptions. We evaluate our estimates and assumptions on an ongoing basis and we base these estimates on historical experiences and various other factors and assumptions that are believed to be reasonable under the circumstances. Actual results may differ materially from these estimates under different assumptions or conditions.

There have been no significant changes during the nine months ended September 30, 2022 to the items that we disclosed as our critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” under Part II, Item 7 of our 2021 Form 10-K.

Recent Accounting Pronouncements

In March 2022, the FASB issued Accounting Standard Update No. 2022-01, Derivatives and Hedging (Topic 815), which allows multiple hedged layers to be designated in a single closed portfolio of financial assets. As a result, an entity can achieve hedge accounting for hedges of a greater proportion of the interest rate risk inherent in the assets included in the closed portfolio, further aligning hedge accounting with our risk management strategies. The update allows for a one-time transfer of certain debt securities from HTM to AFS upon adoption. This update is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. We are evaluating early adoption of this standard in the fourth quarter of 2022 as a result of the hedging opportunities permitted by the standard in a rising interest rate environment. We are assessing the effect of this update on our consolidated financial statements and related disclosures.

In March 2022, the FASB issued Accounting Standard Update No. 2022-02, Financial Instruments — Credit Losses (Topic 326), which eliminates the accounting guidance for TDRs by creditors while enhancing disclosure requirements for certain loan refinancings and restructurings by creditors made to borrowers experiencing financial difficulty. The update also requires disclosure of current-period gross write-offs by year of origination for financing receivables. The update is effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. We do not expect the adoption of the update to have a material impact on our consolidated financial statements and related disclosures.

In June 2022, the FASB issued Accounting Standard Update No. 2022-03, Fair Value Measurement (Topic 820), which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The update is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. SVB currently applies a discount on securities covered by contractual restrictions, and these discounts will be removed upon adoption. We do not expect the adoption of the update to have a material impact on our consolidated financial statements and related disclosures.

Results of Operations

Net Interest Income and Margin (Fully Taxable Equivalent Basis)

Net interest income is defined as the difference between: (i) interest earned on loans, fixed income investments in our AFS and HTM securities portfolios and short-term investment securities and (ii) interest paid on funding sources. Net interest margin is defined as annualized net interest income, on a fully taxable equivalent basis, as a percentage of average interest-earning assets. Net interest income and net interest margin are presented on a fully taxable equivalent basis to consistently reflect income from taxable loans and securities and tax-exempt securities based on the applicable federal statutory tax rate.

Analysis of Net Interest Income Changes Due to Volume and Rate (Fully Taxable Equivalent Basis)

Net interest income is affected by changes in the amount and mix of interest-earning assets and interest-bearing liabilities, referred to as “volume change.” Net interest income is also affected by changes in yields earned on interest-earning assets and rates paid on interest-bearing liabilities, referred to as “rate change.” The following table sets forth changes in interest income for each major category of interest-earning assets and interest expense for each major category of interest-bearing liabilities. The table also reflects the amount of simultaneous changes attributable to both volume and rate changes for the periods indicated. For this table, changes that are not solely due to either volume or rate are allocated in proportion to the percentage changes in average volume and average rate.

58

	2022 Compared to 2021						2022 Compared to 2021
	Three months ended September 30, increase (decrease) due to change in						Nine months ended September 30, increase (decrease) due to change in
(Dollars in millions)	Volume		Rate		Total		Volume		Rate		Total
Interest income:
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities	$	(28)	$	99	$	71	$	(36)	$	129	$	93
Fixed income investment portfolio (taxable)	131		83		214		667		145		812
Fixed income investment portfolio (non-taxable)	9		(1)		8		45		(5)		40
Loans, amortized cost	142		204		346		472		195		667
Increase in interest income, net	254		385		639		1,148		464		1,612
Interest expense:
Interest bearing checking and savings accounts	78		21		99		88		34		122
Money market deposits	19		89		108		58		95		153
Money market deposits in foreign offices	—		—		—		—		1		1
Time deposits	17		6		23		24		7		31
Total increase in deposits expense	114		116		230		170		137		307
Short-term borrowings	48		—		48		57		—		57
Long term debt	11		2		13		31		1		32
Total increase in borrowings expense	59		2		61		88		1		89
Increase in interest expense, net	173		118		291		258		138		396
Increase in net interest income	$	81	$	267	$	348	$	890	$	326	$	1,216

Net Interest Income (Fully Taxable Equivalent Basis)

NII increased by $348 million to $1.2 billion for the three months ended September 30, 2022, compared to $859 million for the comparable 2021 period. Overall, our NII increased primarily from higher yields as well as increases in average balances of our fixed income investment securities and loans. The increase in NII was partially offset by higher rates on deposits as well as increases in average balances of interest-bearing deposits. Upon the completion of the Boston Private acquisition in July 2021, a $104 million fair market value adjustment was made on the acquired loans that will be amortized into loan interest income over the contractual terms of the underlying loans using the constant effective yield method. The adjustment will be approximately 90 percent amortized by the end of fiscal year 2023. For the three and nine months ended September 30, 2022, respectively, $8 million and $33 million of this premium amortization partially offset the overall increase in NII.

The main factors affecting interest income and interest expense for the three months ended September 30, 2022, compared to the comparable 2021 period are discussed below:

•Interest income for the three months ended September 30, 2022 increased by $639 million due primarily to:

◦A $346 million increase in interest income on loans due primarily to higher loan interest yields driven by the increase in market rates as well as an increase in average loan balances of $11.8 billion,

◦A $222 million increase in interest income from our fixed income investment securities due primarily to an increase of $29.2 billion in average fixed income investment securities and an increase in yields earned on these investments reflective of the higher rate environment in 2022 as well as lower premium amortization as a result of higher rates reducing estimated prepayment speeds, and

◦A $71 million increase in interest income from increased market yields on interest-earning cash, partially offset by a $6.0 billion decrease in average cash balances.

•Interest expense for the three months ended September 30, 2022 increased by $291 million due primarily to:

◦A $230 million increase in interest expense on deposits due primarily to an increase in interest paid on our interest-bearing deposits driven by higher market rates as well as by an increase in average interest-bearing deposit balances, and

◦A $61 million increase in interest expense on borrowings due primarily to an increase in average short-term borrowings resulting from deposit outflows in the third quarter of 2022.

Nine months ended September 30, 2022 and 2021

•Interest income for the nine months ended September 30, 2022 increased by $1.6 billion due primarily to:

59

◦An $852 million increase in interest income from our fixed income investment securities due primarily to an increase of $51.7 billion in average fixed income investment securities and an increase in yields earned on these investments reflective of the higher rate environment in 2022 as well as lower premium amortization as a result of higher rates reducing estimated prepayment speeds,

◦A $667 million increase in interest income on loans due primarily to an increase in average loan balances of $17.3 billion as well as higher loan interest yields driven by the increase in market rates, and

◦A $93 million increase in interest income from increased market yields on interest-earning cash, partially offset by a $5.2 billion decrease in average cash balances.

•Interest expense for the nine months ended September 30, 2022 increased by $396 million due primarily to:

◦A $307 million increase in interest expense on deposits due primarily to an increase in average interest-bearing deposit balances as well as by an increase in interest expense paid on our interest-bearing deposits driven by higher market rates, and

◦An $89 million increase in interest expense on borrowings due primarily to an increase in average short-term borrowings driven by an increase in deposit outflows as well as interest expense on our 2.100% Senior Notes issued in May 2021, our 1.800% Senior Notes issued in October 2021 and our 4.345% and 4.570% Senior Fixed Rate/Floating Rate Notes issued in April 2022.

Net Interest Margin (Fully Taxable Equivalent Basis)

Three months ended September 30, 2022 and 2021

•Our net interest margin increased by 33 bps to 2.28 percent for the three months ended September 30, 2022, compared to 1.95 percent for the comparable 2021 period. The higher margin for the three months ended September 30, 2022 was due primarily to improved yields reflective of a higher rate environment and the decrease in premium amortization mentioned above, partially offset by the increase in interest-bearing deposit expense and borrowing costs mentioned above.

Nine months ended September 30, 2022 and 2021

•Our net interest margin increased by 14 bps to 2.22 percent for the nine months ended September 30, 2022, compared to 2.08 percent for the comparable 2021 period. The higher margin for the nine months ended September 30, 2022 was due primarily to improved yields reflective of a higher rate environment and the decrease in premium amortization mentioned above, partially offset by lower loan fee yields and the increase in interest-bearing deposit expense and borrowing costs mentioned above.

Average Balances, Yields and Rates Paid (Fully Taxable Equivalent Basis)

The average yield earned on interest-earning assets is the amount of annualized fully taxable equivalent interest income expressed as a percentage of average interest-earning assets. The average rate paid on funding sources is the amount of annualized interest expense expressed as a percentage of average funding sources. The following tables set forth average assets, liabilities, noncontrolling interests, preferred stock, and SVBFG stockholders’ equity, interest income, interest expense, annualized yields and rates, and the composition of our annualized net interest margin for the three and nine months ended September 30, 2022 and 2021:

60

Average Balances, Rates and Yields for the Three Months Ended September 30, 2022 and 2021

	Three months ended September 30,
	2022						2021
(Dollars in millions)	Average Balance		Interest Income/ Expense		Yield/ Rate		Average Balance		Interest Income/ Expense		Yield/ Rate
Interest-earning assets:
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities (1)	$	15,739	$	76	1.91	%	$	21,779	$	5	0.10	%
Investment securities: (2)
AFS securities:
Taxable	28,855		124		1.71		23,290		69		1.17
HTM securities:
Taxable	87,130		421		1.92		64,899		262		1.61
Non-taxable (3)	7,011		44		2.51		5,613		36		2.53
Total loans, amortized cost (4) (5)	71,098		865		4.83		59,291		519		3.47
Total interest-earning assets	209,833		1,530		2.89		174,872		891		2.02
Cash and due from banks	1,866						2,285
ACL	(556)						(451)
Other assets (6)	4,597						5,984
Total assets	$	215,740					$	182,690
Funding sources:
Interest-bearing liabilities:
Interest bearing checking and savings accounts	$	19,625	$	100	2.02	%	$	4,310	$	1	0.14	%
Money market deposits	54,668		125		0.91		46,051		17		0.14
Money market deposits in foreign offices	62		—		0.01		1,039		—		0.01
Time deposits	4,118		24		2.24		1,245		1		0.32
Sweep deposits in foreign offices	971		—		0.05		1,109		—		0.01
Total interest-bearing deposits	79,444		249		1.24		53,754		19		0.14
Short-term borrowings	7,655		48		2.52		99		—		0.17
Long-term debt	3,367		26		3.04		1,936		13		2.66
Total interest-bearing liabilities	90,466		323		1.42		55,789		32		0.23
Portion of noninterest-bearing funding sources	119,367						119,083
Total funding sources	209,833		323		0.61		174,872		32		0.07
Noninterest-bearing funding sources:
Demand deposits	106,112						109,638
Other liabilities	2,663						3,279
Preferred stock	3,646						2,065
SVBFG common stockholders’ equity	12,498						11,613
Noncontrolling interests	355						306
Portion used to fund interest-earning assets	(119,367)						(119,083)
Total liabilities, noncontrolling interest, and SVBFG stockholders’ equity	$	215,740					$	182,690
Net interest income and margin			$	1,207	2.28	%			$	859	1.95	%
Total deposits	$	185,556					$	163,392
Average SVBFG common stockholders’ equity as a percentage of average assets					5.79	%					6.36	%
Reconciliation to reported net interest income:
Adjustments for taxable equivalent basis			(9)						(7)
Net interest income, as reported			$	1,198					$	852

(1)Includes average interest-earning deposits in other financial institutions of $5.8 billion and $5.5 billion for the three months ended September 30, 2022 and 2021, respectively. For the three months ended September 30, 2022 and 2021, balances also include $9.6 billion and $15.9 billion, respectively, deposited at the FRB, earning interest at the Federal Funds target rate.

(2)Yields on interest-earning investment securities do not give effect to changes in fair value that are reflected in other comprehensive income.

(3)Interest income on non-taxable investment securities is presented on a fully taxable equivalent basis using the federal statutory tax rate of 21.0 percent for all periods presented.

(4)Nonaccrual loans are reflected in the average balances of loans.

(5)Interest income includes loan fees of $49 million and $43 million for the three months ended September 30, 2022 and 2021, respectively.

(6)Average investment securities of $906 million and $3.0 billion for the three months ended September 30, 2022 and 2021, respectively, were classified as other assets as they were noninterest-earning assets. These investments primarily consisted of non-marketable and other equity securities.

61

Average Balances, Rates and Yields for the Nine Months Ended September 30, 2022 and 2021

	Nine months ended September 30,
	2022						2021
(Dollars in millions)	Average Balance		Interest Income/ Expense		Yield/ Rate		Average Balance		Interest Income/ Expense		Yield/ Rate
Interest-earning assets:
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities (1)	$	15,118	$	105	0.93	%	$	20,357	$	12	0.08	%
Investment securities: (2)
AFS securities:
Taxable	28,581		332		1.55		25,280		266		1.40
HTM securities:
Taxable	89,512		1,286		1.92		43,439		540		1.67
Non-taxable (3)	6,988		133		2.54		4,634		93		2.69
Total loans, amortized cost (4) (5)	69,158		2,089		4.04		51,843		1,422		3.67
Total interest-earning assets	209,357		3,945		2.52		145,553		2,333		2.15
Cash and due from banks	2,608						1,979
ACL	(477)						(449)
Other assets (6)	5,164						5,869
Total assets	$	216,652					$	152,952
Funding sources:
Interest-bearing liabilities:
Interest bearing checking and savings accounts	$	12,587	$	125	1.32	%	$	3,692	$	3	0.12	%
Money market deposits	54,783		189		0.46		37,876		36		0.13
Money market deposits in foreign offices	665		1		0.16		900		—		0.03
Time deposits	2,993		33		1.46		847		2		0.33
Sweep deposits in foreign offices	1,018		—		0.03		1,198		—		0.02
Total interest-bearing deposits	72,046		348		0.65		44,513		41		0.12
Short-term borrowings	4,815		57		1.60		50		—		0.16
Long-term debt	3,023		65		2.86		1,571		33		2.79
Total interest-bearing liabilities	79,884		470		0.79		46,134		74		0.21
Portion of noninterest-bearing funding sources	129,473						99,419
Total funding sources	209,357		470		0.30		145,553		74		0.07
Noninterest-bearing funding sources:
Demand deposits	117,382						91,600
Other liabilities	2,893						3,831
Preferred stock	3,646						1,502
SVBFG common stockholders’ equity	12,481						9,639
Noncontrolling interests	366						246
Portion used to fund interest-earning assets	(129,473)						(99,419)
Total liabilities, noncontrolling interest, and SVBFG stockholders’ equity	$	216,652					$	152,952
Net interest income and margin			$	3,475	2.22	%			$	2,259	2.08	%
Total deposits	$	189,428					$	136,113
Average SVBFG common stockholders’ equity as a percentage of average assets					5.76	%					6.30	%
Reconciliation to reported net interest income:
Adjustments for taxable equivalent basis			(28)						(19)
Net interest income, as reported			$	3,447					$	2,240

(1)Includes average interest-earning deposits in other financial institutions of $5.4 billion and $4.3 billion for the nine months ended September 30, 2022 and 2021, respectively. The balance also includes $9.4 billion and $15.8 billion deposited at the FRB, earning interest at the Federal Funds target rate for the nine months ended September 30, 2022 and 2021, respectively.

(2)Yields on interest-earning investment securities do not give effect to changes in fair value that are reflected in other comprehensive income.

(3)Interest income on non-taxable AFS securities is presented on a fully taxable-equivalent basis using the federal statutory tax rate of 21.0 percent for all periods presented.

(4)Nonaccrual loans are reflected in the average balances of loans.

(5)Interest income includes loan fees of $148 million and $169 million for the nine months ended September 30, 2022 and 2021, respectively.

(6)Average investment securities of $1.3 billion and $3.2 billion for the nine months ended September 30, 2022 and 2021, respectively, were classified as other assets as they were noninterest-earning assets. These investments consisted primarily of non-marketable and other equity securities.

62

Provision for Credit Losses

The provision for credit losses is the combination of (i) the provision for loans, (ii) the provision for unfunded credit commitments and (iii) the provision for HTM securities. Our allowance for credit losses reflects our best estimate of probable credit losses that are inherent in the portfolios at the balance sheet date.

The following table summarizes our ACL for loans, unfunded credit commitments and HTM securities for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022			2021			2022			2021
ACL, beginning balance	$	545		$	396		$	422		$	448
Initial allowance on PCD loans	—			22			—			22
Provision (reduction in ACL) for loans (1) (2)	30			(9)			184			41
Gross loan charge-offs (2)	(26)			(19)			(66)			(129)
Loan recoveries	11			8			23			16
Foreign currency translation adjustments	(3)			—			(6)			—
ACL, ending balance	$	557		$	398		$	557		$	398
ACL for unfunded credit commitments, beginning balance	224			120			171			121
Provision for unfunded credit commitments (1)	42			29			96			28
Foreign currency translation adjustments	(1)			—			(2)			—
ACL for unfunded credit commitments, ending balance (3)	$	265		$	149		$	265		$	149
ACL for HTM securities, beginning balance	6			5			7			—
Provision (reduction in ACL) for HTM securities	—			1			(1)			6
ACL for HTM securities, ending balance (4)	$	6		$	6		$	6		$	6
Ratios and other information:
Provision (reduction in ACL) for loans as a percentage of period-end total loans (annualized) (2)	0.17		%	(0.06)		%	0.34		%	0.09		%
Gross loan charge-offs as a percentage of average total loans (annualized) (2)	0.15			0.13			0.13			0.33
Net loan charge-offs as a percentage of average total loans (annualized) (2)	0.08			0.07			0.08			0.29
ACL for loans as a percentage of period-end total loans	0.77			0.65			0.77			0.65
Provision for credit losses	$	72		$	21		$	279		$	75
Period-end total loans	72,129			61,487			72,129			61,487
Average total loans	71,098			59,291			69,158			51,843
Allowance for loan losses for nonaccrual loans	25			33			25			33
Nonaccrual loans	76			114			76			114

(1)The provision for credit losses for the three and nine months ended September 30, 2021 includes $46 million recognized as a result of the Boston Private acquisition, which consists of a $44 million provision for loan losses related to non-PCD loans and a $2 million provision for unfunded commitments.

(2)Metrics for the nine months ended September 30, 2021 includes the impact of an $80 million charge-off related to fraudulent activity as disclosed in previous filings.

(3)The “ACL for unfunded credit commitments” is included as a component of “Other liabilities” on our consolidated balance sheets.

(4)The "ACL for HTM securities" is included as a component of "HTM securities" and presented net in our consolidated financial statements.

Provision for Loans

We had a provision for credit losses for loans of $30 million and $184 million for the three and nine months ended September 30, 2022, respectively, compared to a reduction in provision of $9 million and a provision of $41 million for the three and nine months ended September 30, 2021, respectively. The provision for loans of $30 million for the three months ended September 30, 2022 was driven primarily by loan growth which accounted for $18 million. The provision also includes $10 million of charge-offs not previously reserved for, and $9 million related to a deterioration in projected economic conditions.

The reduction in provision for loans of $9 million for the three months ended September 30, 2021 was driven primarily by a $69 million reduction in provision due to model enhancements and an $8 million reduction for recoveries. These reductions were largely offset by a $44 million day one provision for Boston Private non-PCD loans, a $10 million provision for loan growth, and an increase of $15 million for charge-offs not specifically reserved for at June 30, 2021.

The provision for credit losses for loans of $184 million for the nine months ended September 30, 2022, was driven primarily by the deterioration in projected financial conditions which accounted for $98 million, of which $89 million was

63

taken in the second quarter. Other major drivers of the provision were $51 million due to loan growth and $46 million in charge-offs not previously reserved for. The largest offset was $23 million in recoveries.

The provision for credit losses for loans of $41 million for the nine months ended September 30, 2021, was driven primarily by a $43 million increase for growth in our legacy loan portfolio, the $44 million provision for Boston Private loans, and $104 million of charge-offs not specifically reserved for at December 31, 2020, of which $80 million was related to a single instance of potentially fraudulent activity as disclosed in previous filings. These increases in the provision were partially offset by $16 million of recoveries, a $68 million reduction in performing reserves as a result of the improvement of economic scenarios used at September 30, 2021, and the $69 million reduction in provision due to the previously discussed model enhancements.

See “Results of Operations—Provision for Credit Losses—(Reduction) Provision for Loans” under Part 1, Item 2 of our Form 10-Q for the quarterly period ended September 30, 2021 for the model enhancements made and reflected in our provision for credit losses for the three and nine months ended September 30, 2021 provision for credit losses.

Provision for Unfunded Credit Commitments

We recorded a provision for unfunded credit commitments of $42 million and $96 million for the three and nine months ended September 30, 2022, respectively, compared to a provision of $29 million and $28 million for the three and nine months ended September 30, 2021, respectively. The provision of $42 million for the three months ended September 30, 2022 was driven primarily by $22 million from growth in our unfunded commitments. The deterioration of economic forecasts described above drove an additional $15 million in provision.

The provision of $29 million for the three months ended September 30, 2021 was driven primarily by a $17 million increase attributable to commitment growth and changes in portfolio composition and a $10 million increase primarily from an increase in the expected future commitments for milestone tranches of Investor Dependent loans, which are tied to company performance or additional funding rounds, resulting in a longer weighted average life of these higher risk segments. Additionally, we recorded a provision of $2 million related to Boston Private unfunded commitments.

The provision of $96 million for the nine months ended September 30, 2022 was driven primarily by the deterioration in economic forecasts described above which accounted for $54 million. Growth in our unfunded commitments contributed to an additional $36 million in provision.

The provision for unfunded credit commitments of $28 million for the nine months ended September 30, 2021, was driven primarily by growth in our outstanding commitments and changes in the unfunded credit commitments composition within our portfolio segments, including the model enhancements mentioned above. These increases were partially offset by improved economic scenarios in our forecast models.

Gross Loan Charge-Offs

Gross loan charge-offs were $26 million for the three months ended September 30, 2022, of which $10 million was not previously reserved for at June 30, 2022. Gross loan charge-offs were primarily driven by clients in our Technology and Life Sciences/Healthcare portfolios, including $17 million of charge-offs from Investor Dependent - Early Stage clients.

Gross loan charge-offs were $19 million for the three months ended September 30, 2021, of which $15 million was not specifically reserved for at June 30, 2021. Gross loan charge-offs were partly driven by an $8 million charge-off from one Investor Dependent - Early Stage client. The remaining $7 million gross loan charge-offs not previously reserved for were driven primarily by our Investor Dependent and Innovation C&I loan portfolios.

Gross loan charge-offs were $66 million for the nine months ended September 30, 2022, of which $46 million was not specifically reserved for in prior quarters. Gross loan charge-offs were primarily driven by our Investor Dependent portfolios. Early Stage clients accounted for $37 million of charge-offs and Growth Stage clients accounted for $17 million in charge-offs.

Gross loan charge-offs were $129 million for the nine months ended September 30, 2021, of which $104 million was not specifically reserved for in prior quarters. Gross loan charge-offs not previously reserved for were primarily driven by $80 million related to a single instance of potentially fraudulent activity disclosed in previous filings. The remaining $24 million of gross loan charge-offs not previously reserved for came primarily from our Investor Dependent, and Innovation C&I loan portfolios.

See “Consolidated Financial Condition—Credit Quality and Allowance for Credit Losses for Loans and for Unfunded Credit Commitments” below and Note 6 — “Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for further details on our ACL for loans and unfunded credit commitments.

64

Provision for HTM Securities

We recorded a provision for HTM securities of less than $1 million for the three months ended September 30, 2022, and a reduction of our credit loss estimate of $1 million for the nine months ended September 30, 2022. The nominal provision for HTM securities for the third quarter of September 30, 2022 was based on ongoing stability within the HTM bond portfolio. Our HTM portfolio as of September 30, 2022 was entirely made up of A3 or better rated bonds, all considered investment grade.

We recorded a provision for credit losses for HTM securities of $1 million and $6 million for the three and nine months ended September 30, 2021, respectively. Our provision for HTM securities for the third quarter of September 30, 2021 was driven primarily by the continued expansion of our corporate bond portfolio, which increased by $160 million from prior quarter. Our HTM portfolio as of September 30, 2021 was entirely made up of A2 or better rated bonds, all considered investment grade.

See Note 5 — “Investment Securities" of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for further details on our ACL for HTM securities.

Noninterest Income

For the three and nine months ended September 30, 2022, noninterest income was $359 million and $1.2 billion, respectively, compared to $672 million and $2.2 billion for the comparable 2021 periods. For the three and nine months ended September 30, 2022, non-GAAP core fee income plus SVB Securities revenue was $415 million and $1.2 billion, respectively, compared to $311 million and $928 million for the comparable 2021 periods. For the three and nine months ended September 30, 2022, non-GAAP core fee income was $316 million and $832 million, respectively compared to $204 million and $535 million for the comparable 2021 periods. (See reconciliations of non-GAAP measures used below under “Use of Non-GAAP Financial Measures.”)

Use of Non-GAAP Financial Measures

To supplement our unaudited interim consolidated financial statements presented in accordance with GAAP, we use certain non-GAAP measures of financial performance (including, but not limited to, non-GAAP core fee income, non-GAAP SVB Securities revenue, non-GAAP core fee income plus non-GAAP SVB Securities revenue, non-GAAP net gains on investment securities, net of noncontrolling interests and non-GAAP financial ratios). These supplemental performance measures may vary from, and may not be comparable to, similarly titled measures by other companies in our industry. Non-GAAP financial measures are not in accordance with, or an alternative for, GAAP. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. A non-GAAP financial measure may also be a financial metric that is not required by GAAP or other applicable requirement.

We believe these non-GAAP financial measures, when taken together with the corresponding GAAP financial measures, provide meaningful supplemental information regarding our performance by (i) excluding items that represent income attributable to investors other than us and our subsidiaries and (ii) providing additional information used by management that is not otherwise required by GAAP or other applicable requirements. Our management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing our operating results and when planning, forecasting and analyzing future periods. However, these non-GAAP financial measures should be considered in addition to, and not as a substitute for or preferable to, financial measures prepared in accordance with GAAP.

Included in net income is income and expense attributable to noncontrolling interests. We recognize, as part of our investment funds management business through SVB Capital and SVB Securities, the entire income or loss from funds consolidated in accordance with ASC Topic 810 as discussed in Note 1 — “Basis of Presentation” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report. We are required under GAAP to consolidate 100% of the results of these entities, even though we may own less than 100% of such entities. The relevant amounts attributable to investors other than us are reflected under “Net Income Attributable to Noncontrolling Interests” on our statements of income. Where applicable, the tables below for noninterest income and net gains on investment securities exclude noncontrolling interests.

Core fee income is a non-GAAP financial measure, which represents GAAP noninterest income, but excludes (i) SVB Securities revenue, (ii) certain line items where performance is typically subject to market or other conditions beyond our control, primarily our net gains (losses) on investment securities and equity warrant assets, and (iii) other noninterest income. Core fee income represents client investment fees, wealth management and trust fees, foreign exchange fees, credit card fees, deposit service charges, lending related fees and letters of credit and standby letters of credit fees.

SVB Securities revenue is a non-GAAP financial measure, which represents noninterest income but excludes (i) Core fee income, and (ii) certain line items where performance is typically subject to market or other conditions beyond our control,

65

primarily our net gains (losses) on investment securities and equity warrant assets, and other noninterest income. SVB Securities revenue represents investment banking revenue and commissions.

Core fee income plus SVB Securities revenue is a non-GAAP measure, which represents GAAP noninterest income, but excludes certain line items where performance is typically subject to market or other conditions beyond our control, primarily our net gains (losses) on investment securities and equity warrant assets, and other noninterest income. Core fee income plus SVB Securities revenue represents core fee income plus investment banking revenue and commissions.

The following table provides a reconciliation of GAAP noninterest income to non-GAAP core fee income for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
GAAP noninterest income	$	359	$	672	(46.6)	%	$	1,238	$	2,177	(43.1)	%
Less: (losses) gains on investment securities, net	(127)		189		(167.2)		(199)		661		(130.1)
Less: gains on equity warrant assets, net	40		147		(72.8)		120		491		(75.6)
Less: other noninterest income	31		25		24.0		119		97		22.7
Non-GAAP core fee income plus SVB Securities revenue (1)	$	415	$	311	33.4		$	1,198	$	928	29.1
Investment banking revenue	75		90		(16.7)		293		335		(12.5)
Commissions	24		17		41.2		73		58		25.9
Non-GAAP SVB Securities revenue (2)	$	99	$	107	(7.5)		$	366	$	393	(6.9)
Non-GAAP core fee income (3)	$	316	$	204	54.9		$	832	$	535	55.5

(1)Non-GAAP core fee income plus SVB Securities revenue represents noninterest income, but excludes certain line items where performance is typically subject to market or other conditions beyond our control and other noninterest income. Core fee income plus SVB Securities revenue is non-GAAP core fee income (as defined in footnote (3) below) with the addition of investment banking revenue and commissions.

(2)Non-GAAP SVB Securities revenue represents investment banking revenue and commissions, but excludes certain line items where performance is typically subject to market or other conditions beyond our control and other noninterest income.

(3)Non-GAAP core fee income represents noninterest income, but excludes (i) certain line items where performance is typically subject to market or other conditions beyond our control, (ii) our investment banking revenue and commissions and (iii) other noninterest income. Non-GAAP core fee income includes client investment fees, wealth management and trust fees, foreign exchange fees, credit card fees, deposit service charges, lending related fees and letters of credit and standby letters of credit fees.

Gains (losses) on Investment Securities, Net

Net gains (losses) on investment securities include gains and losses from our non-marketable and other equity securities, which include public equity securities held as a result of exercised equity warrant assets, as well as gains and losses from sales of our AFS debt securities portfolio, when applicable.

Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies and qualified affordable housing projects. We experience variability in the performance of our non-marketable and other equity securities from period to period, which results in net gains or losses on investment securities (both realized and unrealized). This variability is due to a number of factors, including unrealized changes in the values of our investments, changes in the amount of realized gains and losses from distributions, changes in liquidity events and general economic and market conditions. Unrealized gains or losses from non-marketable and other equity securities for any single period are typically driven by valuation changes, and are therefore subject to potential increases or decreases in future periods. Such variability may lead to volatility in the gains or losses from investment securities. As such, our results for a particular period are not necessarily indicative of our expected performance in a future period.

The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of certain sales restrictions to which these equity securities may be subject to (e.g. lock-up agreements), changes in prevailing market prices, market conditions, the actual sales or distributions of securities, and the timing of such actual sales or distributions, which, to the extent such securities are managed by our managed funds, are subject to our funds' separate discretionary sales/distributions and governance processes.

Our AFS securities portfolio is a fixed income investment portfolio that is managed with the objective of earning an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification as well as addressing our asset/liability management objectives. Though infrequent, sales of debt securities in our AFS securities portfolio may result in net gains or losses and are conducted pursuant to the guidelines of our investment policy related to the management of our liquidity position and interest rate risk.

66

The following tables provide a reconciliation of GAAP total gains (losses) on investment securities, net, to non-GAAP net gains (losses) on investment securities, net of noncontrolling interests, for the three and nine months ended September 30, 2022 and 2021:

(Dollars in millions)	Managed Funds of Funds		Managed Direct Venture Funds		Managed Credit Funds		Public Equity Securities		Debt Funds		Sales of AFS Debt Securities		Strategic and Other Investments		SVB Securities		Total
Three months ended September 30, 2022
Total gains (losses) on investment securities, net	$	(78)	$	3	$	5	$	(6)	$	—	$	—	$	(47)	$	(4)	$	(127)
Less: income attributable to noncontrolling interests, including carried interest allocation	(52)		2		1		—		—		—		—		(2)		(51)
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests	$	(26)	$	1	$	4	$	(6)	$	—	$	—	$	(47)	$	(2)	$	(76)
Three months ended September 30, 2021
Total gains (losses) on investment securities, net	$	109	$	5	$	7	$	(39)	$	—	$	—	$	51	$	56	$	189
Less: income attributable to noncontrolling interests, including carried interest allocation	53		—		1		—		—		—		—		34		88
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests	$	56	$	5	$	6	$	(39)	$	—	$	—	$	51	$	22	$	101
Nine months ended September 30, 2022
Total gains (losses) on investment securities, net	$	(115)	$	18	$	14	$	(44)	$	—	$	48	$	(91)	$	(29)	$	(199)
Less: income attributable to noncontrolling interests, including carried interest allocation	(56)		6		2		—		—		—		—		(5)		(53)
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests	$	(59)	$	12	$	12	$	(44)	$	—	$	48	$	(91)	$	(24)	$	(146)
Nine months ended September 30, 2021
Total gains on investment securities, net	$	337	$	42	$	20	$	49	$	2	$	—	$	107	$	104	$	661
Less: income attributable to noncontrolling interests, including carried interest allocation	153		17		3		—		—		—		—		53		226
Non-GAAP net gains on investment securities, net of noncontrolling interests	$	184	$	25	$	17	$	49	$	2	$	—	$	107	$	51	$	435

Non-GAAP net losses on investment securities, net of noncontrolling interests, of $76 million for the three months ended September 30, 2022, were driven by the following:

•Total net losses of $125 million ($73 million, net of noncontrolling interests) in our managed funds of funds, strategic and other investment portfolios were driven primarily by further valuation declines reflective of continued adverse market conditions.

Non-GAAP net losses on investment securities, net of noncontrolling interests, of $146 million for the nine months ended September 30, 2022, were driven by the following:

•Total net losses of $235 million ($174 million, net of noncontrolling interests) in our managed funds of funds, SVB Securities, and strategic and other investment portfolios were driven primarily by valuation declines reflective of continued adverse market conditions, partially offset by

67

•Net gains of $48 million on the sale of $8.7 billion of AFS debt securities, which include the first quarter net gains of $49 million related to the $5.1 billion sale of U.S. treasury securities and agency-issued MBS and the termination of related swaps.

•Net losses in our managed funds of funds portfolio are also partially offset by gains of $25 million, included in other noninterest income, for the change in fair value of hedge instruments for certain funds.

Gains on Equity Warrant Assets, Net

A summary of gains on equity warrant assets, net, for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Equity warrant assets (1):
Gains on exercises, net	$	9	$	91	(90.1)	%	$	44	$	381	(88.5)	%
Terminations	(1)		(1)		—		(3)		(2)		50.0
Changes in fair value, net	32		57		(43.9)		79		112		(29.5)
Total gains on equity warrant assets, net	$	40	$	147	(72.8)		$	120	$	491	(75.6)

(1)    At September 30, 2022, we held warrants in 3,019 companies, compared to 2,749 companies at September 30, 2021. The total fair value of our warrant portfolio was $351 million at September 30, 2022 and $274 million at September 30, 2021. Warrants in 57 companies each had fair values greater than $1 million and collectively represented $180 million, or 51.4 percent, of the fair value of the total warrant portfolio at September 30, 2022. Warrants in 50 companies each had fair values greater than $1 million and collectively represented $139 million, or 50.8 percent, of the fair value of the total warrant portfolio at September 30, 2021.

Three months ended September 30, 2022 and 2021

Net gains on equity warrant assets were $40 million for the three months ended September 30, 2022, compared to net gains of $147 million for the comparable September 30, 2021 period. Net gains on equity warrant assets were driven by $32 million in private company valuation updates and $9 million in gains on exercises of warrants driven mainly by M&A activity.

Nine months ended September 30, 2022 and 2021

Net gains on equity warrant assets were $120 million for the nine months ended September 30, 2022, compared to net gains of $491 million for the comparable September 30, 2021 period. Net gains on equity warrant assets were driven by $79 million in net valuation increases reflective of private company valuation updates and inclusive of a downward valuation adjustment of $8 million for illiquid investments during the three months ended June 30, 2022, reflective of current market volatility.

Non-GAAP Core Fee Income

	Three months ended September 30,					Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change	2022		2021		% Change
Non-GAAP core fee income (1):
Client investment fees	$	119	$	20	NM	$	237	$	55	NM
Wealth management and trust fees	19		22		(13.6)	63		22		186.4
Foreign exchange fees	74		65		13.8	216		189		14.3
Credit card fees	37		34		8.8	114		93		22.6
Deposit service charges	32		29		10.3	94		82		14.6
Lending related fees	20		21		(4.8)	65		55		18.2
Letters of credit and standby letters of credit fees	15		13		15.4	43		39		10.3
Total non-GAAP core fee income (1)	$	316	$	204	54.9	$	832	$	535	55.5
Investment banking revenue	75		90		(16.7)	293		335		(12.5)
Commissions	24		17		41.2	73		58		25.9
Total non-GAAP Securities revenue (2)	$	99	$	107	(7.5)	$	366	$	393	(6.9)
Total non-GAAP core fee income plus SVB Securities revenue (3)	$	415	$	311	33.4	$	1,198	$	928	29.1

(1)This non-GAAP measure represents noninterest income, but excludes (i) certain line items where performance is typically subject to market or other conditions beyond our control, (ii) our investment banking revenue and commissions and (iii) other noninterest income. See “Use of Non-GAAP Measures” above.

(2)Non-GAAP SVB Securities revenue represents noninterest income, but excludes (i) certain line items where performance is typically subject to market or other conditions beyond our control, (ii) non-GAAP core fee income, and (iii) other noninterest income. See “Use of Non-GAAP Measures” above.

68

(3)Non-GAAP core fee income plus SVB Securities revenue represents noninterest income, but excludes (i) certain line items where performance is typically subject to market or other conditions beyond our control, and (ii) other noninterest income. See “Use of Non-GAAP Measures” above.

Client Investment Fees

Client investment fees were $119 million and $237 million for the three and nine months ended September 30, 2022, compared to $20 million and $55 million for the comparable 2021 periods. The increases were reflective of improved fee margins resulting from higher short-term interest rates driven by the 2022 Federal Funds rate hikes.

A summary of client investment fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,					Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change	2022		2021		% Change
Client investment fees by type:
Sweep money market fees	$	64	$	12	NM	$	144	$	31	NM
Asset management fees	16		7		128.6	41		22		86.4
Repurchase agreement fees	39		1		NM	52		2		NM
Total client investment fees	$	119	$	20	NM	$	237	$	55	NM

The following table summarizes average client investment funds for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Sweep money market funds	$	81,726	$	97,590	(16.3)	%	$	95,340	$	82,434	15.7	%
Managed client investment funds (1)	86,100		79,400		8.4		85,286		76,537		11.4
Repurchase agreements	15,033		14,296		5.2		13,919		13,426		3.7
Total average client investment funds (2)	$	182,859	$	191,286	(4.4)		$	194,545	$	172,397	12.8

(1)These funds represent investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.

(2)Client investment funds are maintained at third-party financial institutions and are not recorded on our balance sheet.

The following table summarizes period-end client investment funds at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021		% Change
Sweep money market funds	$	76,111	$	109,241	(30.3)	%
Managed client investment funds (1)	85,926		85,475		0.5
Repurchase agreements	14,824		15,370		(3.6)
Total period-end client investment funds (2)	$	176,861	$	210,086	(15.8)

(1)These funds represent investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.

(2)Client investment funds are maintained at third-party financial institutions and are not recorded on our balance sheet.

Wealth Management and Trust Fees

Wealth management and trust fees were $19 million and $63 million for the three and nine months ended September 30, 2022, respectively, compared to $22 million for both the three and nine months ended September 30, 2021. The decrease for the three months ended September 30, 2022 compared to the same period in 2021 was due to a decrease in AUM driven by unfavorable market returns reflective of persistent market volatility. The increase for the nine months ended September 30, 2022 compared to the same period in 2021 was due to the acquisition of Boston Private in the third quarter of 2021. A summary of wealth management and trust fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Wealth management and trust fees by type:
Wealth management fees	$	17	$	20	(15.0)	%	$	58	$	20	190.0	%
Trust fees	2		2		—		5		2		150.0
Total wealth management and trust fees	$	19	$	22	(13.6)		$	63	$	22	186.4

69

The following table summarizes the activity relating to AUM for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Beginning balance (1)	$	16,512	$	1,667	$	19,646	$	1,667
Assets acquired (2)	—		17,980		—		17,980
Net flows	(76)		(31)		(351)		(31)
Market returns	(576)		(51)		(3,435)		(51)
Ending balance	$	15,860	$	19,565	$	15,860	$	19,565

(1)Represents Private Bank assets under management previously reported in off-balance sheet managed client investment funds above for the three and nine months ended September 30, 2021.

(2)Represents AUM acquired from the acquisition of Boston Private on July 1, 2021.

Foreign Exchange Fees

Foreign exchange fees were $74 million and $216 million for the three and nine months ended September 30, 2022, compared to $65 million and $189 million for the comparable 2021 periods. The increases in foreign exchange fees were driven primarily by increases in forward and spot contract commissions reflective of the increased volume of trades.

A summary of foreign exchange fee income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Foreign exchange fees by instrument type:
Foreign exchange contract commissions	$	74	$	65	13.8	%	$	215	$	188	14.4	%
Option premium fees	—		—		—		1		1		—
Total foreign exchange fees	$	74	$	65	13.8		$	216	$	189	14.3

Credit Card Fees

Credit card fees were $37 million and $114 million for the three and nine months ended September 30, 2022, compared to $34 million and $93 million for the comparable 2021 periods. Credit card fees increased due to higher transaction volumes reflective of increased spending and client growth, as well as higher travel spending, compared to the comparable 2021 periods.

A summary of credit card fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Credit card fees by instrument type:
Card interchange fees, net	$	29	$	29	—	%	$	91	$	78	16.7	%
Merchant service fees	6		4		50.0		18		12		50.0
Card service fees	2		1		100.0		5		3		66.7
Total credit card fees	$	37	$	34	8.8		$	114	$	93	22.6

Deposit Service Charges

Deposit service charges were $32 million and $94 million for the three and nine months ended September 30, 2022, compared to $29 million and $82 million for the comparable 2021 periods. Deposit service charges increased primarily driven by higher volumes of our transaction-based fee products.

Lending Related Fees

Lending related fees were $20 million and $65 million for the three and nine months ended September 30, 2022, compared to $21 million and $55 million for the comparable 2021 periods. The increase for the nine months ended September 30, 2022, was primarily due to an increase in unused commitment fees associated with an increase in unfunded credit commitments.

70

A summary of lending related fees by type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Lending related fees by instrument type:
Unused commitment fees	$	14	$	14	—	%	$	49	$	42	16.7	%
Other	6		7		(14.3)		16		13		23.1
Total lending related fees	$	20	$	21	(4.8)		$	65	$	55	18.2

Letters of Credit and Standby Letters of Credit Fees

Letters of credit and standby letters of credit fees were $15 million and $43 million for the three and nine months ended September 30, 2022, compared to $13 million and $39 million for the comparable 2021 periods. The increases were driven primarily by an increase in deferred fee income reflective of larger letter of credit issuances.

Investment Banking Revenue

Investment banking revenue was $75 million and $293 million for the three and nine months ended September 30, 2022, compared to $90 million and $335 million for the comparable 2021 periods. The decreases were primarily driven by the slowdown in public and private markets which limited underwriting fees and partially offset by increased advisory fees reflective of hiring and investment over the past year to expand our investment banking capabilities.

A summary of investment banking revenue by type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Investment banking revenue:
Underwriting fees	$	24	$	39	(38.5)	%	$	97	$	248	(60.9)	%
Advisory fees	40		26		53.8		163		39		NM
Private placements and other	11		25		(56.0)		33		48		(31.3)
Total investment banking revenue	$	75	$	90	(16.7)		$	293	$	335	(12.5)

Commissions

Commissions for the three and nine months ended September 30, 2022 were $24 million and $73 million, compared to $17 million and $58 million for the comparable 2021 periods. Commissions include commissions received from clients for the execution of agency-based brokerage transactions in listed and over-the-counter equities. The Company also earns subscription fees for market intelligence services that are recognized over the period in which they are delivered. Fees received before the subscription period ends is initially recorded as deferred revenue (a contract liability) in other liabilities in our consolidated balance sheet. The increases in commissions were driven by subscription fees, which are new to core fee income due to the acquisition of MoffettNathanson in December 2021.

Other

Other noninterest income was $31 million and $119 million for the three and nine months ended September 30, 2022, compared to $25 million and $97 million for the comparable 2021 periods. The increase for the three months ended September 30, 2022, was primarily due to an increase in foreign exchange exposure gains. The increase for the nine months ended September 30, 2022, was primarily due to the $25 million increase in fair value of hedge instruments for certain funds.

71

Noninterest Expense

A summary of noninterest expense for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Compensation and benefits	$	563	$	548	2.7	%	$	1,649	$	1,418	16.3	%
Professional services	117		104		12.5		355		282		25.9
Premises and equipment	71		54		31.5		189		124		52.4
Net occupancy	25		25		—		74		60		23.3
Business development and travel	21		6		NM		62		13		NM
FDIC and state assessments	25		13		92.3		57		33		72.7
Merger-related charges	7		83		(91.6)		39		102		(61.8)
Other	63		46		37.0		188		136		38.2
Total noninterest expense	$	892	$	879	1.5		$	2,613	$	2,168	20.5

Compensation and Benefits Expense

The following table provides a summary of our compensation and benefits expense for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Compensation and benefits:
Salaries and wages	$	280	$	195	43.6	%	$	780	$	504	54.8	%
Incentive compensation plans	145		229		(36.7)		456		541		(15.7)
Other employee incentives and benefits (1)	138		124		11.3		413		373		10.7
Total compensation and benefits	$	563	$	548	2.7		$	1,649	$	1,418	16.3
Period-end full-time equivalent employees	8,429		6,208		35.8		8,429		6,208		35.8
Average full-time equivalent employees	8,236		6,024		36.7		7,579		5,144		47.3

(1)Other employee incentives and benefits includes employer payroll taxes, group health and life insurance, share-based compensation, 401(k), ESOP, warrant and other incentive plans, retention plans, agency fees and other employee-related expenses.

Compensation and benefits expense was $563 million for the three months ended September 30, 2022, compared to $548 million for the comparable 2021 period. The key factors affecting changes in compensation and benefits expense were as follows:

•An increase of $85 million in salaries and wages expense primarily due to an increase in FTE employees, as we continue to invest in our revenue-generating lines of business and support functions as well as the impact of annual merit increases,

•An increase of $14 million in other employee incentives and benefits driven primarily by the increase in FTE employees, partially offset by

•A decrease of $84 million in incentive compensation plans expense attributable to a decrease in our incentive compensation plan accrual as a result of our updated financial outlook.

Compensation and benefits expense was $1.6 billion for the nine months ended September 30, 2022, compared to $1.4 billion for the comparable 2021 period. The key factors affecting changes in compensation and benefits expense were as follows:

•An increase of $276 million in salaries and wages expense primarily due to an increase in FTE employees, as we continue to invest in our revenue-generating lines of business and support functions as well as the impact of annual merit increases,

•An increase of $40 million in other employee incentives and benefits driven primarily by an increase in stock compensation expenses due to higher grant volume, increased first quarter seasonal expenses relating to additional 401(k) matching contributions and employer-related payroll taxes driven by our increased headcount, partially offset by

•A decrease of $85 million in incentive compensation plans expense related primarily to a decrease in our incentive compensation plan accrual as a result of our updated financial outlook, partially offset by an increase in the number of plan participants along with higher targets due to annual merit increases and promotions.

72

Our variable compensation plans consist primarily of our Incentive Compensation Plan, Direct Drive Incentive Compensation Plan, Retention Program, Warrant Incentive Plan, Deferred Compensation Plan, 401(k) and ESOP Plan, SVB Securities Incentive Compensation Plan, SVB Securities Retention Award, EHOP, 2006 Incentive Plan and ESPP (see descriptions in our 2021 Form 10-K). Total costs incurred under these plans were $163 million and $515 million for the three and nine months ended September 30, 2022, respectively, compared to $255 million and $648 million for the comparable 2021 periods. These amounts are included in total compensation and benefits expense discussed above.

Professional Services

Professional services expense was $117 million and $355 million for the three and nine months ended September 30, 2022, compared to $104 million and $282 million for the comparable 2021 periods. The increases were driven by higher consulting fees associated with our initiatives related to our regulatory programs as well as continued investments in our infrastructure and operating projects to support our presence both domestically and internationally.

Premises and Equipment

Premises and equipment expense was $71 million and $189 million for the three and nine months ended September 30, 2022, compared to $54 million and $124 million for the comparable 2021 periods. The increases were primarily related to higher computer software support and maintenance fees driven by new contracts and the renewal of existing contracts, and an increase in software project depreciation.

Net Occupancy

Net occupancy expense was $25 million and $74 million for the three and nine months ended September 30, 2022, compared to $25 million and $60 million for the comparable 2021 periods. The increase for the nine months ended September 30, 2022 was primarily driven by increased amortization expenses on new leases and extensions.

Business Development and Travel

Business development and travel was $21 million and $62 million for the three and nine months ended September 30, 2022, compared to $6 million and $13 million for the comparable 2021 periods. The increases were primarily due to the continued easing of COVID-19 restrictions on in-person meetings and travel that were previously in place.

FDIC and State Assessments

FDIC and state assessments expense was $25 million and $57 million for the three and nine months ended September 30, 2022, compared to $13 million and $33 million for the comparable 2021 periods. The increases were due primarily to the increase in our average deposits as well as the acquisition of Boston Private deposits during the comparable nine month period.

Merger-Related Charges

Merger-related charges was a new noninterest expense line item for the second quarter of 2021 as a result of the Boston Private acquisition. A summary of merger-related charges, which includes direct acquisition costs for the three and nine months ended September 30, 2022 and 2021 are as follows:

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Personnel-related	$	1	$	10	(90.0)	%	$	6	$	10	(40.0)	%
Occupancy and facilities	—		39		—		4		39		(89.7)
Professional services	4		28		(85.7)		14		43		(67.4)
Systems integration and related charges	2		6		(66.7)		15		10		50.0
Total merger-related charges	$	7	$	83	(91.6)		$	39	$	102	(61.8)

Other Noninterest Expense

Other noninterest expense was $63 million and $188 million for the three and nine months ended September 30, 2022, compared to $46 million and $136 million for the comparable 2021 periods. This increase was driven by expenses primarily related to increased lending, deposit and other client-related processing costs as well as higher advertising and promotional expenses.

73

Operating Efficiency Ratio

Our operating efficiency ratio was 57.29 and 55.77 percent, respectively, for the three and nine months ended September 30, 2022, compared to 57.68 and 49.08 percent for the comparable 2021 periods. The decrease for the three months ended September 30, 2022 compared to the same period in 2021 was driven by higher net interest income partially offset by lower noninterest income from market-driven revenue reflective of the current public market volatility and higher noninterest expense as we continue to invest and support long-term growth. The increase for the nine months ended September 30, 2022 compared to the same period in 2021 was driven by lower noninterest income and higher noninterest expense, partially offset by higher net interest income.

Income Taxes

Our effective tax rate was 27.2 percent and 26.5 percent for the three and nine months ended September 30, 2022, compared to 27.6 percent and 26.1 percent for the comparable 2021 periods. The decrease in our effective tax rate for the three months ended September 30, 2022 was attributable to an increase in tax exempt income and resolution of certain tax matters. The increase in our effective tax rate for the nine months ended September 30, 2022 was attributable to lower recognition of excess tax benefits from share based compensation. Our effective tax rate is calculated by dividing income tax expense by the sum of income before income tax expense and the net income attributable to noncontrolling interests.

Net Income Attributable to Noncontrolling Interests

Included in net income is income and expense attributable to noncontrolling interests. The relevant amounts allocated to investors in our consolidated subsidiaries, other than us, are reflected under “net income attributable to noncontrolling interests” on our statements of income.

In the table below, noninterest income consists primarily of net investment gains and losses from our consolidated funds. A summary of net income attributable to noncontrolling interests for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,					Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change	2022		2021		% Change
Noninterest income (1)	$	38	$	(64)	(159.4)	$	61	$	(116)	(152.6)
Carried interest allocation (2)	13		(24)		(154.2)	(8)		(110)		(92.7)
Net loss (income) attributable to noncontrolling interests	$	51	$	(88)	(158.0)	$	53	$	(226)	(123.5)

(1)Represents noncontrolling interests’ share in noninterest income or loss.

(2)Represents the preferred allocation of income (or change in income) earned by us as the general partner of certain consolidated funds.

Net losses attributable to noncontrolling interests were $51 million and $53 million for the three and nine months ended September 30, 2022, respectively, compared to net income attributable to noncontrolling interests of $88 million and $226 million, respectively, for the comparable 2021 periods. Net losses attributable to noncontrolling interests for the three and nine months ended at September 30, 2022, were driven primarily by net losses on investment securities (including carried interest allocation) from unrealized valuation decreases of our managed funds of funds portfolio and our SVB Securities funds.

Operating Segment Results

We have four segments for which we report our financial information: Silicon Valley Bank, SVB Private, SVB Capital and SVB Securities. We report segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of our reporting segments. Please refer to Note 10 — “Segment Reporting” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for additional details.

74

The following is our reportable segment information for the three and nine months ended September 30, 2022 and 2021:

Silicon Valley Bank

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Net interest income	$	1,107	$	766	44.5	%	$	2,993	$	2,084	43.6	%
Provision for (reduction of) credit losses	(32)		29		NM		(174)		(27)		NM
Noninterest income	308		182		69.2		781		514		51.9
Noninterest expense	(381)		(336)		13.4		(1,148)		(911)		26.0
Income before income tax expense	$	1,002	$	641	56.3		$	2,452	$	1,660	47.7
Total average loans, amortized cost	$	55,177	$	44,789	23.2		$	53,855	$	41,591	29.5
Total average assets	175,620		151,352		16.0		178,209		130,177		36.9
Total average deposits	172,427		148,879		15.8		175,370		128,006		37.0

Three months ended September 30, 2022 and 2021

Income before income tax expense from Silicon Valley Bank increased to $1,002 million for the three months ended September 30, 2022, compared to $641 million for the comparable 2021 period. The key components of Silicon Valley Bank's performance for the three months ended September 30, 2022 compared to the comparable 2021 period are discussed below.

Net interest income from Silicon Valley Bank increased by $341 million for the three months ended September 30, 2022, due primarily from increases in deposit funding credits, yields and average loans, partially offset by higher rates on deposits as well as increases in average balances of interest-bearing deposits.

A provision for credit losses of $32 million for the three months ended September 30, 2022, compared to a reduction of credit losses of $29 million for the comparable 2021 period. The provision for credit losses of $32 million for the three months ended September 30, 2022 was driven primarily by growth in both funded loans and unfunded commitments, and a deterioration in projected economic conditions.

A reduction of credit losses of $29 million for the three months ended September 30, 2021 was driven primarily by a reduction in credit losses due to the previously discussed model enhancements (see “Results of Operations—Provision for Credit Losses— (Reduction) Provision for Loans.”), a decrease in net new nonaccrual loans and recoveries, partially offset by an increase in charge-offs not specifically reserved for at June 30, 2021 and an increase in provision for loan growth.

Noninterest income increased by $126 million for the three months ended September 30, 2022 related primarily to an overall increase in our non-GAAP core fee income. The overall increase was due primarily to higher client investment fees driven by improved fee margins resulting from higher short-term interest rates driven by the 2022 Federal Funds rate hikes and higher foreign exchange fees driven by increases in forward and spot contract commissions reflective of the increased volume of trades.

Noninterest expense increased by $45 million for the three months ended September 30, 2022, due primarily to premises and equipment expense, business development and travel expense and compensation and benefits expense. Premises and equipment expense increased due to higher software support and maintenance fees as well as an increase in software depreciation. Business development and travel expense increased due to the easing of COVID-19 restrictions on in-person meetings and travel that were previously in place. Compensation and benefits expense increased as a result of higher salaries and wages expenses driven by an increase in FTE employees as we continue to invest in our business as well as from the impact of annual merit increases.

Nine months ended September 30, 2022 and 2021

Net interest income from Silicon Valley Bank increased by $909 million for the nine months ended September 30, 2022, due primarily from increases in deposit funding credits, yields and average loans, partially offset by higher rates on deposits as well as increases in average balances of interest-bearing deposits.

There was a provision for credit losses of $174 million for the nine months ended September 30, 2022, compared to a provision of credit losses of $27 million for the comparable 2021 period. The provision for credit losses of $174 million for the nine months ended September 30, 2022 was driven by a deterioration in projected economic conditions, as well as growth in funded loans and unfunded commitments.

The provision for credit losses of $27 million for the nine months ended September 30, 2021 was driven primarily by charge-offs not specifically reserved for at December 31, 2020, of which $80 million was related to the single instance of potentially fraudulent activity discussed in prior filings and an increase in provision related to loan growth, partially offset by a

75

reduction in provision due to model enhancements, a decrease in net new nonaccrual loans and recoveries.

Noninterest income increased by $267 million for the nine months ended September 30, 2022 related primarily to an overall increase in our non-GAAP core fee income. The overall increase was due primarily to higher client investment fees driven by improved fee margins resulting from higher short-term interest rates as a result of the 2022 Federal Funds rate hikes, higher foreign exchange fees primarily due to increases in spot contract commissions reflective of the increased volume of trades, and credit card fees driven by higher transaction volumes reflective of increased spending and client growth, as well as higher travel spending compared to the first nine months of 2021.

Noninterest expense increased by $237 million for the nine months ended September 30, 2022, due primarily to compensation and benefits expense, business development and travel expenses and premises and equipment expense. Compensation and benefits expense increased as a result of higher salaries and wages expenses. Salaries and wages expense increased primarily due to an increase in FTE employees as we continue to invest in our business, as well as from the impact of annual merit increases. Premises and equipment expense increased due to higher software support and maintenance fees as well as an increase in software depreciation. Business development and travel expense increased due to the easing of COVID-19 restrictions on in-person meetings and travel that were previously in place.

SVB Private

	Three months ended September 30,						Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change		2022		2021		% Change
Net interest income	$	111	$	74	50.0	%	$	296	$	146	102.7	%
Reduction of (provision for) credit losses	3		(20)		(115.0)		(9)		(16)		(43.8)
Noninterest income	22		25		(12.0)		72		28		157.1
Noninterest expense	(85)		(93)		(8.6)		(267)		(126)		111.9
Income (loss) before income tax expense	$	51	$	(14)	NM		$	92	$	32	187.5
Total average loans, amortized cost	$	15,181	$	13,515	12.3		$	14,711	$	8,610	70.9
Total average assets	17,032		15,930		6.9		16,456		9,459		74.0
Total average deposits	12,436		13,431		(7.4)		13,327		7,108		87.5

Three months ended September 30, 2022 and 2021

Net interest income from SVB Private increased by $37 million from the comparable 2021 period due primarily from higher average loans, yields and deposit funding credits, partially offset by higher rates on deposits, average balances of interest-bearing deposits and loan funding charges.

The reduction of credit losses of $3 million for the three months ended September 30, 2022 was reflective primarily of a reduction in reserves for our performing loans due to a reduction in CRE reserve rate driven by the CRE model’s sensitivity to the lower weighting placed on the downside scenario, offset by increases in reserves for the other loan classes within SVB Private.

Noninterest income decreased by $3 million for the three months ended September 30, 2022 primarily due to lower wealth management and trust fees as AUM saw a decrease driven by unfavorable market returns resulting from persistent market volatility.

Noninterest expense decreased by $8 million for the three months ended September 30, 2022, related primarily to compensation and benefits expense. Compensation and benefits expense decreased as a result of lower incentive compensation plan expense.

Nine months ended September 30, 2022 and 2021

Net interest income from our SVB Private increased by $150 million from the comparable 2021 period, as average loans increased driven primarily by the acquisition of Boston Private as well as higher average loans, yields and deposit funding credits, partially offset by higher rates on deposits, average balances of interest-bearing deposits and loan funding charges.

The provision for credit losses of $9 million for the nine months ended September 30, 2022 was driven primarily by a deterioration in projected economic conditions.

Noninterest income increased by $44 million for the nine months ended September 30, 2022 primarily due to wealth management and trust fees, which is a new financial statement line item for the third quarter of 2021 as a result of the Boston Private acquisition.

Noninterest expense increased by $141 million for the nine months ended September 30, 2022, related primarily to compensation and benefits expense. Compensation and benefits expense increased as a result of an increase in average number of FTE employees primarily due to the acquisition of Boston Private.

76

SVB Capital

	Three months ended September 30,					Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change	2022		2021		% Change
Noninterest (loss) income	$	(54)	$	145	(137.2)	(78)		389		(120.1)
Noninterest expense	(17)		(15)		13.3	(53)		(48)		10.4
(Loss) income before income tax expense	$	(71)	$	130	(154.6)	$	(131)	$	341	(138.4)
Total average assets	$	883	$	730	21.0	$	956	$	641	49.1

 SVB Capital’s components of noninterest income primarily include net gains and losses on non-marketable and other equity securities, carried interest and fund management fees. All components of income before income tax expense discussed below are net of noncontrolling interests.

We experience variability in the performance of SVB Capital from quarter to quarter due to a number of factors, including changes in the values of our funds’ underlying investments, changes in the amount of distributions and general economic and market conditions. Such variability may lead to volatility in the gains and losses from investment securities and cause our results to differ from period to period.

Three months ended September 30, 2022 and 2021

SVB Capital had a noninterest loss of $54 million for the three months ended September 30, 2022, compared to noninterest income of $145 million for the comparable 2021 period. The decrease in noninterest income was due primarily to reduced valuations reflecting adverse market conditions during the third quarter of 2022, which drove net losses on investment securities, net of NCI, of $72 million for the three months ended September 30, 2022, compared to net gains on investment securities, net of NCI, of $123 million for the comparable 2021 period.

Nine months ended September 30, 2022 and 2021

SVB Capital had a noninterest loss of $78 million for the nine months ended September 30, 2022, compared to noninterest income of $389 million for the comparable 2021 period. The decrease in noninterest income was due primarily to reduced valuations reflecting adverse market conditions during the nine months ended September 30, 2022, which drove net losses on investment securities, net of NCI, of $126 million for the nine months ended September 30, 2022, compared to net gains on investment securities, net of NCI, of $320 million for the comparable 2021 period.

SVB Securities

	Three months ended September 30,					Nine months ended September 30,
(Dollars in millions)	2022		2021		% Change	2022		2021		% Change
Net interest income	$	1	$	—	—	$	1	$	—	—
Noninterest income	$	100	$	131	(23.7)	352		450		(21.8)
Noninterest expense	(131)		(142)		(7.7)	(406)		(376)		8.0
(Loss) income before income tax expense	$	(30)	$	(11)	172.7	$	(53)	$	74	(171.6)
Total average assets	$	898	$	837	7.3	$	912	$	778	17.2

SVB Securities’ components of noninterest income primarily include investment banking revenue, commissions and net gains and losses on non-marketable and other equity securities, carried interest and fund management fees. All components of income before income tax expense discussed below are net of noncontrolling interests.

Three months ended September 30, 2022 and 2021

SVB Securities had noninterest income of $100 million for the three months ended September 30, 2022, compared to $131 million for the comparable September 30, 2021 period. The $31 million decrease in noninterest income was driven primarily by strong investment gains recognized during the three months ended September 30, 2021 and lower investment banking revenue due to the slowdown in transactions as a result of market volatility partially offset by an increase in commissions driven by subscription fees due to the acquisition of MoffettNathanson in December 2021.

SVB Securities had noninterest expense of $131 million for the three months ended September 30, 2022, compared to $142 million for the comparable 2021 period. The $11 million decrease in noninterest expense was driven primarily by an decrease in compensation and benefits expense due to lower incentive compensation expense.

77

Nine months ended September 30, 2022 and 2021

SVB Securities had noninterest income of $352 million for the nine months ended September 30, 2022, compared to $450 million for the comparable September 30, 2021 period. The $98 million decrease in noninterest income was driven primarily by strong investment gains recognized during the nine months ended September 30, 2021 and lower investment banking revenue due to the slowdown in transactions as a result of market volatility partially offset by an increase in commissions driven by subscription fees.

SVB Securities had noninterest expense of $406 million for the nine months ended September 30, 2022, compared to $376 million for the comparable 2021 period. The $30 million increase in noninterest expense was driven primarily by an increase in compensation and benefits expense due to an increase in strategic hires throughout the past twelve months to support the continued expansion of SVB Securities.

Consolidated Financial Condition

Our total assets, and total liabilities and stockholders' equity, were $212.9 billion at September 30, 2022 compared to $211.3 billion at December 31, 2021, an increase of $1.6 billion, or 0.7 percent. Refer below to a summary of the individual components driving the changes in total assets, total liabilities and stockholders' equity.

Cash and Cash Equivalents

Cash and cash equivalents totaled $14.0 billion at September 30, 2022, a decrease of $618 million, or 4.2 percent, compared to $14.6 billion at December 31, 2021. The decrease was primarily driven by a decrease in interest-earning deposits in other financial institutions. As of September 30, 2022, $7.6 billion of our cash and due from banks was deposited at the Federal Reserve Bank and was earning interest at the Federal Funds target rate and interest-earning deposits in other financial institutions were $4.6 billion. As of December 31, 2021, $5.7 billion of our cash and due from banks was deposited at the Federal Reserve Bank and was earning interest at the Federal Funds target rate and interest-earning deposits in other financial institutions were $5.8 billion.

Investment Securities

Investment securities totaled $122.6 billion at September 30, 2022, a decrease of $5.4 billion, or 4.2 percent, compared to $128.0 billion at December 31, 2021. Our investment securities portfolio is comprised of: (i) an AFS securities portfolio and a HTM securities portfolio, both of which represent interest earning fixed income investment securities; and (ii) a non-marketable and other equity securities portfolio, which represents primarily investments managed as part of our funds management business, investments in qualified affordable housing projects, as well as public equity securities held as a result of equity warrant assets exercised.

AFS Securities

Period-end AFS securities were $26.7 billion at September 30, 2022, compared to $27.2 billion at December 31, 2021, a decrease of $510 million, or 1.9 percent. The decrease in period-end AFS securities balances from December 31, 2021 to September 30, 2022 was driven by a the sale of $8.5 billion of AFS securities and a $2.9 billion decrease in the fair value of our AFS securities portfolio, reflective of higher interest rates, as well as paydowns and maturities of AFS securities of $1.2 billion, partially offset by $12.4 billion of purchases.

The following table summarizes the remaining contractual principal maturities and fully taxable equivalent yields on fixed income securities, carried at fair value, classified as AFS as of September 30, 2022. The weighted average yield is computed using the amortized cost of fixed income investment securities, which are reported at fair value. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments. The weighted average yield on mortgage-backed securities is based on prepayment assumptions at the purchase date. Actual yields earned may differ significantly based upon actual prepayments.

78

	September 30, 2022
	Total				One Year or Less				After One Year to Five Years				After Five Years to Ten Years				After Ten Years
(Dollars in millions)	Carrying Value		Weighted Average Yield		Carrying Value		Weighted Average Yield		Carrying Value		Weighted Average Yield		Carrying Value		Weighted Average Yield		Carrying Value		Weighted Average Yield
U.S. Treasury securities	$	16,845	1.38	%	$	936	0.26	%	$	15,133	1.37	%	$	776	2.96	%	$	—	—	%
U.S. agency debentures	100		4.20		—		—		34		4.30		66		4.15		—		—
Foreign government debt securities	913		2.24		41		(0.02)		46		2.29		826		2.46		—		—
Residential MBS:
Agency-issued MBS	6,683		1.53		—		—		—		—		45		2.86		6,638		1.53
Agency-issued CMO—fixed rate	714		1.34		—		—		—		—		—		—		714		1.34
Agency-issued CMBS	1,456		1.89		—		—		100		1.29		1,356		1.94		—		—
Total	$	26,711	1.49		$	977	0.25		$	15,313	1.38		$	3,069	2.40		$	7,352	1.51

HTM Securities

Period-end HTM securities were $93.3 billion at September 30, 2022, compared to $98.2 billion at December 31, 2021, a decrease of $4.9 billion, or 5.0 percent. The $4.9 billion decrease in period-end HTM securities balances from December 31, 2021 to September 30, 2022 was driven by $9.6 billion in paydowns and maturities, partially offset by purchases of $5.0 billion.

Securities classified as HTM are accounted for at cost with no adjustments for changes in fair value. For securities re-designated as HTM from AFS, the net unrealized gains or losses at the date of transfer will continue to be reported as a separate component of shareholders' equity and amortized over the life of the securities in a manner consistent with the amortization of a premium or discount.

The following table summarizes the remaining contractual principal maturities, net of ACL, and fully taxable equivalent yields on fixed income investment securities classified as HTM as of September 30, 2022. Interest income on certain municipal bonds and notes (non-taxable investments) are presented on a fully taxable equivalent basis using the federal statutory tax rate of 21.0 percent. The weighted average yield is computed using the amortized cost of fixed income investment securities. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected remaining maturities for certain U.S. agency debentures may occur earlier than their contractual maturities because the note issuers have the right to call outstanding amounts ahead of their contractual maturity. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as HTM typically have original contractual maturities from 10 to 30 years whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments. The expected yield on mortgage-backed securities is based on prepayment assumptions at the purchase date. Actual yields earned may differ significantly based upon actual prepayments.

	September 30, 2022
	Total				One Year or Less				After One Year to Five Years				After Five Years to Ten Years				After Ten Years
(Dollars in millions)	Net Carry Value		Weighted Average Yield		Net Carry Value		Weighted Average Yield		Net Carry Value		Weighted Average Yield		Net Carry Value		Weighted Average Yield		Net Carry Value		Weighted Average Yield
U.S. agency debentures	$	486	1.91	%	$	1	2.39	%	$	118	2.50	%	$	367	1.72	%	$	—	—	%
Residential MBS:
Agency-issued MBS	59,200		1.55		1		1.65		2		2.95		1,148		2.32		58,049		1.54
Agency-issued CMO—fixed rate	10,741		1.48		—		—		87		1.47		154		1.70		10,500		1.48
Agency-issued CMO—variable rate	83		0.74		—		—		—		—		—		—		83		0.74
Agency-issued CMBS	14,644		1.63		45		0.41		159		0.85		968		1.93		13,472		1.62
Municipal bonds and notes	7,428		2.82		25		2.30		235		2.50		1,265		2.73		5,903		2.85
Corporate bonds	704		1.86		—		—		115		1.72		589		1.88		—		—
Total	$	93,286	1.66		$	72	1.12		$	716	1.88		$	4,491	2.40		$	88,007	1.63

Portfolio duration is a standard measure used to approximate changes in the market value of fixed income instruments due to a change in market interest rates. The measure is an estimate based on the level of current market interest rates, expectations for changes in the path of forward rates and the effect of forward rates on mortgage prepayment speed assumptions. As such, portfolio duration will fluctuate with changes in market interest rates. Changes in portfolio duration are also impacted by changes in the mix of longer versus shorter term-to-maturity securities. The estimated weighted-average duration of our fixed income investment securities portfolio was 5.7 years and 4.0 years at September 30, 2022 and December 31, 2021, respectively. The weighted-average duration of our total fixed income securities portfolio including the impact of our fair value swaps was 3.7 years at December 31, 2021. There were no outstanding fair value swaps at September 30, 2022.

79

The weighted-average duration of our AFS securities portfolio was 3.7 years at September 30, 2022 and 3.5 years at December 31, 2021. The weighted-average duration of our AFS securities portfolio including the impact of our fair value swaps was 2.4 years at December 31, 2021. The weighted-average duration of our HTM securities portfolio was 6.3 years at September 30, 2022 and 4.1 years at December 31, 2021.

Non-Marketable and Other Equity Securities

Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies, including public equity securities held as a result of equity warrant assets exercised, and qualified affordable housing projects. Included in our non-marketable and other equity securities carried under fair value accounting are amounts that are attributable to noncontrolling interests. We are required under GAAP to consolidate 100% of these investments that we are deemed to control, even though we may own less than 100% of such entities. See below for a summary of the carrying value (as reported) of non-marketable and other equity securities compared to the amounts attributable to SVBFG.

Period-end non-marketable and other equity securities were $2.6 billion ($2.3 billion net of noncontrolling interest) at September 30, 2022 compared to $2.5 billion ($2.2 billion net of noncontrolling interest) at December 31, 2021, an increase of $52 million, or 2.0 percent. The following table summarizes the carrying value (as reported) of non-marketable and other equity securities compared to the amounts attributable to SVBFG (which generally represents the carrying value times our ownership percentage) at September 30, 2022 and December 31, 2021:

	September 30, 2022				December 31, 2021
(Dollars in millions)	Carrying value (as reported)		Amount attributable to SVBFG		Carrying value (as reported)		Amount attributable to SVBFG
Non-marketable and other equity securities:
Non-marketable securities (fair value accounting):
Consolidated venture capital and private equity fund investments (1)	$	147	$	105	$	130	$	36
Unconsolidated venture capital and private equity fund investments (2)	123		123		208		208
Other investments without a readily determinable fair value (3)	176		176		164		164
Other equity securities in public companies (fair value accounting (4)	29		29		117		117
Non-marketable securities (equity method accounting) (5):
Venture capital and private equity fund investments	639		373		671		397
Debt funds	4		4		5		5
Other investments	272		272		294		294
Investments in qualified affordable housing projects, net	1,205		1,205		954		954
Total non-marketable and other equity securities	$	2,595	$	2,287	$	2,543	$	2,175

(1)The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and amounts attributable to SVBFG for each fund at September 30, 2022 and December 31, 2021:

	September 30, 2022				December 31, 2021
(Dollars in millions)	Carrying value (as reported)		Amount attributable to SVBFG		Carrying value (as reported)		Amount attributable to SVBFG
Strategic Investors Fund, LP	$	2	$	—	$	2	$	—
Capital Preferred Return Fund, LP	30		7		61		13
Growth Partners, LP	25		8		67		23
Redwood Evergreen Fund, LP	90		90		—		—
Total consolidated venture capital and private equity fund investments	$	147	$	105	$	130	$	36

(2)The carrying value represents investments in 141 and 150 funds (primarily venture capital funds) at September 30, 2022 and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships' operating activities and financial policies. Our unconsolidated venture capital and private equity fund investments are carried at fair value based on the fund investments' net asset values per share as obtained from the general partners of the funds. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30th for our September 30th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

(3)Investments classified as "Other investments without a readily determinable fair value" include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment and a discount for certain investments that have

80

lock-up restrictions or other features that indicate a discount to fair value is warranted. For further details on the carrying value of these investments refer to Note 5 — “Investment Securities" of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report.

(4)Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in the fair value recognized through net income.

(5)The following table shows the carrying value and our ownership percentage of each investment at September 30, 2022 and December 31, 2021 (equity method accounting):

	September 30, 2022				December 31, 2021
(Dollars in millions)	Carrying value (as reported)		Amount attributable to SVBFG		Carrying value (as reported)		Amount attributable to SVBFG
Venture capital and private equity fund investments:
Strategic Investors Fund II, LP	$	2	$	2	$	3	$	3
Strategic Investors Fund III, LP	13		11		25		21
Strategic Investors Fund IV, LP	23		19		36		30
Strategic Investors Fund V, LP	59		31		87		45
CP II, LP (1)	2		1		2		1
Other venture capital and private equity fund investments	540		309		518		298
Total venture capital and private equity fund investments	$	639	$	373	$	671	$	398
Debt funds:
Gold Hill Capital 2008, LP (2)	$	3	$	3	$	4	$	4
Other debt funds	1		1		1		1
Total debt funds	$	4	$	4	$	5	$	5
Other investments:
SPD Silicon Valley Bank Co., Ltd.	$	143	$	143	$	154	$	154
Other investments	129		129		140		140
Total other investments	$	272	$	272	$	294	$	294

(1)Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.

(2)Our ownership includes direct ownership interest of 11.5 percent in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.

Volcker Rule

The Volcker Rule prohibits, subject to certain exceptions, a banking entity, such as the Company, from sponsoring, investing in, or having certain relationships with covered funds. Under the currently effective regulations implementing the Volcker Rule, covered funds are defined to include many venture capital and private equity funds.

In June 2017, we received notice that the Federal Reserve approved the Company’s application for an extension of the permitted conformance period for the Company’s investments in “illiquid” covered funds (“Restricted Volcker Investments”). The approval extended the deadline by which the Company must sell, divest, restructure or otherwise conform such investments to the provisions of the Volcker Rule by the earlier of (i) July 21, 2022, or (ii) the date by which each fund matures by its terms or is otherwise conformed to the Volcker Rule. As a result of various subsequent amendments to the Volcker Rule, we believe all of our Restricted Volcker Investments (i) qualify for exclusions; (ii) otherwise are excluded from the definition of "covered fund"; or (iii) are subject to a liquidation or dissolution process (For more information about the Volcker Rule, see “Business — Supervision and Regulation” under Part 1, Item 1 of our 2021 Form 10-K).

Loans

Loans at amortized cost basis increased by $5.9 billion to $72.1 billion at September 30, 2022, compared to $66.3 billion at December 31, 2021. Unearned income was $244 million at September 30, 2022 and $250 million at December 31, 2021. The increase in period-end loans was driven primarily by our Global Fund Banking, Technology and Life Science/Healthcare and Private Bank loan portfolios.

81

The breakdown of total loans and loans as a percentage of total loans by class of financing receivable is as follows:

	September 30, 2022				December 31, 2021
(Dollars in millions)	Amount		Percentage		Amount		Percentage
Global fund banking	$	40,337	55.9	%	$	37,958	57.3	%
Investor dependent:
Early stage	1,911		2.6		1,593		2.4
Growth stage	4,398		6.1		3,951		5.9
Total investor dependent	6,309		8.7		5,544		8.3
Cash flow dependent- SLBO	1,845		2.6		1,798		2.7
Innovation C&I	8,321		11.6		6,673		10.1
Private bank	10,102		14.0		8,743		13.2
CRE	2,609		3.6		2,670		4.0
Premium wine	1,117		1.5		985		1.5
Other C&I	1,087		1.5		1,257		1.9
Other	374		0.5		317		0.5
PPP	28		0.1		331		0.5
Total loans	$	72,129	100.0	%	$	66,276	100.0	%

For additional details on our loan classes, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Loans” under Part II, Item 7 of our 2021 Form 10-K.

The table below details loans that are secured by real estate, at amortized cost as of September 30, 2022 and December 31, 2021.

(Dollars in millions)	September 30, 2022		December 31, 2021
Real estate secured loans:
Private bank:
Loans for personal residence	$	7,998	$	6,939
Loans to eligible employees	540		455
Home equity lines of credit	125		130
Other	138		135
Total private bank loans secured by real estate	$	8,801	$	7,659
CRE:
Multifamily and residential investment	910		1,021
Retail	462		524
Office and medical	509		499
Manufacturing, industrial and warehouse	465		336
Hospitality	110		142
Other	153		148
Total CRE loans secured by real estate	$	2,609	$	2,670
Premium wine	881		793
Other	417		334
Total real estate secured loans	$	12,708	$	11,456

82

Loan Concentration

The following table provides a summary of total loans by size and class of financing receivable. The breakout below is based on total client balances (individually or in the aggregate) as of September 30, 2022:

	September 30, 2022
(Dollars in millions)	Less than Five Million		Five to Ten Million		Ten to Twenty Million		Twenty to Thirty Million		Thirty Million or More		Total
Global fund banking	$	1,146	$	1,785	$	3,461	$	3,739	$	30,206	$	40,337
Investor dependent:
Early stage	1,307		348		226		42		—		1,923
Growth stage	890		1,145		1,298		440		626		4,399
Total Investor Dependent	$	2,197	$	1,493	$	1,524	$	482	$	626	$	6,322
Cash flow dependent - SLBO	4		53		239		546		1,003		1,845
Innovation C&I	443		428		912		1,089		5,457		8,329
Private bank	7,527		1,170		901		238		266		10,102
CRE	750		567		757		346		189		2,609
Premium wine	217		290		273		143		194		1,117
Other C&I	351		138		251		224		130		1,094
Other	92		81		157		44		—		374
Total loans (1)	$	12,727	$	6,005	$	8,475	$	6,851	$	38,071	$	72,129

(1)Included in total loans at amortized cost is approximately $28 million in PPP loans. The PPP loans consist of loans across all of our classes of financing receivables.

At September 30, 2022, loans equal to or greater than $20 million to any single client (individually or in the aggregate) totaled $44.9 billion of our total loan portfolio. These loans represented 824 clients, none of which were on nonaccrual status as of September 30, 2022.

The following table provides a summary of loans by size and class of financing receivable. The breakout below is based on total client balances (individually or in the aggregate) as of December 31, 2021:

	December 31, 2021
(Dollars in millions)	Less than Five Million		Five to Ten Million		Ten to Twenty Million		Twenty to Thirty Million		Thirty Million or More		Total
Global fund banking	$	996	$	1,494	$	2,905	$	3,163	$	29,405	$	37,963
Investor dependent:
Early stage	1,392		219		124		—		—		1,735
Growth stage	855		1,068		1,122		374		551		3,970
Total investor dependent	2,247		1,287		1,246		374		551		5,705
Cash flow dependent - SLBO	7		31		287		508		965		1,798
Innovation C&I	462		432		920		912		4,018		6,744
Private bank	6,674		950		735		217		167		8,743
CRE	823		652		869		246		80		2,670
Premium wine	215		267		269		124		120		995
Other C&I	444		169		262		217		249		1,341
Other	93		123		101		—		—		317
Total loans (1)	$	11,961	$	5,405	$	7,594	$	5,761	$	35,555	$	66,276

(1)Included in total loans at amortized cost is approximately $331 million in PPP loans. The PPP loans consist of loans from all classes of financing receivables.

At December 31, 2021, loans equal to or greater than $20 million to any single client (individually or in the aggregate) totaled $41.3 billion, or 62 percent of our total loan portfolio. These loans represented 768 clients, and of these loans, $21 million were on nonaccrual status as of December 31, 2021.

State Concentrations

Approximately 28 percent of our outstanding total loan balances as of September 30, 2022 were to borrowers based in California, compared to 30 percent as of December 31, 2021. Borrowers in New York increased to 12 percent at September 30, 2022, compared to 10 percent as of December 31, 2021, and borrowers in Massachusetts represented approximately 13 percent of total loan balances at September 30, 2022 compared to 12 percent as of December 31, 2021. Other than California,

83

New York, and Massachusetts, there are no additional states with loan balances greater than or equal to 10 percent of total loans as of September 30, 2022.

See generally “Risk Factors–Credit Risks” set forth under Part I, Item 1A in our 2021 Form 10-K and "Risk Factors" under Part II, Item 1A of this report.

Paycheck Protection Program

We accepted applications under the PPP administered by the SBA under the CARES Act and originated loans to qualified small businesses until the loan origination phase of the PPP ended on June 30, 2021. Under the terms of the program, loans funded through the PPP are eligible to be forgiven if certain requirements are met, including using the funds for certain costs relating to payroll, healthcare and qualifying mortgage interest, rent and utility payments. We continued to participate in the forgiveness stage of the PPP through the third quarter of 2022.

As of September 30, 2022, we have outstanding PPP loans in the amount of $28 million, as approved by the SBA, compared to $331 million at December 31, 2021. This funded amount reflects repayments received as of such date.

Loan Deferral Programs

In April 2020, we implemented three loan payment deferral programs targeted to assist borrowers who were the most impacted by the COVID-19 pandemic. As of September 30, 2022, no loan modifications remained active under these programs. As of December 31, 2021, loans modified under these programs had outstanding balances of $10 million, which consisted entirely of venture-backed borrowers who lengthened their existing interest-only payment period under the deferral program.

For additional details on our PPP and loan deferral programs, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Loans” under Part II, Item 7 of our 2021 Form 10-K.

Credit Quality Indicators

Our total criticized loans and nonaccrual loans represented three percent of our total loans at both September 30, 2022 and December 31, 2021. Criticized and nonaccrual loans to early-stage clients represented 12 percent of our total criticized and nonaccrual loan balances at September 30, 2022 compared to 13 percent as of December 31, 2021. Loans to early-stage investor dependent clients represent a relatively small percentage of our overall portfolio at three percent of total loans at September 30, 2022 and two percent at December 31, 2021. It is common for an early-stage client’s remaining liquidity to fall temporarily below the threshold for a pass-rated credit during its capital-raising period for a new round of funding. Based on our experience, for most early-stage clients, this situation typically lasts one to two quarters and generally resolves itself with a subsequent round of venture funding, though there are exceptions, from time to time. As a result, we expect that each of our early-stage clients will reside in our criticized portfolio during a portion of their life cycle.

As of September 30, 2022, we have identified the following risks to credit quality: (i) pressured public and private markets, (ii) larger Growth Stage, Innovation C&I, and Cash Flow Dependent - SLBO loan sizes and (iii) exposure from CRE loans.

(i) Pressured public and private markets - Prolonged market volatility may impact the performance of the Technology and Life Science/Healthcare portfolio. This risk particularly applies to Investor Dependent loans, where repayment is dependent on the borrower's ability to fundraise or exit.

(ii) Larger Growth Stage, Innovation C&I and Cash Flow Dependent - SLBO loan sizes - The growth of our balance sheet and our clients continues to increase the number of large loans, which may introduce greater volatility in credit metrics.

(iii) Exposure from CRE loans - We acquired these loans from Boston Private in 2021. The exposure is mitigated by the well-margined collateral on these loans and our limited overall exposure, with CRE making up only 4 percent of total loans at September 30, 2022.

Additionally, we have identified the following factors that could have a positive impact on credit quality: (i) strong client balance sheets and (ii) an improved risk profile of our loan portfolio.

(i) Strong client balance sheets - Record venture capital investment over the past two years has generally extended client runways. We currently believe our clients are generally in stronger positions compared to similar stages of previous economic cycles.

(ii) Improved risk profile of loan portfolio - As described above, our Investor Dependent - Early Stage class, which historically has been the most vulnerable loan class with the most losses, is only three percent of total loans. Furthermore, seventy percent of total loans are now in our Global Fund Banking and Private Bank classes, which have low credit loss experience.

84

We continue to monitor the current environment to evaluate the impact of the above on our portfolio's credit quality and to identify the emergence of additional factors.

Credit Quality, Allowance for Credit Losses and Nonperforming Assets

Nonperforming assets consist of loans on nonaccrual status, loans past due 90 days or more still accruing interest and OREO and other foreclosed assets. We measure all loans placed on nonaccrual status for impairment based on the fair value of the underlying collateral or the net present value of the expected cash flows. The table below sets forth certain data and ratios between nonperforming loans, nonperforming assets and the ACL for loans and unfunded credit commitments:

(Dollars in millions)	September 30, 2022			December 31, 2021
Nonperforming, past due, and restructured loans:
Nonaccrual loans	$	76		$	84
Loans past due 90 days or more still accruing interest	6			7
Total nonperforming loans	82			91
OREO and other foreclosed assets	—			1
Total nonperforming assets	$	82		$	92
Performing TDRs	$	32		$	40
Nonaccrual loans as a percentage of total loans	0.11		%	0.13		%
Nonperforming loans as a percentage of total loans	0.11		%	0.14
Nonperforming assets as a percentage of total assets	0.04			0.04
ACL for loans (1)	$	557		$	422
As a percentage of total loans	0.77		%	0.64		%
As a percentage of total nonperforming loans	679.27			463.74
ACL for nonaccrual loans (1)	$	25		$	35
As a percentage of total loans	0.03		%	0.05		%
As a percentage of total nonperforming loans	30.49			38.46
ACL for total performing loans (1)	$	532		$	387
As a percentage of total loans	0.74		%	0.58		%
As a percentage of total performing loans	0.74			0.58
Total loans	$	72,129		$	66,276
Total performing loans	72,047			66,185
ACL for unfunded credit commitments (2)	265			171
As a percentage of total unfunded credit commitments	0.48		%	0.39		%
Total unfunded credit commitments (3)	$	55,698		$	44,016

(1)The "ACL for loans" at December 31, 2021 includes an initial allowance of $66 million related to acquired Boston Private loans, of which $2 million was related to nonaccrual loans. See “Provision for Credit Losses” for a detailed discussion of the changes to the allowance.

(2)The “ACL for unfunded credit commitments” is included as a component of other liabilities and any provision is included in the “provision for credit losses” in the statement of income. At December 31, 2021, this includes an initial allowance of $2 million related to acquired Boston Private commitments. See “Provision for Credit Losses” for a detailed discussion of the changes to the allowance.

(3)Includes unfunded loan commitments and letters of credit.

To determine the ACL for performing loans as of September 30, 2022 and December 31, 2021, we utilized three scenarios, on a weighted basis, from Moody's Analytics September 2022 and December 2021 forecasts, respectively, in our expected lifetime loss estimate. The table below summarizes the key assumptions within each period's baseline forecasts, as well as the weightings we applied to the three economic forecast scenarios in our model.

	September 30, 2022		December 31, 2021
Key economic factors from Moody's baseline forecasts
Gross domestic product projected growth rate	1.3	%	6.8	%
Projected unemployment rate	3.7	%	4.3	%
Housing price index projected growth rate	(2.2)	%	5.9	%
Weightings applied to different Moody's economic scenarios
Upward outlook (Moody's S1)	25	%	30	%
Baseline (Moody's B)	35		40
Downward outlook (Moody's S3)	40		30
Total	100	%	100	%

85

While utilizing the Moody's September 2022 forecast, we determined that a higher weighting should be applied to the economic downturn scenario to align with our expectations as of September 30, 2022, compared to the standard weighting applied at December 31, 2021. After adjusting the weightings accordingly, we determined the forecast to be a reasonable view of the outlook for the economy given the available information at current quarter end.

Our ACL for loans as a percentage of total loans increased 13 basis points to 0.77 percent at September 30, 2022, compared to 0.64 percent at December 31, 2021. The 13 basis points increase was due to the increase in our performing loans reserve rate, which was a result of the deterioration of current and forecasted economic conditions, as well as continued loan growth. For a detailed discussion of changes in the current period's reserve, see "Provision for Credit Losses."

The following table presents a summary of changes in nonaccrual loans for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Balance, beginning of period	$	93	$	79	$	84	$	104
Additions	31		53		113		67
Paydowns and other reductions	(23)		(12)		(79)		(30)
Charge-offs	(25)		(6)		(42)		(27)
Balance, end of period	$	76	$	114	$	76	$	114
Average nonaccrual loans	$	94	$	111	$	87	$	108

Our nonaccrual loan balance decreased by $8 million to $76 million at September 30, 2022, compared to $84 million at December 31, 2021. The decrease was due primarily to paydowns and charge-offs of existing nonaccrual loans driven by clients in our Technology and Life Science/Healthcare portfolios. In the third quarter of 2022, our Investor Dependent clients accounted for $12 million of the paydowns and other reductions, $10 million specifically coming from Early Stage clients. Charge-offs were also primarily driven by Early Stage clients. Offsetting new nonaccrual loans were largely driven by both Early Stage and Growth Stage Investor Dependent clients. As of September 30, 2022, we have specifically reserved $25 million for our nonaccrual loans.

Accrued Interest Receivable and Other Assets

A summary of accrued interest receivable and other assets at September 30, 2022 and December 31, 2021 is as follows:

(Dollars in millions)	September 30, 2022		December 31, 2021		% Change
Derivative assets (1)	$	666	$	428	55.6	%
Accrued interest receivable	600		470		27.7
FHLB and Federal Reserve Bank stock	665		107		NM
Net deferred tax assets	1,016		24		NM
Accounts receivable	61		54		13.0
Other assets	515		708		(27.3)
Total accrued interest receivable and other assets	$	3,523	$	1,791	96.7

(1)See “Derivatives” section below.

FHLB and Federal Reserve Bank stock

The increase of $558 million in FHLB and Federal Reserve Bank stock is primarily due to purchases of additional shares as required by the Federal Reserve.

Net Deferred Tax Assets

Net deferred tax assets increased $992 million primarily due to an increase in unrealized losses on AFS securities attributable to an increase in market rates.

Derivatives

Derivative instruments are recorded as a component of other assets and other liabilities on the balance sheet. The following table provides a summary of derivative assets and liabilities at September 30, 2022 and December 31, 2021:

86

(Dollars in millions)	September 30, 2022		December 31, 2021		% Change
Assets:
Equity warrant assets	$	351	$	277	26.7	%
Contingent conversion rights	6		—		—
Foreign exchange contracts	651		171		NM
Total return swaps	25		—		—
Client interest rate derivatives	128		99		29.3
Interest rate swaps	—		18		—
Total gross derivative assets	1,161		565		105.5
Less: netting adjustments	(495)		(137)		NM
Total derivative assets	$	666	$	428	55.6
Liabilities:
Foreign exchange contracts	$	523	$	137	NM
Client interest rate derivatives	235		101		132.7
Total gross derivative liabilities	$	758	$	238	NM
Less: netting adjustments (1)	(234)		(120)		95.0
Total derivative liabilities	$	524	$	118	NM

(1)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

Equity Warrant Assets

In connection with negotiating credit facilities and certain other services, we often obtain rights to acquire stock in the form of equity warrant assets in primarily private, venture-backed companies in the technology and life science/healthcare industries. At September 30, 2022, we held warrants in 3,019 companies, compared to 2,831 companies at December 31, 2021. Warrants in 57 companies each had fair values greater than $1 million and collectively represented $180 million, or 51.4 percent, of the fair value of the total warrant portfolio at September 30, 2022. The change in fair value of equity warrant assets is recorded in "Gains on equity warrant assets, net" in noninterest income, a component of consolidated net income.

The following table provides a summary of transactions and valuation changes for equity warrant assets for the three and nine months ended September 30, 2022 and 2021: 

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Balance, beginning of period	$	322	$	266	$	277	$	203
New equity warrant assets	9		6		21		19
Non-cash changes in fair value, net	32		57		79		112
Exercised equity warrant assets	(11)		(54)		(23)		(58)
Terminated equity warrant assets	(1)		(1)		(3)		(2)
Balance, end of period	$	351	$	274	$	351	$	274

Foreign Exchange Contracts

We enter into foreign exchange contracts with clients involved in foreign activities, either as the purchaser or seller, depending upon the clients’ needs. For each contract entered into with our clients, we enter into an opposite way contract with a correspondent bank, which mitigates the risk of fluctuations in currency rates. We also enter into forward contracts with correspondent banks to economically reduce our foreign exchange exposure related to certain foreign currency denominated instruments. Net gains and losses on the revaluation of foreign currency denominated instruments are recorded in the line item “Other” as part of noninterest income, a component of consolidated net income. To manage our exposure to variability on the foreign currency translation of net investments in non-U.S. subsidiaries, we enter into certain foreign exchange contracts to hedge against the foreign currency risk of a net investment in foreign operations. We designate these foreign exchange contracts as net investment hedges that qualify for hedge accounting under ASC 815. We have not experienced nonperformance by any of our counterparties and therefore have not incurred any related losses. Further, we anticipate performance by all counterparties. For additional information on our foreign exchange contracts, see Note 8 — “Derivative Financial Instruments” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report.

87

Client Interest Rate Derivatives

We sell interest rate contracts to clients who wish to mitigate their interest rate exposure. We economically reduce the interest rate risk from this business by entering into opposite way contracts with correspondent banks. For additional information on our client interest rate derivatives, see Note 8 — “Derivative Financial Instruments” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report.

Interest Rate Swaps

To manage interest rate risk on our AFS securities portfolio, we enter into pay-fixed, receive-floating interest rate swap contracts to hedge against exposure to changes in the fair value of the securities resulting from changes in interest rates. We designate these interest rate swap contracts as fair value hedges that qualify for hedge accounting under ASC 815 and record them in other assets and other liabilities. Refer to Note 8 — “Derivative Financial Instruments” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report for additional information.

Deposits

Deposits were $176.8 billion at September 30, 2022, a decrease of $12.4 billion, or 6.5 percent, compared to $189.2 billion at December 31, 2021. The decrease in deposits was primarily driven by slowdown in public and private fundraising and exits as well as increased client cash burn, partially offset by flexible liquidity solutions that shifted off-balance sheet client funds on-balance sheet, all of which reduced the proportion of noninterest bearing deposits. Noninterest bearing demand deposits to total deposits decreased by 13 percentage points to 53 percent at September 30, 2022, compared to December 31, 2021.

Approximately 7 percent and 9 percent of our total deposits at September 30, 2022 and December 31, 2021, respectively, were from our clients in Asia.

Long-Term Debt

Our long-term debt was $3.4 billion at September 30, 2022 and $2.6 billion at December 31, 2021. The increase in our long-term debt was due to issuances of 4.345% Senior Fixed Rate/Floating Rate Notes due 2028 and 4.570% Senior Fixed Rate/Floating Rate Notes due 2033 in the second quarter of 2022.

As of September 30, 2022, long-term debt was comprised of our 3.50% Senior Notes due 2025, 3.125% Senior Notes due 2030, 1.800% Senior Notes due 2031, 2.100% Senior Notes due 2028, 1.800% Senior Notes due 2026, 4.345% Senior Fixed Rate/Floating Rate Notes due 2028, 4.570% Senior Fixed Rate/Floating Rate Notes due 2033 and junior subordinated debentures.

Other Liabilities

A summary of other liabilities at September 30, 2022 and December 31, 2021 is as follows:

(Dollars in millions)	September 30, 2022		December 31, 2021		% Change
Accrued compensation	$	600	$	896	(33.0)	%
Allowance for unfunded credit commitments	265		171		55.0
Derivative liabilities (1)	524		118		NM
Other liabilities	1,500		1,282		17.0
Total other liabilities	$	2,889	$	2,467	17.1

(1)See “Derivatives” section above.

Accrued Compensation

Accrued compensation includes amounts for our Incentive Compensation Plan, Direct Drive Incentive Compensation Plan, Retention Program, Warrant Incentive Plan, ESOP, SVB Securities Incentive Compensation Plan, SVB Securities Retention Award and other compensation arrangements. The decrease of $296 million was primarily a result of the payout of our 2021 incentive compensation plans during the first quarter of 2022, partially offset by the accrual for the nine months ended September 30, 2022.

Allowance for Unfunded Credit Commitments

Allowance for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit. The increase of $94 million was primarily attributable to projected economic conditions, a higher weighting assigned to our downturn outlook scenario and higher unfunded credit commitment balances.

88

Noncontrolling Interests

Noncontrolling interests totaled $301 million and $373 million at September 30, 2022 and December 31, 2021, respectively. The decrease of $72 million was primarily due to $19 million in distributions and $53 million in net loss attributable to noncontrolling interests for the nine months ended September 30, 2022.

Capital Resources

We maintain an adequate capital base to support anticipated asset growth, operating needs, and credit and other business risks, and to provide for SVB Financial and the Bank to be in compliance with applicable regulatory capital guidelines, including the joint agency rules implementing the "Basel III" capital rules (the "Capital Rules"). Our primary sources of new capital include retained earnings and proceeds from the sale and issuance of our capital stock or other securities. Under the oversight of the Finance Committee of our Board of Directors, management engages in regular capital planning processes in an effort to optimize the use of the capital available to us and to appropriately plan for our future capital needs. The capital plan considers capital needs for the foreseeable future and allocates capital to both existing and future business activities. Expected future use or activities for which capital may be set aside include balance sheet growth and associated relative increases in market or credit exposure, investment activity, potential product and business expansions, acquisitions and strategic or infrastructure investments. In addition, we conduct capital stress tests as part of our annual capital planning process. The capital stress tests allow us to assess the impact of adverse changes in the economy and interest rates on our capital adequacy position.

SVBFG Stockholders’ Equity

SVBFG stockholders’ equity totaled $15.5 billion at September 30, 2022, a decrease of $727 million, or 4.5 percent, compared to $16.2 billion at December 31, 2021. The decrease was primarily driven by other comprehensive income from unrealized losses recorded on AFS securities, net of tax, reflective of an increase in market rates. The decrease was partially offset by an increase in retained earnings driven by net income for the nine months ended September 30, 2022.

Funds generated through retained earnings are a significant source of capital and liquidity and are expected to continue to be so in the future.

89

Capital Ratios

Both SVB Financial and the Bank are subject to various regulatory capital requirements administered by state and federal banking agencies. The following table represents the capital components for SVB Financial and the Bank used in calculating CET1, Tier 1 capital and total capital as of September 30, 2022 and December 31, 2021:

	SVB Financial				Bank
	September 30, 2022		December 31, 2021		September 30, 2022		December 31, 2021
Common stock plus related surplus, net of treasury stock	$	5,272	$	5,157	$	10,061	$	9,265
Retained earnings	8,676		7,442		7,144		5,537
AOCI	(2,085)		(9)		(2,076)		(7)
CET1 capital before adjustments and deductions	11,863		12,590		15,129		14,795
Less: Goodwill (net of associated deferred tax liabilities)	366		369		199		200
Intangibles (net of associated deferred tax liabilities)	117		133		63		70
AOCI opt-out election related adjustments	(2,035)		(18)		(2,030)		(17)
Add: CECL transition provision	60		80		60		80
Total adjustments and deductions from CET1 capital	(1,612)		404		(1,828)		173
CET1 Capital	13,475		12,186		16,957		14,622
Add: Qualifying Preferred stock	3,646		3,646		—		—
Minority interest	301		373		—		—
Less: Additional tier 1 capital deductions	114		—		—		—
Additional tier 1 capital	3,833		4,019		—		—
Tier 1 Capital	17,308		16,205		16,957		14,622
Allowance for credit losses included in Tier 2 capital	828		600		828		600
CECL transition provision for allowance for credit losses	(70)		(93)		(70)		(93)
Tier 2 Capital	758		507		758		507
Total capital	$	18,066	$	16,712	$	17,715	$	15,129
Total risk-weighted assets	$	111,108	$	100,812	$	109,132	$	98,214
Average quarterly total assets (1)	$	216,482	$	204,380	$	214,278	$	201,880

(1)Average quarterly total assets as defined by the Federal Reserve less: (i) goodwill net of associated deferred tax liabilities, (ii) disallowed intangible assets net of associated deferred tax liabilities and deferred tax assets and (iii) other deductions from assets for leverage capital purposes.

Regulatory capital ratios for SVB Financial and the Bank exceeded minimum federal regulatory guidelines under the Capital Rules as well as for a "well capitalized" bank holding company and insured depository institution, respectively, as of September 30, 2022 and December 31, 2021. Capital ratios for SVB Financial and the Bank, compared to the minimum capital ratios, are set forth below:

	September 30, 2022		December 31, 2021		Required Minimum		Required Minimum + Capital Conservation Buffer (1)		Well Capitalized Minimum
SVB Financial:
CET1 risk-based capital ratio (2)(3)	12.13	%	12.09	%	4.5	%	7.0	%	N/A
Tier 1 risk-based capital ratio (3)	15.58		16.08		6.0		8.5		6.0
Total risk-based capital ratio (3)	16.26		16.58		8.0		10.5		10.0
Tier 1 leverage ratio (2)(3)	8.00		7.93		4.0		N/A		N/A
Tangible common equity to tangible assets ratio (4)(5)	5.36		5.73		N/A		N/A		N/A
Tangible common equity to risk-weighted assets ratio (4)(5)	10.24		11.98		N/A		N/A		N/A
Bank:
CET1 risk-based capital ratio (3)	15.54	%	14.89	%	4.5	%	7.0	%	6.5	%
Tier 1 risk-based capital ratio (3)	15.54		14.89		6.0		8.5		8.0
Total risk-based capital ratio (3)	16.23		15.40		8.0		10.5		10.0
Tier 1 leverage ratio (3)	7.91		7.24		4.0		N/A		5.0
Tangible common equity to tangible assets ratio (4)(5)	7.08		7.09		N/A		N/A		N/A
Tangible common equity to risk-weighted assets ratio (4)(5)	13.62		15.06		N/A		N/A		N/A

90

(1)Percentages represent the minimum capital ratios plus, as applicable, the fully phased-in 2.5% CET1 capital conservation buffer under the Capital Rules.

(2)"Well Capitalized Minimum" CET1 risk-based capital and Tier 1 leverage ratios are not formally defined under applicable banking regulations for bank holding companies.

(3)Capital ratios include regulatory capital phase-in of the ACL under the 2021 CECL Transition Rule.

(4)See below for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.

(5)The Federal Reserve has not issued any minimum guidelines for the tangible common equity to tangible assets ratio or the tangible common equity to risk-weighted assets ratio, however, we believe these ratios provide meaningful supplemental information regarding our capital levels and are therefore provided above.

As of September 30, 2022, the CET1 risk-based capital ratio for SVB Financial increased from December 31, 2021, reflective of the growth in CET1 capital outpacing the growth in risk-weighted assets. The increase in CET1 risk-based capital was driven primarily by net income, while the increase in risk-weighted assets was driven by an increase in cash and other assets and loan growth partially offset by a decrease in our investment security portfolio. The Tier 1 risk-based and total risk-based capital ratios decreased from December 31, 2021, reflective of the growth in risk-weighted assets outpacing the growth in Tier 1 capital and total capital. The increase in Tier 1 capital and total capital was driven primarily by net income and an increase in the allowance for credit losses, partially offset by Tier 1 capital deductions and preferred stock dividends.

The increase in our Tier 1 leverage ratio for SVB Financial is reflective of the growth in our regulatory capital outpacing our growth in average assets. The increase in average assets for SVB Financial was driven by an increase in cash and loan growth partially offset by a decrease in our investment security portfolio.

The tangible common equity, or tangible book value, to tangible assets ratio and the tangible common equity to risk-weighted assets ratios are not required by GAAP or applicable bank regulatory requirements. However, we believe these ratios provide meaningful supplemental information regarding our capital levels. Our management uses, and believes that investors benefit from referring to, these ratios in evaluating the adequacy of the Company’s capital levels; however, these financial measures should be considered in addition to, not as a substitute for or preferable to, comparable financial measures prepared in accordance with GAAP. These ratios are calculated by dividing total SVBFG stockholders' equity, by total period-end assets and risk-weighted assets, after reducing both amounts by acquired intangibles, if any. The manner in which this ratio is calculated varies among companies. Accordingly, our ratio is not necessarily comparable to similar measures of other companies.

The following table provides a reconciliation of non-GAAP financial measures with financial measures defined by GAAP for SVB Financial and the Bank for the periods ended September 30, 2022 and December 31, 2021:

	SVB Financial						Bank
(Dollars in millions)	September 30, 2022			December 31, 2021			September 30, 2022			December 31, 2021
GAAP stockholders’ equity	$	15,509		$	16,236		$	15,129		$	14,795
Less: preferred stock	3,646			3,646			—			—
Less: intangible assets	517			535			288			—
Plus: net deferred taxes on intangible assets	34			26			26			—
Tangible common equity	$	11,380		$	12,081		$	14,867		$	14,795
GAAP total assets	$	212,867		$	211,308		$	210,243		$	208,406
Less: intangible assets	517			535			288			—
Plus: net deferred taxes on intangible assets	34			26			26			—
Tangible assets	$	212,384		$	210,799		$	209,981		$	208,406
Risk-weighted assets	$	111,108		$	100,812		$	109,132		$	98,214
Non-GAAP tangible common equity to tangible assets	5.36		%	5.73		%	7.08		%	7.10		%
Non-GAAP tangible common equity to risk-weighted assets	10.24			11.98			13.62			15.06

Off-Balance Sheet Arrangements

In the normal course of business, we use financial instruments with off-balance sheet risk to meet the financing needs of our customers. These financial instruments include commitments to extend credit, commercial and standby letters of credit and commitments to invest in venture capital and private equity fund investments. These instruments involve, to varying degrees, elements of credit risk. Credit risk is defined as the possibility of sustaining a loss because other parties to the financial instrument fail to perform in accordance with the terms of the contract. For details of our commitments to extend credit, and commercial and standby letters of credit, please refer to Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report.

91

Commitments to Invest in Venture Capital and Private Equity Funds

Subject to applicable regulatory requirements, including the Volcker Rule, we make commitments to invest in venture capital and private equity funds, which in turn make investments generally in, or in some cases make loans to, privately-held companies. Commitments to invest in these funds are generally made for a 10-year period from the inception of the fund. Although the limited partnership agreements governing these investments typically do not restrict the general partners from calling 100% of committed capital in one year, it is customary for these funds to generally call most of the capital commitments over 5 to 7 years; however, in certain cases, the funds may not call 100% of committed capital over the life of the fund. The actual timing of future cash requirements to fund these commitments is generally dependent upon the investment cycle, overall market conditions, and the nature and type of industry in which the privately held companies operate.

For further details on our commitments to invest in venture capital and private equity funds, refer to Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report.

Liquidity

The objective of liquidity management is to ensure that funds are available in a timely manner to meet our financial obligations, including, the availability of funds for both anticipated and unanticipated funding uses as necessary, paying creditors, meeting depositors’ needs, accommodating loan demand and growth, funding investments, repurchasing securities and other operating or capital needs, without incurring undue cost or risk, or causing a disruption to normal operating conditions.

We regularly assess the amount and likelihood of projected funding requirements through a range of business-as-usual and potential stress scenarios based on a review of factors such as historical deposit volatility and funding patterns, present and forecasted market and economic conditions, individual client funding needs and existing and planned business activities. Our ALCO, which is a management committee, provides oversight to the liquidity management process and recommends policy guidelines for the approval of the Finance Committee and Risk Committee of our Board of Directors, and courses of action to address our actual and projected liquidity needs. Additionally, we routinely conduct liquidity stress testing as part of our liquidity management practices.

Our client deposits base is, and historically has been, our primary source of liquidity funding. Our deposit levels and cost of deposits may fluctuate from time to time due to a variety of factors, including market conditions, prevailing interest rates, changes in client deposit behaviors, availability of insurance protection and our offering of deposit products. We may also offer more investment alternatives for our off-balance sheet products which may impact deposit levels. At September 30, 2022, our period-end total deposit balances were $176.8 billion, compared to $189.2 billion at December 31, 2021.

We maintain a liquidity risk management and monitoring process designed to ensure appropriate liquidity to meet expected and contingent funding needs under both normal and stress environments, subject to the regular supervisory review process. Our liquidity requirements can also be met through the use of our portfolio of liquid assets. Our definition of liquid assets includes cash and cash equivalents in excess of the minimum levels necessary to carry out normal business operations, short-term investment securities maturing within one year, AFS and HTM securities eligible and available for financing or pledging purposes with a maturity in excess of one year and anticipated near-term cash flows from investments.

We have certain facilities in place to enable us to access short-term borrowings on a secured and unsecured basis. Our secured facilities include collateral pledged to the FHLB of San Francisco and the discount window at the FRB (using both fixed income securities and loans as collateral). Our unsecured facility consists of our uncommitted federal funds lines. As of September 30, 2022, collateral pledged to the FHLB of San Francisco was comprised primarily of fixed income investment securities and loans and had a carrying value of $18.7 billion, of which $2.9 billion was available to support borrowings. As of September 30, 2022, collateral pledged to the discount window at the FRB was comprised of fixed income investment securities and had a carrying value of $4.9 billion, all of which was unused and available to support additional borrowings. Our total unused and available borrowing capacity for our uncommitted federal funds lines totaled $3.2 billion at September 30, 2022. Our total unused and available secured borrowing capacity under our master repurchase agreements with various financial institutions totaled $30.5 billion at September 30, 2022.

As a banking organization, our liquidity is subject to supervision by our banking regulators. Because we are a Category IV firm with less than $250 billion in average total consolidated assets, less than $50 billion in average weighted short-term wholesale funding and less than $75 billion in cross-jurisdictional activity, we currently are not subject to the Federal Reserve’s LCR or NSFR requirements, either on a full or reduced basis. It is possible that, as a result of further growth, we may exceed one or more of those thresholds and therefore become subject to LCR and NSFR requirements or other heightened liquidity requirements in the future, which would require us to maintain high-quality liquid assets in accordance with specific quantitative requirements and increase the use of long-term debt as a funding source. In addition, if we were to exceed $75

92

billion in cross-jurisdictional activity, as a Category II firm, we could no longer opt out of excluding AOCI in calculating regulatory capital ratios and would become subject to the advance approaches framework as well as more stringent liquidity reporting requirements.

On a stand-alone basis, SVB Financial’s primary liquidity channels include dividends from the Bank, its portfolio of liquid assets and its ability to raise debt and capital. The ability of the Bank to pay dividends is subject to certain regulations described in “Business—Supervision and Regulation—Restriction on Dividends” under Part I, Item 1 of our 2021 Form 10-K.

Consolidated Summary of Cash Flows

Below is a summary of our average cash position and statement of cash flows for the nine months ended September 30, 2022 and 2021. For further details, see our “Interim Consolidated Statements of Cash Flows (Unaudited)” under Part I, Item 1 of this report.

	Nine months ended September 30,
(Dollars in millions)	2022			2021
Average cash and cash equivalents	$	17,726		$	22,336
Percentage of total average assets	8.2		%	14.6		%
Net cash provided by operating activities	$	1,844		$	1,142
Net cash used for investing activities	(4,184)			(65,080)
Net cash provided by financing activities	1,722			65,195
Net (decrease) increase in cash and cash equivalents	$	(618)		$	1,257

Average cash and cash equivalents decreased by $4.6 billion, or 20.6 percent, to $17.7 billion for the nine months ended September 30, 2022, compared to $22.3 billion for the comparable 2021 period.

Cash provided by operating activities was $1.8 billion for the nine months ended September 30, 2022, reflective primarily of net income before noncontrolling interests of $1.3 billion and adjustments to reconcile net income to net cash of $1.0 billion, partially offset by $484 million changes in other assets and liabilities.

Cash used for investing activities of $4.2 billion for the nine months ended September 30, 2022 was driven by $17.4 billion in purchases of fixed income investment securities and a $5.8 billion increase in loan balances, partially offset by the $10.8 billion in proceeds from maturities and principal pay downs from our fixed income investment securities portfolio and sale of $8.5 billion of our AFS portfolio

Cash provided by financing activities was $1.7 billion for the nine months ended September 30, 2022, reflective primarily of a $14.3 billion increase in short and long-term borrowings, partially offset by a $12.4 billion decrease in deposits.

Cash and cash equivalents were $14.0 billion and $18.9 billion, respectively, at September 30, 2022 and 2021.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk Management

Market risk is defined as the risk of adverse fluctuations in the market value of financial instruments due to changes in market interest rates. Interest rate risk is our primary market risk and can result from timing and volume differences in the repricing of our rate-sensitive assets and liabilities, widening or tightening of credit spreads, changes in the general level of market interest rates and changes in the shape and level of the benchmark interest rates. Additionally, changes in interest rates can influence the rate of principal prepayments on mortgage securities, which affects the rate of amortization of purchase premiums and discounts. Other market risks include foreign currency exchange risk and equity price risk (including the effect of competition on product pricing). These risks and related impacts are important market considerations but are inherently difficult to assess through simulation results. Consequently, simulations used to analyze the sensitivity of net interest income to changes in interest rates will differ from actual results due to differences in the timing and frequency of rate resets, the magnitude of changes in market rates, the impact of competition, fluctuating business conditions and the impact of strategies taken by management to mitigate these risks.

Interest rate risk is managed by our ALCO. ALCO reviews the sensitivity of the market valuation on earning assets and funding liabilities and modeled 12-month projections of net interest income from changes in interest rates, structural changes in investment and funding portfolios, loan and deposit activity and market conditions. Relevant metrics and guidelines, which are approved by the Finance Committee of our Board of Directors and are included in our Interest Rate Risk Policy, are monitored on an ongoing basis.

Interest rate risk is managed primarily through strategies involving our fixed income securities portfolio, available funding channels and capital market activities. In addition, our policies permit the use of off-balance sheet derivatives, such as interest rate swaps, to assist with managing interest rate risk.

93

We utilize a simulation model to perform sensitivity analysis on the economic value of equity and net interest income under a variety of interest rate scenarios, balance sheet forecasts and business strategies. The simulation model provides a dynamic assessment of interest rate sensitivity which is embedded within our balance sheet. Rate sensitivity measures the potential variability in economic value and net interest income relating solely to changes in market interest rates over time. We review our interest rate risk position and sensitivity to market interest rates regularly.

Model Simulation and Sensitivity Analysis

A specific application of our simulation model involves measurement of the impact of changes in market interest rates on the EVE. EVE is defined as the market value of assets, less the market value of liabilities. Another application of the simulation model measures the impact of changes in market interest rates on NII assuming a static balance sheet, in both size and composition, as of the period-end reporting date. In the NII simulation, the level of market interest rates and the size and composition of the balance sheet are held constant over the simulation horizon. Simulated cash flows during the scenario horizon are assumed to be replaced as they occur, which maintains the balance sheet at its current size and composition. Yield and spread assumptions on cash and investment balances reflect current market rates and the shape of the yield curve. Yield and spread assumptions on loans reflect recent market impacts on product pricing. Similarly, we make certain deposit balance decay rate assumptions on demand deposits and interest-bearing deposits, which are replenished to hold the level and mix of funding liabilities constant. Changes in market interest rates that affect net interest income are principally short-term interest rates and include the following benchmark indexes: (i) the National Prime Rate, (ii) 1-month and 3-month LIBOR, alternate indices such as SOFR and (iii) the Federal Funds target rate. Changes in these short-term rates impact interest earned on our variable rate loans and balances held as cash and cash equivalents. Additionally, simulated changes in deposit pricing relative to changes in market rates, commonly referred to as deposit beta, generally follow overall changes in short-term interest rates, although actual changes may lag in terms of timing and magnitude.

Both EVE and NII measures rely upon the use of models to simulate cash flow behavior for loans and deposits. These models were developed internally and are based on historical balance and rate observations. Investment portfolio cash flow is based on a combination of third-party prepayment models and internally managed prepayment vectors depending on security type. As part of our ongoing governance structure, each of these models and assumptions are periodically reviewed and recalibrated as needed to ensure that they are representative of our understanding of existing behaviors.

Simulation results presented include a beta assumption that is applied in the NII and EVE simulation models for interest-bearing deposits. This reflects management expectations about deposit repricing behavior. This model assumes the overall through a rate-cycle beta for interest-bearing deposits is approximately 65 percent at September 30, 2022 which is higher than the 60 percent assumption used at December 31, 2021. That is, overall changes in interest-bearing deposit rates would be approximately 65 percent of the change in short-term market rates going forward. These repricing assumptions are reflected as changes in interest expense on interest-bearing deposit balances.

The following table presents our EVE and NII sensitivity exposure related to an instantaneous and sustained parallel shift in market interest rates of 100 and 200 bps at September 30, 2022 and December 31, 2021.

(Dollars in millions)	Estimated		Estimated Increase/(Decrease) in EVE				Estimated		Estimated Increase/(Decrease) in NII
	EVE		Amount		Percent		NII		Amount		Percent
September 30, 2022:
+200	$	13,253	$	(5,546)	(29.5)	%	$	5,656	$	293	5.5	%
+100	15,822		(2,977)		(15.8)		5,522		159		3.0
-100	22,333		3,534		18.8		5,210		(153)		(2.9)
-200	26,201		7,402		39.4		4,987		(376)		(7.0)
December 31, 2021:
+200	$	24,476	$	(1,073)	(4.2)	%	$	5,258	$	981	22.9	%
+100	25,140		(409)		(1.6)		4,745		468		10.9
-100	24,042		(1,507)		(5.9)		4,002		(275)		(6.4)
-200	21,410		(4,139)		(16.2)		3,911		(366)		(8.6)

Economic Value of Equity

The estimated EVE in the preceding table is based on a combination of valuation methodologies including a discounted cash flow analysis and a multi-path lattice-based valuation. Both methodologies use publicly available market interest rates to determine discounting factors on projected cash flows. The model simulations and calculations are highly assumption-dependent and will change regularly as the composition of earning assets and funding liabilities change (including the impact of changes in the value of interest rate derivatives, if any), as interest rate environments evolve, and as we change our assumptions in response to relevant market conditions, competition, or business circumstances. These calculations do not

94

reflect forecast changes in our balance sheet or changes we may make to reduce our EVE exposure as a part of our overall interest rate risk management strategy.

As with any method of measuring interest rate risk, certain limitations are inherent in the method of analysis presented in the preceding table. We are exposed to yield curve risk, prepayment risk, basis risk and yield spread compression, which cannot be fully modeled and expressed using the above methodology. Accordingly, the results in the preceding table should not be relied upon as a precise indicator of actual results in the event of changing market interest rates. Additionally, the resulting EVE and NII estimates are not intended to represent and should not be construed to represent our estimate of the underlying EVE or forecast of NII.

Our base EVE as of September 30, 2022 decreased $6.8 billion from December 31, 2021, driven primarily by a change in the mix of our balance sheet, which includes a shift from non-interest bearing deposits to interest bearing deposits and short term borrowings; and higher rates during the third quarter of 2022, which extended the duration of our fixed income investment securities portfolio while shortening the duration of our deposits and overall liabilities. The EVE profile of our balance sheet at September 30, 2022, now shows an increasing risk in the +100 and +200 bps instantaneous parallel shift scenarios as the extended duration of our fixed income portfolio has increased the market value sensitivity of these securities to rising rates, while the shift in mix from non-interest bearing deposits to interest bearing deposits and short term borrowings has reduced duration of our liabilities.

12-Month Net Interest Income Simulation

NII sensitivity is measured as the percentage change in projected 12-month net interest income earned in +/-100 and +/-200 basis point interest rate shock scenarios compared to a base scenario where balances and interest rates are held constant over the forecast horizon. At September 30, 2022, NII sensitivity was 3.0 percent in the +100 bps interest rate scenario, compared to 10.9 percent at December 31, 2021. Our NII sensitivity in the +200bps interest rate shock scenario was 5.5 percent compared to 22.9 percent at December 31, 2021. NII sensitivity in the -100bps scenario of negative 2.9 percent was lower at September 30, 2022, compared to a negative 6.4 percent at December 31, 2021. The -200bps scenario currently indicates a lower percentage change in NII of negative 7.0 percent at September 30, 2022, compared to negative 8.6 percent at December 31, 2021. The changes in NII sensitivity are primarily the result of the changes in balance sheet composition described previously, combined with the impact of hedges in the respective parallel rate shock scenarios.

A majority of our loans are indexed to Prime, LIBOR and alternate indices such as SOFR. In the upward parallel simulated rate shock scenarios, interest income on assets that are tied to variable rate indexes, primarily our variable rate loans, are expected to benefit our base 12-month NII projections. The opposite is true for downward rate shock scenarios.

The 12-month NII simulations include repricing assumptions on our interest-bearing deposit products of approximately 65 percent as of September 30, 2022 which is higher than the 60 percent assumed as of December 31, 2021. This assumption is model based and can change based on changing client needs, behavior and our overall funding mix. Repricing of interest-bearing deposits impacts estimated interest expense for a relative change in underlying interest rates.

For the interest rate scenarios, the simulation model incorporates embedded rate floors on loans, where present, which prevents model benchmark rates from moving below zero percent in the down rate scenarios. The embedded rate floors are also a factor in the up-rate scenarios to the extent a simulated increase in rates is needed before floored rates are cleared. In addition, we assume deposit balance decay rates based on a historical deposit study of our clients. These assumptions may change in future periods based on changes in client behavior and at management's discretion. Actual changes in our deposit pricing strategies may differ from our current model assumptions and may have an impact on our actual sensitivity overall.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Disclosure controls and procedures are the controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms. Disclosure controls and procedures include, among other things, processes, controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of our most recently completed fiscal quarter, pursuant to Exchange Act Rule 13a-15(b). Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were effective.

95

Changes in Internal Control

There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

96

PART II–OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Please refer to Note 14 — “Legal Matters” of the “Notes to Interim Consolidated Financial Statements (unaudited)” under Part I, Item 1 of this report.

ITEM 1A. RISK FACTORS

There are no material changes to the risk factors set forth in our 2021 Annual Report on Form 10-K.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Recent Sales of Unregistered Securities

None.

Issuer Purchases of Equity Securities

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None.

ITEM 6. EXHIBITS

Exhibit Number	Exhibit Description	Incorporated by Reference				Filed Herewith
		Form	File No.	Exhibit	Filing Date
18.1	Preferability Letter of KPMG LLP, Independent Registered Public Accounting Firm					X
31.1	Rule 13a-14(a) / 15(d)-14(a) Certification of Principal Executive Officer					X
31.2	Rule 13a-14(a) / 15(d)-14(a) Certification of Principal Financial Officer					X
32.1	Section 1350 Certifications					X
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document					X
101.SCH	XBRL Taxonomy Extension Schema Document					X
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document					X
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document					X
101.LAB	XBRL Taxonomy Extension Label Linkbase Document					X
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document					X
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)					X

Note: Other instruments defining the rights of holders of the Company’s long-term debt are omitted pursuant to Section(b)(4)(iii) of Item 601 of Regulation S-K. The Company hereby agrees to furnish copies of these instruments to the Securities and Exchange Commission upon request.

97

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	SVB Financial Group
Date: November 7, 2022	/s/ DANIEL BECK
	Daniel Beck
	Chief Financial Officer
	(Principal Financial Officer)
	SVB Financial Group
Date: November 7, 2022	/s/ KAREN HON
	Karen Hon
	Chief Accounting Officer
	(Principal Accounting Officer)

98

EX-18.1

EXHIBIT 18.1

(KPMG LLP Letterhead)

November 7, 2022

The Board of Directors

SVB Financial Group

San Francisco, California

Ladies and Gentlemen:

We have been furnished with a copy of the quarterly report on Form 10-Q of SVB Financial Group (and subsidiaries) (the Company) for the three months and nine months ended September 30, 2022, and have read the Company’s statements contained in Note 1 to the interim consolidated financial statements included therein. As stated in Note 1 to those financial statements, the Company changed its method of accounting for the presentation of derivatives subject to master netting arrangements and states that the newly adopted accounting principle is preferable in the circumstances because the newly adopted accounting policy is in accordance with ASC 815-10-45-5 and it better reflects the credit risk of derivatives traded under master netting agreements. In accordance with your request, we have reviewed and discussed with Company officials the circumstances and business judgment and planning upon which the decision to make this change in the method of accounting was based.

We have not audited any financial statements of the Company as of any date or for any period subsequent to December 31, 2021, nor have we audited the information set forth in the aforementioned Note 1 to the interim consolidated financial statements; accordingly, we do not express an opinion concerning the factual information contained therein.

With regard to the aforementioned accounting change, authoritative criteria have not been established for evaluating the preferability of one acceptable method of accounting over another acceptable method. However, for purposes of the Company's compliance with the requirements of the Securities and Exchange Commission, we are furnishing this letter.

Based on our review and discussion, with reliance on management’s business judgment and planning, we concur that the newly adopted method of accounting is preferable in the Company’s circumstances.

Very truly yours,

/s/ KPMG LLP

EX-31.1

EXHIBIT 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Greg Becker, certify that:

1.I have reviewed this quarterly report on Form 10-Q of SVB Financial Group;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 7, 2022	/s/ GREG BECKER
	Greg Becker
	President and Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION

I, Daniel Beck, certify that:

1.I have reviewed this quarterly report on Form 10-Q of SVB Financial Group;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting..

Date: November 7, 2022	/s/ DANIEL BECK
	Daniel Beck
	Chief Financial Officer
	(Principal Financial Officer)

EX-32.1

EXHIBIT 32.1

SECTION 1350 CERTIFICATIONS

I, Greg Becker, certify, pursuant to 18 U.S.C. Section 1350, that, to my knowledge, the quarterly report of SVB Financial Group on Form 10-Q for the quarterly period ended September 30, 2022, (i) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) that the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of SVB Financial Group.

Date: November 7, 2022	/s/ GREG BECKER
	Greg Becker
	President and Chief Executive Officer
	(Principal Executive Officer)

I, Daniel Beck, certify, pursuant to 18 U.S.C. Section 1350, that, to my knowledge, the quarterly report of SVB Financial Group on Form 10-Q for the quarterly period ended September 30, 2022, (i) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) that the information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of SVB Financial Group.

Date: November 7, 2022	/s/ DANIEL BECK
	Daniel Beck
	Chief Financial Officer
	(Principal Financial Officer)

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2022	Oct. 31, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-39154
Entity Registrant Name	SVB FINANCIAL GROUP
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	91-1962278
Entity Address, Address Line One	3003 Tasman Drive
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054-1191
City Area Code	408
Local Phone Number	654-7400
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		59,104,124
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Central Index Key	0000719739
Amendment Flag	false
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	SIVB
Security Exchange Name	NASDAQ
Series A Preferred Stock
Entity Information [Line Items]
Title of 12(b) Security	Depositary shares, each representing a 1/40th ownership interest in a share of 5.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock, Series A
Trading Symbol	SIVBP
Security Exchange Name	NASDAQ

XML

Interim Consolidated Balance Sheets - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Assets:
Cash and cash equivalents	$ 13,968	$ 14,586
Available-for-sale securities, at fair value (cost of $29,502 and $27,370, respectively)	26,711	27,221
Held-to-maturity securities, at amortized cost and net of allowance for credit losses of $6 and $7 (fair value of $77,370 and $97,227, respectively)	93,286	98,195
Non-marketable and other equity securities	2,595	2,543
Total investment securities	122,592	127,959
Loans, amortized cost	72,129	66,276
Allowance for credit losses: loans	(557)	(422)
Net loans	71,572	65,854
Premises and equipment, net of accumulated depreciation and amortization	346	270
Goodwill	375	375
Other intangible assets, net	142	160
Lease right-of-use assets	349	313
Accrued interest receivable and other assets	3,523	1,791
Total assets	212,867	211,308
Liabilities:
Noninterest-bearing demand deposits	93,988	125,851
Interest-bearing deposits	82,831	63,352
Total deposits	176,819	189,203
Short-term borrowings	13,552	71
Lease liabilities	429	388
Other liabilities	2,889	2,467
Long-term debt	3,368	2,570
Total liabilities	197,057	194,699
Commitments and contingencies (Note 11 and Note 14)
SVBFG stockholders’ equity:
Preferred stock, $0.001 par value, 20,000,000 shares authorized; 383,500 and 383,500 shares issued and outstanding, respectively	3,646	3,646
Common stock, $0.001 par value, 150,000,000 shares authorized; 59,104,124 and 58,748,469 shares issued and outstanding, respectively	0	0
Additional paid-in capital	5,272	5,157
Retained earnings	8,676	7,442
Accumulated other comprehensive income (loss)	(2,085)	(9)
Total SVBFG stockholders’ equity	15,509	16,236
Noncontrolling interests	301	373
Total equity	15,810	16,609
Total liabilities and total equity	$ 212,867	$ 211,308

XML

Interim Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Available-for-sale, amortized cost	$ 29,502	$ 27,370
Held-to-maturity securities, allowance for credit losses	6	7
HTM securities	$ 77,370	$ 97,227
Preferred stock, par value, in usd per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	383,500	383,500
Preferred stock, shares outstanding	383,500	383,500
Common stock, par value, in usd per share	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares, issued	59,104,124	58,748,469
Common stock, shares outstanding	59,104,124	58,748,469

XML

Interim Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Interest income:
Loans	$ 865	$ 519	$ 2,089	$ 1,422
Investment securities:
Taxable	545	332	1,618	807
Non-taxable	35	28	105	73
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities	76	5	105	12
Total interest income	1,521	884	3,917	2,314
Interest expense:
Deposits	249	19	348	41
Borrowings	74	13	122	33
Total interest expense	323	32	470	74
Net interest income	1,198	852	3,447	2,240
Provision for credit losses	72	21	279	75
Net interest income after provision for credit losses	1,126	831	3,168	2,165
Noninterest income:
Gains (losses) on investment securities, net	(127)	189	(199)	661
Gains on equity warrant assets, net	40	147	120	491
Client investment fees	119	20	237	55
Wealth management and trust fees	19	22	63	22
Foreign exchange fees	74	65	216	189
Credit card fees	37	34	114	93
Deposit service charges	32	29	94	82
Lending related fees	20	21	65	55
Letters of credit and standby letters of credit fees	15	13	43	39
Investment banking revenue	75	90	293	335
Commissions	24	17	73	58
Other	31	25	119	97
Total noninterest income	359	672	1,238	2,177
Noninterest expense:
Compensation and benefits	563	548	1,649	1,418
Professional services	117	104	355	282
Premises and equipment	71	54	189	124
Net occupancy	25	25	74	60
Business development and travel	21	6	62	13
FDIC and state assessments	25	13	57	33
Merger-related charges	7	83	39	102
Other	63	46	188	136
Total noninterest expense	892	879	2,613	2,168
Income before income tax expense	593	624	1,793	2,174
Income tax expense	175	149	489	509
Net income before noncontrolling interests and dividends	418	475	1,304	1,665
Net (income) loss attributable to noncontrolling interests	51	(88)	53	(226)
Preferred stock dividends	(40)	(22)	(123)	(40)
Net income available to common stockholders	$ 429	$ 365	$ 1,234	$ 1,399
Earnings per common share—basic (dollars per share)	$ 7.26	$ 6.33	$ 20.94	$ 25.54
Earnings per common share—diluted (dollars per share)	$ 7.21	$ 6.24	$ 20.73	$ 25.16

XML

Interim Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net income before noncontrolling interests	$ 418	$ 475	$ 1,304	$ 1,665
Change in foreign currency cumulative translation gains and losses:
Foreign currency translation gains (losses), net of hedges	(39)	(6)	(81)	(4)
Related tax benefit (expense)	11	2	23	1
Change in unrealized gains and losses on AFS securities:
Unrealized holding gains (losses)	(1,187)	(30)	(2,734)	(584)
Related tax benefit (expense)	336	8	774	163
Reclassification adjustment for (gains) losses included in net income	0	0	(48)	0
Related tax benefit (expense)	0	0	14	0
Cumulative-effect adjustment for unrealized losses on securities transferred from AFS to HTM	0	(54)	0	(132)
Related tax benefit (expense)	0	15	0	36
Amortization of unrealized holding net gains (losses) on securities transferred from AFS to HTM	3	0	10	(5)
Related tax benefit (expense)	(1)	0	(3)	1
Change in unrealized gains and losses on cash flow hedges:
Reclassification adjustment for gains included in net income	(14)	(16)	(43)	(47)
Related tax benefit (expense)	4	4	12	13
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Comprehensive income (loss)	(469)	398	(772)	1,107
Comprehensive (income) loss attributable to noncontrolling interests	51	(88)	53	(226)
Comprehensive income (loss) attributable to SVBFG	$ (418)	$ 310	$ (719)	$ 881

XML

Interim Consolidated Statements of Stockholders' Equity - USD ($) $ in Millions	Total	Noncumulative Preferred Stock	Preferred Stock	Preferred Stock Noncumulative Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Total SVBFG Stockholders’ Equity	Total SVBFG Stockholders’ Equity Noncumulative Preferred Stock	Noncontrolling Interests
Balance (in shares) at Dec. 31, 2020					51,888,463
Balance, beginning of period, net of tax at Dec. 31, 2020	$ 8,433		$ 340		$ 0	$ 1,585	$ 5,672	$ 623	$ 8,220		$ 213
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					374,039
Common stock issued under employee benefit plans, net of restricted stock cancellations	(1)				$ 0	(1)			(1)
Issuance of stock (in shares)					4,527,000
Issuance of stock	2,363	$ 1,724		$ 1,724	$ 0	2,363			2,363	$ 1,724
Issuance of common stock for the acquisition of Boston Private (in shares)					1,887,981
Issuance of common stock for the acquisition of Boston Private	1,060					1,060			1,060
Net income	1,665						1,439		1,439		226
Capital calls and distributions, net	(70)										(70)
Other comprehensive income (loss), net of tax	(558)							(558)	(558)
Share-based compensation, net	93					93			93
Dividends on preferred stock	(40)						(40)		(40)
Balance (in shares) at Sep. 30, 2021					58,677,483
Balance, end of period, net of tax at Sep. 30, 2021	14,669		2,064		$ 0	5,100	7,071	65	14,300		369
Balance (in shares) at Jun. 30, 2021					54,530,307
Balance, beginning of period, net of tax at Jun. 30, 2021	11,967		2,064		$ 0	2,755	6,706	142	11,667		300
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					32,195
Common stock issued under employee benefit plans, net of restricted stock cancellations	2					2			2
Issuance of stock (in shares)					2,227,000
Issuance of stock	1,245				$ 0	1,245			1,245
Issuance of common stock for the acquisition of Boston Private (in shares)					1,887,981
Issuance of common stock for the acquisition of Boston Private	1,060				$ 0	1,060			1,060
Net income	475						387		387		88
Capital calls and distributions, net	(19)										(19)
Other comprehensive income (loss), net of tax	(77)							(77)	(77)
Share-based compensation, net	38					38			38
Dividends on preferred stock	(22)						(22)		(22)
Balance (in shares) at Sep. 30, 2021					58,677,483
Balance, end of period, net of tax at Sep. 30, 2021	14,669		2,064		$ 0	5,100	7,071	65	14,300		369
Balance (in shares) at Dec. 31, 2021					58,748,469
Balance, beginning of period, net of tax at Dec. 31, 2021	16,609		3,646		$ 0	5,157	7,442	(9)	16,236		373
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					355,655
Common stock issued under employee benefit plans, net of restricted stock cancellations	(31)				$ 0	(31)			(31)
Net income	1,304						1,357		1,357		(53)
Capital calls and distributions, net	(19)										(19)
Other comprehensive income (loss), net of tax	(2,076)							(2,076)	(2,076)
Share-based compensation, net	146					146			146
Dividends on preferred stock	(123)						(123)		(123)
Balance (in shares) at Sep. 30, 2022					59,104,124
Balance, end of period, net of tax at Sep. 30, 2022	15,810		3,646		$ 0	5,272	8,676	(2,085)	15,509		301
Balance (in shares) at Jun. 30, 2022					59,081,326
Balance, beginning of period, net of tax at Jun. 30, 2022	16,276		3,646		$ 0	5,223	8,247	(1,198)	15,918		358
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)					22,798
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)					(2)			(2)
Net income	418						469		469		(51)
Capital calls and distributions, net	(6)										(6)
Other comprehensive income (loss), net of tax	(887)							(887)	(887)
Share-based compensation, net	51					51			51
Dividends on preferred stock	(40)						(40)		(40)
Balance (in shares) at Sep. 30, 2022					59,104,124
Balance, end of period, net of tax at Sep. 30, 2022	$ 15,810		$ 3,646		$ 0	$ 5,272	$ 8,676	$ (2,085)	$ 15,509		$ 301

XML

Interim Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net income before noncontrolling interests	$ 1,304,000	$ 1,665,000
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	279,000	75,000
Changes in fair values of equity warrant assets, net of proceeds from exercises	(38,000)	(36,000)
Changes in fair values of derivatives, net	345,000	18,000
Losses (Gains) on investment securities, net	199,000	(661,000)
Distributions of earnings from non-marketable and other equity securities	52,000	166,000
Depreciation and amortization	155,000	106,000
Amortization of premiums and discounts on investment securities, net	271,000	294,000
Amortization of share-based compensation	146,000	93,000
Amortization of deferred loan fees	(192,000)	(193,000)
Deferred income tax (benefit) expense	(173,000)	73,000
Excess tax benefit from exercise of stock options and vesting of restricted shares	(20,000)	(34,000)
Losses from the write-off of premises and equipment and right-of-use assets	0	38,000
Changes in other assets and liabilities:
Accrued interest receivable and payable, net	(72,000)	(117,000)
Accounts receivable and payable, net	(6,000)	5,000
Income tax receivable and payable, net	377,000	(141,000)
Accrued compensation	(296,000)	89,000
Other, net	(487,000)	(298,000)
Net cash provided by operating activities	1,844,000	1,142,000
Cash flows from investing activities:
Purchases of AFS securities	(12,407,000)	(5,395,000)
Sales proceeds	8,511,000	168,000
Proceeds from maturities and paydowns of AFS securities	1,174,000	3,892,000
Purchases of HTM securities	(4,961,000)	(65,048,000)
Proceeds from maturities and paydowns of HTM securities	9,605,000	8,993,000
Purchases of non-marketable and other equity securities	(292,000)	(310,000)
Proceeds from sales and distributions of capital of non-marketable and other securities	86,000	587,000
Net increase in loans	(5,759,000)	(9,006,000)
Purchases of premises and equipment	(141,000)	(77,000)
Cash Acquired from Acquisition	0	1,116,000
Net cash used for investing activities	(4,184,000)	(65,080,000)
Cash flows from financing activities:
Net (decrease) increase in deposits	(12,384,000)	60,216,000
Net increase in short-term borrowings	13,481,000	13,000
Proceeds from issuance of long-term debt	798,000	990,000
(Distributions to noncontrolling interests), net of contributions from noncontrolling interests	(19,000)	(70,000)
Net proceeds from the issuance of preferred stock	0	1,724,000
Payment of preferred stock dividend	(123,000)	(40,000)
Proceeds from issuance of common stock, ESPP and ESOP, net of restricted stock awards	(31,000)	2,362,000
Net cash provided by financing activities	1,722,000	65,195,000
Net (decrease) increase in cash and cash equivalents	(618,000)	1,257,000
Cash and cash equivalents at beginning of period	14,586,000	17,622,000
Cash and cash equivalents at end of period	13,968,000	18,879,000
Cash paid during the period for:
Interest	412,000	57,000
Income taxes, net of refunds	249,000	547,000
Noncash items during the period:
Changes in unrealized gains and losses on AFS securities, net of tax	(1,994,000)	(421,000)
Distributions of stock from investments	1,000	62,000
Transfers from AFS securities to HTM	$ 0	$ 8,953,000

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation

Basis of Presentation

SVB Financial Group is a diversified financial services company, as well as a bank holding company and a financial holding company. SVB Financial was incorporated in the state of Delaware in March 1999. Through our various subsidiaries and divisions, we offer a diverse set of banking and financial products and services to support our clients of all sizes and stages throughout their life cycles. In these notes to our unaudited interim consolidated financial statements, when we refer to “SVB,” “SVB Financial Group,” “SVBFG," the “Company,” “we,” “our,” “us” or use similar words, we mean SVB Financial Group and all of its subsidiaries collectively, including Silicon Valley Bank (the “Bank”), unless the context requires otherwise. When we refer to “SVB Financial” or the “Parent” we are referring only to the parent company, SVB Financial Group (not including subsidiaries).

The accompanying unaudited interim consolidated financial statements reflect all adjustments of a normal and recurring nature that are, in the opinion of management, necessary to fairly present our financial position, results of operations and cash flows in accordance with GAAP. Such unaudited interim consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results to be expected for any future periods. These unaudited interim consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”).

Use of Estimates and Assumptions

The preparation of unaudited interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Among the more significant estimates are those that relate to: 1) ACL for loans and for unfunded credit commitments, 2) valuation of non-marketable and other equity securities, 3) valuation of equity warrant assets, 4) goodwill, intangible assets and other purchase accounting related adjustments, and 5) income taxes.

Principles of Consolidation and Presentation

Our unaudited interim consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. All significant intercompany accounts and transactions with consolidated entities have been eliminated. For a further description of our accounting policies regarding consolidation refer to Consolidated Financial Statements and Supplementary Data — Note 2 — “Summary of Significant Accounting Policies” under Part II, Item 8 of our 2021 Form 10-K.

Reclassifications

Certain prior period amounts have been reclassified to conform to current period presentation to account for the change in presentation of derivative asset and liability positions and the related cash collateral disclosed in the Summary of Significant Accounting Polices in Part 1, Item 1 of this report. These changes are included in our Consolidated Balance Sheets (unaudited) and Consolidated Statements of Cash Flows (unaudited) as well as the Cash and Cash Equivalents, Derivative Financial Instruments and Fair Value of Financial Instruments footnotes.

Summary of Significant Accounting Policies

During the third quarter of 2022, we changed our presentation of derivative asset and liability positions and the related cash collateral in the unaudited interim consolidated balance sheets. The balances are presented net by counterparty when a legally enforceable right of setoff exists under a master netting arrangement in accordance with ASC 815, Derivatives and Hedging. Previously, fair values of derivative positions were reported in the line items “Accrued interest receivable and other assets” and “Other liabilities” gross. The related cash collateral was reported in the line items "Cash and cash equivalents" and "Short-term borrowings". For impact on presentation, please refer to the balance sheet offsetting section of Note 8 – “Derivative Financial Instruments”. This change had no impact on our net income. We concluded that this presentation was preferable as it better reflects the credit risk of derivatives traded under master netting arrangements. This change represents a change in accounting principle under ASC 250, Accounting Changes and Error Corrections, with retrospective application to the earliest period presented.

In the third quarter of 2022, we also adjusted the allowance models for the CRE and Other C&I loan portfolios to more precisely forecast lifetime loan losses for those portfolios. As a result, the allowance model for the CRE loan portfolio uses a reasonable and supportable forecast period that is less than, but approximately, three years; the Company continues to use a three-year reasonable and supportable forecast period for all other loan loss models. Subsequent to the forecast period

period, the CRE and Other C&I models' reversion to average historical losses uses an approach that gradually trends towards the mean historical loss over the remaining contractual lives of loans, whereas all other loan models continue to use an autoregressive approach. The impact on overall reserves as a result of these changes was not material. This change represents a change in accounting estimate under ASC 250, Accounting Changes and Error Corrections, with prospective application.Other than the above, the accompanying unaudited interim consolidated financial statements have been prepared on a consistent basis with the accounting policies described in Consolidated Financial Statements and Supplementary Data — Note 2 — “Summary of Significant Accounting Policies” under Part II, Item 8 of our 2021 Form 10-K.

XML

Stockholders' Equity and EPS

9 Months Ended

Sep. 30, 2022

Equity and Earnings Per Share [Abstract]

Stockholders' Equity and EPS

Stockholders' Equity and EPS

AOCI

The following table summarizes the items reclassified out of AOCI into the Consolidated Statements of Income (unaudited) for the three and nine months ended September 30, 2022 and 2021:

		Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	Income Statement Location	2022		2021		2022		2021
Reclassification adjustment for losses (gains) included in net income	Gains (losses) on investment securities, net	$	—	$	—	$	(48)	$	—
Related tax expense	Income tax expense	—		—		14		—
Reclassification adjustment for gains on cash flow hedges included in net income	Net interest income	(14)		(16)		(43)		(47)
Related tax expense	Income tax expense	4		4		12		13
Total reclassification adjustment for gains included in net income, net of tax		$	(10)	$	(12)	$	(65)	$	(34)

The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in AOCI for the three and nine months ended September 30, 2022 and 2021. Over the next 12 months, we expect that approximately $46 million in AOCI at September 30, 2022, related to unrealized gains will be reclassified out of AOCI and recognized in net income.

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Balance, beginning of period, net of tax	$	62	$	107	$	83	$	129
Net realized (gain) loss reclassified to net income, net of tax	(10)		(12)		(31)		(34)
Balance, end of period, net of tax	$	52	$	95	$	52	$	95

EPS

Basic EPS is the amount of earnings available to each share of common stock outstanding during the reporting period. Diluted EPS is the amount of earnings available to each share of common stock outstanding during the reporting period adjusted to include the effect of potentially dilutive common shares. Potentially dilutive common shares include incremental shares issuable for stock options and restricted stock unit awards outstanding under our 2006 Equity Incentive Plan and our ESPP. Potentially dilutive common shares are excluded from the computation of dilutive EPS in periods in which the effect would be antidilutive. The following is a reconciliation of basic EPS to diluted EPS for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions except per share amounts, shares in thousands)	2022		2021		2022		2021
Numerator:
Net income available to common stockholders	$	429	$	365	$	1,234	$	1,399
Denominator:
Weighted average common shares outstanding—basic	59,096		57,723		58,945		54,772
Weighted average effect of dilutive securities:
Stock options and ESPP	165		268		206		278
Restricted stock units and awards	288		530		384		567
Weighted average common shares outstanding—diluted	59,549		58,521		59,535		55,617
Earnings per common share:
Basic	$	7.26	$	6.33	$	20.94	$	25.54
Diluted	7.21		6.24		20.73		25.16

The following table summarizes the weighted-average common shares excluded from the diluted EPS calculation due to the antidilutive effect for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,		Nine months ended September 30,
(Shares in thousands)	2022	2021	2022	2021
Stock options	142	56	105	31
Restricted stock units	477	—	99	—
Total	619	56	204	31

Preferred Stock

The following table summarizes our preferred stock at September 30, 2022:

Series	Description	Amount outstanding (in millions)		Carrying value (in millions)		Shares issued and outstanding	Par Value		Ownership interest per depositary share	Liquidation preference per depositary share		2022 dividends paid per depositary share
Series A	5.25% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	$	350	$	340	350,000	$	0.001	1/40th	$	25	$	0.984375
Series B	4.100% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	750		739		7,500	0.001		1/100th	1,000		30.75
Series C	4.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	1,000		985		10,000	0.001		1/100th	1,000		30.00
Series D	4.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	1,000		989		10,000	0.001		1/100th	1,000		33.88
Series E	4.700% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	600		593		6,000	0.001		1/100th	1,000		37.47

Consolidated Statement of Changes in Equity

The following table summarizes the changes in our consolidated equity for the three months ended September 30, 2022 and 2021:

	Preferred Stock		Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total SVBFG Stockholders’ Equity		Noncontrolling Interests		Total  Equity
(Dollars in millions, except share data)			Shares	Amount
Balance at June 30, 2021	$	2,064	54,530,307	$	—	$	2,755	$	6,706	$	142	$	11,667	$	300	$	11,967
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		32,195	—		2		—		—		2		—		2
Issuance of Common Stock	—		2,227,000	—		1,245		—		—		1,245		—		1,245
Issuance of common stock for the acquisition of Boston Private	—		1,887,981	—		1,060						1,060				1,060
Net income	—		—	—		—		387		—		387		88		475
Capital calls and distributions, net	—		—	—		—		—		—		—		(19)		(19)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(77)		(77)		—		(77)
Share-based compensation, net	—		—	—		38		—		—		38		—		38
Dividends on preferred stock	—		—	—		—		(22)		—		(22)		—		(22)
Balance at September 30, 2021	$	2,064	58,677,483	$	—	$	5,100	$	7,071	$	65	$	14,300	$	369	$	14,669
Balance at June 30, 2022	$	3,646	59,081,326	$	—	$	5,223	$	8,247	$	(1,198)	$	15,918	$	358	$	16,276
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		22,798	—		(2)		—		—		(2)		—		(2)
Net income	—		—	—		—		469		—		469		(51)		418
Capital calls and distributions, net	—		—	—		—		—		—		—		(6)		(6)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(887)		(887)		—		(887)
Share-based compensation, net	—		—	—		51		—		—		51		—		51
Dividends on preferred stock	—		—	—		—		(40)		—		(40)		—		(40)
Balance at September 30, 2022	$	3,646	59,104,124	$	—	$	5,272	$	8,676	$	(2,085)	$	15,509	$	301	$	15,810

XML

Variable Interest Entities

9 Months Ended

Sep. 30, 2022

Investments In Variable Interest Entities [Abstract]

Variable Interest Entities

Variable Interest EntitiesOur involvement with VIEs includes our investments in venture capital and private equity funds, debt funds, private and public portfolio companies, qualified affordable housing projects, and subordinated debt instruments.

The following table presents the carrying amounts and classification of variable interests in consolidated and unconsolidated VIEs as of September 30, 2022 and December 31, 2021:

(Dollars in millions)	Consolidated VIEs		Unconsolidated VIEs		Maximum Exposure to Loss in Unconsolidated VIEs
September 30, 2022:
Assets:
Cash and cash equivalents	$	7	$	—	$	—
Non-marketable and other equity securities (1)	767		1,369		1,369
Accrued interest receivable and other assets (2)	35		6		—
Total assets	$	809	$	1,375	$	1,369
Liabilities:
Other liabilities (1)	$	23	$	672	$	—
Long term debt (2)	—		91		—
Total liabilities	$	23	$	763	$	—
December 31, 2021:
Assets:
Cash and cash equivalents	$	13	$	—	$	—
Non-marketable and other equity securities (1)	768		1,233		1,233
Accrued interest receivable and other assets (2)	31		6		—
Total assets	$	812	$	1,239	$	1,233
Liabilities:
Other liabilities (1)	$	18	$	482	$	—
Long term debt (2)	—		90		—
Total liabilities	$	18	$	572	$	—

(1)    Included in our unconsolidated non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are investments in qualified affordable housing projects of $1.2 billion and $954 million, respectively, and related other liabilities consisting of unfunded commitments of $672 million and $482 million, respectively.

(2)    Included in our unconsolidated accrued interest receivable and other assets are investments in statutory trusts for junior subordinated debt and included in long term debt previously issued by Boston Private and assumed in the acquisition of $6 million and $91 million at September 30, 2022 and $6 million and $90 million at December 31, 2021.

Non-marketable and other equity securities

Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt funds, private and public portfolio companies and qualified affordable housing projects. Many of these are investments held by SVB Financial in third-party funds in which we do not have controlling or significant variable interests. These investments represent our unconsolidated VIEs in the table above. Our non-marketable and other equity securities portfolio also includes investments from SVB Capital. SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds. We have a controlling and significant variable interest in four of these SVB Capital funds and consolidate these funds for financial reporting purposes.

Most investments are generally nonredeemable, and distributions are expected to be received through the liquidation of the underlying investments throughout the life of the investment fund. Investments may only be sold or transferred subject to the notice and approval provisions of the underlying investment agreement. Subject to applicable regulatory requirements, including the Volcker Rule, we also make commitments to invest in venture capital and private equity funds. For additional details, see Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments.”

The Bank also has variable interests in low income housing tax credit funds, in connection with fulfilling its responsibilities under the CRA, that are designed to generate a return primarily through the realization of federal tax credits. These investments are typically limited partnerships in which the general partner, other than the Bank, holds the power over significant activities of the VIE; therefore, these investments are not consolidated. For additional information on our investments in qualified affordable housing projects, see Note 5 — “Investment Securities.".

As of September 30, 2022, our exposure to loss with respect to the consolidated VIEs is limited to our net assets of $786 million and our exposure to loss for our unconsolidated VIEs is equal to our investment in these assets of $1.4 billion.

Junior subordinated debentures

SVB Financial Group assumed two statutory trusts during the merger with Boston Private. These trusts were for the purpose of issuing trust preferred securities and investing the proceeds in junior subordinated debentures. These statutory trusts created by legacy Boston Private are not consolidated within the financial statements as the Company is not the primary beneficiary of the trusts; however, the total junior subordinated debentures payable to the preferred stockholders of statutory trusts are reported as long-term debt in the financial statements.

XML

Cash and Cash Equivalents

9 Months Ended

Sep. 30, 2022

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents

Cash and Cash Equivalents

The following table details our cash and cash equivalents at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Cash and due from banks	$	1,411	$	2,168
Interest bearing deposits with the Federal Reserve Bank	7,550		5,686
Interest bearing deposits with other institutions	4,610		5,773
Securities purchased under agreements to resell (1)	397		607
Other short-term investment securities	—		352
Total cash and cash equivalents	$	13,968	$	14,586

(1)At September 30, 2022 and December 31, 2021, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $402 million and $620 million, respectively. None of these securities were sold or repledged as of September 30, 2022 and December 31, 2021.

XML

Investment Securities

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Investment Securities

Investment Securities

Our investment securities portfolio consists of: (i) an AFS securities portfolio and a HTM securities portfolio, both of which represent interest-earning investment securities, and (ii) a non-marketable and other equity securities portfolio, which primarily represents investments managed as part of our funds management business, investments in qualified affordable housing projects, as well as public equity securities held as a result of equity warrant assets exercised.

AFS Securities

The major components of our AFS investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

	September 30, 2022
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Carrying Value
AFS securities, at fair value:
U.S. Treasury securities	$	18,041	$	—	$	(1,196)	$	16,845
U.S. agency debentures	120		—		(20)		100
Foreign government debt securities	1,062		—		(149)		913
Residential MBS:
Agency-issued MBS	7,883		—		(1,200)		6,683
Agency-issued CMO—fixed rate	792		—		(78)		714
Agency-issued CMBS	1,604		—		(148)		1,456
Total AFS securities	$	29,502	$	—	$	(2,791)	$	26,711

	December 31, 2021
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Carrying Value
AFS securities, at fair value:
U.S. Treasury securities	$	15,799	$	121	$	(70)	$	15,850
U.S. agency debentures	200		—		(4)		196
Foreign government debt securities	61		—		—		61
Residential MBS:
Agency-issued MBS	8,786		13		(210)		8,589
Agency-issued CMO—fixed rate	988		3		(9)		982
Agency-issued CMBS	1,536		27		(20)		1,543
Total AFS securities	$	27,370	$	164	$	(313)	$	27,221

The following table summarizes sale activity of AFS securities during the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Sales proceeds	$	—	$	168	$	8,511	$	168
Net realized gains and losses:
Gross realized gains	—		—		146		—
Gross realized losses	—		—		(98)		—
Net realized gains (losses)	$	—	$	—	$	48	$	—

The following tables summarize our AFS securities in an unrealized loss position for which an ACL has not been recorded and summarized into categories of AFS securities that were in an unrealized loss for position for less than 12 months, or 12 months or longer, as of September 30, 2022 and December 31, 2021:

	September 30, 2022
	Less than 12 months				12 months or longer				Total
(Dollars in millions)	Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses
AFS securities:
U.S. Treasury securities	$	13,359	$	(958)	$	3,487	$	(238)	$	16,846	$	(1,196)
U.S. agency debentures	20		(1)		80		(19)		100		(20)
Foreign government debt securities	913		(149)		—		—		913		(149)
Residential MBS:
Agency-issued MBS	2,236		(304)		4,448		(896)		6,684		(1,200)
Agency-issued CMO —fixed rate	534		(55)		168		(23)		702		(78)
Agency-issued CMBS	806		(59)		649		(89)		1,455		(148)
Total AFS securities (1)	$	17,868	$	(1,526)	$	8,832	$	(1,265)	$	26,700	$	(2,791)

(1)As of September 30, 2022, we identified a total of 804 investments that were in unrealized loss positions with 289 investments in an unrealized loss position for a period of time greater than 12 months. Based on our analysis of the securities in an unrealized loss position as of September 30, 2022, the decline in value is unrelated to credit loss and is related to changes in market interest rates since purchase, and therefore, changes in value for securities are included in other comprehensive income. Market valuations and credit loss analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis. As of September 30, 2022, we do not intend to sell any of our securities in an unrealized loss position prior to recovery of our amortized cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our amortized cost basis. None of the investments in our AFS securities portfolio were past due as of September 30, 2022.

	December 31, 2021
	Less than 12 months				12 months or longer				Total
(Dollars in millions)	Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses
AFS securities:
U.S. Treasury securities	$	7,777	$	(70)	$	—	$	—	$	7,777	$	(70)
U.S. agency debentures	196		(4)		—		—		196		(4)
Residential MBS:
Agency-issued MBS	8,280		(210)		—		—		8,280		(210)
Agency-issued CMO—fixed rate	740		(9)		—		—		740		(9)
Agency-issued CMBS	603		(11)		163		(9)		766		(20)
Total AFS securities (1)	$	17,596	$	(304)	$	163	$	(9)	$	17,759	$	(313)

(1)As of December 31, 2021, we identified a total of 475 investments that were in unrealized loss positions, of which 4 investments are in an unrealized loss position for a period of time greater than 12 months. None of the investments in our AFS securities portfolio were past due as of December 31, 2021.

The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of September 30, 2022 by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments.

	September 30, 2022
(Dollars in millions)	Total		One Year or Less		After One Year to Five Years		After Five Years to Ten Years		After Ten Years
U.S. Treasury securities	$	16,845	$	936	$	15,133	$	776	$	—
U.S. agency debentures	100		—		34		66		—
Foreign government debt securities	913		41		46		826		—
Residential MBS:
Agency-issued MBS	6,683		—		—		45		6,638
Agency-issued CMO—fixed rate	714		—		—		—		714
Agency-issued CMBS	1,456		—		100		1,356		—
Total	$	26,711	$	977	$	15,313	$	3,069	$	7,352

HTM Securities

The components of our HTM investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

	September 30, 2022
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value		ACL
HTM securities, at cost:
U.S. agency debentures (1)	$	486	$	—	$	(53)	$	433	$	—
Residential MBS:
Agency-issued MBS	59,200		—		(10,017)		49,183		—
Agency-issued CMO—fixed rate	10,741		—		(1,813)		8,928		—
Agency-issued CMO—variable rate	83		—		(1)		82		—
Agency-issued CMBS	14,644		—		(2,304)		12,340		—
Municipal bonds and notes	7,429		—		(1,612)		5,817		1
Corporate bonds	709		—		(122)		587		5
Total HTM securities	$	93,292	$	—	$	(15,922)	$	77,370	$	6

(1)    Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.

	December 31, 2021
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value		ACL
HTM securities, at amortized cost:
U.S. agency debentures (1)	$	609	$	8	$	(2)	$	615	$	—
Residential MBS:
Agency-issued MBS	64,439		124		(887)		63,676		—
Agency-issued CMO—fixed rate	10,226		9		(145)		10,090		—
Agency-issued CMO—variable rate	100		1		—		101		—
Agency-issued CMBS	14,959		39		(277)		14,721		—
Municipal bonds and notes	7,157		185		(27)		7,315		1
Corporate bonds	712		2		(5)		709		6
Total HTM securities	$	98,202	$	368	$	(1,343)	$	97,227	$	7

(1)    Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.

Allowance for Credit Losses for HTM Securities

For HTM securities, for the three months ended September 30, 2022, the ACL balance remained consistent at $6 million. For HTM securities, for the nine months ended September 30, 2022 the beginning ACL balance was $7 million, the reduction of credit losses was $1 million, and the ending ACL balance was $6 million.

For HTM securities, for the three months ended September 30, 2021, the beginning ACL balance was $5 million, the provision for credit losses was $1 million and the ending ACL balance was $6 million. For HTM securities, for the nine months ended September 30, 2021 the beginning ACL balance was less than $1 million, the provision for credit losses was $6 million and the ending ACL balance was $6 million.

AIR from HTM securities totaled $205 million at September 30, 2022 and $225 million at December 31, 2021 and is reported in "Accrued interest receivable and other assets" in our unaudited interim consolidated balance sheets.

Credit Quality Indicators

On a quarterly basis, management monitors the credit quality for HTM securities through the use of standard credit ratings. The following table summarizes our amortized cost of HTM securities aggregated by credit quality indicator at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Municipal bonds and notes:
Aaa	$	4,270	$	3,774
Aa1	1,880		2,031
Aa2	1,081		1,154
Aa3	171		172
A1	27		26
Total municipal bonds and notes	$	7,429	$	7,157
Corporate bonds:
Aaa	$	39	$	39
Aa2	42		42
Aa3	105		105
A1	282		251
A2	230		264
A3	11		11
Total corporate bonds	$	709	$	712

The following table summarizes the remaining contractual principal maturities on fixed income investment securities classified as HTM as of September 30, 2022. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected remaining maturities for certain U.S. agency debentures may occur earlier than their contractual maturities because the note issuers have the right to call outstanding amounts ahead of their contractual maturity. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as HTM typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments; however, we expect to collect substantially all of the recorded investment on these securities.

	September 30, 2022
	Total				One Year or Less				After One Year to Five Years				After Five Years to Ten Years				After Ten Years
(Dollars in millions)	Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value
U.S. agency debentures	$	486	$	433	$	1	$	1	$	118	$	111	$	367	$	321	$	—	$	—
Residential MBS:
Agency-issued MBS	59,200		49,183		1		1		2		2		1,148		1,063		58,049		48,117
Agency-issued CMO—fixed rate	10,741		8,928		—		—		87		83		154		146		10,500		8,699
Agency-issued CMO—variable rate	83		82		—		—		—		—		—		—		83		82
Agency-issued CMBS	14,644		12,340		45		44		159		146		968		802		13,472		11,348
Municipal bonds and notes	7,428		5,817		25		25		235		222		1,265		1,114		5,903		4,456
Corporate bonds	704		587		—		—		115		102		589		485		—		—
Total	$	93,286	$	77,370	$	72	$	71	$	716	$	666	$	4,491	$	3,931	$	88,007	$	72,702

Non-marketable and Other Equity Securities

The major components of our non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

(Dollars in millions)	September 30, 2022		December 31, 2021
Non-marketable and other equity securities:
Non-marketable securities (fair value accounting):
Consolidated venture capital and private equity fund investments (1)	$	147	$	130
Unconsolidated venture capital and private equity fund investments (2)	123		208
Other investments without a readily determinable fair value (3)	176		164
Other equity securities in public companies (fair value accounting) (4)	29		117
Non-marketable securities (equity method accounting) (5):
Venture capital and private equity fund investments	639		671
Debt funds	4		5
Other investments	272		294
Investments in qualified affordable housing projects, net (6)	1,205		954
Total non-marketable and other equity securities	$	2,595	$	2,543

(1)The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at September 30, 2022 and December 31, 2021 (fair value accounting):

	September 30, 2022				December 31, 2021
(Dollars in millions)	Amount		Ownership %		Amount		Ownership %
Strategic Investors Fund, LP	$	2	12.6	%	$	2	12.6	%
Capital Preferred Return Fund, LP	30		20.0		61		20.0
Growth Partners, LP	25		33.0		67		33.0
Redwood Evergreen Fund, LP	90		100.0		—		—
Total consolidated venture capital and private equity fund investments	$	147			$	130

(2)The carrying value represents investments in 141 and 150 funds (primarily venture capital funds) at September 30, 2022 and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30th for our September 30th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

(3)These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment, and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.

The following table shows the changes to the carrying amount of other investments without a readily determinable fair value for the nine months ended September 30, 2022:

(Dollars in millions)	Nine months ended September 30, 2022		Cumulative Adjustments
Measurement alternative:
Carrying value at September 30, 2022	$	176
Carrying value adjustments:
Impairment	$	—	$	(1)
Upward changes for observable prices	—		52
Downward changes for observable prices	(6)		(11)

(4)Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in equity securities measured at fair value are recognized through net income.

(5)The following table shows the carrying value and our ownership percentage of each investment at September 30, 2022 and December 31, 2021 (equity method accounting):

	September 30, 2022				December 31, 2021
(Dollars in millions)	Amount		Ownership %		Amount		Ownership %
Venture capital and private equity fund investments:
Strategic Investors Fund II, LP	$	2	8.6	%	$	3	8.6	%
Strategic Investors Fund III, LP	13		5.9		25		5.9
Strategic Investors Fund IV, LP	23		5.0		36		5.0
Strategic Investors Fund V funds	59		Various		87		Various
CP II, LP (i)	2		5.1		2		5.1
Other venture capital and private equity fund investments	540		Various		518		Various
Total venture capital and private equity fund investments	$	639			$	671
Debt funds:
Gold Hill Capital 2008, LP (ii)	$	3	15.5	%	$	4	15.5	%
Other debt funds	1		Various		1		Various
Total debt funds	$	4			$	5
Other investments:
SPD Silicon Valley Bank Co., Ltd.	$	143	50.0	%	$	154	50.0	%
Other investments	129		Various		140		Various
Total other investments	$	272			$	294

(i)Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.

(ii)Our ownership includes direct ownership interest of 11.5 percent and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.

(6)The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of “Other liabilities” on our consolidated balance sheets at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Investments in qualified affordable housing projects, net	$	1,205	$	954
Other liabilities	672		482

The following table presents other information relating to our investments in qualified affordable housing projects for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Tax credits and other tax benefits recognized	$	30	$	9	$	80	$	63
Amortization expense included in provision for income taxes (i)	17		17		52		48

(i)All investments are amortized using the proportional amortization method, and amortization expense is included in the provision for income taxes.

The following table presents the net gains and losses on non-marketable and other equity securities for the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Net (losses) gains on non-marketable and other equity securities:
Non-marketable securities (fair value accounting):
Consolidated venture capital and private equity fund investments	$	(52)	$	36	$	(100)	$	72
Unconsolidated venture capital and private equity fund investments	(61)		47		(80)		79
Other investments without a readily determinable fair value	—		(2)		(3)		11
Other equity securities in public companies (fair value accounting)	(8)		(39)		(52)		53
Non-marketable securities (equity method accounting):
Venture capital and private equity fund investments	(12)		144		(20)		438
Debt funds	(1)		—		(1)		2
Other investments	7		3		9		6
Total net (losses) gains on non-marketable and other equity securities	$	(127)	$	189	$	(247)	$	661
Less: realized net gains (losses) on sales of non-marketable and other equity securities	13		(17)		(16)		110
Net (losses) gains on non-marketable and other equity securities still held	$	(140)	$	206	$	(231)	$	551

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments

We serve a variety of commercial clients in the private equity/venture capital, technology, life science/healthcare, premium wine and commercial real estate industries. Loans made to private equity/venture capital firm clients typically enable them to fund investments prior to their receipt of funds from capital calls and are reported under the Global Fund Banking class of financing receivable below. Our technology clients generally tend to be in the industries of hardware (such as semiconductors, communications, data, storage and electronics), software/internet (such as infrastructure software, applications, software services, digital content and advertising technology) and ERI. Our life science/healthcare clients primarily tend to be in the industries of biotechnology, medical devices, healthcare information technology and healthcare services. Loans to our technology and life science/healthcare clients are reported under the Investor Dependent, Cash Flow Dependent - SLBO and Innovation C&I classes of financing receivable below. We also make commercial and industrial loans, such as working capital lines and term loans for equipment and fixed assets, to clients that are not in the technology and life science/healthcare industries which are reported in the Other C&I class of financing receivable below. Loans to the premium wine industry focus on vineyards and wineries that produce grapes and wines of high quality. Commercial real estate loans are generally acquisition financing for commercial properties such as office buildings, retail properties, apartment buildings, and industrial/warehouse space, which moving forward, will predominantly support the innovation economy segments. In addition to commercial loans, we make consumer loans through SVB Private and provide real estate secured loans to eligible employees through our EHOP.

We also provide community development loans made as part of our responsibilities under the CRA. The majority of these loans are included within the Other loan class below and are primarily secured by real estate. Additionally, beginning in April 2020, we accepted applications under the PPP administered by the SBA under the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") and originated loans to qualified small businesses. PPP funds under the CARES Act were disbursed throughout 2020 and up to June 30, 2021.

Loan Portfolio Segments and Classes of Financing Receivables

The composition of loans at amortized cost basis broken out by class of financing receivable at September 30, 2022 and December 31, 2021 is presented in the following table:

(Dollars in millions)	September 30, 2022		December 31, 2021
Global fund banking	$	40,337	$	37,958
Investor dependent:
Early stage	1,911		1,593
Growth stage	4,398		3,951
Total investor dependent	6,309		5,544
Cash flow dependent - SLBO	1,845		1,798
Innovation C&I	8,321		6,673
Private bank	10,102		8,743
CRE	2,609		2,670
Premium wine	1,117		985
Other C&I	1,087		1,257
Other	374		317
PPP	28		331
Total loans (1) (2) (3)	$	72,129	$	66,276
ACL	(557)		(422)
Net loans	$	71,572	$	65,854

(1)    Total loans at amortized cost is net of unearned income, deferred fees and costs, and net unamortized premiums and discounts of $244 million and $250 million at September 30, 2022 and December 31, 2021, respectively.

(2)     Included within our total loan portfolio are credit card loans of $582 million and $583 million at September 30, 2022 and December 31, 2021, respectively.

(3)     Included within our total loan portfolio are construction loans of $454 million and $367 million at September 30, 2022 and December 31, 2021, respectively.

Credit Quality Indicators

For each individual client, we establish an internal credit risk rating for that loan, which is used for assessing and monitoring credit risk as well as performance of the loan and the overall portfolio. Our internal credit risk ratings are also used to summarize the risk of loss due to failure by an individual borrower to repay the loan. For our internal credit risk ratings, each individual loan is given a risk rating of 1 through 10. Loans risk-rated 1 through 4 are performing loans and translate to an internal rating of “Pass,” with loans risk-rated 1 being cash secured. Loans risk-rated 5 through 7 are performing loans; however, we consider them as demonstrating higher risk, which requires more frequent review of the individual exposures; these translate to an internal rating of “Criticized.” All of our nonaccrual loans are risk-rated 8 or 9 and are classified with the internal rating of "Nonperforming." Loans rated 10 are charged-off and are not included as part of our loan portfolio balance. We review our credit quality indicators on a quarterly basis for performance and appropriateness of risk ratings as part of our evaluation process for our ACL for loans.

The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of September 30, 2022 and December 31, 2021:

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Global fund banking:
Risk rating:
Pass	$	512	$	95	$	63	$	31	$	1	$	10	$	39,616	$	—	$	—	$	40,328
Criticized	—		—		—		—		—		—		9		—		—		9
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total global fund banking	$	512	$	95	$	63	$	31	$	1	$	10	$	39,625	$	—	$	—	$	40,337
Investor dependent:
Early stage:
Risk rating:
Pass	$	727	$	626	$	73	$	36	$	2	$	1	$	191	$	—	$	—	$	1,656
Criticized	67		122		27		7		—		2		26		—		—		251
Nonperforming	1		1		—		—		—		—		2		—		—		4
Total early stage	$	795	$	749	$	100	$	43	$	2	$	3	$	219	$	—	$	—	$	1,911

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Growth stage:
Risk rating:
Pass	$	1,684	$	1,456	$	360	$	72	$	28	$	6	$	243	$	5	$	—	$	3,854
Criticized	147		233		53		14		5		—		49		—		—		501
Nonperforming	19		18		2		—		—		—		4		—		—		43
Total growth stage	$	1,850	$	1,707	$	415	$	86	$	33	$	6	$	296	$	5	$	—	$	4,398
Total investor dependent	$	2,645	$	2,456	$	515	$	129	$	35	$	9	$	515	$	5	$	—	$	6,309
Cash flow dependent - SLBO:
Risk rating:
Pass	$	678	$	609	$	199	$	203	$	14	$	39	$	30	$	—	$	—	$	1,772
Criticized	20		—		16		2		1		22		5		—		—		66
Nonperforming	—		—		—		—		5		—		2		—		—		7
Total cash flow dependent - SLBO	$	698	$	609	$	215	$	205	$	20	$	61	$	37	$	—	$	—	$	1,845
Innovation C&I
Risk rating:
Pass	$	1,788	$	1,734	$	773	$	166	$	18	$	54	$	3,102	$	—	$	—	$	7,635
Criticized	49		148		121		32		11		—		324		—		—		685
Nonperforming	—		—		—		—		—		—		1		—		—		1
Total innovation C&I	$	1,837	$	1,882	$	894	$	198	$	29	$	54	$	3,427	$	—	$	—	$	8,321
Private bank:
Risk rating:
Pass	$	2,210	$	2,817	$	1,753	$	948	$	441	$	1,054	$	818	$	5	$	—	$	10,046
Criticized	—		16		—		2		—		15		10		—		—		43
Nonperforming	—		—		1		2		1		8		1		—		—		13
Total private bank	$	2,210	$	2,833	$	1,754	$	952	$	442	$	1,077	$	829	$	5	$	—	$	10,102
CRE
Risk rating:
Pass	$	406	$	292	$	181	$	240	$	143	$	894	$	96	$	5	$	—	$	2,257
Criticized	2		4		51		135		24		114		17		—		—		347
Nonperforming	—		—		—		5		—		—		—		—		—		5
Total CRE	$	408	$	296	$	232	$	380	$	167	$	1,008	$	113	$	5	$	—	$	2,609
Premium wine:
Risk rating:
Pass	$	255	$	213	$	91	$	137	$	47	$	144	$	156	$	34	$	—	$	1,077
Criticized	1		5		—		7		9		9		9		—		—		40
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total premium wine	$	256	$	218	$	91	$	144	$	56	$	153	$	165	$	34	$	—	$	1,117
Other C&I
Risk rating:
Pass	$	31	$	149	$	161	$	70	$	81	$	304	$	234	$	10	$	—	$	1,040
Criticized	1		—		3		6		3		19		11		1		—		44
Nonperforming	—		—		1		—		1		1		—		—		—		3
Total other C&I	$	32	$	149	$	165	$	76	$	85	$	324	$	245	$	11	$	—	$	1,087
Other:
Risk rating:
Pass	$	25	$	151	$	172	$	30	$	—	$	—	$	11	$	—	$	(44)	$	345
Criticized	—		3		17		9		—		—		—		—		—		29
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total other	$	25	$	154	$	189	$	39	$	—	$	—	$	11	$	—	$	(44)	$	374
PPP:
Risk rating:
Pass	$	—	$	16	$	3	$	—	$	—	$	—	$	—	$	—	$	—	$	19
Criticized	—		3		6		—		—		—		—		—		—		9
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total PPP	$	—	$	19	$	9	$	—	$	—	$	—	$	—	$	—	$	—	$	28

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Total loans	$	8,623	$	8,711	$	4,127	$	2,154	$	835	$	2,696	$	44,967	$	60	$	(44)	$	72,129

(1)    These amounts consist of fees and clearing items that have not yet been allocated at the loan level.

	Term Loans by Origination Year
December 31, 2021 (Dollars in millions)	2021		2020		2019		2018		2017		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Global fund banking:
Risk rating:
Pass	$	764	$	115	$	36	$	6	$	8	$	4	$	36,955	$	—	$	—	$	37,888
Criticized	50		18		—		—		—		1		1		—		—		70
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total global fund banking	$	814	$	133	$	36	$	6	$	8	$	5	$	36,956	$	—	$	—	$	37,958
Investor dependent:
Early stage:
Risk rating:
Pass	$	754	$	287	$	122	$	26	$	6	$	1	$	171	$	—	$	—	$	1,367
Criticized	64		87		30		5		—		—		29		—		—		215
Nonperforming	2		5		3		—		—		—		1		—		—		11
Total early stage	$	820	$	379	$	155	$	31	$	6	$	1	$	201	$	—	$	—	$	1,593
Growth stage:
Risk rating:
Pass	$	2,072	$	910	$	265	$	78	$	14	$	1	$	286	$	5	$	—	$	3,631
Criticized	159		85		27		6		3		—		34		—		—		314
Nonperforming	2		—		1		2		—		—		1		—		—		6
Total growth stage	$	2,233	$	995	$	293	$	86	$	17	$	1	$	321	$	5	$	—	$	3,951
Total investor dependent	$	3,053	$	1,374	$	448	$	117	$	23	$	2	$	522	$	5	$	—	$	5,544
Cash flow dependent - SLBO:
Risk rating:
Pass	$	875	$	384	$	252	$	72	$	76	$	2	$	35	$	—	$	—	$	1,696
Criticized	—		—		20		25		—		13		10		—		—		68
Nonperforming	—		—		12		10		7		—		5		—		—		34
Total cash flow dependent - SLBO	$	875	$	384	$	284	$	107	$	83	$	15	$	50	$	—	$	—	$	1,798
Innovation C&I:
Risk rating:
Pass	$	2,230	$	1,058	$	288	$	123	$	58	$	—	$	2,411	$	—	$	—	$	6,168
Criticized	64		130		62		12		—		—		236		—		—		504
Nonperforming	—		—		—		—		—		—		1		—		—		1
Total Innovation C&I	$	2,294	$	1,188	$	350	$	135	$	58	$	—	$	2,648	$	—	$	—	$	6,673
Private bank:
Risk rating:
Pass	$	2,952	$	2,015	$	1,122	$	520	$	432	$	952	$	705	$	8	$	—	$	8,706
Criticized	—		—		2		—		2		9		3		—		—		16
Nonperforming	—		—		2		9		—		8		2		—		—		21
Total private bank	$	2,952	$	2,015	$	1,126	$	529	$	434	$	969	$	710	$	8	$	—	$	8,743
CRE
Risk rating:
Pass	$	326	$	215	$	344	$	155	$	236	$	868	$	110	$	2	$	—	$	2,256
Criticized	3		39		114		37		47		139		18		12		—		409
Nonperforming	—		—		5		—		—		—		—		—		—		5
Total CRE	$	329	$	254	$	463	$	192	$	283	$	1,007	$	128	$	14	$	—	$	2,670
Premium wine:
Risk rating:
Pass	$	217	$	112	$	156	$	69	$	71	$	162	$	125	$	34	$	—	$	946
Criticized	1		7		11		9		—		—		11		—		—		39
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total Premium wine	$	218	$	119	$	167	$	78	$	71	$	162	$	136	$	34	$	—	$	985
Other C&I
Risk rating:
Pass	$	181	$	175	$	82	$	86	$	28	$	301	$	350	$	11	$	—	$	1,214
Criticized	5		6		6		7		2		—		8		5		—		39
Nonperforming	—		—		—		2		—		1		1		—		—		4
Total other C&I	$	186	$	181	$	88	$	95	$	30	$	302	$	359	$	16	$	—	$	1,257
Other:

	Term Loans by Origination Year
December 31, 2021 (Dollars in millions)	2021		2020		2019		2018		2017		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Risk rating:
Pass	$	61	$	144	$	82	$	20	$	14	$	—	$	7	$	—	$	(21)	$	307
Criticized	—		7		1		—		2		—		—		—		—		10
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total other	$	61	$	151	$	83	$	20	$	16	$	—	$	7	$	—	$	(21)	$	317
PPP:
Risk rating:
Pass	$	226	$	72	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	298
Criticized	22		9		—		—		—		—		—		—		—		31
Nonperforming	2		—		—		—		—		—		—		—		—		2
Total PPP	$	250	$	81	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	331
Total loans	$	11,032	$	5,880	$	3,045	$	1,279	$	1,006	$	2,462	$	41,516	$	77	$	(21)	$	66,276

Allowance for Credit Losses: Loans

In the third quarter of 2022, the ACL for loans increased by $12 million, driven primarily by loan growth and the continued deterioration in projected economic conditions.

The Moody's Analytics September 2022 forecast was utilized in our quantitative model for the ACL as of September 30, 2022. The forecast assumptions included a significantly worse housing price index growth rate than that of last quarter, as well as a lower gross domestic product growth rate. The forecast's starting unemployment rate was unchanged from prior quarter, but it is worse in future quarters than in previous projections. The overall impact of these assumptions was a worse forecast than that used at June 30, 2022.

Additionally, we reduced the weighting applied to the Moody's downside economic scenario to reflect that the September forecasts more closely aligned with our expectations as of September 30, 2022, thereby no longer requiring a downside weighting as significant as in the previous quarter. To the extent we identified credit risk considerations that were not captured by the Moody's Analytics September 2022 forecast, we addressed the risk through management's adjustments to the scenario weightings. After adjusting the weightings accordingly, we determined the forecast to be representative of our outlook for the economy given the available information at current quarter end.

We do not estimate expected credit losses on AIR on loans, as AIR is reversed or written off when the full collection of the AIR related to a loan becomes doubtful. AIR on loans totaled $294 million at September 30, 2022 and $171 million at December 31, 2021 and is reported in "Accrued interest receivable and other assets" in our unaudited interim consolidated balance sheets.

The following tables summarize the activity relating to our ACL for loans for the three and nine months ended September 30, 2022 and 2021, broken out by portfolio segment:

Three months ended September 30, 2022	Beginning Balance June 30, 2022		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	89	$	—	$	6	$	(4)	$	—	$	91
Investor dependent	224		(20)		4		25		1		234
Cash flow dependent and innovation C&I	130		(5)		—		11		—		136
Private bank	45		—		—		2		—		47
CRE	34		—		—		(7)		—		27
Other C&I	12		(1)		1		—		—		12
Premium wine and other	11		—		—		3		(4)		10
Total ACL	$	545	$	(26)	$	11	$	30	$	(3)	$	557

Three months ended September 30, 2021	Beginning Balance June 30, 2021		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	66	$	—	$	—	$	—	$	(7)	$	59
Investor dependent	158		—		(17)		5		(8)		138
Cash flow dependent and innovation C&I	119		—		(1)		3		(12)		109
Private bank	47		1		(1)		—		(16)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	6		—		—		—		3		9
Total ACL	$	396	$	22	$	(19)	$	8	$	(9)	$	398

Nine months ended September 30, 2022	Beginning Balance December 31, 2021		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	67	$	—	$	6	$	18	$	—	$	91
Investor dependent	146		(53)		13		126		2		234
Cash flow dependent and innovation C&I	118		(9)		—		27		—		136
Private Bank	33		—		2		12		—		47
CRE	36		—		—		(9)		—		27
Other C&I	14		(3)		1		—		—		12
Premium wine and other	8		(1)		1		10		(8)		10
Total ACL	$	422	$	(66)	$	23	$	184	$	(6)	$	557

Nine months ended September 30, 2021	Beginning Balance December 31, 2020		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	46	$	—	$	(80)	$	—	$	93	$	59
Investor dependent	213		—		(37)		13		(51)		138
Cash flow dependent and innovation C&I	125		—		(8)		3		(11)		109
Private Bank	53		1		(3)		—		(20)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	9		—		(1)		—		1		9
PPP	2		—		—		—		(2)		—
Total ACL	$	448	$	22	$	(129)	$	16	$	41	$	398

The following table summarizes the aging of our loans broken out by class of financing receivable as of September 30, 2022 and December 31, 2021:

(Dollars in millions)	30 - 59   Days Past   Due		60 - 89   Days Past   Due		Equal to or Greater Than 90   Days Past   Due		Total Past   Due		Current		Total		Loans Past Due 90 Days or More Still Accruing Interest
September 30, 2022:
Global fund banking	$	—	$	—	$	—	$	—	$	40,337	$	40,337	$	—
Investor dependent:
Early stage	2		2		1		5		1,906		1,911		—
Growth stage	26		13		2		41		4,357		4,398		—
Total investor dependent	28		15		3		46		6,263		6,309		—
Cash flow dependent - SLBO	4		—		—		4		1,841		1,845		—
Innovation C&I	6		3		—		9		8,312		8,321		—
Private bank	1		12		5		18		10,084		10,102		1
CRE	1		7		5		13		2,596		2,609		—
Premium wine	3		—		—		3		1,114		1,117		—
Other C&I	—		3		—		3		1,084		1,087		—
Other	—		—		—		—		374		374		—
PPP	—		—		6		6		22		28		5
Total loans	$	43	$	40	$	19	$	102	$	72,027	$	72,129	$	6
December 31, 2021:
Global fund banking	$	—	$	—	$	—	$	—	$	37,958	$	37,958	$	—
Investor dependent:
Early stage	6		5		—		11		1,582		1,593		—
Growth stage	16		—		—		16		3,935		3,951		—
Total investor dependent	22		5		—		27		5,517		5,544		—
Cash flow dependent - SLBO	—		—		—		—		1,798		1,798		—
Innovation C&I	7		—		7		14		6,659		6,673		7
Private bank	28		1		12		41		8,702		8,743		—
CRE	1		—		—		1		2,669		2,670		—
Premium wine	3		—		—		3		982		985		—
Other C&I	1		2		1		4		1,253		1,257		—
Other	—		—		—		—		317		317		—
PPP	1		—		—		1		330		331		—
Total loans	$	63	$	8	$	20	$	91	$	66,185	$	66,276	$	7

Nonaccrual Loans

The following table summarizes our nonaccrual loans with no allowance for credit loss at September 30, 2022 and December 31, 2021:

	September 30, 2022				December 31, 2021
(Dollars in millions)	Nonaccrual Loans		Nonaccrual Loans with no Allowance for Credit Loss		Nonaccrual Loans		Nonaccrual Loans with no Allowance for Credit Loss
Investor dependent:
Early stage	$	4	$	—	$	11	$	—
Growth stage	43		1		6		—
Total investor dependent	47		1		17		—
Cash flow dependent - SLBO	7		—		34		—
Innovation C&I	1		—		1		1
Private bank	13		6		21		8
CRE	5		—		5		—
Other C&I	3		—		4		—
PPP	—		—		2		—
Total nonaccrual loans	$	76	$	7	$	84	$	9

TDRs

As of September 30, 2022, we had 39 TDRs with a total carrying value of $85 million where concessions have been granted to borrowers experiencing financial difficulties, in an attempt to maximize collection. We had no unfunded commitments available for funding to the clients associated with these TDRs as of September 30, 2022.

The following table summarizes our loans modified in TDRs, broken out by class of financing receivable at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Loans modified in TDRs:
Investor dependent:
Early stage	$	1	$	12
Growth stage	32		3
Total investor dependent	33		15
Cash flow dependent - SLBO	8		34
Innovation C&I	1		—
Private bank	8		12
CRE	33		33
Other C&I	2		2
Total loans modified in TDRs	$	85	$	96

The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivable, for modifications made during the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Loans modified in TDRs during the period:
Investor dependent:
Early stage	$	1	$	—	$	1	$	1
Growth stage	12		8		32		8
Total investor dependent	13		8		33		9
Cash flow dependent - SLBO	—		—		—		12
Innovation C&I	1		—		1		—
Private bank	—		2		1		2
CRE	5		43		5		43
Total loans modified in TDRs during the period (1)	$	19	$	53	$	40	$	66

(1)There were $4 million of partial charge-offs for the three months ended September 30, 2022 and $9 million of partial charge-offs for the nine months then ended. There were no partial charge-offs for the three months ended September 30, 2021 and $7 million of partial charge-offs for the nine months then ended.

During the three months ended September 30, 2022, new TDRs of $19 million were modified through payment deferrals granted to our clients. During the three months ended September 30, 2021, new TDRs of $17 million were modified through payment deferrals granted to our clients, $14 million were modified through term extensions and $22 million were modified through a combination thereof.

During the nine months ended September 30, 2022, new TDRs of $38 million were modified through payment deferrals granted to our clients, $1 million were modified through rate reductions and $1 million were modified through settlement. During the nine months ended September 30, 2021, new TDRs of $30 million were modified through payment deferrals granted to our clients, $14 million were modified through term extensions and $22 million were modified through a combination thereof.

Of loans modified in TDRs within the previous 12 months, $1 million in Investor Dependent - Early Stage defaulted on the modified terms during the three and nine months ended September 30, 2022. There were no defaults of loans modified in TDRs during the three and nine months ended September 30, 2021.

Charge-offs and defaults on previously restructured loans are evaluated to determine the impact to the ACL for loans, if any. The evaluation of these defaults may impact the assumptions used in calculating the reserve on other TDRs and nonaccrual loans as well as management’s overall outlook of macroeconomic factors that affect the reserve on the loan portfolio as a whole. After evaluating the charge-offs and defaults experienced on our TDRs, we determined that no change to our reserving methodology for TDRs was necessary to determine the ACL for loans as of September 30, 2022.

ACL: Unfunded Credit Commitments

We maintain a separate ACL for unfunded credit commitments that is determined using a methodology that is inherently similar to the methodology used for calculating the ACL for loans. At September 30, 2022, our ACL estimates utilized the Moody's economic forecasts from September 30, 2022 as mentioned above. In the third quarter of 2022, the ACL for unfunded commitments increased by $41 million from the prior quarter, driven primarily by continued growth in our outstanding commitments, as well as the same deterioration in projected economic conditions described above.

The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
ACL: unfunded credit commitments, beginning balance	$	224	$	120	171		$	121
Provision for (reduction in) credit losses	42		29		96		28
Foreign currency translation adjustments	(1)		—		(2)		—
ACL: unfunded credit commitments, ending balance (1)	$	265	$	149	$	265	$	149

(1)The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.

XML

Goodwill and Other Intangible Assets

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets

Goodwill

Goodwill at both September 30, 2022 and December 31, 2021 was $375 million, which was a result of goodwill recognized for the acquisitions of SVB Securities, WestRiver Group's debt fund business, Boston Private and MoffettNathanson LLC.

Other Intangible Assets

The components of net other intangible assets were as follows:

	September 30, 2022						December 31, 2021
(Dollars in millions)	Gross Amount		Accumulated Amortization		Net Carrying Amount		Gross Amount		Accumulated Amortization		Net Carrying Amount
Other intangible assets:
Customer relationships	$	135	$	27	$	108	$	135	$	16	$	119
Other	57		23		34		57		16		41
Total other intangible assets	$	192	$	50	$	142	$	192	$	32	$	160

For the nine months ended September 30, 2022, we recorded amortization expense of $18 million. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of September 30, 2022:

Years ended December 31, (Dollars in millions)	Other Intangible Assets
2022 (excluding the nine months ended September 30, 2022)	$	6
2023	22
2024	20
2025	17
2026	15
2027 and thereafter	62
Total future amortization expense	$	142

XML

Derivative Financial Instruments

9 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

We primarily use derivative financial instruments to manage interest rate risk and currency exchange rate risk and to assist customers with their risk management objectives, which may include currency exchange rate risks and interest rate risks. Also, in connection with negotiating credit facilities and certain other services, we often obtain equity warrant assets, giving us the right to acquire stock in private, venture-backed companies in the technology and life science/healthcare industries.

Interest Rate Risk

Interest rate risk is our primary market risk and can result from timing and volume differences in the repricing of our interest rate sensitive assets and liabilities and changes in market interest rates. To manage interest rate risk on our interest rate sensitive assets, we have entered into interest rate swap contracts to hedge against future changes in interest rates.

Fair Value Hedges

To manage interest rate risk on our AFS securities portfolio, we enter into pay-fixed, receive-floating interest rate swap contracts to hedge against exposure to changes in the fair value of the securities resulting from changes in interest rates. We designate these interest rate swap contracts as fair value hedges that qualify for hedge accounting under ASC 815, Derivatives and Hedging ("ASC 815") and have elected to account for a portion of the hedges using the last-of-layer method as outlined in ASC 815. We record the interest rate swaps in other assets and other liabilities. For qualifying fair value hedges, both the changes in the fair value of the derivative and the portion of the fair value adjustments associated with the last-of-layer attributable to the hedged risk are recognized into earnings as they occur. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "investment securities" as part of interest income, a component of consolidated net income.

We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. In conjunction with the assessment of effectiveness, we assess the hedged item to ensure it is expected to be outstanding at the hedged item’s assumed maturity date and the last-of-layer method of accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any remaining fair value basis adjustments are allocated to the individual assets in the portfolio and amortized into earnings over a period consistent with the amortization of other discounts and premiums associated with the respective assets. As allowed under GAAP, we apply the "shortcut" method of accounting to a portion of our fair value hedges which assumes there is perfect effectiveness.

The following table summarizes the amortized cost basis of hedged assets that are designated and qualify as fair value hedges and the cumulative amount of fair value hedging adjustments included in the carrying value that have been recorded on our unaudited interim consolidated balance sheets as of September 30, 2022 and December 31, 2021:

			Cumulative Amount of Fair Value Hedging Adjustment Included in the Amortized Cost Basis of the Hedged Assets
(Dollars in millions)	Amortized Cost Basis of the Hedged Assets		Active		Terminated
September 30, 2022
AFS securities	$	8,773	$	—	$	(301)
December 31, 2021
AFS securities (1)	$	15,260	$	(131)	$	6

(1)These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At December 31, 2021, the amortized cost basis of the closed portfolios used in these hedging relationships was $11.2 billion, the amounts of the designated hedged items was $6.7 billion and the cumulative basis adjustments associated with these hedging relationships was $83 million.

Cash Flow Hedges

To manage interest rate risk on our variable-interest rate loan portfolio, we enter into interest rate swap contracts to hedge against future changes in interest rates by using hedging instruments to lock in future cash inflows that would otherwise be impacted by movements in the market interest rates. We designate these interest rate swap contracts as cash flow hedges that qualify for hedge accounting under ASC 815 and record them in other assets and other liabilities. For qualifying cash flow hedges, changes in the fair value of the derivative are recorded in AOCI and recognized in earnings as the hedged item affects earnings. Derivative amounts affecting earnings are recognized consistent with the classification of the hedged item in the line item "loans" as part of interest income, a component of consolidated net income.

We assess hedge effectiveness under ASC 815 on a quarterly basis to ensure all hedges remain highly effective and hedge accounting under ASC 815 can be applied. If the hedging relationship no longer exists or no longer qualifies as a hedge per ASC 815, any amounts remaining as gain or loss in AOCI are reclassified into earnings in the line item "loans" as part of interest income, a component of consolidated net income. As of March 31, 2020, all derivatives previously classified as hedges with notional balances totaling $5.0 billion and a net asset fair value of $228 million were terminated. As of September 30, 2022, the total unrealized gains on terminated cash flow hedges remaining in AOCI was $73 million ($52 million net of tax). The unrealized gains will be reclassified into interest income as the underlying forecasted transactions impact earnings through the original maturity of the hedged forecasted transactions. The total remaining term over which the unrealized gains will be reclassified into earnings is approximately three years.

Currency Exchange Risk

Derivatives not designated as hedging instruments

We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure risk associated with the net difference between foreign currency denominated assets and liabilities. Gains or losses from changes in currency rates on foreign currency denominated instruments are recorded in the line item “other” as part of noninterest income, a component of consolidated net income. We may experience ineffectiveness in the economic hedging relationship, because the instruments are revalued based upon changes in the currency’s spot rate on the principal value, while the forwards are revalued on a discounted cash flow basis. We record forward agreements in gain positions in other assets and loss positions in other liabilities, while net changes in fair value are recorded in the line item “other” as part of noninterest income, a component of consolidated net income.

Derivatives designated as hedging instruments

We enter into net investment hedges to hedge against the foreign currency risk of a net investment in foreign operations. Certain foreign exchange contracts are designated as net investment hedges to minimize our exposure to variability in the foreign currency translation of net investments in non-U.S. subsidiaries. For qualifying net investment hedges under ASC 815, changes in the spot rate of the net investment hedges of foreign operations are recorded in OCI in the line item "foreign currency translation (losses) gains, net of hedges." We assess hedge effectiveness under ASC 815 at least quarterly to ensure all hedges remain effective and hedge accounting can be applied. Net investment hedge pretax gains (losses) of $94 million were recognized in AOCI related to foreign exchange contracts for the three and nine months ending September 30, 2022.

Other Derivative Instruments

We issue loans to clients with conversion features allowing SVBFG to convert the contingent conversion rights to stock in private or public companies. All of our contingent conversion rights qualify as derivatives and are reported at fair value as a component of other assets on our consolidated balance sheet. Any changes in fair value after the grant date are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income.

We enter into total return swaps related to certain of our equity funds, which manages the risk of exposure from the volatility of equity investments in the funds. We do not designate any total return swaps as derivative instruments that qualify for hedge accounting. Gains or losses from changes in fair value are recognized as net gains or losses in the line item "other" in noninterest income, a component of consolidated net income.

Also included in our derivative instruments are equity warrant assets and client forward, option, swap, and interest rate contracts. For further description of these other derivative instruments, refer to Note 2 — “Summary of Significant Accounting Policies" under Part II, Item 8 of our 2021 Form 10-K.

Counterparty Credit Risk

We are exposed to credit risk if counterparties to our derivative contracts do not perform as expected. We mitigate counterparty credit risk through credit approvals, limits, and monitoring procedures and by obtaining collateral, as

appropriate. With respect to measuring counterparty credit risk for derivative instruments, we measure the fair value of a group of financial assets and financial liabilities on a net risk basis by counterparty portfolio.

The total notional or contractual amounts and fair value of our derivative financial instruments at September 30, 2022 and December 31, 2021 were as follows:

	September 30, 2022						December 31, 2021
	Notional or Contractual Amount		Fair Value				Notional or Contractual Amount		Fair Value
(Dollars in millions)			Derivative Assets (1)		Derivative Liabilities (1)				Derivative Assets (1)		Derivative Liabilities (1)
Derivatives designated as hedging instruments:
Interest rate risks:
Interest rate swaps (2)	$	—	$	—	$	—	$	10,700	$	18	$	—
Currency exchange risks:
Foreign exchange contracts	1,546		94		—		—		—		—
Total derivatives designated as hedging instruments			94		—				18		—
Derivatives not designated as hedging instruments:
Currency exchange risks:
Foreign exchange contracts	2,860		46		—		701		16		—
Foreign exchange contracts	308		—		13		62		—		2
Other derivative instruments:
Equity warrant assets	353		351		—		322		277		—
Contingent conversion rights	52		6		—		—		—		—
Client foreign exchange contracts	10,658		500		—		8,245		146		—
Client foreign exchange contracts	10,615		—		499		7,764		—		126
Total return swaps	110		25		—		—		—		—
Client foreign currency options	266		11		—		688		9		—
Client foreign currency options	266		—		11		688		—		9
Client interest rate derivatives (2)	2,248		128		—		2,178		99		—
Client interest rate derivatives	2,447		—		235		2,315		—		101
Total derivatives not designated as hedging instruments			1,067		758				547		238
Total gross derivatives			1,161		758				565		238
Less: netting adjustment (3)			(495)		(234)				(137)		(120)
Total derivatives			$	666	$	524			$	428	$	118

(1)Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities", respectively, on our consolidated balance sheets.

(2)The amount reported reflects reductions of approximately $117 million and $112 million of derivative assets at September 30, 2022 and December 31, 2021, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses.

(3)For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. There was approximately $6 million of cash collateral in excess of net derivative receivables and $1 million of cash collateral in excess of net derivative payables balances not included in the netting adjustment at September 30, 2022, and December 31, 2021, respectively.

A summary of our derivative activity and the related impact on our consolidated statements of income for the three and nine months ended September 30, 2022 and 2021 is as follows:

		Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	Statement of income location	2022		2021		2022		2021
Derivatives designated as hedging instruments:
Interest rate risks:
Amounts reclassified from AOCI into income	Interest income - loans	$	14	$	16	$	43	$	47
Change in fair value of interest rate swaps hedging investment securities	Interest income - investment securities taxable	(2)		5		384		18
Change in fair value of hedged investment securities	Interest income - investment securities taxable	1		(6)		(385)		(19)
Net gains associated with interest rate risk derivatives		$	13	$	15	$	42	$	46
Derivatives not designated as hedging instruments:
Currency exchange risks:
Gains (losses) on revaluations of internal foreign currency instruments, net	Other noninterest income	$	47	$	(14)	26		$	(35)
(Losses) gains on internal foreign exchange forward contracts, net	Other noninterest income	(51)		14		(31)		35
Net losses associated with internal currency risk		$	(4)	$	—	$	(5)	$	—
Other derivative instruments:
Gains on revaluations of client foreign currency instruments, net	Other noninterest income	$	12	$	1	$	7	$	16
(Losses) gains on client foreign exchange forward contracts, net	Other noninterest income	(2)		(5)		5		(15)
Net gains (losses) associated with client currency risk		$	10	$	(4)	$	12	$	1
(Losses) gains on total return swaps	Other noninterest income	$	(2)	$	—	$	25	$	—
Net gains on equity warrant assets	Gains on equity warrant assets, net	$	40	$	147	$	120	$	491
Net gains on other derivatives	Other noninterest income	$	2	$	2	$	8	$	4

Balance Sheet Offsetting

Certain of our derivative and other financial instruments are subject to enforceable master netting arrangements with our counterparties. These agreements provide for the net settlement of multiple contracts with a single counterparty through a single payment, in a single currency, in the event of default on or termination of any one contract.

The following table summarizes our assets subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021:

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Statement of Financial Position (1)				Net Amounts of Assets Presented in the Statement of Financial Position (1)		Gross Amounts Not Offset in the Statement of Financial Position		Net Amount
(Dollars in millions)			Financial Instruments		Cash Collateral Received
September 30, 2022
Derivatives	$	597	$	(229)	$	(266)	$	102	$	—	$	102
Reverse repurchase, securities borrowing, and similar arrangements	397		—		—		397		(397)		—
Total	$	994	$	(229)	$	(266)	$	499	$	(397)	$	102
December 31, 2021
Derivatives	$	165	$	(87)	$	(50)	$	28	$	—	$	28
Reverse repurchase, securities borrowing, and similar arrangements	607		—		—		607		(607)		—
Total	$	772	$	(87)	$	(50)	$	635	$	(607)	$	28

(1)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

The following table summarizes our liabilities subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021:

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Statement of Financial Position (1)				Net Amounts of Liabilities Presented in the Statement of Financial Position (1)		Gross Amounts Not Offset in the Statement of Financial Position		Net Amount
(Dollars in millions)			Financial Instruments		Cash Collateral Pledged
September 30, 2022
Derivatives	$	256	$	(229)	$	(5)	$	22	$	—	$	22
Repurchase, securities lending, and similar arrangements	36		—		—		36		—		36
Total	$	292	$	(229)	$	(5)	$	58	$	—	$	58
December 31, 2021
Derivatives	$	148	$	(87)	$	(33)	$	28	$	—	$	28
Repurchase, securities lending, and similar arrangements	61		—		—		61		—		61
Total	$	209	$	(87)	$	(33)	$	89	$	—	$	89

(1)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

XML

Noninterest Income

9 Months Ended

Sep. 30, 2022

Other Income and Expenses [Abstract]

Noninterest Income

Noninterest IncomeAll of the Company's revenue from contracts with customers within the scope of ASC 606, Revenue from Contracts with Customers, is recognized within noninterest income. Included below is a summary of noninterest income for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Noninterest income:
Gains (losses) on investment securities, net	$	(127)	$	189	$	(199)	$	661
Gains on equity warrant assets, net	40		147		120		491
Client investment fees	119		20		237		55
Wealth management and trust fees	19		22		63		22
Foreign exchange fees	74		65		216		189
Credit card fees	37		34		114		93
Deposit service charges	32		29		94		82
Lending related fees	20		21		65		55
Letters of credit and standby letters of credit fees	15		13		43		39
Investment banking revenue	75		90		293		335
Commissions	24		17		73		58
Other	31		25		119		97
Total noninterest income	$	359	$	672	$	1,238	$	2,177

Gains on investment securities, net

Net gains (losses) on investment securities include both gains and losses from our non-marketable and other equity securities, which include public equity securities held as a result of exercised equity warrant assets, gains and losses from sales of our AFS debt securities portfolio, when applicable, and carried interest.

Our non-marketable and other equity securities portfolio primarily represents investments in venture capital and private equity funds, SPD-SVB, debt and credit funds, private and public portfolio companies, which include public equity securities held as a result of exercised equity warrant assets, and qualified affordable housing projects. We experience variability in the performance of our non-marketable and other equity securities from period to period, which results in net gains or losses on investment securities (both realized and unrealized). This variability is due to a number of factors, including unrealized changes in the values of our investments, changes in the amount of realized gains from distributions, changes in liquidity events and general economic and market conditions. Unrealized gains and losses from non-marketable and other equity securities for any single period are typically driven by valuation changes.

The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of certain sales restrictions to which these equity securities may be subject to (e.g., lock-up agreements), changes in prevailing market prices, market conditions, the actual sales or distributions of securities, and the timing of such actual sales or distributions, which, to the extent such securities are managed by our managed funds, are subject to our funds' separate discretionary sales/distributions and governance processes.

Carried interest is comprised of preferential allocations of profits recognizable when the return on assets of our individual managed fund of funds and direct venture funds exceeds certain performance targets and is payable to us, as the general partners of the managed funds. The carried interest we earn is often shared with employees, who are also members of the general partner entities. We record carried interest on a quarterly basis by measuring fund performance to date versus the performance target. For our unconsolidated managed funds, carried interest is recorded as gains on investment securities, net. For our consolidated managed funds, it is recorded as a component of net income attributable to noncontrolling interests. Carried interest allocated to others is recorded as a component of net income attributable to noncontrolling interests. Any carried interest paid to us (or our employees) may be subject to reversal to the extent fund performance declines to a level where inception to date carried interest is lower than actual payments made by the funds. The limited partnership agreements for our funds provide that carried interest is generally not paid to the general partners until the funds have provided a full return of contributed capital to the limited partners. Accrued, but unpaid carried interest may be subject to reversal to the extent that the fund performance declines to a level where inception-to-date carried interest is less than prior amounts recognized. Carried interest income is accounted for under an ownership model based on ASC 323, Equity Method of Accounting and ASC 810, Consolidation.

Our AFS securities portfolio is a fixed income investment portfolio that is managed with the objective of earning an appropriate portfolio yield over the long-term while maintaining sufficient liquidity and credit diversification as well as addressing our asset/liability management objectives. Though infrequent, sales of debt securities in our AFS securities portfolio may result in net gains or losses and are conducted pursuant to the guidelines of our investment policy related to the management of our liquidity position and interest rate risk.

Gains and losses on investment securities are recognized outside of the scope of ASC 606, as it explicitly excludes noninterest income earned from our investment-related activities. A summary of gains and losses on investment securities for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Gains (losses) on non-marketable and other equity securities, net	$	(127)	$	189	$	(247)	$	661
Gains (losses) on sales of AFS securities, net	—		—		48		—
Total gains (losses) on investment securities, net	$	(127)	$	189	$	(199)	$	661

Gains on equity warrant assets, net

In connection with negotiating credit facilities and certain other services, we often obtain rights to acquire stock in the form of equity warrant assets in primarily private, venture-backed companies in the technology and life science/healthcare industries. Any changes in fair value from the grant date fair value of equity warrant assets will be recognized as increases or decreases to other assets on our balance sheet and as net gains or losses on equity warrant assets, in noninterest income, a component of consolidated net income.

Gains on equity warrant assets are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of net gains on equity warrant assets for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Equity warrant assets:
Gains on exercises, net	$	9	$	91	$	44	$	381
Terminations	(1)		(1)		(3)		(2)
Changes in fair value, net	32		57		79		112
Total net gains on equity warrant assets	$	40	$	147	$	120	$	491

Client investment fees

Client investment fees include fees earned from discretionary investment management services for managing clients’ portfolios based on their investment policies, strategies and objectives. Revenue is recognized on a monthly basis upon completion of our performance obligation, and consideration is typically received in the subsequent month. Included in our sweep money market fees are Rule 12(b)-1 fees, revenue sharing and customer transactional-based fees. Rule 12(b)-1 fees and revenue sharing are recognized as earned based on client funds that are invested in the period, typically monthly. Transactional based fees are earned and recognized on fixed income securities when the transaction is executed on the clients' behalf. Amounts paid to third-party service providers are predominantly expensed, such that client investment fees are recorded gross of payments made to third parties. A summary of client investment fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Client investment fees by type:
Sweep money market fees	$	64	$	12	$	144	$	31
Asset management fees (1)	16		7		41		22
Repurchase agreement fees	39		1		52		2
Total client investment fees (2)	$	119	$	20	$	237	$	55

(1)Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.

(2)Represents fees earned on client investment funds that are maintained at third-party financial institutions and are not recorded on our balance sheet.

Wealth management and trust fees

Wealth management fees are earned for providing wealth management, retirement plan advisory, family office, financial planning, trust services and other financial advisory services to clients. The Company’s performance obligation under these contracts is satisfied over time as the services are provided. Fees are recognized monthly based on the average monthly, beginning-of-quarter, or, for a small number of clients, end-of-quarter market value of the Private Bank AUM and the applicable fee rate, depending on the terms of the contracts. Fees are also recognized monthly based either on a fixed fee amount or are based on the quarter-end (in arrears) market value of the Private Bank AUM and the applicable fee rate,

depending on the terms of the contracts. No performance-based incentives are earned under wealth management contracts. Receivables are recorded on the Consolidated Balance Sheets in the "Accrued interest receivable and other assets" line item.

Trust fees are earned when the Company is appointed as trustee for clients. As trustee, the Company administers the client’s trust and manages the assets of the trust, including investments and property. The Company’s performance obligation under these agreements is satisfied over time as the administration and management services are provided. Fees are recognized monthly or, in certain circumstances, quarterly based on a percentage of the market value of the account as outlined in the agreement. Payment frequency is defined in the individual contracts, which primarily stipulate monthly in arrears. No performance-based incentives are earned on trust fee contracts. Receivables are recorded on the Consolidated Balance Sheets in the "Accrued interest receivable and other assets" line item. A summary of wealth management and trust fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Wealth management and trust fees by type:
Wealth management fees	$	17	$	20	$	58	$	20
Trust fees	2		2		5		2
Total wealth management and trust fees	$	19	$	22	$	63	$	22

Foreign exchange fees

Foreign exchange fees represent the income differential between purchases and sales of foreign currency on behalf of our clients, primarily from spot contracts. Foreign exchange spot contract fees recognized upon the completion of a single performance obligation are recognized within the scope of ASC 606.

Foreign exchange contracts and option premium fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities. A summary of foreign exchange fee income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Foreign exchange fees by instrument type:
Foreign exchange contract commissions	$	74	$	65	$	215	$	188
Option premium fees	—		—		1		1
Total foreign exchange fees	$	74	$	65	$	216	$	189

Credit card fees

Credit card fees include interchange income from credit and debit cards and fees earned from processing transactions for merchants. Interchange income is earned after satisfying our performance obligation of providing nightly settlement services to a payment network. Costs related to rewards programs are recorded when the rewards are earned by the customer and presented as a reduction to interchange fee income. Rewards programs continue to be accounted for under ASC 310, Receivables. Our performance obligations for merchant service fees are to transmit data and funds between the merchant and the payment network. Credit card interchange and merchant service fees are earned daily upon completion of transaction settlement services.

Annual card service fees are recognized on a straight-line basis over a 12-month period and continue to be accounted for under ASC 310, Receivables.

A summary of credit card fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Credit card fees by instrument type:
Card interchange fees, net	$	29	$	29	$	91	$	78
Merchant service fees	6		4		18		12
Card service fees	2		1		5		3
Total credit card fees	$	37	$	34	$	114	$	93

Deposit service charges

Deposit service charges include fees earned from performing cash management activities and other deposit account services. Deposit services include, but are not limited to, the following: receivables services, which include merchant services, remote capture, lockbox, electronic deposit capture, and fraud control services. Payment and cash management products and services include wire transfer and automated clearing house payment services to enable clients to transfer funds more quickly, as well as business bill pay, business credit and debit cards, account analysis, and disbursement services. Deposit service charges are recognized over the period in which the related performance obligation is provided, generally on a monthly basis, and are presented in the "Disaggregation of revenue from contracts with customers" tables below.

Lending related fees

Unused commitment fees, minimum finance fees and unused line fees are recognized as earned on a monthly basis. Fees that qualify for syndication treatment are recognized at the completion of the syndicated loan deal for which the fees were received. Lending related fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our lending-related activities. A summary of lending related fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Lending related fees by instrument type:
Unused commitment fees	$	14	$	14	$	49	$	42
Other	6		7		16		13
Total lending related fees	$	20	$	21	$	65	$	55

Letters of credit and standby letters of credit fees

Standby letters of credit represent conditional commitments issued by us on behalf of a client to guarantee the performance of the client to a third party when certain specified future events have occurred. Fees generated from letters of credit and standby letters of credit are deferred as a component of other liabilities and recognized in noninterest income over the commitment period using the straight-line method, based on the likelihood that the commitment being drawn down will be remote. Letters of credit and standby letters of credit fees are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our lending related activities.

Investment banking revenue

We earn investment banking revenue from clients for providing services related to securities underwriting, private placements and advisory services on strategic matters such as mergers and acquisitions. Underwriting fees are attributable to public and private offerings of equity and debt securities and are recognized at the point in time when the offering has been deemed to be completed by the lead manager of the underwriting group. Once the offering is completed, the performance obligation has been satisfied; we recognize the applicable management fee as well as the underwriting fee, net of consideration payable to customers. Private placement fees are recognized at the point in time when the private placement is completed, which is generally when the client accepts capital from the fund raise. Advisory fees from mergers and acquisitions engagements are generally recognized at the point in time when the related transaction is completed. Expenses are deferred only to the extent they are explicitly reimbursable by the client and the related revenue is recognized at a point in time. All other deal-related expenses are expensed as incurred. We have determined that we act as principal in the majority of these transactions and therefore present expenses gross within other operating expenses.

A summary of investment banking revenue by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Investment banking revenue:
Underwriting fees	$	24	$	39	$	97	$	248
Advisory fees	40		26		163		39
Private placements and other	11		25		33		48
Total investment banking revenue	$	75	$	90	$	293	$	335

Commissions

Commissions include commissions received from customers for the execution of agency-based brokerage transactions in listed and over-the-counter equities. The execution of each trade order represents a distinct performance obligation, and the transaction price is fixed at the point in time or trade order execution. Trade execution is satisfied at the point in time that the customer has control of the asset and as such, fees are recorded on a trade date basis. The Company also earns subscription fees for market intelligence services that are recognized over the period in which they are delivered. Fees received before the subscription period ends are initially recorded as deferred revenue (a contract liability) in other liabilities in our consolidated balance sheet. Commissions are presented in the "Disaggregation of revenue from contracts with customers" table below.

Other

Other noninterest income primarily includes income from fund management fees, gains from conversion of convertible debt options and service revenue. Fund management fees are comprised of fees charged directly to our managed funds of funds and direct venture funds. Fund management fees are based upon the contractual terms of the limited partnership agreements and are generally recognized as earned over the specified contract period, which is generally equal to the life of the individual fund. Fund management fees are calculated as a percentage of committed capital and collected quarterly in advance and recognized over the quarter. Fund management fees for certain of our limited partnership agreements are calculated as a percentage of distributions made by the funds, and revenue is recorded only at the time of a distribution event. As distribution events are not predetermined for these certain funds, management fees are considered variable and constrained under ASC 606.

Gains from conversion of convertible debt options represent unrealized valuation gains on loan conversion derivative assets, and realized gains from the conversion of debt instruments, convertible into a third party’s common stock upon a triggering event such as an IPO. Gains from conversion of convertible debt options are recognized outside of the scope of ASC 606 as it explicitly excludes noninterest income earned from our derivative-related activities.

Other service revenue primarily consists of gains or losses from changes in fair value of total return swaps, dividend income on FHLB/FRB stock, correspondent bank rebate income, incentive fees, or performance fees related to carried interest and other fee income. We recognize revenue when our performance obligations are met and record revenues on a daily/monthly, quarterly, semi-annual or annual basis. For event driven revenue sources, we recognize revenue when: (i) persuasive evidence of an arrangement exists, (ii) we have performed the service, provided we have no other remaining obligations to the customer, (iii) the fee is fixed or determinable and (iv) collectability is probable.

A summary of other noninterest income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Other noninterest income by instrument type:
Fund management fees	$	16	$	15	$	43	$	51
Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)	6		(4)		7		1
Gains on total return swaps	(3)		—		25		—
Other service revenue	12		14		44		45
Total other noninterest income	$	31	$	25	$	119	$	97

(1)Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.

Disaggregation of revenue from contracts with customers

The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the three and nine months ended September 30, 2022 and 2021:

Three months ended September 30, 2022	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	119	$	—	$	—	$	—	$	—	$	119
Wealth management and trust fees	—		19		—		—		—		19
Card interchange fees, gross	54		1		—		—		—		55
Merchant service fees	7		—		—		—		—		7
Deposit service charges	32		—		—		—		—		32
Investment banking revenue	—		—		—		75		—		75
Commissions	—		—		—		24		—		24
Fund management fees	1		—		13		2		—		16
Other (1)	1		—		2		—		—		3
Total revenue from contracts with customers	$	214	$	20	$	15	$	101	$	—	$	350
Revenues outside the scope of ASC 606 (2)	94		2		(69)		(1)		(17)		9
Total noninterest income	$	308	$	22	$	(54)	$	100	$	(17)	$	359

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Three months ended September 30, 2021	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	20	$	—	$	—	$	—	$	—	$	20
Wealth management and trust fees	—		22								22
Card interchange fees, gross	52		—		—		—		—		52
Merchant service fees	4		—		—		—		—		4
Deposit service charges	28		—		—		—		1		29
Investment banking revenue	—		—		—		90		—		90
Commissions	—		—		—		17		—		17
Fund management fees	—		—		14		1		—		15
Other (1)	61		1		4		—		—		66
Total revenue from contracts with customers	165		23		18		108		1		315
Revenues outside the scope of ASC 606 (2)	17		2		127		23		188		357
Total noninterest income	$	182	$	25	$	145	$	131	$	189	$	672

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Nine months ended September 30, 2022	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	236	$	—	$	—	$	—	$	1	$	237
Wealth management and trust fees	—		63		—		—		—		63
Card interchange fees, gross	170		1		—		—		2		173
Merchant service fees	18		—		—		—		—		18
Deposit service charges	92		1		—		—		1		94
Investment banking revenue	—		—		—		293		—		293
Commissions	—		—		—		73		—		73
Fund management fees	1		—		37		5		—		43
Other (1)	69		1		6		—		—		76
Total revenue from contracts with customers	$	586	$	66	$	43	$	371	$	4	$	1,070
Revenues outside the scope of ASC 606 (2)	195		6		(121)		(19)		107		168
Total noninterest income	$	781	$	72	$	(78)	$	352	$	111	$	1,238

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Nine months ended September 30, 2021	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	53	$	2	$	—	$	—	$	—	$	55
Wealth management and trust fees	—		22		—		—		—		22
Card interchange fees, gross	140		1		—		—		1		142
Merchant service fees	12		—		—		—		—		12
Deposit service charges	80		—		—		—		2		82
Investment banking revenue	—		—		—		335		—		335
Commissions	—		—		—		58		—		58
Fund management fees	—		—		47		4		—		51
Other (1)	178		1		12		—		—		191
Total revenue from contracts with customers	$	463	$	26	$	59	$	397	$	3	$	948
Revenues outside the scope of ASC 606 (2)	51		2		330		53		793		1,229
Total noninterest income	$	514	$	28	$	389	$	450	$	796	$	2,177

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

The timing of revenue recognition may differ from the timing of cash settlements or invoicing to customers. We record a receivable when revenue is recognized prior to invoicing, and unearned revenue when revenue is recognized subsequent to receipt of consideration. These assets and liabilities are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period. During the three and nine months ended September 30, 2022 and 2021, changes in our contract assets, contract liabilities and receivables were not material. Additionally, revenues recognized during the three and nine months ended September 30, 2022 and 2021 that were included in the corresponding contract liability balance at the beginning of the periods were not material.

XML

Segment Reporting

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Segment Reporting

Segment ReportingWe have four reportable segments for management reporting purposes: Silicon Valley Bank, SVB Private, SVB Capital and SVB Securities. The results of our reportable and operating segments are based on our internal management reporting process.

We report segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of our reporting segments. During the quarter ended March 31, 2022, we reevaluated our segments. Based on this reevaluation, the Premium Wine reporting division was moved from Silicon Valley Bank to the SVB Private segment. These changes were made to reflect the manner in which the Company is organized for purposes of making operating decisions and assessing performance. For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been recast to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reclassification of historical segment information has no effect on the Company's previously reported consolidated balance sheets, statements of income, or cash flows, and the change did not have any impact on the determination of the reporting units used to assess impairment under ASC 350, Intangibles - Goodwill and Other.

Our Silicon Valley Bank and SVB Private segments primary source of revenue is from net interest income, which is primarily the difference between interest earned on loans, net of FTP, and interest paid on deposits, net of FTP. Accordingly, these segments are reported using net interest income, net of FTP. FTP is an internal measurement framework designed to assess the financial impact of a financial institution’s sources and uses of funds. It is the mechanism by which a funding credit is given for deposits raised, and a funding charge is made for funded loans. FTP is calculated at an instrument level based on account characteristics.

We also evaluate performance based on provision for credit losses, noninterest income and noninterest expense, which are presented as components of segment operating profit or loss. In calculating each operating segment’s noninterest expense, we consider the direct costs incurred by the operating segment as well as certain allocated direct costs. As part of this review, we allocate certain corporate overhead costs to a corporate account. We do not allocate income tax expense, the provisions for unfunded credit commitments, or HTM securities (included in provision for credit losses) to our segments. Additionally, our management reporting model is predicated on average asset balances; therefore, period-end asset balances are not presented for segment reporting purposes. Changes in an individual client’s primary relationship designation have resulted, and in the future may result, in the inclusion of certain clients in different segments in different periods.

Unlike financial reporting, which benefits from the comprehensive structure provided by GAAP, our internal management reporting process is highly subjective, as there is no comprehensive, authoritative guidance for management reporting. Our management reporting process measures the performance of our operating segments based on our internal operating structure, which is subject to change from time to time, and is not necessarily comparable with similar information for other financial services companies.

For reporting purposes, SVB Financial Group has four operating segments for which we report our financial information:

•Silicon Valley Bank is our commercial bank which offers products and services provided by the Bank and its subsidiaries to commercial clients in key innovation markets. The Bank provides solutions to the financial needs of commercial clients through credit, treasury management, foreign exchange, trade finance, and other services. In addition, the Bank and its subsidiaries offer a variety of investment services and solutions to its clients that enable them to effectively manage their assets. Our commercial bank consists of services provided to clients in the Tech and Healthcare industries, as well as private equity and venture capital firms, and includes clients from international operations in EMEA, Asia and Canada.

•SVB Private is our private bank and wealth management segment of the Bank. SVB Private provides a range of personal financial solutions for consumers. Our clients are primarily private equity/venture capital professionals and executive leaders of the innovation companies they support as well as high net worth clients acquired from Boston Private and our premium wine clients. We offer a customized suite of private banking services, including mortgages, home equity lines of credit, restricted and private stock loans, capital call lines of credit, other secured and unsecured lending products and vineyard development loans, as well as planning-based financial strategies, wealth management, family office, financial planning, tax planning and trust services. In addition, we provide real estate secured loans to eligible employees through our EHOP.

•SVB Capital is the funds management business of SVB Financial Group, which focuses primarily on venture capital investments. SVB Capital manages funds (primarily venture capital funds) on behalf of third-party limited partners and, on a more limited basis, SVB Financial Group. The SVB Capital family of funds is comprised of direct venture funds that invest in companies and funds of funds that invest in other venture capital funds, as well as debt funds that provide lending and other financing solutions. SVB Capital generates income for the Company primarily from investment returns (including carried interest allocations) and management fees.

•SVB Securities is an investment bank focused on the innovation economy and operates as a wholly-owned subsidiary of SVB Financial Group. SVB Securities provides investment banking services across all major sub-sectors of Healthcare and Technology. Healthcare sub-sectors include Biopharma, Digital Health and HealthTech,

Healthcare Services, Medical Devices and Tools and Diagnostics. Technology sub-sectors include Consumer Internet, Commerce Enablement and Marketing Software, Digital Infrastructure and Tech-Enabled Services, Education Technology, Enterprise Software, Industrial Technology and FinTech. SVB Securities focuses on four main product and service offerings: Capital Raising, M&A Advisory, Equity Research and Sales and Trading.

The following table presents a summary of financial results of our reportable segments along with a reconciliation to our consolidated interim results. Our reportable segment information for the three and nine months ended September 30, 2022 and 2021 is as follows:

(Dollars in millions)	Silicon Valley Bank (1)		SVB Private		SVB Capital (1)		SVB Securities (1)		Other Items (2)		Total
Three months ended September 30, 2022
Net interest income	$	1,107	$	111	$	—	$	1	$	(21)	$	1,198
(Provision for) reduction of credit losses	(32)		3		—		—		(43)		(72)
Noninterest income (loss)	308		22		(54)		100		(17)		359
Noninterest expense (3)	(381)		(85)		(17)		(131)		(278)		(892)
Income (loss) before income tax expense (4)	$	1,002	$	51	$	(71)	$	(30)	$	(359)	$	593
Total average loans, amortized cost	$	55,177	$	15,181	$	—	$	—	$	740	$	71,098
Total average assets (5) (6)	175,620		17,032		883		898		21,307		215,740
Total average deposits	172,427		12,436		—		—		693		185,556
Three months ended September 30, 2021
Net interest income (7)	$	766	$	74	$	—	$	—	$	12	$	852
Provision for credit losses	29		(20)		—		—		(30)		(21)
Noninterest income	182		25		145		131		189		672
Noninterest expense (3) (7)	(336)		(93)		(15)		(142)		(293)		(879)
Income before income tax expense (4) (7)	$	641	$	(14)	$	130	$	(11)	$	(122)	$	624
Total average loans, amortized cost (7)	$	44,789	$	13,515	$	—	$	—	$	987	$	59,291
Total average assets (5) (6) (7)	151,352		15,930		730		837		13,841		182,690
Total average deposits (7)	148,879		13,431		—		—		1,082		163,392
Nine months ended September 30, 2022
Net interest income	$	2,993	$	296	$	—	$	1	$	157	$	3,447
Provision for credit losses	(174)		(9)		—		—		(96)		(279)
Noninterest income (loss)	781		72		(78)		352		111		1,238
Noninterest expense (3)	(1,148)		(267)		(53)		(406)		(739)		(2,613)
Income before income tax expense (4)	$	2,452	$	92	$	(131)	$	(53)	$	(567)	$	1,793
Total average loans, amortized cost	$	53,855	$	14,711	$	—	$	—	$	592	$	69,158
Total average assets (5) (6)	178,209		16,456		956		912		20,119		216,652
Total average deposits	175,370		13,327		—		—		731		189,428
Nine months ended September 30, 2021
Net interest income (7)	$	2,084	$	146	$	—	$	—	$	10	$	2,240
(Provision for) reduction of credit losses	(27)		(16)		—		—		(32)		(75)
Noninterest income	514		28		389		450		796		2,177
Noninterest expense (3) (7)	(911)		(126)		(48)		(376)		(707)		(2,168)
Income before income tax expense (4) (7)	$	1,660	$	32	$	341	$	74	$	67	2,174
Total average loans, amortized cost (7)	$	41,591	$	8,610	$	—	$	—	$	1,642	$	51,843
Total average assets (5) (6) (7)	130,177		9,459		641		778		11,897		152,952
Total average deposits (7)	128,006		7,108		—		—		999		136,113

(1)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within “Other Items."

(2)The “Other Items” column reflects the adjustments necessary to reconcile the results of the reportable segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains or losses on equity warrant assets, gains or losses on the sale of AFS securities and gains or losses on equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses.

(3)The Silicon Valley Bank segment includes direct depreciation and amortization of $13 million and $10 million for the three months ended September 30, 2022 and 2021, respectively and $34 million and $25 million for the nine months ended September 30, 2022 and 2021, respectively.

(4)The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.

(5)Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders' equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP.

(6)Included in the total average assets for SVB Securities and SVB Private is goodwill of $174 million and $201 million, respectively, for the three and nine months ended September 30, 2022, and included in the total average assets for SVB Securities and SVB Private is goodwill of $138 million and $201 million for the three and nine months ended September 30, 2021, respectively.

(7)For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been allocated to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reallocation had no impact on the "Total" amount.

XML

Off-Balance Sheet Arrangements, Guarantees and Other Commitments

9 Months Ended

Sep. 30, 2022

Disclosure Off Balance Sheet Arrangements Guarantees And Other Commitments Additional Information [Abstract]

Off-Balance Sheet Arrangements, Guarantees and Other Commitments

Off-Balance Sheet Arrangements, Guarantees and Other Commitments

In the normal course of business, we use financial instruments with off-balance sheet risk to meet the financing needs of our customers. These financial instruments include commitments to extend credit, commercial and standby letters of credit and commitments to invest in venture capital and private equity fund investments. These instruments involve, to varying degrees, elements of credit risk. Credit risk is defined as the possibility of sustaining a loss because other parties to the financial instrument fail to perform in accordance with the terms of the contract.

Commitments to Extend Credit

The following table summarizes information related to our commitments to extend credit at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Loan commitments (1)	$	51,769	$	40,327
Standby letters of credit (2)	3,824		3,612
Commercial letters of credit (3)	105		77
Total unfunded credit commitments	$	55,698	$	44,016
Allowance for unfunded credit commitments (4)	265		171

(1)Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.

(2)See below for additional information on our standby letters of credit.

(3)Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature.

(4)Our allowance for credit losses for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.

The table below summarizes our standby letters of credit at September 30, 2022. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged.

(Dollars in millions)	Expires in One Year or Less		Expires After One Year		Total Amount Outstanding		Maximum Amount of Future Payments
Financial standby letters of credit	$	3,617	$	126	$	3,743	$	3,743
Performance standby letters of credit	72		9		81		81
Total	$	3,689	$	135	$	3,824	$	3,824

Deferred fees related to financial and performance standby letters of credit were $20 million at both September 30, 2022 and December 31, 2021.

Commitments to Invest in Venture Capital and Private Equity Funds

We make commitments to invest in venture capital and private equity funds, which generally make investments in privately-held companies. Commitments to invest in these funds are generally made for a 10-year period from the inception of the fund. Although the limited partnership agreements governing these investments typically do not restrict the general partners from calling 100% of committed capital in one year, it is customary for these funds to call most of the capital commitments over 5 to 7 years, and in certain cases, the funds may not call 100% of committed capital. The actual timing of future cash requirements to fund these commitments is generally dependent upon the investment cycle, overall market conditions, and the nature and type of industry in which the privately held companies operate. The following table details our total capital commitments, unfunded capital commitments, and our ownership percentage in each fund at September 30, 2022:

(Dollars in millions)	SVBFG Capital Commitments		SVBFG Unfunded Commitments		SVBFG Ownership of each Fund
Redwood Evergreen Fund, LP	$	250	$	119	100.0	%
CP II, LP (1)	1		—		5.1
Capital Preferred Return Fund, LP	13		—		20.0
Growth Partners, LP	25		1		33.0
Strategic Investors Fund, LP	15		1		12.6
Strategic Investors Fund II, LP	15		1		8.6
Strategic Investors Fund III, LP	15		1		5.9
Strategic Investors Fund IV, LP	12		2		5.0
Strategic Investors Fund V funds	1		—		Various
Other venture capital and private equity fund investments (equity method accounting)	18		5		Various
Debt funds (equity method accounting)	59		—		Various
Other fund investments (2)	248		12		Various
Total	$	672	$	142

(1)Our ownership includes direct ownership of 1.3 percent and indirect ownership interest of 3.8 percent through our investment in Strategic Investors Fund II, LP.

(2)Represents commitments to 147 funds (primarily venture capital funds) where our ownership interest is generally less than 5.0 percent of the voting interests of each such fund.

At September 30, 2022 we had $3 million of remaining unfunded commitments to venture capital and private equity funds by our consolidated managed funds of funds (including our interest and the noncontrolling interests).

XML

Income Taxes

9 Months Ended

Sep. 30, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

We are subject to income tax and non-income based taxes by the U.S. federal tax authorities as well as various state and foreign tax authorities. We have identified the U.S. federal and California state jurisdictions as major tax filings. The state of California is currently examining the years 2013-2016. Our U.S. federal tax returns remain open to full examination for 2019 and subsequent tax years. Our California tax returns remain open to full examination for 2017 and subsequent tax years.

At September 30, 2022, our unrecognized tax benefit was $42 million, the recognition of which would reduce our income tax expense by $34 million. We are unable to estimate the unrecognized tax benefit that will materially change in the next 12 months.

We recognize interest and penalties related to income tax matters as part of income before income taxes. Interest and penalties were not material for the three and nine months ended September 30, 2022.

XML

Fair Value of Financial Instruments

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Fair Value Measurements

Our AFS securities, derivative instruments and certain non-marketable and other equity securities are financial instruments recorded at fair value on a recurring basis. We make estimates regarding valuation of assets and liabilities measured at fair value in preparing our interim consolidated financial statements.

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (the “exit price”) in an orderly transaction between market participants at the measurement date. There is a three-level hierarchy for disclosure of assets and liabilities recorded at fair value. The classification of assets and liabilities within the hierarchy is based on whether the inputs to the valuation methodology used for measurement are observable or unobservable and on the significance of those inputs in the fair value measurement. Observable inputs reflect market-derived or market-based

information obtained from independent sources, while unobservable inputs reflect our estimates about market data and views of market participants. The three levels for measuring fair value are based on the reliability of inputs and are as follows:

Level 1

Fair value measurements based on quoted prices in active markets for identical assets or liabilities that we have the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these instruments does not entail a significant degree of judgment. Assets utilizing Level 1 inputs include U.S. Treasury securities, foreign government debt securities, exchange-traded equity securities, certain marketable securities accounted for under fair value accounting, and assets and liabilities related to the deferred compensation plan assumed during the merger with Boston Private.    

Level 2

Fair value measurements based on quoted prices in markets that are not active or for which all significant inputs are observable, directly or indirectly. Valuations for the AFS securities are provided by independent pricing service providers who have experience in valuing these securities and are compared to the average of quoted market prices obtained from independent brokers. We perform a monthly analysis on the values received from third parties to ensure that the prices represent a reasonable estimate of the fair value. The procedures include, but are not limited to, initial and ongoing review of third-party pricing methodologies, review of pricing trends and monitoring of trading volumes. Additional corroboration, such as obtaining a non-binding price from a broker, may be obtained depending on the frequency of trades of the security and the level of liquidity or depth of the market. Prices received from independent brokers represent a reasonable estimate of the fair value and are validated through the use of observable market inputs including comparable trades, yield curve, spreads and, when available, market indices. If we determine that there is a more appropriate fair value based upon the available market data, the price received from the third party is adjusted accordingly. Below is a summary of the significant inputs used for each class of Level 2 assets and liabilities:

U.S. agency debentures: Fair value measurements of U.S. agency debentures are based on the characteristics specific to bonds held, such as issuer name, issuance date, coupon rate, maturity date and any applicable issuer call option features. Valuations are based on market spreads relative to similar term benchmark market interest rates, generally U.S. Treasury securities.

Agency-issued MBS: Agency-issued MBS are pools of individual conventional mortgage loans underwritten to U.S. agency standards with similar coupon rates, tenor, and other attributes such as geographic location, loan size and origination vintage. Fair value measurements of these securities are based on observable price adjustments relative to benchmark market interest rates taking into consideration estimated loan prepayment speeds.

Agency-issued CMO: Agency-issued CMO are structured into classes or tranches with defined cash flow characteristics and are collateralized by U.S. agency-issued mortgage pass-through securities. Fair value measurements of these securities incorporate similar characteristics of mortgage pass-through securities such as coupon rate, tenor, geographic location, loan size and origination vintage, in addition to incorporating the effect of estimated prepayment speeds on the cash flow structure of the class or tranche. These measurements incorporate observable market spreads over an estimated average life after considering the inputs listed above.

Agency-issued CMBS: Fair value measurements of these securities are based on spreads to benchmark market interest rates (usually U.S. Treasury rates or rates observable in the swaps market), prepayment speeds, loan default rate assumptions and loan loss severity assumptions on underlying loans.

Derivative assets and liabilities: Fair value measurements of these assets and liabilities are priced based on the following:

•Foreign exchange forward and option contract assets and liabilities are priced based on spot and forward foreign currency rates and option volatility assumptions.

•Interest rate derivative and interest rate swap assets and liabilities are priced considering the coupon rate of the fixed leg of the contract and the variable coupon rate on the floating leg of the contract. Valuation is based on both spot and forward rates on the swap yield curve and the credit worthiness of the contract counterparty.

•Total return swaps are based upon the performance of the reference asset, the variable coupon rate and spread of the floating leg of the contract.

Other equity securities: Fair value measurements of equity securities of public companies are priced based on quoted market prices less a discount if the securities are subject to certain sales restrictions. Certain sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sale restrictions which typically range from three to six months.

Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions.

Level 3

The fair value measurement is derived from valuation techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect our own estimates of assumptions we believe market participants would use in pricing the asset. The valuation techniques are consistent with the market approach, income approach and/or the cost approach used to measure fair value. Below is a summary of the valuation techniques used for each class of Level 3 assets:

Venture capital and private equity fund investments not measured at net asset value: Fair value measurements are based on consideration of a range of factors including, but not limited to, the price at which the investment was acquired, the term and nature of the investment, local market conditions, values for comparable securities, and as it relates to the private company, the current and projected operating performance, exit strategies and financing transactions subsequent to the acquisition of the investment. The significant unobservable inputs used in the fair value measurement include the information about each portfolio company, including actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Significant changes to any one of these inputs in isolation could result in a significant change in the fair value measurement; however, we generally consider all factors available through ongoing communication with the portfolio companies and venture capital fund managers to determine whether there are changes to the portfolio company or the environment that indicate a change in the fair value measurement.

Equity warrant assets (public portfolio): Fair value measurements of equity warrant assets of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain warrants that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed.

Equity warrant assets (private portfolio): Fair value measurements of equity warrant assets of private portfolio companies are priced based on a Black-Scholes option pricing model to estimate the asset value by using stated strike prices, option expiration dates, risk-free interest rates and option volatility assumptions. Option volatility assumptions used in the Black-Scholes model are based on public market indices whose members operate in similar industries as companies in our private company portfolio. Option expiration dates are modified to account for estimates to actual life relative to stated expiration. Overall model asset values are further adjusted for a general lack of liquidity due to the private nature of the associated underlying company. There is a direct correlation between changes in the volatility and remaining life assumptions in isolation and the fair value measurement while there is an inverse correlation between changes in the liquidity discount assumption and the fair value measurement.

Contingent conversion rights (public portfolio): Fair value measurements of contingent conversion rights of publicly-traded portfolio companies are valued based on the Black-Scholes option pricing model. The model uses the price of publicly-traded companies (underlying stock price), stated strike prices, warrant expiration dates, the risk-free interest rate and market-observable option volatility assumptions. Modeled asset values are further adjusted by applying a discount of up to 20 percent for certain conversion rights that have certain sales restrictions or other features that indicate a discount to fair value is warranted. As sale restrictions are lifted, discounts are adjusted downward to zero once all restrictions expire or are removed.

Contingent conversion rights (private portfolio): Fair value measurements are based on consideration of a range of factors including, but not limited to, actual and forecasted enterprise values, probability of conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.

The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022:

(Dollars in millions)	Level 1		Level 2		Level 3		Netting Adjustments (1)		Balance at September 30, 2022
Assets:
AFS securities:
U.S. Treasury securities	$	16,845	$	—	$	—	$	—	$	16,845
U.S. agency debentures	—		100		—		—		100
Foreign government debt securities	913		—		—		—		913
Residential MBS:
Agency-issued MBS	—		6,683		—		—		6,683
Agency-issued CMO—fixed rate	—		714		—		—		714
Agency-issued CMBS	—		1,456		—		—		1,456
Total AFS securities	17,758		8,953		—		—		26,711
Non-marketable and other equity securities (fair value accounting):
Non-marketable securities:
Venture capital and private equity fund investments measured at net asset value	—		—		—		—		270
Other equity securities in public companies	27		2		—		—		29
Total non-marketable and other equity securities (fair value accounting)	27		2		—		—		299
Other assets:
Derivative assets	—		804		—		(495)		309
Equity warrant assets	—		6		345		—		351
Contingent conversion rights	—		—		6		—		6
Other assets	4		—		—		—		4
Total assets	$	17,789	$	9,765	$	351	$	(495)	$	27,680
Liabilities:
Derivative liabilities	$	—	$	758	$	—	$	(234)	$	524
Other liabilities	4		—		—		—		4
Total liabilities	$	4	$	758	$	—	$	(234)	$	528

(1)Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties

The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021:

(Dollars in millions)	Level 1		Level 2		Level 3		Netting Adjustments (1) (2)		Balance at December 31, 2021
Assets:
AFS securities:
U.S. Treasury securities	$	15,850	$	—	$	—	$	—	$	15,850
U.S. agency debentures	—		196		—		—		196
Foreign government debt securities	61		—		—		—		61
Residential MBS:
Agency-issued MBS	—		8,589		—		—		8,589
Agency-issued CMO—fixed rate	—		982		—		—		982
Agency-issued CMBS	—		1,543		—		—		1,543
Total AFS securities	15,911		11,310		—		—		27,221
Non-marketable and other equity securities (fair value accounting):
Non-marketable securities:
Venture capital and private equity fund investments measured at net asset value	—		—		—		—		338
Other equity securities in public companies	43		74		—		—		117
Total non-marketable and other equity securities (fair value accounting)	43		74		—		—		455
Other assets:
Derivative assets (2)	—		288		—		(137)		151
Equity warrant assets	—		8		269		—		277
Other assets	8		—		—		—		8
Total assets	$	15,962	$	11,680	$	269	$	(137)	$	28,112
Liabilities:
Derivative liabilities (2)	$	—	$	238	$	—	$	(120)	$	118
Other liabilities	8		—		—		—		8
Total liabilities	$	8	$	238	$	—	$	(120)	$	126

The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three and nine months ended September 30, 2022 and 2021:

(Dollars in millions)	Beginning Balance		Total Net Gains (Losses) Included in Net Income		Sales/Exits		Issuances		Transfers Out of Level 3		Ending Balance
Three months ended September 30, 2022
Equity warrant assets (1)	$	318	$	39	$	(21)	$	9	$	—	$	345
Contingent conversion rights (2)	6		—		—		—		—		6
Three months ended September 30, 2021
Equity warrant assets (1)	257		149		(146)		6		(1)		265
Nine months ended September 30, 2022
Equity warrant assets (1)	269		124		(67)		21		(2)		345
Contingent conversion rights (2)	—		(1)		—		7		—		6
Nine months ended September 30, 2021
Equity warrant assets (1)	192		490		(431)		18		(4)		265

(1)Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income.

(2)Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.

The following table presents the amount of net unrealized gains and losses included in earnings attributable to Level 3 assets still held at September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Other assets:
Equity warrant assets (1)	$	26	$	21	$	84	$	113
Contingent conversion rights (2)	—		—		(1)		—
Total unrealized gains, net	$	26	$	21	$	83	$	113

(1)Unrealized gains and losses are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income.

(2)Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.

The extent to which any unrealized gains or losses will become realized is subject to a variety of factors, including, among other things, the expiration of current sales restrictions to which these securities are subject, the actual sales of securities and the timing of such actual sales.

The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at September 30, 2022 and December 31, 2021. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.

(Dollars in millions)	Fair value	Valuation Technique	Significant Unobservable Inputs	Input Range	Weighted  Average
September 30, 2022:
Equity warrant assets (private portfolio)	345	Black-Scholes option pricing model	Volatility	23.8 - 51.3	42.3
			Risk-Free interest rate	3.3 - 4.4	4.2
			Marketability discount (2)	17.1	17.1
			Remaining life assumption (3)	40.0	40.0
Contingent conversion rights (private portfolio)	6	Private company equity pricing	(4)	(4)	(4)
December 31, 2021:
Equity warrant assets (public portfolio)	2	Black-Scholes option pricing model	Volatility	27.8% - 55.0%	43.7	%
			Risk-Free interest rate	0.6- 1.5	1.1
			Sales restrictions discount (1)	10.0 - 20.0	10.7
Equity warrant assets (private portfolio)	267	Black-Scholes option pricing model	Volatility	24.7 - 55.0	43.0
			Risk-Free interest rate	0.06 - 1.40	0.8
			Marketability discount (2)	20.1	20.1
			Remaining life assumption (3)	40.0	40.0

    

(1)We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions, which typically range from three to six months.

(2)Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.

(3)We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At September 30, 2022, the weighted average contractual remaining term was 6.2 years, compared to our estimated remaining life of 2.5 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.

(4)In determining the fair value of our private contingent conversion rights portfolio (not valued using the Black-Scholes model), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted enterprise values, the probability of a conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.

For the three and nine months ended September 30, 2022 and 2021, we did not have any transfers between Level 3 and Level 1. All transfers from Level 3 to Level 2 for the three and nine months ended September 30, 2022 and 2021 were due to the transfer of equity warrant assets from our private portfolio to our public portfolio (see our Level 3 reconciliation above).

Financial Instruments not Carried at Fair Value

FASB guidance over financial instruments requires that we disclose estimated fair values for our financial instruments not carried at fair value. The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at September 30, 2022 and December 31, 2021:

			Estimated Fair Value
(Dollars in millions)	Carrying Amount		Total		Level 1		Level 2		Level 3
September 30, 2022:
Financial assets:
Cash and cash equivalents	$	13,968	$	13,968	$	13,968	$	—	$	—
HTM securities	93,286		77,370		—		77,370		—
Non-marketable securities not measured at net asset value	431		431		—		—		431
Non-marketable securities measured at net asset value	660		660		—		—		—
Net loans	71,572		72,489		—		—		72,489
FHLB and Federal Reserve Bank stock	665		665		—		—		665
Financial liabilities:
Short-term borrowings	13,552		13,552		—		13,552		—
Non-maturity deposits (1)	171,545		171,545		171,545		—		—
Time deposits	5,274		4,916		—		4,916		—
3.50% Senior Notes	349		336		—		336		—
3.125% Senior Notes	496		407		—		407		—
1.800% Senior Notes due 2031	495		358		—		358		—
2.100% Senior Notes due 2028	496		408		—		408		—
1.800% Senior Notes due 2026	646		559		—		559		—
4.345% Senior Notes due 2028	348		327		—		327		—
4.570% Senior Notes due 2033	447		396		—		396		—
Junior subordinated debentures	91		91		—		91		—
Off-balance sheet financial assets:
Commitments to extend credit	—		49		—		—		49
December 31, 2021:
Financial assets:
Cash and cash equivalents	$	14,586	$	14,586	$	14,586	$	—	$	—
HTM securities	98,195		97,227		—		97,227		—
Non-marketable securities not measured at net asset value	424		424		—		—		424
Non-marketable securities measured at net asset value	710		710		—		—		—
Net loans	65,854		67,335		—		—		67,335
FHLB and Federal Reserve Bank stock	107		107		—		—		107
Financial liabilities:
Short-term borrowings	71		71		—		71		—
Non-maturity deposits (1)	187,464		187,464		187,464		—		—
Time deposits	1,739		1,728		—		1,728		—
3.50% Senior Notes	349		370		—		370		—
3.125% Senior Notes	496		526		—		526		—
1.800% Senior Notes due 2031	494		474		—		474		—
2.100% Senior Notes due 2028	496		501		—		501		—
1.800% Senior Notes due 2026	645		649		—		649		—
Junior subordinated debentures	90		92		—		92		—
Off-balance sheet financial assets:
Commitments to extend credit	—		47		—		—		47

(1)Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.

Investments in Entities that Calculate Net Asset Value Per Share

FASB guidance over certain fund investments requires that we disclose the fair value of funds, significant investment strategies of the investees, redemption features of the investees, restrictions on the ability to sell investments, estimate of the period of time over which the underlying assets are expected to be liquidated by the investee and unfunded commitments related to the investments.

Our investments in debt funds and venture capital and private equity fund investments generally cannot be redeemed. Alternatively, we expect distributions, if any, to be received primarily through IPO and M&A activity of the underlying assets of the fund. Subject to applicable requirements under the Volcker Rule, we do not have any plans to sell any of these fund investments. If we decide to sell these investments in the future, the investee fund’s management must approve of the buyer before the sale of the investments can be completed. The fair values of the fund investments have been estimated using the net asset value per share of the investments, adjusted for any differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30th for our September 30th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of September 30, 2022:

(Dollars in millions)	Carrying Amount		Fair Value		Unfunded Commitments
Non-marketable securities (fair value accounting):
Venture capital and private equity fund investments (1)	$	270	$	270	$	13
Non-marketable securities (equity method accounting):
Venture capital and private equity fund investments (2)	639		639		11
Debt funds (2)	4		4		—
Other investments (2)	17		17		1
Total	$	930	$	930	$	25

(1)Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $42 million and $2 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.

(2)Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.

XML

Legal Matters

9 Months Ended

Sep. 30, 2022

Commitments and Contingencies Disclosure [Abstract]

Legal Matters

Legal Matters

Certain lawsuits and claims arising in the ordinary course of business have been filed or are pending against us and/or our affiliates, and we may from time to time be involved in other legal or regulatory proceedings. In accordance with applicable accounting guidance, we establish accruals for all such matters, including expected settlements, when we believe it is probable that a loss has been incurred and the amount of the loss is reasonably estimable. When a loss contingency is not both probable and estimable, we do not establish an accrual. Any such loss estimates are inherently uncertain, based on currently available information and are subject to management’s judgment and various assumptions. Due to the inherent subjectivity of these estimates and unpredictability of outcomes of legal proceedings, any amounts accrued may not represent the ultimate resolution of such matters.

To the extent we believe any potential loss relating to such matters may have a material impact on our liquidity, consolidated financial position, results of operations, and/or our business as a whole and is reasonably possible but not probable, we aim to disclose information relating to such potential loss. Assessments of litigation and claims exposure are difficult because they involve inherently unpredictable factors including, but not limited to, the following: whether the proceeding is in the early stages of litigation; whether damages are unspecified, unsupported, or uncertain; whether there is a potential for punitive or other pecuniary damages; whether the matter involves legal uncertainties, including novel issues of law; whether the matter involves multiple parties and/or jurisdictions; whether discovery has not begun or is not complete; whether meaningful settlement discussions have commenced; and whether the lawsuit involves class allegations. Assessments of class action litigation, which is generally more complex than other types of litigation, are particularly difficult, especially in the early stages of the proceeding when it is not known whether a class will be certified or how a potential class,

if certified, will be defined. As a result, even if a loss is reasonably possible, the Company may be unable to estimate reasonably possible losses with respect to some matters.

We also aim to disclose information relating to any material potential loss that is probable but not reasonably estimable. In such cases, where reasonably practicable, we aim to provide an estimate of loss or range of potential loss. No disclosures are generally made for any loss contingencies that are deemed to be remote.

Silicon Valley Bank is among the lenders named as defendants in a complaint originally filed on September 27, 2016 by Unicom Systems, Inc. (“Unicom”) in Los Angeles County Superior Court. The lawsuit alleges breach of the syndicated 2015 Credit Agreement between Unicom and the defendants, breach of the implied covenant of good faith and fair dealing, and seeks monetary damages and declaratory relief. Pursuant to the Credit Agreement and California law, the matter has been referred to a duly appointed judicial referee for trial. The parties have engaged in extensive fact discovery which we currently expect to be concluded in November 2022, with expert witness depositions to follow. Trial is currently scheduled to take place over a three week period in late March 2023.

The Company currently estimates that it is reasonably possible that it may experience a loss in relation to the Unicom matter. However, for various reasons including the current stage of discovery proceedings, the uncertainty regarding damage claims and certain of the other factors noted above, the Company is unable to estimate the reasonably possible loss or range of losses at this time.

Based upon information available to us, our review of lawsuits and claims filed or pending against us to date and consultation with our outside legal counsel, we have not recognized a material accrual liability for any such matters, nor do we currently expect that these matters will result in a material liability to the Company. However, the outcome of litigation and other legal and regulatory matters is inherently uncertain, and it is possible that one or more of such matters currently pending or threatened could have an unanticipated material adverse effect on our liquidity, consolidated financial position, results of operations, and/or our business as a whole, in the future.

XML

Related Parties	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Parties	Related PartiesWe have no material related party transactions requiring disclosure. In the ordinary course of business, the Bank may extend credit to related parties, including executive officers, directors, principal shareholders and their related interests. Additionally, we provide real estate secured loans to eligible employees through our EHOP. For additional details, see Note 19 — “Employee Compensation and Benefit Plans" under Part II, Item 8 of our 2021 Form 10-K.

XML

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	SVB Financial Group is a diversified financial services company, as well as a bank holding company and a financial holding company. SVB Financial was incorporated in the state of Delaware in March 1999. Through our various subsidiaries and divisions, we offer a diverse set of banking and financial products and services to support our clients of all sizes and stages throughout their life cycles. In these notes to our unaudited interim consolidated financial statements, when we refer to “SVB,” “SVB Financial Group,” “SVBFG," the “Company,” “we,” “our,” “us” or use similar words, we mean SVB Financial Group and all of its subsidiaries collectively, including Silicon Valley Bank (the “Bank”), unless the context requires otherwise. When we refer to “SVB Financial” or the “Parent” we are referring only to the parent company, SVB Financial Group (not including subsidiaries).The accompanying unaudited interim consolidated financial statements reflect all adjustments of a normal and recurring nature that are, in the opinion of management, necessary to fairly present our financial position, results of operations and cash flows in accordance with GAAP. Such unaudited interim consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of results to be expected for any future periods. These unaudited interim consolidated financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”).
Use of Estimates	The preparation of unaudited interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Estimates may change as new information is obtained. Among the more significant estimates are those that relate to: 1) ACL for loans and for unfunded credit commitments, 2) valuation of non-marketable and other equity securities, 3) valuation of equity warrant assets, 4) goodwill, intangible assets and other purchase accounting related adjustments, and 5) income taxes.
Principles of Consolidation and Presentation	Our unaudited interim consolidated financial statements include the accounts of SVB Financial Group and consolidated entities. All significant intercompany accounts and transactions with consolidated entities have been eliminated. For a further description of our accounting policies regarding consolidation refer to Consolidated Financial Statements and Supplementary Data — Note 2 — “Summary of Significant Accounting Policies” under Part II, Item 8 of our 2021 Form 10-K.
Reclassifications	Certain prior period amounts have been reclassified to conform to current period presentation to account for the change in presentation of derivative asset and liability positions and the related cash collateral disclosed in the Summary of Significant Accounting Polices in Part 1, Item 1 of this report. These changes are included in our Consolidated Balance Sheets (unaudited) and Consolidated Statements of Cash Flows (unaudited) as well as the Cash and Cash Equivalents, Derivative Financial Instruments and Fair Value of Financial Instruments footnotes.
Derivatives, Offsetting Fair Value	During the third quarter of 2022, we changed our presentation of derivative asset and liability positions and the related cash collateral in the unaudited interim consolidated balance sheets. The balances are presented net by counterparty when a legally enforceable right of setoff exists under a master netting arrangement in accordance with ASC 815, Derivatives and Hedging. Previously, fair values of derivative positions were reported in the line items “Accrued interest receivable and other assets” and “Other liabilities” gross. The related cash collateral was reported in the line items "Cash and cash equivalents" and "Short-term borrowings". For impact on presentation, please refer to the balance sheet offsetting section of Note 8 – “Derivative Financial Instruments”. This change had no impact on our net income. We concluded that this presentation was preferable as it better reflects the credit risk of derivatives traded under master netting arrangements. This change represents a change in accounting principle under ASC 250, Accounting Changes and Error Corrections, with retrospective application to the earliest period presented.
Loans and Leases Receivable, Allowance for Loan Losses	In the third quarter of 2022, we also adjusted the allowance models for the CRE and Other C&I loan portfolios to more precisely forecast lifetime loan losses for those portfolios. As a result, the allowance model for the CRE loan portfolio uses a reasonable and supportable forecast period that is less than, but approximately, three years; the Company continues to use a three-year reasonable and supportable forecast period for all other loan loss models. Subsequent to the forecast period period, the CRE and Other C&I models' reversion to average historical losses uses an approach that gradually trends towards the mean historical loss over the remaining contractual lives of loans, whereas all other loan models continue to use an autoregressive approach. The impact on overall reserves as a result of these changes was not material. This change represents a change in accounting estimate under ASC 250, Accounting Changes and Error Corrections, with prospective application.

XML

Stockholders' Equity and EPS (Tables)

9 Months Ended

Sep. 30, 2022

Equity and Earnings Per Share [Abstract]

Reclassification out of Accumulated Other Comprehensive Income

The following table summarizes the items reclassified out of AOCI into the Consolidated Statements of Income (unaudited) for the three and nine months ended September 30, 2022 and 2021:

		Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	Income Statement Location	2022		2021		2022		2021
Reclassification adjustment for losses (gains) included in net income	Gains (losses) on investment securities, net	$	—	$	—	$	(48)	$	—
Related tax expense	Income tax expense	—		—		14		—
Reclassification adjustment for gains on cash flow hedges included in net income	Net interest income	(14)		(16)		(43)		(47)
Related tax expense	Income tax expense	4		4		12		13
Total reclassification adjustment for gains included in net income, net of tax		$	(10)	$	(12)	$	(65)	$	(34)

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

The table below summarizes the activity relating to net gains and losses on our cash flow hedges included in AOCI for the three and nine months ended September 30, 2022 and 2021. Over the next 12 months, we expect that approximately $46 million in AOCI at September 30, 2022, related to unrealized gains will be reclassified out of AOCI and recognized in net income.

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Balance, beginning of period, net of tax	$	62	$	107	$	83	$	129
Net realized (gain) loss reclassified to net income, net of tax	(10)		(12)		(31)		(34)
Balance, end of period, net of tax	$	52	$	95	$	52	$	95

Reconciliation of Basic EPS to Diluted EPS

The following is a reconciliation of basic EPS to diluted EPS for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions except per share amounts, shares in thousands)	2022		2021		2022		2021
Numerator:
Net income available to common stockholders	$	429	$	365	$	1,234	$	1,399
Denominator:
Weighted average common shares outstanding—basic	59,096		57,723		58,945		54,772
Weighted average effect of dilutive securities:
Stock options and ESPP	165		268		206		278
Restricted stock units and awards	288		530		384		567
Weighted average common shares outstanding—diluted	59,549		58,521		59,535		55,617
Earnings per common share:
Basic	$	7.26	$	6.33	$	20.94	$	25.54
Diluted	7.21		6.24		20.73		25.16

Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share

The following table summarizes the weighted-average common shares excluded from the diluted EPS calculation due to the antidilutive effect for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,		Nine months ended September 30,
(Shares in thousands)	2022	2021	2022	2021
Stock options	142	56	105	31
Restricted stock units	477	—	99	—
Total	619	56	204	31

Schedule of Stock by Class

The following table summarizes our preferred stock at September 30, 2022:

Series	Description	Amount outstanding (in millions)		Carrying value (in millions)		Shares issued and outstanding	Par Value		Ownership interest per depositary share	Liquidation preference per depositary share		2022 dividends paid per depositary share
Series A	5.25% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	$	350	$	340	350,000	$	0.001	1/40th	$	25	$	0.984375
Series B	4.100% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	750		739		7,500	0.001		1/100th	1,000		30.75
Series C	4.000% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	1,000		985		10,000	0.001		1/100th	1,000		30.00
Series D	4.250% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	1,000		989		10,000	0.001		1/100th	1,000		33.88
Series E	4.700% Fixed-Rate Non-Cumulative Perpetual Preferred Stock	600		593		6,000	0.001		1/100th	1,000		37.47

Schedule of Stockholders Equity

The following table summarizes the changes in our consolidated equity for the three months ended September 30, 2022 and 2021:

	Preferred Stock		Common Stock			Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total SVBFG Stockholders’ Equity		Noncontrolling Interests		Total  Equity
(Dollars in millions, except share data)			Shares	Amount
Balance at June 30, 2021	$	2,064	54,530,307	$	—	$	2,755	$	6,706	$	142	$	11,667	$	300	$	11,967
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		32,195	—		2		—		—		2		—		2
Issuance of Common Stock	—		2,227,000	—		1,245		—		—		1,245		—		1,245
Issuance of common stock for the acquisition of Boston Private	—		1,887,981	—		1,060						1,060				1,060
Net income	—		—	—		—		387		—		387		88		475
Capital calls and distributions, net	—		—	—		—		—		—		—		(19)		(19)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(77)		(77)		—		(77)
Share-based compensation, net	—		—	—		38		—		—		38		—		38
Dividends on preferred stock	—		—	—		—		(22)		—		(22)		—		(22)
Balance at September 30, 2021	$	2,064	58,677,483	$	—	$	5,100	$	7,071	$	65	$	14,300	$	369	$	14,669
Balance at June 30, 2022	$	3,646	59,081,326	$	—	$	5,223	$	8,247	$	(1,198)	$	15,918	$	358	$	16,276
Common stock issued under employee benefit plans and ESOP, net of restricted stock cancellations	—		22,798	—		(2)		—		—		(2)		—		(2)
Net income	—		—	—		—		469		—		469		(51)		418
Capital calls and distributions, net	—		—	—		—		—		—		—		(6)		(6)
Other comprehensive income (loss), net of tax	—		—	—		—		—		(887)		(887)		—		(887)
Share-based compensation, net	—		—	—		51		—		—		51		—		51
Dividends on preferred stock	—		—	—		—		(40)		—		(40)		—		(40)
Balance at September 30, 2022	$	3,646	59,104,124	$	—	$	5,272	$	8,676	$	(2,085)	$	15,509	$	301	$	15,810

XML

Variable Interest Entities (Tables)

9 Months Ended

Sep. 30, 2022

Investments In Variable Interest Entities [Abstract]

Schedule of Variable Interest Entities

The following table presents the carrying amounts and classification of variable interests in consolidated and unconsolidated VIEs as of September 30, 2022 and December 31, 2021:

(Dollars in millions)	Consolidated VIEs		Unconsolidated VIEs		Maximum Exposure to Loss in Unconsolidated VIEs
September 30, 2022:
Assets:
Cash and cash equivalents	$	7	$	—	$	—
Non-marketable and other equity securities (1)	767		1,369		1,369
Accrued interest receivable and other assets (2)	35		6		—
Total assets	$	809	$	1,375	$	1,369
Liabilities:
Other liabilities (1)	$	23	$	672	$	—
Long term debt (2)	—		91		—
Total liabilities	$	23	$	763	$	—
December 31, 2021:
Assets:
Cash and cash equivalents	$	13	$	—	$	—
Non-marketable and other equity securities (1)	768		1,233		1,233
Accrued interest receivable and other assets (2)	31		6		—
Total assets	$	812	$	1,239	$	1,233
Liabilities:
Other liabilities (1)	$	18	$	482	$	—
Long term debt (2)	—		90		—
Total liabilities	$	18	$	572	$	—

(1)    Included in our unconsolidated non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are investments in qualified affordable housing projects of $1.2 billion and $954 million, respectively, and related other liabilities consisting of unfunded commitments of $672 million and $482 million, respectively.

(2)    Included in our unconsolidated accrued interest receivable and other assets are investments in statutory trusts for junior subordinated debt and included in long term debt previously issued by Boston Private and assumed in the acquisition of $6 million and $91 million at September 30, 2022 and $6 million and $90 million at December 31, 2021.

XML

Cash and Cash Equivalents (Tables)

9 Months Ended

Sep. 30, 2022

Cash and Cash Equivalents [Abstract]

Schedule of Cash and Cash Equivalents

The following table details our cash and cash equivalents at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Cash and due from banks	$	1,411	$	2,168
Interest bearing deposits with the Federal Reserve Bank	7,550		5,686
Interest bearing deposits with other institutions	4,610		5,773
Securities purchased under agreements to resell (1)	397		607
Other short-term investment securities	—		352
Total cash and cash equivalents	$	13,968	$	14,586

(1)At September 30, 2022 and December 31, 2021, securities purchased under agreements to resell were collateralized by U.S. Treasury securities and U.S. agency securities with aggregate fair values of $402 million and $620 million, respectively. None of these securities were sold or repledged as of September 30, 2022 and December 31, 2021.

XML

Investment Securities (Tables)

9 Months Ended

Sep. 30, 2022

Investments, Debt and Equity Securities [Abstract]

Debt Securities, Available-for-sale

The major components of our AFS investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

	September 30, 2022
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Carrying Value
AFS securities, at fair value:
U.S. Treasury securities	$	18,041	$	—	$	(1,196)	$	16,845
U.S. agency debentures	120		—		(20)		100
Foreign government debt securities	1,062		—		(149)		913
Residential MBS:
Agency-issued MBS	7,883		—		(1,200)		6,683
Agency-issued CMO—fixed rate	792		—		(78)		714
Agency-issued CMBS	1,604		—		(148)		1,456
Total AFS securities	$	29,502	$	—	$	(2,791)	$	26,711

	December 31, 2021
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Carrying Value
AFS securities, at fair value:
U.S. Treasury securities	$	15,799	$	121	$	(70)	$	15,850
U.S. agency debentures	200		—		(4)		196
Foreign government debt securities	61		—		—		61
Residential MBS:
Agency-issued MBS	8,786		13		(210)		8,589
Agency-issued CMO—fixed rate	988		3		(9)		982
Agency-issued CMBS	1,536		27		(20)		1,543
Total AFS securities	$	27,370	$	164	$	(313)	$	27,221

Activity of Available-for-Sale Securities

The following table summarizes sale activity of AFS securities during the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Sales proceeds	$	—	$	168	$	8,511	$	168
Net realized gains and losses:
Gross realized gains	—		—		146		—
Gross realized losses	—		—		(98)		—
Net realized gains (losses)	$	—	$	—	$	48	$	—

Summary of Unrealized Losses on Available for Sale Securities

The following tables summarize our AFS securities in an unrealized loss position for which an ACL has not been recorded and summarized into categories of AFS securities that were in an unrealized loss for position for less than 12 months, or 12 months or longer, as of September 30, 2022 and December 31, 2021:

	September 30, 2022
	Less than 12 months				12 months or longer				Total
(Dollars in millions)	Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses
AFS securities:
U.S. Treasury securities	$	13,359	$	(958)	$	3,487	$	(238)	$	16,846	$	(1,196)
U.S. agency debentures	20		(1)		80		(19)		100		(20)
Foreign government debt securities	913		(149)		—		—		913		(149)
Residential MBS:
Agency-issued MBS	2,236		(304)		4,448		(896)		6,684		(1,200)
Agency-issued CMO —fixed rate	534		(55)		168		(23)		702		(78)
Agency-issued CMBS	806		(59)		649		(89)		1,455		(148)
Total AFS securities (1)	$	17,868	$	(1,526)	$	8,832	$	(1,265)	$	26,700	$	(2,791)

(1)As of September 30, 2022, we identified a total of 804 investments that were in unrealized loss positions with 289 investments in an unrealized loss position for a period of time greater than 12 months. Based on our analysis of the securities in an unrealized loss position as of September 30, 2022, the decline in value is unrelated to credit loss and is related to changes in market interest rates since purchase, and therefore, changes in value for securities are included in other comprehensive income. Market valuations and credit loss analyses on assets in the AFS securities portfolio are reviewed and monitored on a quarterly basis. As of September 30, 2022, we do not intend to sell any of our securities in an unrealized loss position prior to recovery of our amortized cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our amortized cost basis. None of the investments in our AFS securities portfolio were past due as of September 30, 2022.

	December 31, 2021
	Less than 12 months				12 months or longer				Total
(Dollars in millions)	Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses		Fair Value of Investments		Unrealized Losses
AFS securities:
U.S. Treasury securities	$	7,777	$	(70)	$	—	$	—	$	7,777	$	(70)
U.S. agency debentures	196		(4)		—		—		196		(4)
Residential MBS:
Agency-issued MBS	8,280		(210)		—		—		8,280		(210)
Agency-issued CMO—fixed rate	740		(9)		—		—		740		(9)
Agency-issued CMBS	603		(11)		163		(9)		766		(20)
Total AFS securities (1)	$	17,596	$	(304)	$	163	$	(9)	$	17,759	$	(313)

(1)As of December 31, 2021, we identified a total of 475 investments that were in unrealized loss positions, of which 4 investments are in an unrealized loss position for a period of time greater than 12 months. None of the investments in our AFS securities portfolio were past due as of December 31, 2021.

Summary of Remaining Contractual Principal Maturities and Fully Taxable Equivalent Yields on Securities

The following table summarizes the fixed income securities, carried at fair value, classified as AFS as of September 30, 2022 by the remaining contractual principal maturities. For U.S. Treasury securities, U.S. agency debentures and foreign government debt securities, the expected maturity is the actual contractual maturity of the notes. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as AFS typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments.

	September 30, 2022
(Dollars in millions)	Total		One Year or Less		After One Year to Five Years		After Five Years to Ten Years		After Ten Years
U.S. Treasury securities	$	16,845	$	936	$	15,133	$	776	$	—
U.S. agency debentures	100		—		34		66		—
Foreign government debt securities	913		41		46		826		—
Residential MBS:
Agency-issued MBS	6,683		—		—		45		6,638
Agency-issued CMO—fixed rate	714		—		—		—		714
Agency-issued CMBS	1,456		—		100		1,356		—
Total	$	26,711	$	977	$	15,313	$	3,069	$	7,352

The following table summarizes the remaining contractual principal maturities on fixed income investment securities classified as HTM as of September 30, 2022. For U.S. agency debentures, the expected maturity is the actual contractual maturity of the notes. Expected remaining maturities for certain U.S. agency debentures may occur earlier than their contractual maturities because the note issuers have the right to call outstanding amounts ahead of their contractual maturity. Expected maturities for MBS may differ significantly from their contractual maturities because mortgage borrowers have the right to prepay outstanding loan obligations with or without penalties. MBS classified as HTM typically have original contractual maturities from 10 to 30 years, whereas expected average lives of these securities tend to be significantly shorter and vary based upon structure and prepayments in lower interest rate environments; however, we expect to collect substantially all of the recorded investment on these securities.

	September 30, 2022
	Total				One Year or Less				After One Year to Five Years				After Five Years to Ten Years				After Ten Years
(Dollars in millions)	Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value		Net Carry Value		Fair Value
U.S. agency debentures	$	486	$	433	$	1	$	1	$	118	$	111	$	367	$	321	$	—	$	—
Residential MBS:
Agency-issued MBS	59,200		49,183		1		1		2		2		1,148		1,063		58,049		48,117
Agency-issued CMO—fixed rate	10,741		8,928		—		—		87		83		154		146		10,500		8,699
Agency-issued CMO—variable rate	83		82		—		—		—		—		—		—		83		82
Agency-issued CMBS	14,644		12,340		45		44		159		146		968		802		13,472		11,348
Municipal bonds and notes	7,428		5,817		25		25		235		222		1,265		1,114		5,903		4,456
Corporate bonds	704		587		—		—		115		102		589		485		—		—
Total	$	93,286	$	77,370	$	72	$	71	$	716	$	666	$	4,491	$	3,931	$	88,007	$	72,702

Held-to-maturity Securities

The components of our HTM investment securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

	September 30, 2022
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value		ACL
HTM securities, at cost:
U.S. agency debentures (1)	$	486	$	—	$	(53)	$	433	$	—
Residential MBS:
Agency-issued MBS	59,200		—		(10,017)		49,183		—
Agency-issued CMO—fixed rate	10,741		—		(1,813)		8,928		—
Agency-issued CMO—variable rate	83		—		(1)		82		—
Agency-issued CMBS	14,644		—		(2,304)		12,340		—
Municipal bonds and notes	7,429		—		(1,612)		5,817		1
Corporate bonds	709		—		(122)		587		5
Total HTM securities	$	93,292	$	—	$	(15,922)	$	77,370	$	6

(1)    Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.

	December 31, 2021
(Dollars in millions)	Amortized Cost		Unrealized Gains		Unrealized Losses		Fair Value		ACL
HTM securities, at amortized cost:
U.S. agency debentures (1)	$	609	$	8	$	(2)	$	615	$	—
Residential MBS:
Agency-issued MBS	64,439		124		(887)		63,676		—
Agency-issued CMO—fixed rate	10,226		9		(145)		10,090		—
Agency-issued CMO—variable rate	100		1		—		101		—
Agency-issued CMBS	14,959		39		(277)		14,721		—
Municipal bonds and notes	7,157		185		(27)		7,315		1
Corporate bonds	712		2		(5)		709		6
Total HTM securities	$	98,202	$	368	$	(1,343)	$	97,227	$	7

(1)    Consists of pools of Small Business Investment Company debentures issued and guaranteed by the U.S. Small Business Administration, an independent agency of the United States.

Debt Securities, Held-to-maturity, Credit Quality Indicator

On a quarterly basis, management monitors the credit quality for HTM securities through the use of standard credit ratings. The following table summarizes our amortized cost of HTM securities aggregated by credit quality indicator at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Municipal bonds and notes:
Aaa	$	4,270	$	3,774
Aa1	1,880		2,031
Aa2	1,081		1,154
Aa3	171		172
A1	27		26
Total municipal bonds and notes	$	7,429	$	7,157
Corporate bonds:
Aaa	$	39	$	39
Aa2	42		42
Aa3	105		105
A1	282		251
A2	230		264
A3	11		11
Total corporate bonds	$	709	$	712

Schedule of Nonmarketable and Other Securities

The major components of our non-marketable and other equity securities portfolio at September 30, 2022 and December 31, 2021 are as follows:

(Dollars in millions)	September 30, 2022		December 31, 2021
Non-marketable and other equity securities:
Non-marketable securities (fair value accounting):
Consolidated venture capital and private equity fund investments (1)	$	147	$	130
Unconsolidated venture capital and private equity fund investments (2)	123		208
Other investments without a readily determinable fair value (3)	176		164
Other equity securities in public companies (fair value accounting) (4)	29		117
Non-marketable securities (equity method accounting) (5):
Venture capital and private equity fund investments	639		671
Debt funds	4		5
Other investments	272		294
Investments in qualified affordable housing projects, net (6)	1,205		954
Total non-marketable and other equity securities	$	2,595	$	2,543

(1)The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at September 30, 2022 and December 31, 2021 (fair value accounting):

	September 30, 2022				December 31, 2021
(Dollars in millions)	Amount		Ownership %		Amount		Ownership %
Strategic Investors Fund, LP	$	2	12.6	%	$	2	12.6	%
Capital Preferred Return Fund, LP	30		20.0		61		20.0
Growth Partners, LP	25		33.0		67		33.0
Redwood Evergreen Fund, LP	90		100.0		—		—
Total consolidated venture capital and private equity fund investments	$	147			$	130

(2)The carrying value represents investments in 141 and 150 funds (primarily venture capital funds) at September 30, 2022 and December 31, 2021, respectively, where our ownership interest is typically less than 5% of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. We carry our unconsolidated venture capital and private equity fund investments at fair value based on the fund investments' net asset values per share as obtained from the general partners of the investments. For each fund investment, we adjust the net asset value per share for differences between our measurement date and the date of the fund investment’s net asset value by using the most recently available financial information from the investee general partner, for example June 30th for our September 30th consolidated financial statements, adjusted for any contributions paid, distributions received from the investment, and significant fund transactions or market events during the reporting period.

(3)These investments include direct equity investments in private companies. The carrying value is based on the price at which the investment was acquired plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments. We consider a range of factors when adjusting the fair value of these investments, including, but not limited to, the term and nature of the investment, local market conditions, values for comparable securities, current and projected operating performance, exit strategies, financing transactions subsequent to the acquisition of the investment, and a discount for certain investments that have lock-up restrictions or other features that indicate a discount to fair value is warranted.

The following table shows the changes to the carrying amount of other investments without a readily determinable fair value for the nine months ended September 30, 2022:

(Dollars in millions)	Nine months ended September 30, 2022		Cumulative Adjustments
Measurement alternative:
Carrying value at September 30, 2022	$	176
Carrying value adjustments:
Impairment	$	—	$	(1)
Upward changes for observable prices	—		52
Downward changes for observable prices	(6)		(11)

(4)Investments classified as other equity securities (fair value accounting) represent shares held in public companies as a result of exercising public equity warrant assets and direct equity investments in public companies held by our consolidated funds. Changes in equity securities measured at fair value are recognized through net income.

(5)The following table shows the carrying value and our ownership percentage of each investment at September 30, 2022 and December 31, 2021 (equity method accounting):

	September 30, 2022				December 31, 2021
(Dollars in millions)	Amount		Ownership %		Amount		Ownership %
Venture capital and private equity fund investments:
Strategic Investors Fund II, LP	$	2	8.6	%	$	3	8.6	%
Strategic Investors Fund III, LP	13		5.9		25		5.9
Strategic Investors Fund IV, LP	23		5.0		36		5.0
Strategic Investors Fund V funds	59		Various		87		Various
CP II, LP (i)	2		5.1		2		5.1
Other venture capital and private equity fund investments	540		Various		518		Various
Total venture capital and private equity fund investments	$	639			$	671
Debt funds:
Gold Hill Capital 2008, LP (ii)	$	3	15.5	%	$	4	15.5	%
Other debt funds	1		Various		1		Various
Total debt funds	$	4			$	5
Other investments:
SPD Silicon Valley Bank Co., Ltd.	$	143	50.0	%	$	154	50.0	%
Other investments	129		Various		140		Various
Total other investments	$	272			$	294

(i)Our ownership includes direct ownership interest of 1.3 percent and indirect ownership interest of 3.8 percent through our investments in Strategic Investors Fund II, LP.

(ii)Our ownership includes direct ownership interest of 11.5 percent and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of 4.0 percent.

(6)The following table presents the balances of our investments in qualified affordable housing projects and related unfunded commitments included as a component of “Other liabilities” on our consolidated balance sheets at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Investments in qualified affordable housing projects, net	$	1,205	$	954
Other liabilities	672		482

The following table presents other information relating to our investments in qualified affordable housing projects for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Tax credits and other tax benefits recognized	$	30	$	9	$	80	$	63
Amortization expense included in provision for income taxes (i)	17		17		52		48

(i)All investments are amortized using the proportional amortization method, and amortization expense is included in the provision for income taxes.

Gain Loss On Investment Securities

The following table presents the net gains and losses on non-marketable and other equity securities for the three and nine months ended September 30, 2022 and 2021 as recorded in the line item “Gains on investment securities, net," a component of noninterest income:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Net (losses) gains on non-marketable and other equity securities:
Non-marketable securities (fair value accounting):
Consolidated venture capital and private equity fund investments	$	(52)	$	36	$	(100)	$	72
Unconsolidated venture capital and private equity fund investments	(61)		47		(80)		79
Other investments without a readily determinable fair value	—		(2)		(3)		11
Other equity securities in public companies (fair value accounting)	(8)		(39)		(52)		53
Non-marketable securities (equity method accounting):
Venture capital and private equity fund investments	(12)		144		(20)		438
Debt funds	(1)		—		(1)		2
Other investments	7		3		9		6
Total net (losses) gains on non-marketable and other equity securities	$	(127)	$	189	$	(247)	$	661
Less: realized net gains (losses) on sales of non-marketable and other equity securities	13		(17)		(16)		110
Net (losses) gains on non-marketable and other equity securities still held	$	(140)	$	206	$	(231)	$	551

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments (Tables)

9 Months Ended

Sep. 30, 2022

Receivables [Abstract]

Loans and Allowance for Loan Losses

The composition of loans at amortized cost basis broken out by class of financing receivable at September 30, 2022 and December 31, 2021 is presented in the following table:

(Dollars in millions)	September 30, 2022		December 31, 2021
Global fund banking	$	40,337	$	37,958
Investor dependent:
Early stage	1,911		1,593
Growth stage	4,398		3,951
Total investor dependent	6,309		5,544
Cash flow dependent - SLBO	1,845		1,798
Innovation C&I	8,321		6,673
Private bank	10,102		8,743
CRE	2,609		2,670
Premium wine	1,117		985
Other C&I	1,087		1,257
Other	374		317
PPP	28		331
Total loans (1) (2) (3)	$	72,129	$	66,276
ACL	(557)		(422)
Net loans	$	71,572	$	65,854

(1)    Total loans at amortized cost is net of unearned income, deferred fees and costs, and net unamortized premiums and discounts of $244 million and $250 million at September 30, 2022 and December 31, 2021, respectively.

(2)     Included within our total loan portfolio are credit card loans of $582 million and $583 million at September 30, 2022 and December 31, 2021, respectively.

(3)     Included within our total loan portfolio are construction loans of $454 million and $367 million at September 30, 2022 and December 31, 2021, respectively.

Credit Quality Indicators, Broken out by Portfolio Segment and Class of Financing Receivables

The following tables summarize the credit quality indicators, broken out by class of financing receivable and vintage year, as of September 30, 2022 and December 31, 2021:

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Global fund banking:
Risk rating:
Pass	$	512	$	95	$	63	$	31	$	1	$	10	$	39,616	$	—	$	—	$	40,328
Criticized	—		—		—		—		—		—		9		—		—		9
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total global fund banking	$	512	$	95	$	63	$	31	$	1	$	10	$	39,625	$	—	$	—	$	40,337
Investor dependent:
Early stage:
Risk rating:
Pass	$	727	$	626	$	73	$	36	$	2	$	1	$	191	$	—	$	—	$	1,656
Criticized	67		122		27		7		—		2		26		—		—		251
Nonperforming	1		1		—		—		—		—		2		—		—		4
Total early stage	$	795	$	749	$	100	$	43	$	2	$	3	$	219	$	—	$	—	$	1,911

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Growth stage:
Risk rating:
Pass	$	1,684	$	1,456	$	360	$	72	$	28	$	6	$	243	$	5	$	—	$	3,854
Criticized	147		233		53		14		5		—		49		—		—		501
Nonperforming	19		18		2		—		—		—		4		—		—		43
Total growth stage	$	1,850	$	1,707	$	415	$	86	$	33	$	6	$	296	$	5	$	—	$	4,398
Total investor dependent	$	2,645	$	2,456	$	515	$	129	$	35	$	9	$	515	$	5	$	—	$	6,309
Cash flow dependent - SLBO:
Risk rating:
Pass	$	678	$	609	$	199	$	203	$	14	$	39	$	30	$	—	$	—	$	1,772
Criticized	20		—		16		2		1		22		5		—		—		66
Nonperforming	—		—		—		—		5		—		2		—		—		7
Total cash flow dependent - SLBO	$	698	$	609	$	215	$	205	$	20	$	61	$	37	$	—	$	—	$	1,845
Innovation C&I
Risk rating:
Pass	$	1,788	$	1,734	$	773	$	166	$	18	$	54	$	3,102	$	—	$	—	$	7,635
Criticized	49		148		121		32		11		—		324		—		—		685
Nonperforming	—		—		—		—		—		—		1		—		—		1
Total innovation C&I	$	1,837	$	1,882	$	894	$	198	$	29	$	54	$	3,427	$	—	$	—	$	8,321
Private bank:
Risk rating:
Pass	$	2,210	$	2,817	$	1,753	$	948	$	441	$	1,054	$	818	$	5	$	—	$	10,046
Criticized	—		16		—		2		—		15		10		—		—		43
Nonperforming	—		—		1		2		1		8		1		—		—		13
Total private bank	$	2,210	$	2,833	$	1,754	$	952	$	442	$	1,077	$	829	$	5	$	—	$	10,102
CRE
Risk rating:
Pass	$	406	$	292	$	181	$	240	$	143	$	894	$	96	$	5	$	—	$	2,257
Criticized	2		4		51		135		24		114		17		—		—		347
Nonperforming	—		—		—		5		—		—		—		—		—		5
Total CRE	$	408	$	296	$	232	$	380	$	167	$	1,008	$	113	$	5	$	—	$	2,609
Premium wine:
Risk rating:
Pass	$	255	$	213	$	91	$	137	$	47	$	144	$	156	$	34	$	—	$	1,077
Criticized	1		5		—		7		9		9		9		—		—		40
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total premium wine	$	256	$	218	$	91	$	144	$	56	$	153	$	165	$	34	$	—	$	1,117
Other C&I
Risk rating:
Pass	$	31	$	149	$	161	$	70	$	81	$	304	$	234	$	10	$	—	$	1,040
Criticized	1		—		3		6		3		19		11		1		—		44
Nonperforming	—		—		1		—		1		1		—		—		—		3
Total other C&I	$	32	$	149	$	165	$	76	$	85	$	324	$	245	$	11	$	—	$	1,087
Other:
Risk rating:
Pass	$	25	$	151	$	172	$	30	$	—	$	—	$	11	$	—	$	(44)	$	345
Criticized	—		3		17		9		—		—		—		—		—		29
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total other	$	25	$	154	$	189	$	39	$	—	$	—	$	11	$	—	$	(44)	$	374
PPP:
Risk rating:
Pass	$	—	$	16	$	3	$	—	$	—	$	—	$	—	$	—	$	—	$	19
Criticized	—		3		6		—		—		—		—		—		—		9
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total PPP	$	—	$	19	$	9	$	—	$	—	$	—	$	—	$	—	$	—	$	28

	Term Loans by Origination Year
September 30, 2022 (Dollars in millions)	2022		2021		2020		2019		2018		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Total loans	$	8,623	$	8,711	$	4,127	$	2,154	$	835	$	2,696	$	44,967	$	60	$	(44)	$	72,129

(1)    These amounts consist of fees and clearing items that have not yet been allocated at the loan level.

	Term Loans by Origination Year
December 31, 2021 (Dollars in millions)	2021		2020		2019		2018		2017		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Global fund banking:
Risk rating:
Pass	$	764	$	115	$	36	$	6	$	8	$	4	$	36,955	$	—	$	—	$	37,888
Criticized	50		18		—		—		—		1		1		—		—		70
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total global fund banking	$	814	$	133	$	36	$	6	$	8	$	5	$	36,956	$	—	$	—	$	37,958
Investor dependent:
Early stage:
Risk rating:
Pass	$	754	$	287	$	122	$	26	$	6	$	1	$	171	$	—	$	—	$	1,367
Criticized	64		87		30		5		—		—		29		—		—		215
Nonperforming	2		5		3		—		—		—		1		—		—		11
Total early stage	$	820	$	379	$	155	$	31	$	6	$	1	$	201	$	—	$	—	$	1,593
Growth stage:
Risk rating:
Pass	$	2,072	$	910	$	265	$	78	$	14	$	1	$	286	$	5	$	—	$	3,631
Criticized	159		85		27		6		3		—		34		—		—		314
Nonperforming	2		—		1		2		—		—		1		—		—		6
Total growth stage	$	2,233	$	995	$	293	$	86	$	17	$	1	$	321	$	5	$	—	$	3,951
Total investor dependent	$	3,053	$	1,374	$	448	$	117	$	23	$	2	$	522	$	5	$	—	$	5,544
Cash flow dependent - SLBO:
Risk rating:
Pass	$	875	$	384	$	252	$	72	$	76	$	2	$	35	$	—	$	—	$	1,696
Criticized	—		—		20		25		—		13		10		—		—		68
Nonperforming	—		—		12		10		7		—		5		—		—		34
Total cash flow dependent - SLBO	$	875	$	384	$	284	$	107	$	83	$	15	$	50	$	—	$	—	$	1,798
Innovation C&I:
Risk rating:
Pass	$	2,230	$	1,058	$	288	$	123	$	58	$	—	$	2,411	$	—	$	—	$	6,168
Criticized	64		130		62		12		—		—		236		—		—		504
Nonperforming	—		—		—		—		—		—		1		—		—		1
Total Innovation C&I	$	2,294	$	1,188	$	350	$	135	$	58	$	—	$	2,648	$	—	$	—	$	6,673
Private bank:
Risk rating:
Pass	$	2,952	$	2,015	$	1,122	$	520	$	432	$	952	$	705	$	8	$	—	$	8,706
Criticized	—		—		2		—		2		9		3		—		—		16
Nonperforming	—		—		2		9		—		8		2		—		—		21
Total private bank	$	2,952	$	2,015	$	1,126	$	529	$	434	$	969	$	710	$	8	$	—	$	8,743
CRE
Risk rating:
Pass	$	326	$	215	$	344	$	155	$	236	$	868	$	110	$	2	$	—	$	2,256
Criticized	3		39		114		37		47		139		18		12		—		409
Nonperforming	—		—		5		—		—		—		—		—		—		5
Total CRE	$	329	$	254	$	463	$	192	$	283	$	1,007	$	128	$	14	$	—	$	2,670
Premium wine:
Risk rating:
Pass	$	217	$	112	$	156	$	69	$	71	$	162	$	125	$	34	$	—	$	946
Criticized	1		7		11		9		—		—		11		—		—		39
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total Premium wine	$	218	$	119	$	167	$	78	$	71	$	162	$	136	$	34	$	—	$	985
Other C&I
Risk rating:
Pass	$	181	$	175	$	82	$	86	$	28	$	301	$	350	$	11	$	—	$	1,214
Criticized	5		6		6		7		2		—		8		5		—		39
Nonperforming	—		—		—		2		—		1		1		—		—		4
Total other C&I	$	186	$	181	$	88	$	95	$	30	$	302	$	359	$	16	$	—	$	1,257
Other:

	Term Loans by Origination Year
December 31, 2021 (Dollars in millions)	2021		2020		2019		2018		2017		Prior		Revolving Loans		Revolving Loans Converted to Term Loans		Unallocated (1)		Total
Risk rating:
Pass	$	61	$	144	$	82	$	20	$	14	$	—	$	7	$	—	$	(21)	$	307
Criticized	—		7		1		—		2		—		—		—		—		10
Nonperforming	—		—		—		—		—		—		—		—		—		—
Total other	$	61	$	151	$	83	$	20	$	16	$	—	$	7	$	—	$	(21)	$	317
PPP:
Risk rating:
Pass	$	226	$	72	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	298
Criticized	22		9		—		—		—		—		—		—		—		31
Nonperforming	2		—		—		—		—		—		—		—		—		2
Total PPP	$	250	$	81	$	—	$	—	$	—	$	—	$	—	$	—	$	—	$	331
Total loans	$	11,032	$	5,880	$	3,045	$	1,279	$	1,006	$	2,462	$	41,516	$	77	$	(21)	$	66,276

(1)    These amounts consist of fees and clearing items that have not yet been allocated at the loan level.

Activity in Allowance for Loan Losses Broken out by Portfolio Segment

The following tables summarize the activity relating to our ACL for loans for the three and nine months ended September 30, 2022 and 2021, broken out by portfolio segment:

Three months ended September 30, 2022	Beginning Balance June 30, 2022		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	89	$	—	$	6	$	(4)	$	—	$	91
Investor dependent	224		(20)		4		25		1		234
Cash flow dependent and innovation C&I	130		(5)		—		11		—		136
Private bank	45		—		—		2		—		47
CRE	34		—		—		(7)		—		27
Other C&I	12		(1)		1		—		—		12
Premium wine and other	11		—		—		3		(4)		10
Total ACL	$	545	$	(26)	$	11	$	30	$	(3)	$	557

Three months ended September 30, 2021	Beginning Balance June 30, 2021		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	66	$	—	$	—	$	—	$	(7)	$	59
Investor dependent	158		—		(17)		5		(8)		138
Cash flow dependent and innovation C&I	119		—		(1)		3		(12)		109
Private bank	47		1		(1)		—		(16)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	6		—		—		—		3		9
Total ACL	$	396	$	22	$	(19)	$	8	$	(9)	$	398

Nine months ended September 30, 2022	Beginning Balance December 31, 2021		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	67	$	—	$	6	$	18	$	—	$	91
Investor dependent	146		(53)		13		126		2		234
Cash flow dependent and innovation C&I	118		(9)		—		27		—		136
Private Bank	33		—		2		12		—		47
CRE	36		—		—		(9)		—		27
Other C&I	14		(3)		1		—		—		12
Premium wine and other	8		(1)		1		10		(8)		10
Total ACL	$	422	$	(66)	$	23	$	184	$	(6)	$	557

Nine months ended September 30, 2021	Beginning Balance December 31, 2020		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	46	$	—	$	(80)	$	—	$	93	$	59
Investor dependent	213		—		(37)		13		(51)		138
Cash flow dependent and innovation C&I	125		—		(8)		3		(11)		109
Private Bank	53		1		(3)		—		(20)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	9		—		(1)		—		1		9
PPP	2		—		—		—		(2)		—
Total ACL	$	448	$	22	$	(129)	$	16	$	41	$	398

The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
ACL: unfunded credit commitments, beginning balance	$	224	$	120	171		$	121
Provision for (reduction in) credit losses	42		29		96		28
Foreign currency translation adjustments	(1)		—		(2)		—
ACL: unfunded credit commitments, ending balance (1)	$	265	$	149	$	265	$	149

(1)The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.

Financing Receivable, Past Due

The following table summarizes the aging of our loans broken out by class of financing receivable as of September 30, 2022 and December 31, 2021:

(Dollars in millions)	30 - 59   Days Past   Due		60 - 89   Days Past   Due		Equal to or Greater Than 90   Days Past   Due		Total Past   Due		Current		Total		Loans Past Due 90 Days or More Still Accruing Interest
September 30, 2022:
Global fund banking	$	—	$	—	$	—	$	—	$	40,337	$	40,337	$	—
Investor dependent:
Early stage	2		2		1		5		1,906		1,911		—
Growth stage	26		13		2		41		4,357		4,398		—
Total investor dependent	28		15		3		46		6,263		6,309		—
Cash flow dependent - SLBO	4		—		—		4		1,841		1,845		—
Innovation C&I	6		3		—		9		8,312		8,321		—
Private bank	1		12		5		18		10,084		10,102		1
CRE	1		7		5		13		2,596		2,609		—
Premium wine	3		—		—		3		1,114		1,117		—
Other C&I	—		3		—		3		1,084		1,087		—
Other	—		—		—		—		374		374		—
PPP	—		—		6		6		22		28		5
Total loans	$	43	$	40	$	19	$	102	$	72,027	$	72,129	$	6
December 31, 2021:
Global fund banking	$	—	$	—	$	—	$	—	$	37,958	$	37,958	$	—
Investor dependent:
Early stage	6		5		—		11		1,582		1,593		—
Growth stage	16		—		—		16		3,935		3,951		—
Total investor dependent	22		5		—		27		5,517		5,544		—
Cash flow dependent - SLBO	—		—		—		—		1,798		1,798		—
Innovation C&I	7		—		7		14		6,659		6,673		7
Private bank	28		1		12		41		8,702		8,743		—
CRE	1		—		—		1		2,669		2,670		—
Premium wine	3		—		—		3		982		985		—
Other C&I	1		2		1		4		1,253		1,257		—
Other	—		—		—		—		317		317		—
PPP	1		—		—		1		330		331		—
Total loans	$	63	$	8	$	20	$	91	$	66,185	$	66,276	$	7

Financing Receivable, Nonaccrual

The following table summarizes our nonaccrual loans with no allowance for credit loss at September 30, 2022 and December 31, 2021:

	September 30, 2022				December 31, 2021
(Dollars in millions)	Nonaccrual Loans		Nonaccrual Loans with no Allowance for Credit Loss		Nonaccrual Loans		Nonaccrual Loans with no Allowance for Credit Loss
Investor dependent:
Early stage	$	4	$	—	$	11	$	—
Growth stage	43		1		6		—
Total investor dependent	47		1		17		—
Cash flow dependent - SLBO	7		—		34		—
Innovation C&I	1		—		1		1
Private bank	13		6		21		8
CRE	5		—		5		—
Other C&I	3		—		4		—
PPP	—		—		2		—
Total nonaccrual loans	$	76	$	7	$	84	$	9

Summary of Loans Modified in Troubled Debt Restructurings ("TDRs") by Risk-based Segment

The following table summarizes our loans modified in TDRs, broken out by class of financing receivable at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Loans modified in TDRs:
Investor dependent:
Early stage	$	1	$	12
Growth stage	32		3
Total investor dependent	33		15
Cash flow dependent - SLBO	8		34
Innovation C&I	1		—
Private bank	8		12
CRE	33		33
Other C&I	2		2
Total loans modified in TDRs	$	85	$	96

Recorded Investment in Loans Modified in TDRs

The following table summarizes the recorded investment in loans modified in TDRs, broken out by class of financing receivable, for modifications made during the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Loans modified in TDRs during the period:
Investor dependent:
Early stage	$	1	$	—	$	1	$	1
Growth stage	12		8		32		8
Total investor dependent	13		8		33		9
Cash flow dependent - SLBO	—		—		—		12
Innovation C&I	1		—		1		—
Private bank	—		2		1		2
CRE	5		43		5		43
Total loans modified in TDRs during the period (1)	$	19	$	53	$	40	$	66

(1)There were $4 million of partial charge-offs for the three months ended September 30, 2022 and $9 million of partial charge-offs for the nine months then ended. There were no partial charge-offs for the three months ended September 30, 2021 and $7 million of partial charge-offs for the nine months then ended.

Activity Relating to ACL for Unfunded Credit Commitments

The following tables summarize the activity relating to our ACL for loans for the three and nine months ended September 30, 2022 and 2021, broken out by portfolio segment:

Three months ended September 30, 2022	Beginning Balance June 30, 2022		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	89	$	—	$	6	$	(4)	$	—	$	91
Investor dependent	224		(20)		4		25		1		234
Cash flow dependent and innovation C&I	130		(5)		—		11		—		136
Private bank	45		—		—		2		—		47
CRE	34		—		—		(7)		—		27
Other C&I	12		(1)		1		—		—		12
Premium wine and other	11		—		—		3		(4)		10
Total ACL	$	545	$	(26)	$	11	$	30	$	(3)	$	557

Three months ended September 30, 2021	Beginning Balance June 30, 2021		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	66	$	—	$	—	$	—	$	(7)	$	59
Investor dependent	158		—		(17)		5		(8)		138
Cash flow dependent and innovation C&I	119		—		(1)		3		(12)		109
Private bank	47		1		(1)		—		(16)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	6		—		—		—		3		9
Total ACL	$	396	$	22	$	(19)	$	8	$	(9)	$	398

Nine months ended September 30, 2022	Beginning Balance December 31, 2021		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Foreign Currency Translation Adjustments		Ending Balance September 30, 2022
(Dollars in millions)
Global fund banking	$	67	$	—	$	6	$	18	$	—	$	91
Investor dependent	146		(53)		13		126		2		234
Cash flow dependent and innovation C&I	118		(9)		—		27		—		136
Private Bank	33		—		2		12		—		47
CRE	36		—		—		(9)		—		27
Other C&I	14		(3)		1		—		—		12
Premium wine and other	8		(1)		1		10		(8)		10
Total ACL	$	422	$	(66)	$	23	$	184	$	(6)	$	557

Nine months ended September 30, 2021	Beginning Balance December 31, 2020		Initial Allowance on PCD Loans		Charge-offs		Recoveries		Provision (Reduction) for Credit Loss for Loans		Ending Balance September 30, 2021
(Dollars in millions)
Global fund banking	$	46	$	—	$	(80)	$	—	$	93	$	59
Investor dependent	213		—		(37)		13		(51)		138
Cash flow dependent and innovation C&I	125		—		(8)		3		(11)		109
Private Bank	53		1		(3)		—		(20)		31
CRE	—		17		—		—		23		40
Other C&I	—		4		—		—		8		12
Premium wine and other	9		—		(1)		—		1		9
PPP	2		—		—		—		(2)		—
Total ACL	$	448	$	22	$	(129)	$	16	$	41	$	398

The following table summarizes the activity relating to our ACL for unfunded credit commitments for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
ACL: unfunded credit commitments, beginning balance	$	224	$	120	171		$	121
Provision for (reduction in) credit losses	42		29		96		28
Foreign currency translation adjustments	(1)		—		(2)		—
ACL: unfunded credit commitments, ending balance (1)	$	265	$	149	$	265	$	149

(1)The “ACL: unfunded credit commitments” is included as a component of “other liabilities” on our unaudited interim consolidated balance sheets. See Note 11 — “Off-Balance Sheet Arrangements, Guarantees and Other Commitments” of this report for additional disclosures related to our commitments to extend credit.

XML

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination

The components of net other intangible assets were as follows:

	September 30, 2022						December 31, 2021
(Dollars in millions)	Gross Amount		Accumulated Amortization		Net Carrying Amount		Gross Amount		Accumulated Amortization		Net Carrying Amount
Other intangible assets:
Customer relationships	$	135	$	27	$	108	$	135	$	16	$	119
Other	57		23		34		57		16		41
Total other intangible assets	$	192	$	50	$	142	$	192	$	32	$	160

Finite-lived Intangible Assets Amortization Expense

For the nine months ended September 30, 2022, we recorded amortization expense of $18 million. Assuming no future impairments of other intangible assets or additional acquisitions or dispositions, the following table presents the Company's future expected amortization expense for other intangible assets that will continue to be amortized as of September 30, 2022:

Years ended December 31, (Dollars in millions)	Other Intangible Assets
2022 (excluding the nine months ended September 30, 2022)	$	6
2023	22
2024	20
2025	17
2026	15
2027 and thereafter	62
Total future amortization expense	$	142

XML

Derivative Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments

The following table summarizes the amortized cost basis of hedged assets that are designated and qualify as fair value hedges and the cumulative amount of fair value hedging adjustments included in the carrying value that have been recorded on our unaudited interim consolidated balance sheets as of September 30, 2022 and December 31, 2021:

			Cumulative Amount of Fair Value Hedging Adjustment Included in the Amortized Cost Basis of the Hedged Assets
(Dollars in millions)	Amortized Cost Basis of the Hedged Assets		Active		Terminated
September 30, 2022
AFS securities	$	8,773	$	—	$	(301)
December 31, 2021
AFS securities (1)	$	15,260	$	(131)	$	6

(1)These amounts include the amortized cost basis of closed portfolios used to designate hedging relationships in which the hedged item is the last layer expected to be remaining at the end of the hedging relationship. At December 31, 2021, the amortized cost basis of the closed portfolios used in these hedging relationships was $11.2 billion, the amounts of the designated hedged items was $6.7 billion and the cumulative basis adjustments associated with these hedging relationships was $83 million.

Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments

The total notional or contractual amounts and fair value of our derivative financial instruments at September 30, 2022 and December 31, 2021 were as follows:

	September 30, 2022						December 31, 2021
	Notional or Contractual Amount		Fair Value				Notional or Contractual Amount		Fair Value
(Dollars in millions)			Derivative Assets (1)		Derivative Liabilities (1)				Derivative Assets (1)		Derivative Liabilities (1)
Derivatives designated as hedging instruments:
Interest rate risks:
Interest rate swaps (2)	$	—	$	—	$	—	$	10,700	$	18	$	—
Currency exchange risks:
Foreign exchange contracts	1,546		94		—		—		—		—
Total derivatives designated as hedging instruments			94		—				18		—
Derivatives not designated as hedging instruments:
Currency exchange risks:
Foreign exchange contracts	2,860		46		—		701		16		—
Foreign exchange contracts	308		—		13		62		—		2
Other derivative instruments:
Equity warrant assets	353		351		—		322		277		—
Contingent conversion rights	52		6		—		—		—		—
Client foreign exchange contracts	10,658		500		—		8,245		146		—
Client foreign exchange contracts	10,615		—		499		7,764		—		126
Total return swaps	110		25		—		—		—		—
Client foreign currency options	266		11		—		688		9		—
Client foreign currency options	266		—		11		688		—		9
Client interest rate derivatives (2)	2,248		128		—		2,178		99		—
Client interest rate derivatives	2,447		—		235		2,315		—		101
Total derivatives not designated as hedging instruments			1,067		758				547		238
Total gross derivatives			1,161		758				565		238
Less: netting adjustment (3)			(495)		(234)				(137)		(120)
Total derivatives			$	666	$	524			$	428	$	118

(1)Derivative assets and liabilities are included in "accrued interest receivable and other assets" and "other liabilities", respectively, on our consolidated balance sheets.

(2)The amount reported reflects reductions of approximately $117 million and $112 million of derivative assets at September 30, 2022 and December 31, 2021, respectively, reflecting variation margin treated as settlement of the related derivative fair values for legal and accounting purposes as required by central clearing houses.

(3)For some counterparties, the collateral amounts of financial instruments may exceed the derivative receivables and derivative payables balances. Where this is the case, the total amount reported is limited to the net derivative receivables and net derivative payables balances with that counterparty. There was approximately $6 million of cash collateral in excess of net derivative receivables and $1 million of cash collateral in excess of net derivative payables balances not included in the netting adjustment at September 30, 2022, and December 31, 2021, respectively.

Summary of Derivative Activity and Related Impact on Consolidated Statements of Income

A summary of our derivative activity and the related impact on our consolidated statements of income for the three and nine months ended September 30, 2022 and 2021 is as follows:

		Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	Statement of income location	2022		2021		2022		2021
Derivatives designated as hedging instruments:
Interest rate risks:
Amounts reclassified from AOCI into income	Interest income - loans	$	14	$	16	$	43	$	47
Change in fair value of interest rate swaps hedging investment securities	Interest income - investment securities taxable	(2)		5		384		18
Change in fair value of hedged investment securities	Interest income - investment securities taxable	1		(6)		(385)		(19)
Net gains associated with interest rate risk derivatives		$	13	$	15	$	42	$	46
Derivatives not designated as hedging instruments:
Currency exchange risks:
Gains (losses) on revaluations of internal foreign currency instruments, net	Other noninterest income	$	47	$	(14)	26		$	(35)
(Losses) gains on internal foreign exchange forward contracts, net	Other noninterest income	(51)		14		(31)		35
Net losses associated with internal currency risk		$	(4)	$	—	$	(5)	$	—
Other derivative instruments:
Gains on revaluations of client foreign currency instruments, net	Other noninterest income	$	12	$	1	$	7	$	16
(Losses) gains on client foreign exchange forward contracts, net	Other noninterest income	(2)		(5)		5		(15)
Net gains (losses) associated with client currency risk		$	10	$	(4)	$	12	$	1
(Losses) gains on total return swaps	Other noninterest income	$	(2)	$	—	$	25	$	—
Net gains on equity warrant assets	Gains on equity warrant assets, net	$	40	$	147	$	120	$	491
Net gains on other derivatives	Other noninterest income	$	2	$	2	$	8	$	4

Offsetting Assets

The following table summarizes our assets subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021:

	Gross Amounts of Recognized Assets		Gross Amounts Offset in the Statement of Financial Position (1)				Net Amounts of Assets Presented in the Statement of Financial Position (1)		Gross Amounts Not Offset in the Statement of Financial Position		Net Amount
(Dollars in millions)			Financial Instruments		Cash Collateral Received
September 30, 2022
Derivatives	$	597	$	(229)	$	(266)	$	102	$	—	$	102
Reverse repurchase, securities borrowing, and similar arrangements	397		—		—		397		(397)		—
Total	$	994	$	(229)	$	(266)	$	499	$	(397)	$	102
December 31, 2021
Derivatives	$	165	$	(87)	$	(50)	$	28	$	—	$	28
Reverse repurchase, securities borrowing, and similar arrangements	607		—		—		607		(607)		—
Total	$	772	$	(87)	$	(50)	$	635	$	(607)	$	28

(1)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

Offsetting Liabilities

The following table summarizes our liabilities subject to enforceable master netting arrangements as of September 30, 2022 and December 31, 2021:

	Gross Amounts of Recognized Liabilities		Gross Amounts Offset in the Statement of Financial Position (1)				Net Amounts of Liabilities Presented in the Statement of Financial Position (1)		Gross Amounts Not Offset in the Statement of Financial Position		Net Amount
(Dollars in millions)			Financial Instruments		Cash Collateral Pledged
September 30, 2022
Derivatives	$	256	$	(229)	$	(5)	$	22	$	—	$	22
Repurchase, securities lending, and similar arrangements	36		—		—		36		—		36
Total	$	292	$	(229)	$	(5)	$	58	$	—	$	58
December 31, 2021
Derivatives	$	148	$	(87)	$	(33)	$	28	$	—	$	28
Repurchase, securities lending, and similar arrangements	61		—		—		61		—		61
Total	$	209	$	(87)	$	(33)	$	89	$	—	$	89

(1)During the third quarter of 2022, we changed our accounting policy to report the fair values of our derivative assets and liabilities subject to ISDA master netting arrangements on a net basis where a right of setoff exists. The net derivative fair values have been further adjusted for cash collateral received/pledged. The change in accounting policy was applied retrospectively, and prior periods have been revised to conform with current period presentation.

XML

Noninterest Income (Tables)

9 Months Ended

Sep. 30, 2022

Other Income and Expenses [Abstract]

Summary of Noninterest Income

Included below is a summary of noninterest income for the three and nine months ended September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Noninterest income:
Gains (losses) on investment securities, net	$	(127)	$	189	$	(199)	$	661
Gains on equity warrant assets, net	40		147		120		491
Client investment fees	119		20		237		55
Wealth management and trust fees	19		22		63		22
Foreign exchange fees	74		65		216		189
Credit card fees	37		34		114		93
Deposit service charges	32		29		94		82
Lending related fees	20		21		65		55
Letters of credit and standby letters of credit fees	15		13		43		39
Investment banking revenue	75		90		293		335
Commissions	24		17		73		58
Other	31		25		119		97
Total noninterest income	$	359	$	672	$	1,238	$	2,177

Components of Gains and Losses (Realized and Unrealized) on Investment Securities

A summary of gains and losses on investment securities for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Gains (losses) on non-marketable and other equity securities, net	$	(127)	$	189	$	(247)	$	661
Gains (losses) on sales of AFS securities, net	—		—		48		—
Total gains (losses) on investment securities, net	$	(127)	$	189	$	(199)	$	661

Components of Gains on Equity Warrant Assets

A summary of net gains on equity warrant assets for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Equity warrant assets:
Gains on exercises, net	$	9	$	91	$	44	$	381
Terminations	(1)		(1)		(3)		(2)
Changes in fair value, net	32		57		79		112
Total net gains on equity warrant assets	$	40	$	147	$	120	$	491

Components of Client Investment Fees

A summary of client investment fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Client investment fees by type:
Sweep money market fees	$	64	$	12	$	144	$	31
Asset management fees (1)	16		7		41		22
Repurchase agreement fees	39		1		52		2
Total client investment fees (2)	$	119	$	20	$	237	$	55

(1)Represents fees earned from investments in third-party money market mutual funds and fixed-income securities managed by SVB Asset Management.

(2)Represents fees earned on client investment funds that are maintained at third-party financial institutions and are not recorded on our balance sheet.

Components of Wealth Management and Trust Fees

A summary of wealth management and trust fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Wealth management and trust fees by type:
Wealth management fees	$	17	$	20	$	58	$	20
Trust fees	2		2		5		2
Total wealth management and trust fees	$	19	$	22	$	63	$	22

Components of Foreign Exchange Fees

A summary of foreign exchange fee income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Foreign exchange fees by instrument type:
Foreign exchange contract commissions	$	74	$	65	$	215	$	188
Option premium fees	—		—		1		1
Total foreign exchange fees	$	74	$	65	$	216	$	189

Components of Credit Card Fees

A summary of credit card fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Credit card fees by instrument type:
Card interchange fees, net	$	29	$	29	$	91	$	78
Merchant service fees	6		4		18		12
Card service fees	2		1		5		3
Total credit card fees	$	37	$	34	$	114	$	93

Components of Lending Related Fees

A summary of lending related fees by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Lending related fees by instrument type:
Unused commitment fees	$	14	$	14	$	49	$	42
Other	6		7		16		13
Total lending related fees	$	20	$	21	$	65	$	55

Schedule of Investment Banking Revenue

A summary of investment banking revenue by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Investment banking revenue:
Underwriting fees	$	24	$	39	$	97	$	248
Advisory fees	40		26		163		39
Private placements and other	11		25		33		48
Total investment banking revenue	$	75	$	90	$	293	$	335

Summary of Other Noninterest Income

A summary of other noninterest income by instrument type for the three and nine months ended September 30, 2022 and 2021 is as follows:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Other noninterest income by instrument type:
Fund management fees	$	16	$	15	$	43	$	51
Net gains on revaluation of foreign currency instruments, net of foreign exchange forward contracts (1)	6		(4)		7		1
Gains on total return swaps	(3)		—		25		—
Other service revenue	12		14		44		45
Total other noninterest income	$	31	$	25	$	119	$	97

(1)Represents the net revaluation of client and internal foreign currency denominated financial instruments. We enter into foreign exchange forward contracts to economically reduce our foreign exchange exposure related to client and internal foreign currency denominated financial instruments.

Disaggregation of Revenue

The following tables present our revenues from contracts with customers disaggregated by revenue source and segment for the three and nine months ended September 30, 2022 and 2021:

Three months ended September 30, 2022	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	119	$	—	$	—	$	—	$	—	$	119
Wealth management and trust fees	—		19		—		—		—		19
Card interchange fees, gross	54		1		—		—		—		55
Merchant service fees	7		—		—		—		—		7
Deposit service charges	32		—		—		—		—		32
Investment banking revenue	—		—		—		75		—		75
Commissions	—		—		—		24		—		24
Fund management fees	1		—		13		2		—		16
Other (1)	1		—		2		—		—		3
Total revenue from contracts with customers	$	214	$	20	$	15	$	101	$	—	$	350
Revenues outside the scope of ASC 606 (2)	94		2		(69)		(1)		(17)		9
Total noninterest income	$	308	$	22	$	(54)	$	100	$	(17)	$	359

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Three months ended September 30, 2021	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	20	$	—	$	—	$	—	$	—	$	20
Wealth management and trust fees	—		22								22
Card interchange fees, gross	52		—		—		—		—		52
Merchant service fees	4		—		—		—		—		4
Deposit service charges	28		—		—		—		1		29
Investment banking revenue	—		—		—		90		—		90
Commissions	—		—		—		17		—		17
Fund management fees	—		—		14		1		—		15
Other (1)	61		1		4		—		—		66
Total revenue from contracts with customers	165		23		18		108		1		315
Revenues outside the scope of ASC 606 (2)	17		2		127		23		188		357
Total noninterest income	$	182	$	25	$	145	$	131	$	189	$	672

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Nine months ended September 30, 2022	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	236	$	—	$	—	$	—	$	1	$	237
Wealth management and trust fees	—		63		—		—		—		63
Card interchange fees, gross	170		1		—		—		2		173
Merchant service fees	18		—		—		—		—		18
Deposit service charges	92		1		—		—		1		94
Investment banking revenue	—		—		—		293		—		293
Commissions	—		—		—		73		—		73
Fund management fees	1		—		37		5		—		43
Other (1)	69		1		6		—		—		76
Total revenue from contracts with customers	$	586	$	66	$	43	$	371	$	4	$	1,070
Revenues outside the scope of ASC 606 (2)	195		6		(121)		(19)		107		168
Total noninterest income	$	781	$	72	$	(78)	$	352	$	111	$	1,238

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

Nine months ended September 30, 2021	Silicon Valley Bank (3)		SVB Private		SVB Capital (3)		SVB Securities (3)		Other Items		Total
(Dollars in millions)
Revenue from contracts with customers:
Client investment fees	$	53	$	2	$	—	$	—	$	—	$	55
Wealth management and trust fees	—		22		—		—		—		22
Card interchange fees, gross	140		1		—		—		1		142
Merchant service fees	12		—		—		—		—		12
Deposit service charges	80		—		—		—		2		82
Investment banking revenue	—		—		—		335		—		335
Commissions	—		—		—		58		—		58
Fund management fees	—		—		47		4		—		51
Other (1)	178		1		12		—		—		191
Total revenue from contracts with customers	$	463	$	26	$	59	$	397	$	3	$	948
Revenues outside the scope of ASC 606 (2)	51		2		330		53		793		1,229
Total noninterest income	$	514	$	28	$	389	$	450	$	796	$	2,177

(1)Includes certain spot contract commissions, performance fees and correspondent bank rebates.

(2)Amounts are accounted for under separate guidance than ASC 606.

(3)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of noninterest income are shown net of noncontrolling interests. Noncontrolling interest is included within “Other Items."

XML

Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Segment Reporting

Our reportable segment information for the three and nine months ended September 30, 2022 and 2021 is as follows:

(Dollars in millions)	Silicon Valley Bank (1)		SVB Private		SVB Capital (1)		SVB Securities (1)		Other Items (2)		Total
Three months ended September 30, 2022
Net interest income	$	1,107	$	111	$	—	$	1	$	(21)	$	1,198
(Provision for) reduction of credit losses	(32)		3		—		—		(43)		(72)
Noninterest income (loss)	308		22		(54)		100		(17)		359
Noninterest expense (3)	(381)		(85)		(17)		(131)		(278)		(892)
Income (loss) before income tax expense (4)	$	1,002	$	51	$	(71)	$	(30)	$	(359)	$	593
Total average loans, amortized cost	$	55,177	$	15,181	$	—	$	—	$	740	$	71,098
Total average assets (5) (6)	175,620		17,032		883		898		21,307		215,740
Total average deposits	172,427		12,436		—		—		693		185,556
Three months ended September 30, 2021
Net interest income (7)	$	766	$	74	$	—	$	—	$	12	$	852
Provision for credit losses	29		(20)		—		—		(30)		(21)
Noninterest income	182		25		145		131		189		672
Noninterest expense (3) (7)	(336)		(93)		(15)		(142)		(293)		(879)
Income before income tax expense (4) (7)	$	641	$	(14)	$	130	$	(11)	$	(122)	$	624
Total average loans, amortized cost (7)	$	44,789	$	13,515	$	—	$	—	$	987	$	59,291
Total average assets (5) (6) (7)	151,352		15,930		730		837		13,841		182,690
Total average deposits (7)	148,879		13,431		—		—		1,082		163,392
Nine months ended September 30, 2022
Net interest income	$	2,993	$	296	$	—	$	1	$	157	$	3,447
Provision for credit losses	(174)		(9)		—		—		(96)		(279)
Noninterest income (loss)	781		72		(78)		352		111		1,238
Noninterest expense (3)	(1,148)		(267)		(53)		(406)		(739)		(2,613)
Income before income tax expense (4)	$	2,452	$	92	$	(131)	$	(53)	$	(567)	$	1,793
Total average loans, amortized cost	$	53,855	$	14,711	$	—	$	—	$	592	$	69,158
Total average assets (5) (6)	178,209		16,456		956		912		20,119		216,652
Total average deposits	175,370		13,327		—		—		731		189,428
Nine months ended September 30, 2021
Net interest income (7)	$	2,084	$	146	$	—	$	—	$	10	$	2,240
(Provision for) reduction of credit losses	(27)		(16)		—		—		(32)		(75)
Noninterest income	514		28		389		450		796		2,177
Noninterest expense (3) (7)	(911)		(126)		(48)		(376)		(707)		(2,168)
Income before income tax expense (4) (7)	$	1,660	$	32	$	341	$	74	$	67	2,174
Total average loans, amortized cost (7)	$	41,591	$	8,610	$	—	$	—	$	1,642	$	51,843
Total average assets (5) (6) (7)	130,177		9,459		641		778		11,897		152,952
Total average deposits (7)	128,006		7,108		—		—		999		136,113

(1)Silicon Valley Bank’s, SVB Capital’s and SVB Securities' components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented. Noncontrolling interest is included within “Other Items."

(2)The “Other Items” column reflects the adjustments necessary to reconcile the results of the reportable segments to the consolidated financial statements prepared in conformity with GAAP. Net interest income consists primarily of interest earned from our fixed income investment portfolio, net of FTP. Noninterest income consists primarily of gains or losses on equity warrant assets, gains or losses on the sale of AFS securities and gains or losses on equity securities from exercised warrant assets. Noninterest expense consists primarily of expenses associated with corporate support functions such as finance, human resources, marketing, legal and other expenses.

(3)The Silicon Valley Bank segment includes direct depreciation and amortization of $13 million and $10 million for the three months ended September 30, 2022 and 2021, respectively and $34 million and $25 million for the nine months ended September 30, 2022 and 2021, respectively.

(4)The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.

(5)Total average assets equal the greater of total average assets or the sum of total average liabilities and total average stockholders' equity for each segment to reconcile the results to the consolidated financial statements prepared in conformity with GAAP.

(6)Included in the total average assets for SVB Securities and SVB Private is goodwill of $174 million and $201 million, respectively, for the three and nine months ended September 30, 2022, and included in the total average assets for SVB Securities and SVB Private is goodwill of $138 million and $201 million for the three and nine months ended September 30, 2021, respectively.

(7)For the three and nine months ended September 30, 2021, prior period balances for our Premium Wine reporting division previously reported in "Silicon Valley Bank" have been allocated to the reportable segment “SVB Private” to properly reflect organizational changes effective January 1, 2022. The reallocation had no impact on the "Total" amount.

XML

Off-Balance Sheet Arrangements, Guarantees and Other Commitments (Tables)

9 Months Ended

Sep. 30, 2022

Disclosure Off Balance Sheet Arrangements Guarantees And Other Commitments Additional Information [Abstract]

Summary Information Related to Commitments to Extend Credit (Excluding Letters of Credit)

The following table summarizes information related to our commitments to extend credit at September 30, 2022 and December 31, 2021:

(Dollars in millions)	September 30, 2022		December 31, 2021
Loan commitments (1)	$	51,769	$	40,327
Standby letters of credit (2)	3,824		3,612
Commercial letters of credit (3)	105		77
Total unfunded credit commitments	$	55,698	$	44,016
Allowance for unfunded credit commitments (4)	265		171

(1)Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.

(2)See below for additional information on our standby letters of credit.

(3)Commercial letters of credit are issued primarily for inventory purchases by a client and are typically short-term in nature.

(4)Our allowance for credit losses for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.

Summary of Commercial and Standby Letters of Credit

The table below summarizes our standby letters of credit at September 30, 2022. The maximum potential amount of future payments represents the amount that could be remitted under letters of credit if there were a total default by the guaranteed parties, without consideration of possible recoveries under recourse provisions or from the collateral held or pledged.

(Dollars in millions)	Expires in One Year or Less		Expires After One Year		Total Amount Outstanding		Maximum Amount of Future Payments
Financial standby letters of credit	$	3,617	$	126	$	3,743	$	3,743
Performance standby letters of credit	72		9		81		81
Total	$	3,689	$	135	$	3,824	$	3,824

Total Capital Commitments, Unfunded Capital Commitments, and Ownership in Each Fund

The following table details our total capital commitments, unfunded capital commitments, and our ownership percentage in each fund at September 30, 2022:

(Dollars in millions)	SVBFG Capital Commitments		SVBFG Unfunded Commitments		SVBFG Ownership of each Fund
Redwood Evergreen Fund, LP	$	250	$	119	100.0	%
CP II, LP (1)	1		—		5.1
Capital Preferred Return Fund, LP	13		—		20.0
Growth Partners, LP	25		1		33.0
Strategic Investors Fund, LP	15		1		12.6
Strategic Investors Fund II, LP	15		1		8.6
Strategic Investors Fund III, LP	15		1		5.9
Strategic Investors Fund IV, LP	12		2		5.0
Strategic Investors Fund V funds	1		—		Various
Other venture capital and private equity fund investments (equity method accounting)	18		5		Various
Debt funds (equity method accounting)	59		—		Various
Other fund investments (2)	248		12		Various
Total	$	672	$	142

(1)Our ownership includes direct ownership of 1.3 percent and indirect ownership interest of 3.8 percent through our investment in Strategic Investors Fund II, LP.

(2)Represents commitments to 147 funds (primarily venture capital funds) where our ownership interest is generally less than 5.0 percent of the voting interests of each such fund.

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2022

Fair Value Disclosures [Abstract]

Fair Value Hierarchy Tables Present Information about Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of September 30, 2022:

(Dollars in millions)	Level 1		Level 2		Level 3		Netting Adjustments (1)		Balance at September 30, 2022
Assets:
AFS securities:
U.S. Treasury securities	$	16,845	$	—	$	—	$	—	$	16,845
U.S. agency debentures	—		100		—		—		100
Foreign government debt securities	913		—		—		—		913
Residential MBS:
Agency-issued MBS	—		6,683		—		—		6,683
Agency-issued CMO—fixed rate	—		714		—		—		714
Agency-issued CMBS	—		1,456		—		—		1,456
Total AFS securities	17,758		8,953		—		—		26,711
Non-marketable and other equity securities (fair value accounting):
Non-marketable securities:
Venture capital and private equity fund investments measured at net asset value	—		—		—		—		270
Other equity securities in public companies	27		2		—		—		29
Total non-marketable and other equity securities (fair value accounting)	27		2		—		—		299
Other assets:
Derivative assets	—		804		—		(495)		309
Equity warrant assets	—		6		345		—		351
Contingent conversion rights	—		—		6		—		6
Other assets	4		—		—		—		4
Total assets	$	17,789	$	9,765	$	351	$	(495)	$	27,680
Liabilities:
Derivative liabilities	$	—	$	758	$	—	$	(234)	$	524
Other liabilities	4		—		—		—		4
Total liabilities	$	4	$	758	$	—	$	(234)	$	528

(1)Amounts represent the impact of legally enforceable master netting arrangements and also cash collateral held or placed with the same counterparties

The following fair value hierarchy table presents information about our assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021:

(Dollars in millions)	Level 1		Level 2		Level 3		Netting Adjustments (1) (2)		Balance at December 31, 2021
Assets:
AFS securities:
U.S. Treasury securities	$	15,850	$	—	$	—	$	—	$	15,850
U.S. agency debentures	—		196		—		—		196
Foreign government debt securities	61		—		—		—		61
Residential MBS:
Agency-issued MBS	—		8,589		—		—		8,589
Agency-issued CMO—fixed rate	—		982		—		—		982
Agency-issued CMBS	—		1,543		—		—		1,543
Total AFS securities	15,911		11,310		—		—		27,221
Non-marketable and other equity securities (fair value accounting):
Non-marketable securities:
Venture capital and private equity fund investments measured at net asset value	—		—		—		—		338
Other equity securities in public companies	43		74		—		—		117
Total non-marketable and other equity securities (fair value accounting)	43		74		—		—		455
Other assets:
Derivative assets (2)	—		288		—		(137)		151
Equity warrant assets	—		8		269		—		277
Other assets	8		—		—		—		8
Total assets	$	15,962	$	11,680	$	269	$	(137)	$	28,112
Liabilities:
Derivative liabilities (2)	$	—	$	238	$	—	$	(120)	$	118
Other liabilities	8		—		—		—		8
Total liabilities	$	8	$	238	$	—	$	(120)	$	126

Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis

The following table presents additional information about Level 3 assets measured at fair value on a recurring basis for the three and nine months ended September 30, 2022 and 2021:

(Dollars in millions)	Beginning Balance		Total Net Gains (Losses) Included in Net Income		Sales/Exits		Issuances		Transfers Out of Level 3		Ending Balance
Three months ended September 30, 2022
Equity warrant assets (1)	$	318	$	39	$	(21)	$	9	$	—	$	345
Contingent conversion rights (2)	6		—		—		—		—		6
Three months ended September 30, 2021
Equity warrant assets (1)	257		149		(146)		6		(1)		265
Nine months ended September 30, 2022
Equity warrant assets (1)	269		124		(67)		21		(2)		345
Contingent conversion rights (2)	—		(1)		—		7		—		6
Nine months ended September 30, 2021
Equity warrant assets (1)	192		490		(431)		18		(4)		265

(1)Realized and unrealized gains (losses) are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income.

(2)Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.

Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held

The following table presents the amount of net unrealized gains and losses included in earnings attributable to Level 3 assets still held at September 30, 2022 and 2021:

	Three months ended September 30,				Nine months ended September 30,
(Dollars in millions)	2022		2021		2022		2021
Other assets:
Equity warrant assets (1)	$	26	$	21	$	84	$	113
Contingent conversion rights (2)	—		—		(1)		—
Total unrealized gains, net	$	26	$	21	$	83	$	113

(1)Unrealized gains and losses are recorded in the line item “Gains on equity warrant assets, net," a component of noninterest income.

(2)Unrealized gains and losses are recorded in the line item "Other noninterest income," a component of noninterest income.

Quantitative Information About Significant Unobservable Inputs

The following table presents quantitative information about the significant unobservable inputs used for certain of our Level 3 fair value measurements at September 30, 2022 and December 31, 2021. We have not included in this table our venture capital and private equity fund investments (fair value accounting) as we use net asset value per share (as obtained from the general partners of the investments) as a practical expedient to determine fair value.

(Dollars in millions)	Fair value	Valuation Technique	Significant Unobservable Inputs	Input Range	Weighted  Average
September 30, 2022:
Equity warrant assets (private portfolio)	345	Black-Scholes option pricing model	Volatility	23.8 - 51.3	42.3
			Risk-Free interest rate	3.3 - 4.4	4.2
			Marketability discount (2)	17.1	17.1
			Remaining life assumption (3)	40.0	40.0
Contingent conversion rights (private portfolio)	6	Private company equity pricing	(4)	(4)	(4)
December 31, 2021:
Equity warrant assets (public portfolio)	2	Black-Scholes option pricing model	Volatility	27.8% - 55.0%	43.7	%
			Risk-Free interest rate	0.6- 1.5	1.1
			Sales restrictions discount (1)	10.0 - 20.0	10.7
Equity warrant assets (private portfolio)	267	Black-Scholes option pricing model	Volatility	24.7 - 55.0	43.0
			Risk-Free interest rate	0.06 - 1.40	0.8
			Marketability discount (2)	20.1	20.1
			Remaining life assumption (3)	40.0	40.0

    

(1)We adjust quoted market prices of public companies, which are subject to certain sales restrictions. Sales restriction discounts generally range from 10 percent to 20 percent depending on the duration of the sales restrictions, which typically range from three to six months.

(2)Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based upon various option-pricing models. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.

(3)We adjust the contractual remaining term of private company warrants based on our estimate of the actual remaining life, which we determine by utilizing historical data on terminations and exercises. At September 30, 2022, the weighted average contractual remaining term was 6.2 years, compared to our estimated remaining life of 2.5 years. On a quarterly basis, a sensitivity analysis is performed on our remaining life assumption.

(4)In determining the fair value of our private contingent conversion rights portfolio (not valued using the Black-Scholes model), we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted enterprise values, the probability of a conversion event occurring and limitations and conversion pricing outlined in the convertible debt agreement. Additionally, we have ongoing communication with the portfolio companies and relationship teams, to determine whether there is a material change in fair value. We use company provided valuation reports, if available, to support our valuation assumptions. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.

Summary of Estimated Fair Values of Financial Instruments Not Carried at Fair Value

The following fair value hierarchy table presents the estimated fair values of our financial instruments that are not carried at fair value at September 30, 2022 and December 31, 2021:

			Estimated Fair Value
(Dollars in millions)	Carrying Amount		Total		Level 1		Level 2		Level 3
September 30, 2022:
Financial assets:
Cash and cash equivalents	$	13,968	$	13,968	$	13,968	$	—	$	—
HTM securities	93,286		77,370		—		77,370		—
Non-marketable securities not measured at net asset value	431		431		—		—		431
Non-marketable securities measured at net asset value	660		660		—		—		—
Net loans	71,572		72,489		—		—		72,489
FHLB and Federal Reserve Bank stock	665		665		—		—		665
Financial liabilities:
Short-term borrowings	13,552		13,552		—		13,552		—
Non-maturity deposits (1)	171,545		171,545		171,545		—		—
Time deposits	5,274		4,916		—		4,916		—
3.50% Senior Notes	349		336		—		336		—
3.125% Senior Notes	496		407		—		407		—
1.800% Senior Notes due 2031	495		358		—		358		—
2.100% Senior Notes due 2028	496		408		—		408		—
1.800% Senior Notes due 2026	646		559		—		559		—
4.345% Senior Notes due 2028	348		327		—		327		—
4.570% Senior Notes due 2033	447		396		—		396		—
Junior subordinated debentures	91		91		—		91		—
Off-balance sheet financial assets:
Commitments to extend credit	—		49		—		—		49
December 31, 2021:
Financial assets:
Cash and cash equivalents	$	14,586	$	14,586	$	14,586	$	—	$	—
HTM securities	98,195		97,227		—		97,227		—
Non-marketable securities not measured at net asset value	424		424		—		—		424
Non-marketable securities measured at net asset value	710		710		—		—		—
Net loans	65,854		67,335		—		—		67,335
FHLB and Federal Reserve Bank stock	107		107		—		—		107
Financial liabilities:
Short-term borrowings	71		71		—		71		—
Non-maturity deposits (1)	187,464		187,464		187,464		—		—
Time deposits	1,739		1,728		—		1,728		—
3.50% Senior Notes	349		370		—		370		—
3.125% Senior Notes	496		526		—		526		—
1.800% Senior Notes due 2031	494		474		—		474		—
2.100% Senior Notes due 2028	496		501		—		501		—
1.800% Senior Notes due 2026	645		649		—		649		—
Junior subordinated debentures	90		92		—		92		—
Off-balance sheet financial assets:
Commitments to extend credit	—		47		—		—		47

(1)Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.

Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments

The following table is a summary of the estimated fair values of these investments and remaining unfunded commitments for each major category of these investments as of September 30, 2022:

(Dollars in millions)	Carrying Amount		Fair Value		Unfunded Commitments
Non-marketable securities (fair value accounting):
Venture capital and private equity fund investments (1)	$	270	$	270	$	13
Non-marketable securities (equity method accounting):
Venture capital and private equity fund investments (2)	639		639		11
Debt funds (2)	4		4		—
Other investments (2)	17		17		1
Total	$	930	$	930	$	25

(1)Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds (consolidated VIEs) and investments in venture capital and private equity fund investments (unconsolidated VIEs). Collectively, these investments in venture capital and private equity funds are primarily in U.S. and global technology and life science/healthcare companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are $42 million and $2 million, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next 10 to 13 years, depending on the age of the funds and any potential extensions of terms of the funds.

(2)Venture capital and private equity fund investments, debt funds, and other fund investments within non-marketable securities (equity method accounting) include funds that invest in or lend money to primarily U.S. and global technology and life science/healthcare companies. It is estimated that we will receive distributions from the funds over the next 5 to 8 years, depending on the age of the funds and any potential extensions of the terms of the funds.

XML

Stockholders' Equity and EPS - Reclassification out of AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains (losses) on investment securities, net	$ (127)	$ 189	$ (199)	$ 661
Related tax benefit	(175)	(149)	(489)	(509)
Net interest income	1,198	852	3,447	2,240
Total reclassification adjustment for gains included in net income, net of tax	429	365	1,234	1,399
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Total reclassification adjustment for gains included in net income, net of tax	(10)	(12)	(65)	(34)
Accumulated Net Investment Gain (Loss) Attributable to Parent | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains (losses) on investment securities, net	0	0	(48)	0
Related tax benefit	0	0	14	0
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent | Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Related tax benefit	4	4	12	13
Net interest income	$ (14)	$ (16)	$ (43)	$ (47)

XML

Stockholders' Equity and EPS - Activity Related to Net Gains on Cash Flow Hedges in AOCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash flow hedge gains expected to reclassified out of AOCI over next 12 months			$ 46
Balance, beginning of period, net of tax	$ 16,276	$ 11,967	16,609	$ 8,433
Balance, end of period, net of tax	15,810	14,669	15,810	14,669
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Line Items]
Balance, beginning of period, net of tax	62	107	83	129
Net realized (gain) loss reclassified to net income, net of tax	(10)	(12)	(31)	(34)
Balance, end of period, net of tax	$ 52	$ 95	$ 52	$ 95

XML

Stockholders' Equity and EPS - Reconciliation of Basic EPS to Diluted EPS (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net income available to common stockholders	$ 429	$ 365	$ 1,234	$ 1,399
Denominator:
Weighted average common shares outstanding-basic (in shares)	59,096	57,723	58,945	54,772
Weighted average common shares outstanding—diluted (in shares)	59,549	58,521	59,535	55,617
Earnings per common share:
Basic (dollars per share)	$ 7.26	$ 6.33	$ 20.94	$ 25.54
Diluted (dollars per share)	$ 7.21	$ 6.24	$ 20.73	$ 25.16
Stock options and ESPP
Denominator:
Weighted average effect of dilutive securities (in shares)	165	268	206	278
Restricted stock units and awards
Denominator:
Weighted average effect of dilutive securities (in shares)	288	530	384	567

XML

Stockholders' Equity and EPS - Common Shares Excluded from Diluted EPS Calculation as They Were Deemed to be Anti-Dilutive (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation	619	56	204	31
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation	142	56	105	31
Restricted stock units and awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from diluted earnings per share calculation	477	0	99	0

XML

Stockholders' Equity and EPS - Preferred Stock Summary (Details) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Dec. 31, 2021 USD ($) $ / shares shares
Class of Stock [Line Items]
Carrying value | $	$ 3,646	$ 3,646
Shares issued and outstanding | shares	383,500	383,500
Par Value	$ 0.001	$ 0.001
Series A Preferred Stock
Class of Stock [Line Items]
Amount outstanding | $	$ 350
Carrying value | $	$ 340
Shares issued and outstanding | shares	350,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.025
Preferred stock, liquidation preference per depositary share	$ 25
2021 dividends paid per depository share, usd per share	$ 0.984375
Preferred stock, dividend rate, percentage	5.25%
Preferred stock, dividend rate, percentage	5.25%
Series B Preferred Stock
Class of Stock [Line Items]
Amount outstanding | $	$ 750
Carrying value | $	$ 739
Shares issued and outstanding | shares	7,500
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 30.75
Preferred stock, dividend rate, percentage	4.10%
Preferred stock, dividend rate, percentage	4.10%
Series C Preferred Stock
Class of Stock [Line Items]
Amount outstanding | $	$ 1,000
Carrying value | $	$ 985
Shares issued and outstanding | shares	10,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 30.00
Preferred stock, dividend rate, percentage	4.00%
Preferred stock, dividend rate, percentage	4.00%
Series D Preferred Stock
Class of Stock [Line Items]
Amount outstanding | $	$ 1,000
Carrying value | $	$ 989
Shares issued and outstanding | shares	10,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 33.88
Preferred stock, dividend rate, percentage	4.25%
Preferred stock, dividend rate, percentage	4.25%
Series E Preferred Stock
Class of Stock [Line Items]
Amount outstanding | $	$ 600
Carrying value | $	$ 593
Shares issued and outstanding | shares	6,000
Par Value	$ 0.001
Preferred stock, depository share ownership interest	0.01
Preferred stock, liquidation preference per depositary share	$ 1,000
2021 dividends paid per depository share, usd per share	$ 37.47
Preferred stock, dividend rate, percentage	4.70%
Preferred stock, dividend rate, percentage	4.70%

XML

Stockholders' Equity and EPS - QTD Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	$ 16,276	$ 11,967	$ 16,609	$ 8,433
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)	2	(31)	(1)
Issuance of stock		1,245		2,363
Issuance of common stock for the acquisition of Boston Private		1,060		1,060
Net income	418	475	1,304	1,665
Capital calls and distributions, net	(6)	(19)	(19)	(70)
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Share-based compensation, net	51	38	146	93
Dividends on preferred stock	(40)	(22)	(123)	(40)
Balance, end of period, net of tax	15,810	14,669	15,810	14,669
Noncumulative Preferred Stock
Stockholders Equity Note [Line Items]
Issuance of stock				1,724
Preferred Stock
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	3,646	2,064	3,646	340
Balance, end of period, net of tax	$ 3,646	$ 2,064	$ 3,646	2,064
Preferred Stock | Noncumulative Preferred Stock
Stockholders Equity Note [Line Items]
Issuance of stock				$ 1,724
Common Stock
Stockholders Equity Note [Line Items]
Balance (in shares)	59,081,326	54,530,307	58,748,469	51,888,463
Balance, beginning of period, net of tax	$ 0	$ 0	$ 0	$ 0
Common stock issued under employee benefit plans, net of restricted stock cancellations (in shares)	22,798	32,195	355,655	374,039
Common stock issued under employee benefit plans, net of restricted stock cancellations			$ 0	$ 0
Issuance of stock (in shares)		2,227,000		4,527,000
Issuance of stock		$ 0		$ 0
Issuance of common stock for the acquisition of Boston Private (in shares)		1,887,981		1,887,981
Issuance of common stock for the acquisition of Boston Private		$ 0
Balance (in shares)	59,104,124	58,677,483	59,104,124	58,677,483
Balance, end of period, net of tax	$ 0	$ 0	$ 0	$ 0
Additional Paid-in Capital
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	5,223	2,755	5,157	1,585
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)	2	(31)	(1)
Issuance of stock		1,245		2,363
Issuance of common stock for the acquisition of Boston Private		1,060		1,060
Share-based compensation, net	51	38	146	93
Balance, end of period, net of tax	5,272	5,100	5,272	5,100
Retained Earnings
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	8,247	6,706	7,442	5,672
Net income	469	387	1,357	1,439
Dividends on preferred stock	(40)	(22)	(123)	(40)
Balance, end of period, net of tax	8,676	7,071	8,676	7,071
Accumulated Other Comprehensive Income (Loss)
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	(1,198)	142	(9)	623
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Balance, end of period, net of tax	(2,085)	65	(2,085)	65
Total SVBFG Stockholders’ Equity
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	15,918	11,667	16,236	8,220
Common stock issued under employee benefit plans, net of restricted stock cancellations	(2)	2	(31)	(1)
Issuance of stock		1,245		2,363
Issuance of common stock for the acquisition of Boston Private		1,060		1,060
Net income	469	387	1,357	1,439
Other comprehensive income (loss), net of tax	(887)	(77)	(2,076)	(558)
Share-based compensation, net	51	38	146	93
Dividends on preferred stock	(40)	(22)	(123)	(40)
Balance, end of period, net of tax	15,509	14,300	15,509	14,300
Total SVBFG Stockholders’ Equity | Noncumulative Preferred Stock
Stockholders Equity Note [Line Items]
Issuance of stock				1,724
Noncontrolling Interests
Stockholders Equity Note [Line Items]
Balance, beginning of period, net of tax	358	300	373	213
Net income	(51)	88	(53)	226
Capital calls and distributions, net	(6)	(19)	(19)	(70)
Balance, end of period, net of tax	$ 301	$ 369	$ 301	$ 369

XML

Variable Interest Entities - Carrying Amounts and Classification of Significant Variable Interests (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Variable Interest Entity [Line Items]
Cash and cash equivalents	$ 13,968	$ 14,586
Non-marketable and other equity securities	2,595	2,543
Accrued interest receivable and other assets	3,523	1,791
Total assets	212,867	211,308
Other liabilities	2,889	2,467
Long-term debt	3,368	2,570
Total liabilities	197,057	194,699
Maximum exposure to loss in unconsolidated VIEs	1,369	1,233
Investments in qualified affordable housing projects, net	1,205	954
Consolidated
Variable Interest Entity [Line Items]
Cash and cash equivalents	7	13
Non-marketable and other equity securities	767	768
Accrued interest receivable and other assets	35	31
Total assets	809	812
Other liabilities	23	18
Long-term debt	0	0
Total liabilities	23	18
Maximum exposure to loss in unconsolidated VIEs	786
Unconsolidated
Variable Interest Entity [Line Items]
Cash and cash equivalents	0	0
Non-marketable and other equity securities	1,369	1,233
Accrued interest receivable and other assets	6	6
Total assets	1,375	1,239
Other liabilities	672	482
Long-term debt	91	90
Total liabilities	763	572
Non-marketable securities | Unconsolidated
Variable Interest Entity [Line Items]
Maximum exposure to loss in unconsolidated VIEs	$ 1,369	$ 1,233

XML

Variable Interest Entities - Additional Information (Details) $ in Millions	Sep. 30, 2022 USD ($) entity	Dec. 31, 2021 USD ($)
Investments In Variable Interest Entities [Abstract]
Number of consolidated entities | entity	4
Variable Interest Entity [Line Items]
Maximum exposure to loss in unconsolidated VIEs	$ 1,369	$ 1,233
Total assets	212,867	211,308
Other liabilities	2,889	2,467
Qualified Affordable Housing Project Investments, Commitment	672	482
Consolidated
Variable Interest Entity [Line Items]
Maximum exposure to loss in unconsolidated VIEs	786
Total assets	809	812
Other liabilities	23	18
Unconsolidated
Variable Interest Entity [Line Items]
Total assets	1,375	1,239
Other liabilities	$ 672	$ 482

XML

Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash and due from banks	$ 1,411	$ 2,168
Interest bearing deposits with the Federal Reserve Bank	7,550	5,686
Interest bearing deposits with other institutions	4,610	5,773
Securities purchased under agreements to resell	397	607
Other short-term investment securities	0	352
Total cash and cash equivalents	$ 13,968	$ 14,586

XML

Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Footnote Information) (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Fair value of securities purchased under agreements to resell	$ 402,000,000	$ 620,000,000
Securities received as collateral, amount repledged and sold	$ 0	$ 0

XML

Investment Securities - Components of Available-for-Sale Investment Securities Portfolio (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 29,502	$ 27,370
Unrealized Gains	0	164
Unrealized Losses	(2,791)	(313)
Carrying value	26,711	27,221
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	18,041	15,799
Unrealized Gains	0	121
Unrealized Losses	(1,196)	(70)
Carrying value	16,845	15,850
U.S. agency debentures
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	120	200
Unrealized Gains	0	0
Unrealized Losses	(20)	(4)
Carrying value	100	196
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,062	61
Unrealized Gains	0	0
Unrealized Losses	(149)	0
Carrying value	913	61
Agency-issued MBS
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	7,883	8,786
Unrealized Gains	0	13
Unrealized Losses	(1,200)	(210)
Carrying value	6,683	8,589
Agency-issued CMO—fixed rate
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	792	988
Unrealized Gains	0	3
Unrealized Losses	(78)	(9)
Carrying value	714	982
Agency-issued CMBS
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,604	1,536
Unrealized Gains	0	27
Unrealized Losses	(148)	(20)
Carrying value	$ 1,456	$ 1,543

XML

Investment Securities - Activity of Available-for-Sale Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investments, Debt and Equity Securities [Abstract]
Sales proceeds	$ 0	$ 168	$ 8,511	$ 168
Gross realized gains	0	0	146	0
Gross realized losses	0	0	(98)	0
Net realized gains (losses)	$ 0	$ 0	$ 48	$ 0

XML

Investment Securities - Summary of Unrealized Losses on Available-for-Sale Securities (Details) $ in Millions	Sep. 30, 2022 USD ($) Investment	Dec. 31, 2021 USD ($) Investment
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	$ 17,868	$ 17,596
Unrealized Losses, Less than 12 months	1,526	304
Fair Value of Investments, 12 months or longer	8,832	163
Unrealized Losses, 12 months or longer	1,265	9
Fair Value of Investments	26,700	17,759
Unrealized Losses	$ 2,791	$ 313
Number of investments in unrealized loss position | Investment	804	475
Number of investments with unrealized losses greater than 12 months | Investment	289	4
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	$ 13,359	$ 7,777
Unrealized Losses, Less than 12 months	958	70
Fair Value of Investments, 12 months or longer	3,487	0
Unrealized Losses, 12 months or longer	238	0
Fair Value of Investments	16,846	7,777
Unrealized Losses	1,196	70
U.S. agency debentures
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	20	196
Unrealized Losses, Less than 12 months	1	4
Fair Value of Investments, 12 months or longer	80	0
Unrealized Losses, 12 months or longer	19	0
Fair Value of Investments	100	196
Unrealized Losses	20	4
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	913
Unrealized Losses, Less than 12 months	149
Fair Value of Investments, 12 months or longer	0
Unrealized Losses, 12 months or longer	0
Fair Value of Investments	913
Unrealized Losses	149
Agency-issued MBS
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	2,236	8,280
Unrealized Losses, Less than 12 months	304	210
Fair Value of Investments, 12 months or longer	4,448	0
Unrealized Losses, 12 months or longer	896	0
Fair Value of Investments	6,684	8,280
Unrealized Losses	1,200	210
Agency-issued CMO—fixed rate
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	534	740
Unrealized Losses, Less than 12 months	55	9
Fair Value of Investments, 12 months or longer	168	0
Unrealized Losses, 12 months or longer	23	0
Fair Value of Investments	702	740
Unrealized Losses	78	9
Agency-issued CMBS
Debt Securities, Available-for-sale [Line Items]
Fair Value of Investments, Less than 12 months	806	603
Unrealized Losses, Less than 12 months	59	11
Fair Value of Investments, 12 months or longer	649	163
Unrealized Losses, 12 months or longer	89	9
Fair Value of Investments	1,455	766
Unrealized Losses	$ 148	$ 20

XML

Investment Securities - Summary of Remaining Contractual Principal Maturities for Available-for-Sale Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	$ 26,711	$ 27,221
One Year or Less	977
After One Year to Five Years	15,313
After Five Years to Ten Years	3,069
After Ten Years	7,352
U.S. treasury securities
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	16,845	15,850
One Year or Less	936
After One Year to Five Years	15,133
After Five Years to Ten Years	776
After Ten Years	0
U.S. agency debentures
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	100	196
One Year or Less	0
After One Year to Five Years	34
After Five Years to Ten Years	66
After Ten Years	0
Foreign government debt securities
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	913	61
One Year or Less	41
After One Year to Five Years	46
After Five Years to Ten Years	826
After Ten Years	0
Agency-issued MBS
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	6,683	8,589
One Year or Less	0
After One Year to Five Years	0
After Five Years to Ten Years	45
After Ten Years	6,638
Agency-issued CMO—fixed rate
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	714	982
One Year or Less	0
After One Year to Five Years	0
After Five Years to Ten Years	0
After Ten Years	714
Agency-issued CMBS
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Total	1,456	$ 1,543
One Year or Less	0
After One Year to Five Years	100
After Five Years to Ten Years	1,356
After Ten Years	$ 0
Available-for-sale Securities | Lower Limit
Debt Securities, Available-for-sale [Line Items]
Mortgage-backed securities contractual maturities (in years)	10 years
Available-for-sale Securities | Upper Limit
Debt Securities, Available-for-sale [Line Items]
Mortgage-backed securities contractual maturities (in years)	30 years

XML

Investment Securities - Components of Held-to-Maturity Investment Securities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	$ 93,292	$ 98,202
Unrealized Gains	0	368
Unrealized Losses	(15,922)	(1,343)
Fair Value	77,370	97,227
Held-to-maturity securities, allowance for credit losses	6	7	$ 6	$ 5	$ 1
U.S. agency debentures
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	486	609
Unrealized Gains	0	8
Unrealized Losses	(53)	(2)
Fair Value	433	615
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued MBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	59,200	64,439
Unrealized Gains	0	124
Unrealized Losses	(10,017)	(887)
Fair Value	49,183	63,676
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued CMO | Fixed rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	10,741	10,226
Unrealized Gains	0	9
Unrealized Losses	(1,813)	(145)
Fair Value	8,928	10,090
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued CMO | Variable rate
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	83	100
Unrealized Gains	0	1
Unrealized Losses	(1)	0
Fair Value	82	101
Held-to-maturity securities, allowance for credit losses	0	0
Agency-issued CMBS
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	14,644	14,959
Unrealized Gains	0	39
Unrealized Losses	(2,304)	(277)
Fair Value	12,340	14,721
Held-to-maturity securities, allowance for credit losses	0	0
Municipal bonds and notes
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	7,429	7,157
Unrealized Gains	0	185
Unrealized Losses	(1,612)	(27)
Fair Value	5,817	7,315
Held-to-maturity securities, allowance for credit losses	1	1
Corporate bonds
Schedule of Held-to-maturity Securities [Line Items]
Amortized Cost	709	712
Unrealized Gains	0	2
Unrealized Losses	(122)	(5)
Fair Value	587	709
Held-to-maturity securities, allowance for credit losses	$ 5	$ 6

XML

Investment Securities - Allowance for Credit Losses for HTM Securities (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity securities, allowance for credit losses	$ 6	$ 6	$ 6	$ 7	$ 5	$ 1
Held-to-maturity securities, (reduction of) provision for credit losses,	$ 1	(1)	$ 6
Held-to-maturity, accrued interest receivable		294		171
Accrued interest receivable and other assets | Held-to-maturity Securities
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity, accrued interest receivable		205		225
Municipal bonds and notes
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity securities, allowance for credit losses		1		1
Corporate bonds
Debt Securities, Held-to-maturity, Allowance for Credit Loss [Line Items]
Held-to-maturity securities, allowance for credit losses		$ 5		$ 6

XML

Investment Securities - Credit Quality Indicators (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	$ 93,292	$ 98,202
Municipal bonds and notes
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	7,429	7,157
Municipal bonds and notes | Aaa
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	4,270	3,774
Municipal bonds and notes | Aa1
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	1,880	2,031
Municipal bonds and notes | Aa2
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	1,081	1,154
Municipal bonds and notes | Aa3
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	171	172
Municipal bonds and notes | A1
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	27	26
Corporate bonds
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	709	712
Corporate bonds | Aaa
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	39	39
Corporate bonds | Aa2
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	42	42
Corporate bonds | Aa3
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	105	105
Corporate bonds | A1
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	282	251
Corporate bonds | A2
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	230	264
Corporate bonds | A3
Financing Receivable, Credit Quality Indicator [Line Items]
Held-to-maturity securities, amortized cost	$ 11	$ 11

XML

Investment Securities - Summary of Remaining Contractual Principal Maturities for Held-to-Maturity Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	$ 93,286
Fair Value	77,370	$ 97,227
One Year or Less, Net Carry Value	72
One Year or Less, Fair Value	71
After One Year to Five Years, Net Carry Value	716
After One Year to Five Years, Fair Value	666
After Five Years to Ten Years, Net Carry Value	4,491
After Five Years to Ten Years, Fair Value	3,931
After Ten Years, Net Carry Value	88,007
After Ten Years, Fair Value	72,702
U.S. agency debentures
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	486
Fair Value	433	615
One Year or Less, Net Carry Value	1
One Year or Less, Fair Value	1
After One Year to Five Years, Net Carry Value	118
After One Year to Five Years, Fair Value	111
After Five Years to Ten Years, Net Carry Value	367
After Five Years to Ten Years, Fair Value	321
After Ten Years, Net Carry Value	0
After Ten Years, Fair Value	0
Agency-issued MBS
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	59,200
Fair Value	49,183	63,676
One Year or Less, Net Carry Value	1
One Year or Less, Fair Value	1
After One Year to Five Years, Net Carry Value	2
After One Year to Five Years, Fair Value	2
After Five Years to Ten Years, Net Carry Value	1,148
After Five Years to Ten Years, Fair Value	1,063
After Ten Years, Net Carry Value	58,049
After Ten Years, Fair Value	48,117
Agency-issued CMO | Fixed rate
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	10,741
Fair Value	8,928	10,090
One Year or Less, Net Carry Value	0
One Year or Less, Fair Value	0
After One Year to Five Years, Net Carry Value	87
After One Year to Five Years, Fair Value	83
After Five Years to Ten Years, Net Carry Value	154
After Five Years to Ten Years, Fair Value	146
After Ten Years, Net Carry Value	10,500
After Ten Years, Fair Value	8,699
Agency-issued CMO | Variable rate
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	83
Fair Value	82	101
One Year or Less, Net Carry Value	0
One Year or Less, Fair Value	0
After One Year to Five Years, Net Carry Value	0
After One Year to Five Years, Fair Value	0
After Five Years to Ten Years, Net Carry Value	0
After Five Years to Ten Years, Fair Value	0
After Ten Years, Net Carry Value	83
After Ten Years, Fair Value	82
Agency-issued CMBS
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	14,644
Fair Value	12,340	14,721
One Year or Less, Net Carry Value	45
One Year or Less, Fair Value	44
After One Year to Five Years, Net Carry Value	159
After One Year to Five Years, Fair Value	146
After Five Years to Ten Years, Net Carry Value	968
After Five Years to Ten Years, Fair Value	802
After Ten Years, Net Carry Value	13,472
After Ten Years, Fair Value	11,348
Municipal bonds and notes
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	7,428
Fair Value	5,817	7,315
One Year or Less, Net Carry Value	25
One Year or Less, Fair Value	25
After One Year to Five Years, Net Carry Value	235
After One Year to Five Years, Fair Value	222
After Five Years to Ten Years, Net Carry Value	1,265
After Five Years to Ten Years, Fair Value	1,114
After Ten Years, Net Carry Value	5,903
After Ten Years, Fair Value	4,456
Corporate bonds
Schedule of Held-to-maturity Securities [Line Items]
Net Carry Value	704
Fair Value	587	$ 709
One Year or Less, Net Carry Value	0
One Year or Less, Fair Value	0
After One Year to Five Years, Net Carry Value	115
After One Year to Five Years, Fair Value	102
After Five Years to Ten Years, Net Carry Value	589
After Five Years to Ten Years, Fair Value	485
After Ten Years, Net Carry Value	0
After Ten Years, Fair Value	$ 0
Held-to-maturity Securities | Lower Limit
Schedule of Held-to-maturity Securities [Line Items]
Mortgage-backed securities contractual maturities (in years)	10 years
Held-to-maturity Securities | Upper Limit
Schedule of Held-to-maturity Securities [Line Items]
Mortgage-backed securities contractual maturities (in years)	30 years

XML

Investment Securities - Components of Non-marketable and Other Equity Securities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Investment Holdings [Line Items]
Investments in qualified affordable housing projects, net	$ 1,205	$ 954
Non-marketable and other equity securities	2,595	2,543
Fair value accounting | Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	147	130
Fair value accounting | Unconsolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	123	208
Fair value accounting | Equity securities
Investment Holdings [Line Items]
Other equity securities in public companies (fair value accounting)	29	117
Fair value accounting | Other investments
Investment Holdings [Line Items]
Nonmarketable securities	176	164
Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	639	671
Equity method accounting | Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	639	671
Equity method accounting | Debt funds
Investment Holdings [Line Items]
Nonmarketable securities	4	5
Equity method accounting | Other investments
Investment Holdings [Line Items]
Nonmarketable securities	$ 272	$ 294

XML

Investment Securities - Summary of Venture Capital and Private Equity Fund Investments Held by Consolidated Funds and Percentage Ownership (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Upper Limit
Investment Holdings [Line Items]
Percentage of ownership	5.00%
Fair value accounting | Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	$ 147		$ 130
Fair value accounting | Consolidated venture capital and private equity fund investments | Strategic Investors Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	2		2
Fair value accounting | Consolidated venture capital and private equity fund investments | Capital Preferred Return Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	30		61
Fair value accounting | Consolidated venture capital and private equity fund investments | Growth Partners, LP
Investment Holdings [Line Items]
Nonmarketable securities	25		67
Fair value accounting | Consolidated venture capital and private equity fund investments | Redwood Evergreen Fund, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 90		$ 0
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | Strategic Investors Fund, LP
Investment Holdings [Line Items]
Percentage of ownership	12.60%	12.60%
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | Capital Preferred Return Fund, LP
Investment Holdings [Line Items]
Percentage of ownership	20.00%	20.00%
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | Growth Partners, LP
Investment Holdings [Line Items]
Percentage of ownership	33.00%	33.00%
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments | Redwood Evergreen Fund, LP
Investment Holdings [Line Items]
Percentage of ownership	100.00%	0.00%

XML

Investment Securities - Non-marketable and Other Securities Additional Information (Details) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022 USD ($) Investment	Sep. 30, 2021 USD ($)	Sep. 30, 2022 USD ($) Investment	Sep. 30, 2021 USD ($)	Dec. 31, 2021 USD ($) Investment
Investment Holdings [Line Items]
Investments in qualified affordable housing projects, net	$ 1,205		$ 1,205		$ 954
Other liabilities	672		672		482
Tax credits and other tax benefits recognized	30	$ 9	80	$ 63
Amortization expense included in provision for income taxes	17	$ 17	52	$ 48
Fair value accounting | Unconsolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	123		123		208
Fair value accounting | Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	147		147		130
Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	639		639		671
Equity method accounting | Consolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	639		639		671
Equity method accounting | Consolidated venture capital and private equity fund investments | CP II, LP
Investment Holdings [Line Items]
Nonmarketable securities	$ 2		$ 2		$ 2
Upper Limit
Investment Holdings [Line Items]
Percentage of ownership	5.00%
Non-marketable securities | Fair value accounting | Unconsolidated venture capital and private equity fund investments
Investment Holdings [Line Items]
Number of investments | Investment	141		141		150
Non-marketable securities | Equity method accounting | Consolidated venture capital and private equity fund investments | CP II, LP
Investment Holdings [Line Items]
Percentage of ownership	5.10%	5.10%
Non-marketable securities | Equity method accounting | Consolidated venture capital and private equity fund investments | CP II, LP | Direct ownership interest
Investment Holdings [Line Items]
Percentage of ownership	1.30%

XML

Investment Securities - Changes to Carrying Amount of Other Investments without Readily Determinable Fair Value (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($)
Investments, Debt and Equity Securities [Abstract]
Carrying value	$ 176
Carrying value adjustments:
Impairment	0
Upward changes for observable prices	0
Downward changes for observable prices	(6)
Cumulative Adjustments
Impairment	(1)
Upward changes for observable prices	52
Downward changes for observable prices	$ (11)

XML

Investment Securities - Carrying Value and Ownership Percentage of Investments (Details) - USD ($) $ in Millions	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	$ 639		$ 671
Consolidated venture capital and private equity fund investments | Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities	147		130
Consolidated venture capital and private equity fund investments | Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	639		671
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund II, LP
Investment Holdings [Line Items]
Nonmarketable securities	2		3
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund III, LP
Investment Holdings [Line Items]
Nonmarketable securities	13		25
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund IV, LP
Investment Holdings [Line Items]
Nonmarketable securities	23		36
Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund V funds
Investment Holdings [Line Items]
Nonmarketable securities	59		87
Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP
Investment Holdings [Line Items]
Nonmarketable securities	2		2
Consolidated venture capital and private equity fund investments | Equity method accounting | Other venture capital and private equity fund investments
Investment Holdings [Line Items]
Nonmarketable securities	540		518
Debt funds | Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	4		5
Debt funds | Equity method accounting | Gold Hill Capital 2008, LP
Investment Holdings [Line Items]
Nonmarketable securities	3		4
Debt funds | Equity method accounting | Other debt funds
Investment Holdings [Line Items]
Nonmarketable securities	1		1
Other investments | Fair value accounting
Investment Holdings [Line Items]
Nonmarketable securities	176		164
Other investments | Equity method accounting
Investment Holdings [Line Items]
Nonmarketable securities	272		294
Other investments | Equity method accounting | SPD Silicon Valley Bank Co., Ltd.
Investment Holdings [Line Items]
Nonmarketable securities	143		154
Other investments | Equity method accounting | Other investments
Investment Holdings [Line Items]
Nonmarketable securities	$ 129		$ 140
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund II, LP
Investment Holdings [Line Items]
Percentage of ownership	8.60%	8.60%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund III, LP
Investment Holdings [Line Items]
Percentage of ownership	5.90%	5.90%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | Strategic Investors Fund IV, LP
Investment Holdings [Line Items]
Percentage of ownership	5.00%	5.00%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP
Investment Holdings [Line Items]
Percentage of ownership	5.10%	5.10%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP | Direct ownership interest
Investment Holdings [Line Items]
Percentage of ownership	1.30%
Non-marketable securities | Consolidated venture capital and private equity fund investments | Equity method accounting | CP II, LP | Indirect ownership interest
Investment Holdings [Line Items]
Percentage of ownership	3.80%
Non-marketable securities | Debt funds | Equity method accounting | Direct ownership interest
Investment Holdings [Line Items]
Percentage of ownership	11.50%
Non-marketable securities | Debt funds | Equity method accounting | Indirect ownership interest
Investment Holdings [Line Items]
Percentage of ownership	4.00%
Non-marketable securities | Debt funds | Equity method accounting | Gold Hill Capital 2008, LP
Investment Holdings [Line Items]
Percentage of ownership	15.50%	15.50%
Non-marketable securities | Other investments | Equity method accounting | SPD Silicon Valley Bank Co., Ltd.
Investment Holdings [Line Items]
Percentage of ownership	50.00%	50.00%

XML

Investment Securities - Net Gains on Non-marketable and Other Equity Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	$ (127)	$ 189	$ (247)	$ 661
Non-marketable securities
Gain (Loss) on Securities [Line Items]
Less: realized net gains (losses) on sales of non-marketable and other equity securities	13	(17)	(16)	110
Net (losses) gains on non-marketable and other equity securities still held	(140)	206	(231)	551
Non-marketable securities | Fair value accounting | Consolidated venture capital and private equity fund investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(52)	36	(100)	72
Non-marketable securities | Fair value accounting | Unconsolidated venture capital and private equity fund investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(61)	47	(80)	79
Non-marketable securities | Fair value accounting | Other investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	0	(2)	(3)	11
Non-marketable securities | Equity method accounting | Consolidated venture capital and private equity fund investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(12)	144	(20)	438
Non-marketable securities | Equity method accounting | Debt funds
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	(1)	0	(1)	2
Non-marketable securities | Equity method accounting | Other investments
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	7	3	9	6
Other equity securities | Fair value accounting
Gain (Loss) on Securities [Line Items]
Total net gains on non-marketable and other equity securities	$ (8)	$ (39)	$ (52)	$ 53

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Composition of Loans, Net of Unearned Income (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	$ 72,129		$ 66,276
ACL	(557)	$ (545)	(422)	$ (398)	$ (396)	$ (448)
Net loans	71,572		65,854
Unearned income on loans	244		250
Credit cards
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	582		583
Construction loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	454		367
Global fund banking
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	40,337		37,958
ACL	(91)	(89)	(67)	(59)	(66)	(46)
Investor dependent
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	6,309		5,544
ACL	(234)	(224)	(146)	(138)	(158)	(213)
Investor dependent | Early stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,911		1,593
Investor dependent | Growth stage
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	4,398		3,951
Cash flow dependent and innovation C&I (Commercial and Industrial)
Accounts, Notes, Loans and Financing Receivable [Line Items]
ACL	(136)	(130)	(118)	(109)	(119)	(125)
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,845		1,798
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	8,321		6,673
Private bank
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	10,102		8,743
ACL	(47)	(45)	(33)	(31)	(47)	(53)
CRE
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	2,609		2,670
ACL	(27)	(34)	(36)	(40)	0	0
Other C&I
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,087		1,257
ACL	(12)	(12)	(14)	(12)	0	0
Premium wine and other
Accounts, Notes, Loans and Financing Receivable [Line Items]
ACL	(10)	$ (11)	(8)	(9)	$ (6)	(9)
Premium wine and other | Premium wine
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	1,117		985
PPP Loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, amortized cost	$ 28		$ 331
ACL				$ 0		$ (2)

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Credit Quality Indicators, Broken out by Risk-Based Segments and Vintage Year (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	$ 8,623	$ 11,032
Year Two	8,711	5,880
Year Three	4,127	3,045
Year Four	2,154	1,279
Year Five	835	1,006
Prior	2,696	2,462
Revolving Loans	44,967	41,516
Revolving Loans Converted to Term Loans	60	77
Unallocated	(44)	(21)
Loans, amortized cost	72,129	66,276
Global fund banking
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	512	814
Year Two	95	133
Year Three	63	36
Year Four	31	6
Year Five	1	8
Prior	10	5
Revolving Loans	39,625	36,956
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	40,337	37,958
Global fund banking | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Global fund banking | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	512	764
Year Two	95	115
Year Three	63	36
Year Four	31	6
Year Five	1	8
Prior	10	4
Revolving Loans	39,616	36,955
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	40,328	37,888
Global fund banking | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	50
Year Two	0	18
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	1
Revolving Loans	9	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	9	70
Investor dependent
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2,645	3,053
Year Two	2,456	1,374
Year Three	515	448
Year Four	129	117
Year Five	35	23
Prior	9	2
Revolving Loans	515	522
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	6,309	5,544
Investor dependent | Early stage
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	795	820
Year Two	749	379
Year Three	100	155
Year Four	43	31
Year Five	2	6
Prior	3	1
Revolving Loans	219	201
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,911	1,593
Investor dependent | Early stage | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1	2
Year Two	1	5
Year Three	0	3
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	2	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	4	11
Investor dependent | Early stage | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	727	754
Year Two	626	287
Year Three	73	122
Year Four	36	26
Year Five	2	6
Prior	1	1
Revolving Loans	191	171
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,656	1,367
Investor dependent | Early stage | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	67	64
Year Two	122	87
Year Three	27	30
Year Four	7	5
Year Five	0	0
Prior	2	0
Revolving Loans	26	29
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	251	215
Investor dependent | Growth stage
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,850	2,233
Year Two	1,707	995
Year Three	415	293
Year Four	86	86
Year Five	33	17
Prior	6	1
Revolving Loans	296	321
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	4,398	3,951
Investor dependent | Growth stage | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	19	2
Year Two	18	0
Year Three	2	1
Year Four	0	2
Year Five	0	0
Prior	0	0
Revolving Loans	4	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	43	6
Investor dependent | Growth stage | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,684	2,072
Year Two	1,456	910
Year Three	360	265
Year Four	72	78
Year Five	28	14
Prior	6	1
Revolving Loans	243	286
Revolving Loans Converted to Term Loans	5	5
Unallocated	0	0
Loans, amortized cost	3,854	3,631
Investor dependent | Growth stage | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	147	159
Year Two	233	85
Year Three	53	27
Year Four	14	6
Year Five	5	3
Prior	0	0
Revolving Loans	49	34
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	501	314
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	698	875
Year Two	609	384
Year Three	215	284
Year Four	205	107
Year Five	20	83
Prior	61	15
Revolving Loans	37	50
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,845	1,798
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	12
Year Four	0	10
Year Five	5	7
Prior	0	0
Revolving Loans	2	5
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	7	34
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	678	875
Year Two	609	384
Year Three	199	252
Year Four	203	72
Year Five	14	76
Prior	39	2
Revolving Loans	30	35
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1,772	1,696
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	20	0
Year Two	0	0
Year Three	16	20
Year Four	2	25
Year Five	1	0
Prior	22	13
Revolving Loans	5	10
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	66	68
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,837	2,294
Year Two	1,882	1,188
Year Three	894	350
Year Four	198	135
Year Five	29	58
Prior	54	0
Revolving Loans	3,427	2,648
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	8,321	6,673
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	1	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	1	1
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1,788	2,230
Year Two	1,734	1,058
Year Three	773	288
Year Four	166	123
Year Five	18	58
Prior	54	0
Revolving Loans	3,102	2,411
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	7,635	6,168
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	49	64
Year Two	148	130
Year Three	121	62
Year Four	32	12
Year Five	11	0
Prior	0	0
Revolving Loans	324	236
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	685	504
Private bank
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2,210	2,952
Year Two	2,833	2,015
Year Three	1,754	1,126
Year Four	952	529
Year Five	442	434
Prior	1,077	969
Revolving Loans	829	710
Revolving Loans Converted to Term Loans	5	8
Unallocated	0	0
Loans, amortized cost	10,102	8,743
Private bank | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	1	2
Year Four	2	9
Year Five	1	0
Prior	8	8
Revolving Loans	1	2
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	13	21
Private bank | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2,210	2,952
Year Two	2,817	2,015
Year Three	1,753	1,122
Year Four	948	520
Year Five	441	432
Prior	1,054	952
Revolving Loans	818	705
Revolving Loans Converted to Term Loans	5	8
Unallocated	0	0
Loans, amortized cost	10,046	8,706
Private bank | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	16	0
Year Three	0	2
Year Four	2	0
Year Five	0	2
Prior	15	9
Revolving Loans	10	3
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	43	16
CRE
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	408	329
Year Two	296	254
Year Three	232	463
Year Four	380	192
Year Five	167	283
Prior	1,008	1,007
Revolving Loans	113	128
Revolving Loans Converted to Term Loans	5	14
Unallocated	0	0
Loans, amortized cost	2,609	2,670
CRE | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	5
Year Four	5	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	5	5
CRE | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	406	326
Year Two	292	215
Year Three	181	344
Year Four	240	155
Year Five	143	236
Prior	894	868
Revolving Loans	96	110
Revolving Loans Converted to Term Loans	5	2
Unallocated	0	0
Loans, amortized cost	2,257	2,256
CRE | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	2	3
Year Two	4	39
Year Three	51	114
Year Four	135	37
Year Five	24	47
Prior	114	139
Revolving Loans	17	18
Revolving Loans Converted to Term Loans	0	12
Unallocated	0	0
Loans, amortized cost	347	409
Premium wine and other | Premium wine
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	256	218
Year Two	218	119
Year Three	91	167
Year Four	144	78
Year Five	56	71
Prior	153	162
Revolving Loans	165	136
Revolving Loans Converted to Term Loans	34	34
Unallocated	0	0
Loans, amortized cost	1,117	985
Premium wine and other | Premium wine | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Premium wine and other | Premium wine | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	255	217
Year Two	213	112
Year Three	91	156
Year Four	137	69
Year Five	47	71
Prior	144	162
Revolving Loans	156	125
Revolving Loans Converted to Term Loans	34	34
Unallocated	0	0
Loans, amortized cost	1,077	946
Premium wine and other | Premium wine | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1	1
Year Two	5	7
Year Three	0	11
Year Four	7	9
Year Five	9	0
Prior	9	0
Revolving Loans	9	11
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	40	39
Premium wine and other | Other
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	25	61
Year Two	154	151
Year Three	189	83
Year Four	39	20
Year Five	0	16
Prior	0	0
Revolving Loans	11	7
Revolving Loans Converted to Term Loans	0	0
Unallocated	(44)	(21)
Loans, amortized cost	374	317
Premium wine and other | Other | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	0
Premium wine and other | Other | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	25	61
Year Two	151	144
Year Three	172	82
Year Four	30	20
Year Five	0	14
Prior	0	0
Revolving Loans	11	7
Revolving Loans Converted to Term Loans	0	0
Unallocated	(44)	(21)
Loans, amortized cost	345	307
Premium wine and other | Other | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	3	7
Year Three	17	1
Year Four	9	0
Year Five	0	2
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	29	10
Other C&I
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	32	186
Year Two	149	181
Year Three	165	88
Year Four	76	95
Year Five	85	30
Prior	324	302
Revolving Loans	245	359
Revolving Loans Converted to Term Loans	11	16
Unallocated	0	0
Loans, amortized cost	1,087	1,257
Other C&I | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	0
Year Two	0	0
Year Three	1	0
Year Four	0	2
Year Five	1	0
Prior	1	1
Revolving Loans	0	1
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	3	4
Other C&I | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	31	181
Year Two	149	175
Year Three	161	82
Year Four	70	86
Year Five	81	28
Prior	304	301
Revolving Loans	234	350
Revolving Loans Converted to Term Loans	10	11
Unallocated	0	0
Loans, amortized cost	1,040	1,214
Other C&I | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	1	5
Year Two	0	6
Year Three	3	6
Year Four	6	7
Year Five	3	2
Prior	19	0
Revolving Loans	11	8
Revolving Loans Converted to Term Loans	1	5
Unallocated	0	0
Loans, amortized cost	44	39
PPP Loans
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	250
Year Two	19	81
Year Three	9	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	28	331
PPP Loans | Nonperforming
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	2
Year Two	0	0
Year Three	0	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	0	2
PPP Loans | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	226
Year Two	16	72
Year Three	3	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	19	298
PPP Loans | Criticized
Financing Receivable, Credit Quality Indicator [Line Items]
Year One	0	22
Year Two	3	9
Year Three	6	0
Year Four	0	0
Year Five	0	0
Prior	0	0
Revolving Loans	0	0
Revolving Loans Converted to Term Loans	0	0
Unallocated	0	0
Loans, amortized cost	$ 9	$ 31

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Activity Relating to our Allowance for Credit Losses for Loans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Jun. 30, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Line Items]
Change in allowance for credit loss	$ 12
Held-to-maturity, accrued interest receivable	294		$ 294		$ 171
Allowance for credit loss, beginning balance	545	$ 396	422	$ 448
Initial Allowance on PCD Loans						$ 22	$ 22
Charge-offs	(26)	(19)	(66)	(129)
Recoveries	11	8	23	16
Provision (Reduction) for Credit Loss for Loans	30	(9)	184	41
Foreign Currency Translation Adjustments	(3)		(6)
Allowance for credit loss, ending balance	557	398	557	398
Global fund banking
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	89	66	67	46
Initial Allowance on PCD Loans						0	0
Charge-offs	0	0	0	(80)
Recoveries	6	0	6	0
Provision (Reduction) for Credit Loss for Loans	(4)	(7)	18	93
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	91	59	91	59
Investor dependent
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	224	158	146	213
Initial Allowance on PCD Loans						0	0
Charge-offs	(20)	(17)	(53)	(37)
Recoveries	4	5	13	13
Provision (Reduction) for Credit Loss for Loans	25	(8)	126	(51)
Foreign Currency Translation Adjustments	1		2
Allowance for credit loss, ending balance	234	138	234	138
Cash flow dependent and innovation C&I (Commercial and Industrial)
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	130	119	118	125
Initial Allowance on PCD Loans						0	0
Charge-offs	(5)	(1)	(9)	(8)
Recoveries	0	3	0	3
Provision (Reduction) for Credit Loss for Loans	11	(12)	27	(11)
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	136	109	136	109
Private bank
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	45	47	33	53
Initial Allowance on PCD Loans						1	1
Charge-offs	0	(1)	0	(3)
Recoveries	0	0	2	0
Provision (Reduction) for Credit Loss for Loans	2	(16)	12	(20)
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	47	31	47	31
CRE
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	34	0	36	0
Initial Allowance on PCD Loans						17	17
Charge-offs	0	0	0
Recoveries	0	0	0
Provision (Reduction) for Credit Loss for Loans	(7)	23	(9)
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	27	40	27	40
Other C&I
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	12	0	14	0
Initial Allowance on PCD Loans						4	4
Charge-offs	(1)	0	(3)
Recoveries	1	0	1
Provision (Reduction) for Credit Loss for Loans	0	8	0
Foreign Currency Translation Adjustments	0		0
Allowance for credit loss, ending balance	12	12	12	12
Premium wine and other
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance	11	6	8	9
Initial Allowance on PCD Loans						$ 0	0
Charge-offs	0	0	(1)	(1)
Recoveries	0	0	1	0
Provision (Reduction) for Credit Loss for Loans	3	3	10	1
Foreign Currency Translation Adjustments	(4)		(8)
Allowance for credit loss, ending balance	$ 10	9	$ 10	9
PPP Loans
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit loss, beginning balance				2
Initial Allowance on PCD Loans							$ 0
Charge-offs				0
Recoveries				0
Provision (Reduction) for Credit Loss for Loans				(2)
Allowance for credit loss, ending balance		$ 0		$ 0

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Summary of the Aging of Loans Broken out by Risk-based Segments (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	$ 72,129	$ 66,276
Loans Past Due 90 Days or More Still Accruing Interest	6	7
30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	43	63
60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	40	8
Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	19	20
Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	102	91
Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	72,027	66,185
Global fund banking
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	40,337	37,958
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Global fund banking | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Global fund banking | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	40,337	37,958
Investor dependent
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6,309	5,544
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	28	22
Investor dependent | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	15	5
Investor dependent | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	0
Investor dependent | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	46	27
Investor dependent | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6,263	5,517
Investor dependent | Early stage
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,911	1,593
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent | Early stage | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2	6
Investor dependent | Early stage | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2	5
Investor dependent | Early stage | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1	0
Investor dependent | Early stage | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	5	11
Investor dependent | Early stage | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,906	1,582
Investor dependent | Growth stage
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4,398	3,951
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Investor dependent | Growth stage | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	26	16
Investor dependent | Growth stage | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	13	0
Investor dependent | Growth stage | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2	0
Investor dependent | Growth stage | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	41	16
Investor dependent | Growth stage | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4,357	3,935
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,845	1,798
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	4	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,841	1,798
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	8,321	6,673
Loans Past Due 90 Days or More Still Accruing Interest	0	7
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6	7
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	7
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	9	14
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	8,312	6,659
Private bank
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	10,102	8,743
Loans Past Due 90 Days or More Still Accruing Interest	1	0
Private bank | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1	28
Private bank | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	12	1
Private bank | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	5	12
Private bank | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	18	41
Private bank | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	10,084	8,702
CRE
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2,609	2,670
Loans Past Due 90 Days or More Still Accruing Interest	0	0
CRE | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1	1
CRE | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	7	0
CRE | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	5	0
CRE | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	13	1
CRE | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	2,596	2,669
Other C&I
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,087	1,257
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Other C&I | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	1
Other C&I | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	2
Other C&I | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	1
Other C&I | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	4
Other C&I | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,084	1,253
Premium wine and other | Premium wine
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,117	985
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Premium wine and other | Premium wine | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	3
Premium wine and other | Premium wine | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other | Premium wine | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other | Premium wine | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	3	3
Premium wine and other | Premium wine | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	1,114	982
Premium wine and other | Other
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	374	317
Loans Past Due 90 Days or More Still Accruing Interest	0	0
Premium wine and other | Other | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other | Other | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other | Other | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other | Other | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
Premium wine and other | Other | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	374	317
PPP Loans
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	28	331
Loans Past Due 90 Days or More Still Accruing Interest	5	0
PPP Loans | 30 - 59   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	1
PPP Loans | 60 - 89   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	0	0
PPP Loans | Equal to or Greater Than 90   Days Past   Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6	0
PPP Loans | Total Past Due
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	6	1
PPP Loans | Current
Financing Receivable, Past Due [Line Items]
Loans, amortized cost	$ 22	$ 330

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Nonaccrual Loans with No Allowance for Credit Loss (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	$ 76	$ 84
Nonaccrual Loans with no Allowance for Credit Loss	7	9
Investor dependent
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	47	17
Nonaccrual Loans with no Allowance for Credit Loss	1	0
Investor dependent | Early stage
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	4	11
Nonaccrual Loans with no Allowance for Credit Loss	0	0
Investor dependent | Growth stage
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	43	6
Nonaccrual Loans with no Allowance for Credit Loss	1	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	7	34
Nonaccrual Loans with no Allowance for Credit Loss	0	0
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	1	1
Nonaccrual Loans with no Allowance for Credit Loss	0	1
Private bank
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	13	21
Nonaccrual Loans with no Allowance for Credit Loss	6	8
CRE
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	5	5
Nonaccrual Loans with no Allowance for Credit Loss	0	0
Other C&I
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	3	4
Nonaccrual Loans with no Allowance for Credit Loss	0	0
PPP Loans
Financing Receivable, Nonaccrual [Line Items]
Nonaccrual Loans	0	2
Nonaccrual Loans with no Allowance for Credit Loss	$ 0	$ 0

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Summary of Loans Modified in Troubled Debt Restructurings (TDRs) (Details) $ in Millions	9 Months Ended
	Sep. 30, 2022 USD ($) troubled_debt_restructuring	Dec. 31, 2021 USD ($)
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of TDRs | troubled_debt_restructuring	39
Loans modified in TDRs	$ 85	$ 96
Unfunded commitments available for funding associated with TDRs	0
Investor dependent
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	33	15
Investor dependent | Early stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	1	12
Investor dependent | Growth stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	32	3
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	8	34
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	1	0
Private bank
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	8	12
CRE
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	33	33
Other C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs	$ 2	$ 2

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Recorded Investment in Loans Modified in TDRs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	$ 19,000	$ 53,000	$ 40,000	$ 66,000
Partial charge-offs on loans classified as TDRs	4,000		9,000	7,000
Payment deferrals
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	19,000	17,000	38,000	30,000
Extended Maturity
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period		14,000		14,000
Interest Rate Below Market Reduction
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period			1,000
Payment Deferral and Extended Maturity
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period		22,000		22,000
Modified Through Settlement
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period			1,000
Investor dependent
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	13,000	8,000	33,000	9,000
Investor dependent | Early stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	1,000	0	1,000	1,000
Recorded investment in loans modified in TDRs			1,000
Investor dependent | Growth stage
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	12,000	8,000	32,000	8,000
Cash flow dependent and innovation C&I (Commercial and Industrial) | Cash flow dependent - SLBO
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	0	0	0	12,000
Cash flow dependent and innovation C&I (Commercial and Industrial) | Innovation C&I
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	1,000	0	1,000	0
Private bank
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	0	2,000	1,000	2,000
CRE
Financing Receivable, Troubled Debt Restructuring [Line Items]
Loans modified in TDRs during the period	$ 5,000	$ 43,000	$ 5,000	$ 43,000

XML

Loans and Allowance for Credit Losses: Loans and Unfunded Credit Commitments - Allowance for Credit Losses: Unfunded Credit Commitments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Financing Receivable, Allowance for Credit Loss [Line Items]
Change in allowance for credit loss	$ 12
Allowance for credit loss, beginning balance	545	$ 396	$ 422	$ 448
Provision for (reduction in) credit losses	30	(9)	184	41
Foreign currency translation adjustments	(3)		(6)
Allowance for credit loss, ending balance	557	398	557	398
Unfunded Credit Commitments
Financing Receivable, Allowance for Credit Loss [Line Items]
Change in allowance for credit loss	41
Allowance for credit loss, beginning balance	224	120	171	121
Provision for (reduction in) credit losses	42	29	96	28
Foreign currency translation adjustments	(1)	0	(2)	0
Allowance for credit loss, ending balance	$ 265	$ 149	$ 265	$ 149

XML

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 375	$ 375
Amortization expense	$ 18

XML

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Other intangible assets:
Estimated Fair Value	$ 192	$ 192
Accumulated Amortization	50	32
Net Carrying Amount	142	160
Customer relationships
Other intangible assets:
Estimated Fair Value	135	135
Accumulated Amortization	27	16
Net Carrying Amount	108	119
Other
Other intangible assets:
Estimated Fair Value	57	57
Accumulated Amortization	23	16
Net Carrying Amount	$ 34	$ 41

XML

Goodwill and Other Intangible Assets - Future Amortization Expense (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022 (excluding the nine months ended September 30, 2022)	$ 6
2023	22
2024	20
2025	17
2026	15
2027 and thereafter	62
Net Carrying Amount	$ 142	$ 160

XML

Derivative Financial Instruments - Fair Value Hedges (Details) - Interest rate swaps - Other assets - Derivatives designated as hedging instruments - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivative [Line Items]
Amortized Cost Basis of the Hedged Assets	$ 8,773	$ 15,260
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets, Active	0	(131)
Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of the Hedged Assets, Terminated	$ (301)	6
Amortized cost of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		11,200
Amount of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		6,700
Cumulative adjustments of hedged items where the hedged item is the last layer expected to be remaining at the end of the hedging relationship		$ 83

XML

Derivative Financial Instruments - Cash Flow Hedges (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Mar. 31, 2020
Derivative [Line Items]
Unrealized gain on terminated cash flow hedge remaining in AOCI, before tax	$ 73
Unrealized gain on terminated cash flow hedge remaining in AOCI, net of tax	$ 52
Term unrealized gains reclassified into earnings	3 years
Derivatives designated as hedging instruments | Interest rate swaps
Derivative [Line Items]
Derivative notional amount		$ 5,000
Derivatives net asset fair value		$ 228

XML

Derivative Financial Instruments - Currency Exchange Risk (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Net investment pretax gains (losses) recognized in AOCI	$ 94	$ 94

XML

Derivative Financial Instruments - Total Notional or Contractual Amounts, Fair Value, Collateral and Net Exposure of Derivative Financial Instruments (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Derivative [Line Items]
Derivative Assets, Fair Value	$ 597	$ 165
Derivative Liabilities, Fair Value	256	148
Derivative Assets, Total Gross Derivatives	1,161	565
Derivative Liabilities, Total Gross Derivatives	758	238
Less: netting adjustment (Derivative Assets)	(495)	(137)
Less: netting adjustment (Derivative Liabilities)	(234)	(120)
Derivative Assets, Total derivatives	666	428
Derivative Liabilities, Total derivatives	524	118
Approximate reduction amounts of derivative assets reflecting variation margin treated as settlement of the related derivative fair values	117	112
Cash collateral in excess of net derivative receivables	6
Cash collateral in excess of net derivative payables		1
Derivatives designated as hedging instruments
Derivative [Line Items]
Derivative Assets, Fair Value	94	18
Derivatives designated as hedging instruments | Interest rate swaps | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	0	10,700
Derivative Assets, Fair Value	0	18
Derivatives designated as hedging instruments | Foreign exchange contracts | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	1,546
Derivative Assets, Fair Value	94	0
Derivatives not designated as hedging instruments
Derivative [Line Items]
Derivative Assets, Fair Value	1,067	547
Derivative Liabilities, Fair Value	758	238
Derivatives not designated as hedging instruments | Foreign exchange contracts | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	2,860	701
Derivative Assets, Fair Value	46	16
Derivatives not designated as hedging instruments | Foreign exchange contracts | Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	308	62
Derivative Liabilities, Fair Value	13	2
Derivatives not designated as hedging instruments | Equity warrant assets | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	353	322
Derivative Assets, Fair Value	351	277
Derivatives not designated as hedging instruments | Contingent conversion rights | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	52
Derivative Assets, Fair Value	6
Derivatives not designated as hedging instruments | Client foreign exchange contracts | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	10,658	8,245
Derivative Assets, Fair Value	500	146
Derivatives not designated as hedging instruments | Client foreign exchange contracts | Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	10,615	7,764
Derivative Liabilities, Fair Value	499	126
Derivatives not designated as hedging instruments | Total return swaps | Other assets
Derivative [Line Items]
Derivative Assets, Fair Value	25	0
Derivatives not designated as hedging instruments | Total return swaps | Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	110	0
Derivatives not designated as hedging instruments | Client foreign currency options | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	266	688
Derivative Assets, Fair Value	11	9
Derivatives not designated as hedging instruments | Client foreign currency options | Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	266	688
Derivative Liabilities, Fair Value	11	9
Derivatives not designated as hedging instruments | Client interest rate derivatives | Other assets
Derivative [Line Items]
Derivative Assets, Notional or Contractual Amount	2,248	2,178
Derivative Assets, Fair Value	128	99
Derivatives not designated as hedging instruments | Client interest rate derivatives | Other liabilities
Derivative [Line Items]
Derivative Liabilities, Notional or Contractual Amount	2,447	2,315
Derivative Liabilities, Fair Value	$ 235	$ 101

XML

Derivative Financial Instruments - Summary of Derivative Activity and Related Impact on Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives			$ (345)	$ (18)
Interest rate risks | Derivatives designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	$ 13	$ 15	42	46
Interest rate risks | Derivatives designated as hedging instruments | Reclassification out of Accumulated Other Comprehensive Income | Interest income - loans
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	14	16	43	47
Interest rate risks | Derivatives designated as hedging instruments | Change In Fair Value Of Interest Rate Swaps Hedging Investment Securities | Interest income - loans
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(2)	5	384	18
Interest rate risks | Derivatives designated as hedging instruments | Change In Fair Value Of Hedged Investment Securities | Interest income - loans
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	1	(6)	(385)	(19)
Currency exchange risk | Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(4)	0	(5)	0
Currency exchange risk | Derivatives not designated as hedging instruments | Revaluations of internal foreign currency instruments, net | Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	47	(14)	26	(35)
Currency exchange risk | Derivatives not designated as hedging instruments | Foreign exchange forward contracts, net | Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(51)	14	(31)	35
Other derivative instruments | Derivatives not designated as hedging instruments
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	10	(4)	12	1
Other derivative instruments | Derivatives not designated as hedging instruments | Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	2	2	8	4
Other derivative instruments | Derivatives not designated as hedging instruments | Revaluations of internal foreign currency instruments, net | Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	12	1	7	16
Other derivative instruments | Derivatives not designated as hedging instruments | Foreign exchange forward contracts, net | Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(2)	(5)	5	(15)
Total return swaps | Derivatives not designated as hedging instruments | Other noninterest income
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	(2)	0	25	0
Equity warrant assets | Derivatives not designated as hedging instruments | Gains on equity warrant assets, net
Derivative Instruments, Gain (Loss) [Line Items]
Unrealized gains (losses) on derivatives	$ 40	$ 147	$ 120	$ 491

XML

Derivative Financial Instruments - Balance Sheet Offsetting, Assets (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivative Assets
Gross Amounts of Recognized Assets	$ 597	$ 165
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Gross Amounts Offset in the Statement of Financial Position, Cash Collateral Received	(266)	(50)
Net Amounts of Assets Presented in the Statement of Financial Position	102	28
Net Amount	102	28
Reverse repurchase, securities borrowing, and similar arrangements
Gross Amounts of Recognized Assets	397	607
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	0	0
Net Amounts of Assets Presented in the Statement of Financial Position	397	607
Gross Amounts Not Offset in the Statement of Financial Position	(397)	(607)
Net Amount	0	0
Total
Gross Amounts of Recognized Assets	994	772
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Net Amounts of Assets Presented in the Statement of Financial Position	499	635
Cash Collateral Received	(397)	(607)
Net Amount	$ 102	$ 28

XML

Derivative Financial Instruments - Balance Sheet Offsetting, Liabilities (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Derivative Liabilities
Gross Amounts of Recognized Liabilities	$ 256	$ 148
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Gross Amounts Offset in the Statement of Financial Position, Cash Collateral Pledged	(5)	(33)
Net Amounts of Liabilities Presented in the Statement of Financial Position	22	28
Net Amount	22	28
Repurchase, securities lending, and similar arrangements
Gross Amounts of Recognized Liabilities	36	61
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	0	0
Net Amounts of Liabilities Presented in the Statement of Financial Position	36	61
Gross Amounts Not Offset in the Statement of Financial Position	0	0
Net Amount	36	61
Total
Gross Amounts of Recognized Liabilities	292	209
Gross Amounts Offset in the Statement of Financial Position, Financial Instruments	(229)	(87)
Net Amounts of Liabilities Presented in the Statement of Financial Position	58	89
Gross Amounts Not Offset in the Statement of Financial Position	0	0
Net Amount	$ 58	$ 89

XML

Noninterest Income - Summary of Noninterest Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Gains (losses) on investment securities, net	$ (127)	$ 189	$ (199)	$ 661
Gains on equity warrant assets, net	40	147	120	491
Client investment fees	119	20	237	55
Wealth management and trust fees	19	22	63	22
Foreign exchange fees	74	65	216	189
Credit card fees	37	34	114	93
Deposit service charges	32	29	94	82
Lending related fees	20	21	65	55
Letters of credit and standby letters of credit fees	15	13	43	39
Investment banking revenue	75	90	293	335
Commissions	24	17	73	58
Other	31	25	119	97
Total noninterest income	$ 359	$ 672	$ 1,238	$ 2,177

XML

Noninterest Income - Gains and Losses on Investments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Total net gains on non-marketable and other equity securities	$ (127)	$ 189	$ (247)	$ 661
Gains (losses) on sales of AFS securities, net	0	0	48	0
Gains on investment securities, net	$ (127)	$ 189	$ (199)	$ 661

XML

Noninterest Income - Gains and Losses on Derivatives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Gains on exercises, net	$ 9	$ 91	$ 44	$ 381
Terminations	(1)	(1)	(3)	(2)
Changes in fair value, net	32	57	79	112
Gains on equity warrant assets, net	$ 40	$ 147	$ 120	$ 491

XML

Noninterest Income - Client Investment Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Sweep money market fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	64	12	144	31
Asset management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	16	7	41	22
Repurchase agreement fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	39	1	52	2
Client investment fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 119	$ 20	$ 237	$ 55

XML

Noninterest Income - Wealth Management and Trust Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Other Income and Expenses [Abstract]
Wealth management fees	$ 17	$ 20	$ 58	$ 20
Trust fees	2	2	5	2
Wealth management and trust fees	$ 19	$ 22	$ 63	$ 22

XML

Noninterest Income - Foreign Exchange Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Revenue not from contract with customer	9	357	168	1,229
Foreign exchange fees	74	65	216	189
Spot contract commissions
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	74	65	215	188
Option premium fees
Disaggregation of Revenue [Line Items]
Revenue not from contract with customer	$ 0	$ 0	$ 1	$ 1

XML

Noninterest Income - Credit Card Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Card interchange fees, net	$ 29	$ 29	$ 91	$ 78
Revenue from contracts with customers	350	315	1,070	948
Revenue not from contract with customer	9	357	168	1,229
Total credit card fees	37	34	114	93
Merchant service fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	6	4	18	12
Card service fees
Disaggregation of Revenue [Line Items]
Revenue not from contract with customer	$ 2	$ 1	$ 5	$ 3

XML

Noninterest Income - Lending Related Fees (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Lending related fees	$ 20	$ 21	$ 65	$ 55
Unused commitment fees
Accounts, Notes, Loans and Financing Receivable [Line Items]
Lending related fees	14	14	49	42
Other
Accounts, Notes, Loans and Financing Receivable [Line Items]
Lending related fees	$ 6	$ 7	$ 16	$ 13

XML

Noninterest Income - Investment Banking Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Investment banking revenue:
Underwriting fees	$ 24	$ 39	$ 97	$ 248
Advisory fees	40	26	163	39
Private placements and other	11	25	33	48
Total investment banking revenue	$ 75	$ 90	$ 293	$ 335

XML

Noninterest Income - Summary of Other Noninterest Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Trading Activity, Gains and Losses, Net [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Net losses on revaluation of foreign currency instruments, net of foreign exchange forward contracts	6	(4)	7	1
Gains on total return swaps	(3)	0	25	0
Other service revenue	12	14	44	45
Other	31	25	119	97
Fund management fees
Trading Activity, Gains and Losses, Net [Line Items]
Revenue from contracts with customers	$ 16	$ 15	$ 43	$ 51

XML

Noninterest Income - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 350	$ 315	$ 1,070	$ 948
Revenues outside the scope of ASC 606	9	357	168	1,229
Noninterest income (loss)	359	672	1,238	2,177
Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	1	4	3
Revenues outside the scope of ASC 606	(17)	188	107	793
Noninterest income (loss)	(17)	189	111	796
Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	214	165	586	463
Revenues outside the scope of ASC 606	94	17	195	51
Noninterest income (loss)	308	182	781	514
SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	20	23	66	26
Revenues outside the scope of ASC 606	2	2	6	2
Noninterest income (loss)	22	25	72	28
SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	15	18	43	59
Revenues outside the scope of ASC 606	(69)	127	(121)	330
Noninterest income (loss)	(54)	145	(78)	389
SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	101	108	371	397
Revenues outside the scope of ASC 606	(1)	23	(19)	53
Noninterest income (loss)	100	131	352	450
Investment banking revenue
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	119	20	237	55
Investment banking revenue | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	1	0
Investment banking revenue | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	119	20	236	53
Investment banking revenue | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	2
Investment banking revenue | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Wealth management and trust fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	19	22	63	22
Wealth management and trust fees | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0		0	0
Wealth management and trust fees | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Wealth management and trust fees | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	19	22	63	22
Wealth management and trust fees | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0		0	0
Wealth management and trust fees | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0		0	0
Spot contract commissions
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	74	65	215	188
Card interchange fees, gross
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	55	52	173	142
Card interchange fees, gross | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	2	1
Card interchange fees, gross | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	54	52	170	140
Card interchange fees, gross | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	0	1	1
Card interchange fees, gross | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Card interchange fees, gross | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	7	4	18	12
Merchant service fees | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	7	4	18	12
Merchant service fees | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Merchant service fees | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Deposit service charges
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	32	29	94	82
Deposit service charges | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	1	1	2
Deposit service charges | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	32	28	92	80
Deposit service charges | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	1	0
Deposit service charges | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Deposit service charges | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	75	90	293	335
Investment banking revenue | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Investment banking revenue | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	75	90	293	335
Commissions
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	24	17	73	58
Commissions | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Commissions | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	24	17	73	58
Fund management fees
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	16	15	43	51
Fund management fees | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Fund management fees | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	0	1	0
Fund management fees | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Fund management fees | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	13	14	37	47
Fund management fees | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	2	1	5	4
Other
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	3	66	76	191
Other | Other Items
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	0	0	0
Other | Silicon Valley Bank
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	1	61	69	178
Other | SVB Private
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	0	1	1	1
Other | SVB Capital
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	2	4	6	12
Other | SVB Securities
Disaggregation of Revenue [Line Items]
Revenue from contracts with customers	$ 0	$ 0	$ 0	$ 0

XML

Segment Reporting - Narrative (Details)	3 Months Ended
	Sep. 30, 2022 Segment
Segment Reporting [Abstract]
Number of reportable segments	4

XML

Segment Reporting - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Net interest income	$ 1,198	$ 852	$ 3,447	$ 2,240
(Provision for) reduction of credit losses	(72)	(21)	(279)	(75)
Noninterest income (loss)	359	672	1,238	2,177
Noninterest expense	(892)	(879)	(2,613)	(2,168)
Income before income tax expense	593	624	1,793	2,174
Total average loans, amortized cost	71,098	59,291	69,158	51,843
Total average assets	215,740	182,690	216,652	152,952
Total average deposits	185,556	163,392	189,428	136,113
Goodwill	375		375		$ 375
Silicon Valley Bank
Segment Reporting Information [Line Items]
Noninterest income (loss)	308	182	781	514
SVB Private
Segment Reporting Information [Line Items]
Noninterest income (loss)	22	25	72	28
SVB Capital
Segment Reporting Information [Line Items]
Noninterest income (loss)	(54)	145	(78)	389
SVB Securities
Segment Reporting Information [Line Items]
Noninterest income (loss)	100	131	352	450
Operating segments | Silicon Valley Bank
Segment Reporting Information [Line Items]
Net interest income	1,107	766	2,993	2,084
(Provision for) reduction of credit losses	(32)	29	(174)	(27)
Noninterest income (loss)	308	182	781	514
Noninterest expense	(381)	(336)	(1,148)	(911)
Income before income tax expense	1,002	641	2,452	1,660
Total average loans, amortized cost	55,177	44,789	53,855	41,591
Total average assets	175,620	151,352	178,209	130,177
Total average deposits	172,427	148,879	175,370	128,006
Operating segments | SVB Private
Segment Reporting Information [Line Items]
Net interest income	111	74	296	146
(Provision for) reduction of credit losses	3	(20)	(9)	(16)
Noninterest income (loss)	22	25	72	28
Noninterest expense	(85)	(93)	(267)	(126)
Income before income tax expense	51	(14)	92	32
Total average loans, amortized cost	15,181	13,515	14,711	8,610
Total average assets	17,032	15,930	16,456	9,459
Total average deposits	12,436	13,431	13,327	7,108
Operating segments | SVB Capital
Segment Reporting Information [Line Items]
Net interest income	0	0	0	0
(Provision for) reduction of credit losses	0	0	0	0
Noninterest income (loss)	(54)	145	(78)	389
Noninterest expense	(17)	(15)	(53)	(48)
Income before income tax expense	(71)	130	(131)	341
Total average loans, amortized cost	0	0	0	0
Total average assets	883	730	956	641
Total average deposits	0	0	0	0
Operating segments | SVB Securities
Segment Reporting Information [Line Items]
Net interest income	1	0	1	0
(Provision for) reduction of credit losses	0	0	0	0
Noninterest income (loss)	100	131	352	450
Noninterest expense	(131)	(142)	(406)	(376)
Income before income tax expense	(30)	(11)	(53)	74
Total average loans, amortized cost	0	0	0	0
Total average assets	898	837	912	778
Total average deposits	0	0	0	0
Goodwill	174	138	174	138
Operating segments | Private bank
Segment Reporting Information [Line Items]
Goodwill	201	201	201	201
Other Items
Segment Reporting Information [Line Items]
Net interest income	(21)	12	157	10
(Provision for) reduction of credit losses	(43)	(30)	(96)	(32)
Noninterest income (loss)	(17)	189	111	796
Noninterest expense	(278)	(293)	(739)	(707)
Income before income tax expense	(359)	(122)	(567)	67
Total average loans, amortized cost	740	987	592	1,642
Total average assets	21,307	13,841	20,119	11,897
Total average deposits	$ 693	$ 1,082	$ 731	$ 999

XML

Segment Reporting - Segment Information (Additional Information) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Segment Reporting Information [Line Items]
Goodwill	$ 375		$ 375		$ 375
Operating segments | Silicon Valley Bank
Segment Reporting Information [Line Items]
Depreciation and amortization	13	$ 10	34	$ 25
Operating segments | SVB Securities
Segment Reporting Information [Line Items]
Goodwill	174	138	174	138
Operating segments | Private bank
Segment Reporting Information [Line Items]
Goodwill	$ 201	$ 201	$ 201	$ 201

XML

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Commitments to Extend Credit (Details) - USD ($) $ in Millions	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	$ 55,698		$ 44,016
Allowance for credit losses: loans	557	$ 545	422	$ 398	$ 396	$ 448
Loan commitments
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	51,769		40,327
Standby letters of credit
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	3,824		3,612
Commercial letters of credit
Financing Receivable, Allowance for Credit Loss [Line Items]
Total unfunded credit commitments	105		77
Unfunded Credit Commitments
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses: loans	$ 265	$ 224	$ 171	$ 149	$ 120	$ 121

XML

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Standby Letters of Credit (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Guarantor Obligations [Line Items]
Expires in One Year or Less	$ 3,689
Expires After One Year	135
Total Amount Outstanding	3,824
Maximum Amount of Future Payments	3,824
Financial standby letters of credit
Guarantor Obligations [Line Items]
Expires in One Year or Less	3,617
Expires After One Year	126
Total Amount Outstanding	3,743
Maximum Amount of Future Payments	3,743
Performance standby letters of credit
Guarantor Obligations [Line Items]
Expires in One Year or Less	72
Expires After One Year	9
Total Amount Outstanding	81
Maximum Amount of Future Payments	81
Standby letters of credit
Guarantor Obligations [Line Items]
Deferred fees	$ 20	$ 20

XML

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Commitments to Invest in Venture Capital and Private Equity Funds (Details) - Parent Company $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 672
SVBFG Unfunded Commitments	142
Redwood Evergreen Fund, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	250
SVBFG Unfunded Commitments	$ 119
SVBFG Ownership of each Fund	100.00%
Capital Preferred Return Fund, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 13
SVBFG Unfunded Commitments	$ 0
SVBFG Ownership of each Fund	20.00%
Growth Partners, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 25
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	33.00%
Strategic Investors Fund, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	12.60%
CP II, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 1
SVBFG Unfunded Commitments	$ 0
SVBFG Ownership of each Fund	5.10%
Strategic Investors Fund II, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	8.60%
Strategic Investors Fund III, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 15
SVBFG Unfunded Commitments	$ 1
SVBFG Ownership of each Fund	5.90%
Strategic Investors Fund IV, LP
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 12
SVBFG Unfunded Commitments	$ 2
SVBFG Ownership of each Fund	5.00%
Strategic Investors Fund V funds
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	$ 1
SVBFG Unfunded Commitments	0
Other venture capital and private equity fund investments
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	18
SVBFG Unfunded Commitments	5
Debt funds (equity method accounting)
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	59
SVBFG Unfunded Commitments	0
Other fund investments
Commitments and Contingencies Disclosure [Line Items]
SVBFG Capital Commitments	248
SVBFG Unfunded Commitments	$ 12
SVBFG Ownership of each Fund	5.00%

XML

Off-Balance Sheet Arrangements, Guarantees and Other Commitments - Commitments to Invest in Venture Capital and Private Equity Funds (Additional Information) (Details) $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($) Investment	Sep. 30, 2021
Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Unfunded commitments	$ 142
Parent Company | Redwood Evergreen Fund, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	100.00%
Unfunded commitments	$ 119
Upper Limit
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.00%
CP II, LP | Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.10%
Unfunded commitments	$ 0
Other fund investments | Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.00%
Unfunded commitments	$ 12
Strategic Investors Fund IV, LP | Parent Company
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.00%
Unfunded commitments	$ 2
Consolidated venture capital and private equity fund investments
Venture Capital and Private Equity Fund Investments [Line Items]
Commitments to invest, period from the inception of the fund	10 years
Call unrestricted, percentage of committed capital	100.00%
Unfunded commitments	$ 3
Consolidated venture capital and private equity fund investments | Lower Limit
Venture Capital and Private Equity Fund Investments [Line Items]
Expected commitment period to invest in venture capital and private equity funds (in years)	5 years
Consolidated venture capital and private equity fund investments | Upper Limit
Venture Capital and Private Equity Fund Investments [Line Items]
Expected commitment period to invest in venture capital and private equity funds (in years)	7 years
Consolidated venture capital and private equity fund investments | Non-marketable securities | Equity method accounting | CP II, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.10%	5.10%
Consolidated venture capital and private equity fund investments | Non-marketable securities | Equity method accounting | Other fund investments
Venture Capital and Private Equity Fund Investments [Line Items]
Number of other funds with investment commitments | Investment	147
Consolidated venture capital and private equity fund investments | Non-marketable securities | Equity method accounting | Strategic Investors Fund IV, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	5.00%	5.00%
Consolidated venture capital and private equity fund investments | Non-marketable securities | Direct ownership interest | Equity method accounting | CP II, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	1.30%
Consolidated venture capital and private equity fund investments | Non-marketable securities | Indirect ownership interest | Equity method accounting | CP II, LP
Venture Capital and Private Equity Fund Investments [Line Items]
Percentage of ownership	3.80%

XML

Income Taxes (Details) $ in Millions	Sep. 30, 2022 USD ($)
Income Tax Disclosure [Abstract]
Unrecognized tax benefits	$ 42
Income tax reduction from recognized tax benefit	$ 34

XML

Fair Value of Financial Instruments - Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2022 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	$ 26,711	$ 26,711	$ 27,221
Derivative Assets, Fair Value	597	597	165
Derivative Liabilities, Fair Value	256	256	148
Less: netting adjustment (Derivative Assets)	(495)	(495)	(137)
Less: netting adjustment	(234)	(234)	(120)
Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	1,067	1,067	547
Derivative Liabilities, Fair Value	758	758	238
Total return swaps | Other assets | Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	25	25	0
Equity warrant assets | Other assets | Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	351	351	277
Contingent conversion rights | Other assets | Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6
Client interest rate derivatives | Other assets | Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	128	128	99
Client interest rate derivatives | Other liabilities | Derivatives not designated as hedging instruments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	235	235	101
U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	16,845	16,845	15,850
U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	100	100	196
Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	913	913	61
Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	6,683	6,683	8,589
Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	714	714	982
Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	1,456	1,456	1,543
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	26,711	26,711	27,221
Total assets	27,680	27,680	28,112
Total liabilities	528	528	126
Recurring | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			8
Recurring | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			8
Recurring | Foreign exchange contract | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	309	309	151
Recurring | Foreign exchange contract | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	524	524	118
Recurring | Equity warrant assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	351	351	277
Recurring | Contingent conversion rights | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6
Recurring | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	299	299	455
Recurring | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	16,845	16,845	15,850
Recurring | U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	100	100	196
Recurring | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	913	913	61
Recurring | Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	6,683	6,683	8,589
Recurring | Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	714	714	982
Recurring | Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	1,456	1,456	1,543
Recurring | Other equity securities in public companies | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	29	29	117
Recurring | Other assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	4	4
Recurring | Other liabilities | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	4	4
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	17,758	17,758	15,911
Total assets	17,789	17,789	15,962
Total liabilities	4	4	8
Recurring | Level 1 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			8
Recurring | Level 1 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			8
Recurring | Level 1 | Foreign exchange contract | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0	0
Recurring | Level 1 | Foreign exchange contract | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	0	0	0
Recurring | Level 1 | Equity warrant assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0	0
Recurring | Level 1 | Contingent conversion rights | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0
Recurring | Level 1 | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	27	27	43
Recurring | Level 1 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	16,845	16,845	15,850
Recurring | Level 1 | U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 1 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	913	913	61
Recurring | Level 1 | Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 1 | Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 1 | Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 1 | Other equity securities in public companies | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	27	27	43
Recurring | Level 1 | Other assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	4	4
Recurring | Level 1 | Other liabilities | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	4	4
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	8,953	8,953	11,310
Total assets	9,765	9,765	11,680
Total liabilities	758	758	238
Recurring | Level 2 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			0
Recurring | Level 2 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			0
Recurring | Level 2 | Foreign exchange contract | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	804	804	288
Recurring | Level 2 | Foreign exchange contract | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	758	758	238
Recurring | Level 2 | Equity warrant assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6	8
Recurring | Level 2 | Contingent conversion rights | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0
Recurring | Level 2 | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	2	2	74
Recurring | Level 2 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 2 | U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	100	100	196
Recurring | Level 2 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 2 | Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	6,683	6,683	8,589
Recurring | Level 2 | Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	714	714	982
Recurring | Level 2 | Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	1,456	1,456	1,543
Recurring | Level 2 | Other equity securities in public companies | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	2	2	74
Recurring | Level 2 | Other assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	0	0
Recurring | Level 2 | Other liabilities | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	0	0
Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Total assets	351	351	269
Total liabilities	0	0	0
Recurring | Level 3 | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets			0
Recurring | Level 3 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities			0
Recurring | Level 3 | Foreign exchange contract | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	0	0	0
Recurring | Level 3 | Foreign exchange contract | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liabilities, Fair Value	0	0	0
Recurring | Level 3 | Equity warrant assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	345	345	269
Recurring | Level 3 | Contingent conversion rights | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value	6	6
Recurring | Level 3 | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	0	0	0
Recurring | Level 3 | U.S. treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 3 | U.S. agency debentures
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 3 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 3 | Agency-issued MBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 3 | Agency-issued CMO
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 3 | Agency-issued CMBS
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying value	0	0	0
Recurring | Level 3 | Other equity securities in public companies | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	0	0	0
Recurring | Level 3 | Other assets | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other assets	0	0
Recurring | Level 3 | Other liabilities | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other liabilities	0	0
Recurring | Measured at net asset value | Venture capital and private equity fund investments | Fair value accounting
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Non-marketable securities	$ 270	$ 270	$ 338
Lower Limit | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, sales restriction, period	3 years
Upper Limit | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, sales restriction, period		6 months
Sales restrictions discount | Lower Limit | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.10	0.10
Sales restrictions discount | Upper Limit | Other equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.20	0.20

XML

Fair Value of Financial Instruments - Additional Information about Level 3 Assets Measured at Fair Value on a Recurring Basis (Details) - Recurring - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Equity warrant assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	$ 318	$ 257	$ 269	$ 192
Total Net Gains Included in Net Income	39	149	124	490
Sales/Exits	(21)	(146)	(67)	(431)
Issuances	9	6	21	18
Transfers Into Level 3	0	(1)	(2)	(4)
Ending Balance	345	$ 265	345	$ 265
Contingent conversion rights
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning Balance	6		0
Total Net Gains Included in Net Income	0		(1)
Sales/Exits	0		0
Issuances	0		7
Transfers Into Level 3	0		0
Ending Balance	$ 6		$ 6

XML

Fair Value of Financial Instruments - Unrealized Gains Included in Earnings Attributable to Level 3 Assets Held (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	$ 26	$ 21	$ 83	$ 113
Equity warrant assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	26	21	84	113
Contingent conversion rights
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Unrealized Gains (Losses) [Line Items]
Unrealized gains included in earnings attributable to Level 3 assets still held	$ 0	$ 0	$ (1)	$ 0

XML

Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Details) - Level 3 $ in Millions	Sep. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Equity warrant assets | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value		$ 2
Equity warrant assets | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value	$ 345	$ 267
Contingent conversion rights | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value	$ 6
Volatility | Equity warrant assets | Lower Limit | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.278
Volatility | Equity warrant assets | Lower Limit | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.238	0.247
Volatility | Equity warrant assets | Upper Limit | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.550
Volatility | Equity warrant assets | Upper Limit | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.513	0.550
Volatility | Equity warrant assets | Weighted Average | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.011
Volatility | Equity warrant assets | Weighted Average | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.423	0.430
Risk-Free interest rate | Equity warrant assets | Lower Limit | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.006
Risk-Free interest rate | Equity warrant assets | Lower Limit | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.033	0.0006
Risk-Free interest rate | Equity warrant assets | Upper Limit | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.015
Risk-Free interest rate | Equity warrant assets | Upper Limit | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.044	0.0140
Risk-Free interest rate | Equity warrant assets | Weighted Average | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.107
Risk-Free interest rate | Equity warrant assets | Weighted Average | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.042	0.008
Sales restrictions discount | Equity warrant assets | Lower Limit | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.100
Sales restrictions discount | Equity warrant assets | Upper Limit | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.200
Sales restrictions discount | Equity warrant assets | Weighted Average | Public Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input		0.437
Marketability discount | Equity warrant assets | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.171	0.201
Marketability discount | Equity warrant assets | Weighted Average | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.171	0.201
Remaining life assumption | Equity warrant assets | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.400	0.400
Remaining life assumption | Equity warrant assets | Weighted Average | Private Portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.400	0.400

XML

Fair Value of Financial Instruments - Quantitative Information About Significant Unobservable Inputs (Additional Information) (Details)	3 Months Ended
	Sep. 30, 2022
Equity warrant assets, private portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Weighted average remaining life	6 years 2 months 12 days
Weighted average remaining life	2 years 6 months
Sales restrictions discount | Upper Limit | Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.20
Level 3 | Lower Limit | Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value inputs, sales restriction, period	3 months
Level 3 | Upper Limit | Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Fair value inputs, sales restriction, period	6 months
Level 3 | Sales restrictions discount | Lower Limit | Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.10
Level 3 | Sales restrictions discount | Upper Limit | Equity warrant asset, public portfolio
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Measurement input	0.20

XML

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Financial Instruments not Carried at Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
HTM securities	$ 77,370	$ 97,227
Net loans	71,572	65,854
Carrying Amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,968	14,586
HTM securities	93,286	98,195
Non-marketable securities not measured at net asset value	431	424
Non-marketable securities measured at net asset value	660	710
Net loans	71,572	65,854
FHLB and Federal Reserve Bank stock	665	107
Non-maturity deposits	171,545	187,464
Time deposits	5,274	1,739
Junior subordinated debentures	91	90
Commitments to extend credit	0	0
Carrying Amount | Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,552	71
Carrying Amount | 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	349	349
Carrying Amount | 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	496	496
Carrying Amount | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	495	494
Carrying Amount | 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	496	496
Carrying Amount | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	646	645
Carrying Amount | 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	348
Carrying Amount | 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	447
Estimate of Fair Value Measurement
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,968	14,586
HTM securities	77,370	97,227
Non-marketable securities not measured at net asset value	431	424
Non-marketable securities measured at net asset value	660	710
Net loans	72,489	67,335
FHLB and Federal Reserve Bank stock	665	107
Non-maturity deposits	171,545	187,464
Time deposits	4,916	1,728
Junior subordinated debentures	91	92
Commitments to extend credit	49	47
Estimate of Fair Value Measurement | Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,552	71
Estimate of Fair Value Measurement | 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	336	370
Estimate of Fair Value Measurement | 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	407	526
Estimate of Fair Value Measurement | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	358	474
Estimate of Fair Value Measurement | 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	408	501
Estimate of Fair Value Measurement | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	559	649
Estimate of Fair Value Measurement | 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	327
Estimate of Fair Value Measurement | 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	396
Estimate of Fair Value Measurement | Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	13,968	14,586
HTM securities	0	0
Non-marketable securities not measured at net asset value	0	0
Non-marketable securities measured at net asset value	0	0
Net loans	0	0
FHLB and Federal Reserve Bank stock	0	0
Non-maturity deposits	171,545	187,464
Time deposits	0	0
Junior subordinated debentures	0	0
Commitments to extend credit	0	0
Estimate of Fair Value Measurement | Level 1 | Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	0	0
Estimate of Fair Value Measurement | Level 1 | 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 1 | 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 1 | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 1 | 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 1 | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 1 | 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0
Estimate of Fair Value Measurement | Level 1 | 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0
Estimate of Fair Value Measurement | Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
HTM securities	77,370	97,227
Non-marketable securities not measured at net asset value	0	0
Non-marketable securities measured at net asset value	0	0
Net loans	0	0
FHLB and Federal Reserve Bank stock	0	0
Non-maturity deposits	0	0
Time deposits	4,916	1,728
Junior subordinated debentures	91	92
Commitments to extend credit	0	0
Estimate of Fair Value Measurement | Level 2 | Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	13,552	71
Estimate of Fair Value Measurement | Level 2 | 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	336	370
Estimate of Fair Value Measurement | Level 2 | 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	407	526
Estimate of Fair Value Measurement | Level 2 | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	358	474
Estimate of Fair Value Measurement | Level 2 | 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	408	501
Estimate of Fair Value Measurement | Level 2 | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	559	649
Estimate of Fair Value Measurement | Level 2 | 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	327
Estimate of Fair Value Measurement | Level 2 | 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	396
Estimate of Fair Value Measurement | Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	0	0
HTM securities	0	0
Non-marketable securities not measured at net asset value	431	424
Non-marketable securities measured at net asset value	0	0
Net loans	72,489	67,335
FHLB and Federal Reserve Bank stock	665	107
Non-maturity deposits	0	0
Time deposits	0	0
Junior subordinated debentures	0	0
Commitments to extend credit	49	47
Estimate of Fair Value Measurement | Level 3 | Short-term borrowings
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term borrowings	0	0
Estimate of Fair Value Measurement | Level 3 | 3.50% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 3 | 3.125% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 3 | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 3 | 2.100% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	0
Estimate of Fair Value Measurement | Level 3 | 1.800% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0	$ 0
Estimate of Fair Value Measurement | Level 3 | 4.345% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	0
Estimate of Fair Value Measurement | Level 3 | 4.570% Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Senior notes	$ 0

XML

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Details) $ in Millions	Sep. 30, 2022 USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	$ 930
Fair Value	930
Unfunded Commitments	25
Non-marketable securities | Venture capital and private equity fund investments | Fair value accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	270
Fair Value	270
Unfunded Commitments	13
Non-marketable securities | Venture capital and private equity fund investments | Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	639
Fair Value	639
Unfunded Commitments	11
Non-marketable securities | Debt funds | Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	4
Fair Value	4
Unfunded Commitments	0
Non-marketable securities | Other investments | Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Carrying Amount	17
Fair Value	17
Unfunded Commitments	$ 1

XML

Fair Value of Financial Instruments - Summary of Estimated Fair Values of Investments and Remaining Unfunded Commitments for Each Major Category of Investments (Textual) (Details) $ in Millions	3 Months Ended
	Sep. 30, 2022 USD ($)
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	$ 930
Unfunded commitments	25
Non-marketable securities | Venture capital and private equity fund investments | Fair value accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	270
Unfunded commitments	$ 13
Non-marketable securities | Venture capital and private equity fund investments | Fair value accounting | Lower Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	10 years
Non-marketable securities | Venture capital and private equity fund investments | Fair value accounting | Upper Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	13 years
Non-marketable securities | Venture capital and private equity fund investments | Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	$ 639
Unfunded commitments	11
Non-marketable securities | Venture capital and private equity fund investments | Noncontrolling Interests | Fair value accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	42
Unfunded commitments	2
Non-marketable securities | Other investments | Equity method accounting
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Fair value	17
Unfunded commitments	$ 1
Non-marketable securities | Other investments | Equity method accounting | Lower Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	5 years
Non-marketable securities | Other investments | Equity method accounting | Upper Limit
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Period distributions from fund investments to be received	8 years